Sentence,class,file
FEBS J 2014; 281:862-76; PMID:24286250;http://dx.doi.org/10.1111/febs.12654 46.,OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Prion 2012; 6:453-60; PMID:23052041; http://dx.doi.org/10.4161/pri.22511 47.,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Brain Res 2003; 970:131-9; PMID:12706254; http://dx.doi.org/10.1016/ S0006-8993(03)02300-XROLE OF SHADOO PROTEIN IN MCAO ISCHEMIA 393,Non-OADS,/arxiv_data1/oa_pdf/94/5c/kprn-09-05-1105432.PMC4964864.pdf
Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/ 10.1073/pnas.95.23.13363.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Virol 2005; 79:10796-806; PMID:16051871; http://dx.doi.org/10.1128/JVI.79.16.10796-10806.2005.INFECTIVITY AND INCUBATION PERIODS OF MOUSE BSE PRIONS 401,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Proc Natl Acad Sci U S A 1993; 90:10962-6; PMID:7902575;http://dx.doi.org/10.1 073/pnas.90.23.10962.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Gen Virol 1996; 77 ( Pt 8):1925-34; PMID:8760444; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Neurology 1991; 41:1482-90; PMID:1679911; http://dx.doi.org/10.1212/WNL.41.9.1482.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Gen Virol 1991; 72 ( Pt 12):2905- 13; PMID:1684986; http://dx.doi.org/10.1099/0022- 1317-72-12-2905.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Biol Chem 2007; 282:35878-86; PMID:1 7923484; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Science 1997; 275:402-5; PMID:8994041; http://dx.doi.org/10.1126/science.275.5298.402.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Cell Biochem 2011; 112:3630-7; PMID:21793041; http://dx.doi.org/10.1002/jcb.23286.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
PloS One 2010; 5:e15679;PMID:21187933; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
PLoS Pathog 2012; 8:e1002547; PMID:22396643; http://dx.doi.org/10.1371/journal.ppat.1002547.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Virol 2007; 81:10532-9; PMID:17652380;http://dx.doi.org/10.1128/JVI.00640-07.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Virol 2004; 78:2088-99; PMID:14747574; http://dx.doi.org/10.1128/JVI.78.4.2088-2099.2004.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Biochemistry 2002; 41:12868-75; PMID:12379130; http://dx.doi.org/ 10.1021/bi025958g.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Gen Virol 2013; 94:453-63; PMID:23136363; http://dx.doi.org/ 10.1099/vir.0.045922-0.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Pathogens 2013; 2:92- 104; PMID:25436883; http://dx.doi.org/10.3390/pathogens2010092.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
PLoS Pathog 2010; 6: e1000859; PMID:20419156; http://dx.doi.org/10.1371/journal.ppat.1000859.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/ nature03989.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Nature 2011; 470:540-2; PMID:21350487; http://dx.doi.org/10.1038/nature09768.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Prion 2012; 6:430-2; PMID:23044510;http://dx.doi.org/10.4161/pri.22309.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Vet Diagn Invest 2005; 17:509-27; PMI D:16475509; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
PLoSPathog 2007; 3:e125; PMID:17784787; http://dx.doi.org/10.1371/journal.ppat.0030125.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Annu Rev Neu- rosci 2003; 26:267-98; PMI D:12704221; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
"Czub M, Braig HR, Diringer H. Pathogenesis of scra- pie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associatedﬁbrils in brains of hamsters infected intraperitoneally.J Gen Virol 1986; 67 ( Pt 9):2005-9; PMID:2875123; http://dx.doi.org/10.1099/0022-1317-67-9-2005.",OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Virology 1996; 216:46-59; PMID:8615006; http://dx.doi.org/ 10.1006/viro.1996.0033.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Nat Commun 2014; 5:4347; PMID:25005024; http://dx.doi.org/10.1038/ncomms5347.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Gen Virol 1983; 64 (Pt 4):971-3; PMID:6403663; http://dx.doi.org/10.1099/0022-1317-64-4-971.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Gen Virol 1983; 64 (Pt9):2045-50; PMID:6411862; http://dx.doi.org/ 10.1099/0022-1317-64-9-2045.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
J Virol 2011; 85:13439-42; PMID:21957291; http://dx.doi.org/10.1128/JVI.06134-11.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Nature2003; 425:717-20; PMID:14562104; http://dx.doi.org/10.1038/nature01979.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Proc Natl Acad Sci U S A 2012; 109:8546-51; PMID:2 2586108; http://dx.doi.org/ 10.1073/pnas.1204498109.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Adv Exp Med Biol 1981; 134:385-99; PMID:7194570; http://dx.doi.org/10.1007/978-1-4757-0495-2_35.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Clin Chem 2003; 49:1774-75; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Microbiol Immunol 2010; 54:112-21; PMID:20377745; http://dx.doi.org/10.1111/j.1348- 0421.2009.00190.x.,Non-OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
Nihon Juigaku Zasshi 1984; 46:913-6; PMID:6441054; http://dx.doi.org/10.1292/jvms1939.,OADS,/arxiv_data1/oa_pdf/57/4a/kprn-09-05-1111507.PMC4964868.pdf
"[a]Dr. D. Millo Department of Physics and Astronomy, VU University Amsterdam De Boelelaan 1081, 1081 HV, Amsterdam (The Netherlands) E-mail: d.millo@vu.nl Supporting Information for this article is available on the WWW underhttp://dx.doi.org/10.1002/celc.201402425.",Non-OADS,/arxiv_data1/oa_pdf/63/97/celc0002-0288.PMC4964880.pdf
"[a]J. T. Babauta, H. Beyenal The Gene and Linda Voiland School of Chemical Engineering andBioengineering, PO Box 646515, Washington State University Pullman, WA 99164-6515 (USA) E-mail: beyenal@wsu.edu [b]C. A. Beasley Gamry Instruments, Inc.734 Louis Dr, Warminster, PA 18974 (USA) Supporting Information for this article is available on the WWW underhttp://dx.doi.org/10.1002/celc.201402127.",Non-OADS,/arxiv_data1/oa_pdf/1c/0b/celc0001-2007.PMC4964883.pdf
Cell Reports 2015; 12(1): 1548-1554; http://dx.doi./org/10.1016/j.celrep.2015.08.007 © 2016 Tomoyuki Honda and Keizo Tomonaga.,OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"3, e1165785 (6 pages)http://dx.doi.org/10.1080/2159256X.2016.1165785",Non-OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Nature 2010; 463:84-7; PMID:20054395;http://dx.doi.org/10.1038/nature08695 [2] Belyi VA, Levine AJ, Skalka AM.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
PLoS Pathog 2010; 6:e1001030; PMID:20686665; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"PLoS Genet 2010; 6:e1001191; PMID:21124940; http://dx.doi.org/10.1371/journal.pgen.1001191 [4] Fujino K, Horie M, Honda T, Merriman DK, Tomonaga K. Inhibition of Borna disease virus replication by an endoge-nous bornavirus-like element in the ground squirrel genome.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Trends Ecol Evol 2012; 27:627-36; PMID:22901901; http://dx.doi.org/10.1016/j.tree.2012.07.007 [8] Hilditch L, Matadeen R, Goldstone DC, Rosenthal PB, Taylor IA, Stoye JP.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Cell Rep 2015; 12:1548-54; PMID:26321645;http://dx.doi.org/10.1016/j.celrep.2015.08.007 [11] Harrison PM, Zheng D, Zhang Z, Carriero N, Gerstein M. Transcribed processed pseudogenes in the humangenome: an intermediate form of expressed retrose- quence lacking protein-coding ability.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Nucleic Acids Res2005; 33:2374-83; PMID:15860774; http://dx.doi.org/ 10.1093/nar/gki531 [12] Parrish NF, Fujino K, Shiromoto Y, Iwasaki YW, Ha H, Xing J, Makino A, Kuramochi-Miyagawa S, Nakano T,Siomi H, et al.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"RNA 2015; 21:1691-703; PMID:26283688; http://dx.doi.org/10.1261/rna.052092.115 [13] Ishizu H, Siomi H, Siomi MC.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Genes Dev 2012;26:2361-73; PMID:23124062; http://dx.doi.org/10.1101/gad.203786.112 [14] Karginov FV, Hannon GJ.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
Mol Cell 2010; 37:7-19; PMID:20129051; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Nature2012; 482:331-8; PMID:22337052; http://dx.doi.org/10.1038/nature10886 [16] Lau NC, Seto AG, Kim J, Kuramochi-Miyagawa S, Nakano T, Bartel DP, Kingston RE.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Science 2006; 313:363-7; PMID:16778019; http://dx.doi.org/10.1126/science.1130164 [17] Girard A, Sachidanandam R, Hannon GJ, Carmell MA.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"RNA 2014; 20:1223-37; PMID:24914035; http://dx.doi.org/10.1261/rna.045310.114 [19] An W, Han JS, Wheelan SJ, Davis ES, Coombes CE, Ye P, Triplett C, Boeke JD.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Proc Natl Acad Sci U S A2006; 103:18662-7; PMID:17124176; http://dx.doi.org/ 10.1073/pnas.0605300103 [20] Berry C, Hannenhalli S, Leipzig J, Bushman FD.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"PLoS Comput Biol 2006; 2:e157; PMID:17166054;http://dx.doi.org/10.1371/journal.pcbi.0020157 [21] Kim A, Terzian C, Santamaria P, P /C19elisson A, Purd ’homme N, Bucheton A. Retroviruses in inverte- brates: the gypsy retrotransposon is apparently an infec- tious retrovirus of Drosophila melanogaster.",Non-OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
Genome Res 2013; 23:292-9; PMID:23132912; http://dx.doi.org/10.1101/ gr.137224.112MOBILE GENETIC ELEMENTS e1165785-5,Non-OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
Cold Spring Harb Symp Quant Biol 1956; 21:197-216;PMID:13433592; http://dx.doi.org/10.1101/SQB.1956.021.01.017 [24] Livak KJ.,OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"J Biol Chem 2005; 280:22222-32; PMID:15799966; http:// dx.doi.org/10.1074/jbc.M501928200 [27] Geuking MB, Weber J, Dewannieux M, Gorelik E, Heidmann T, Hengartner H, Zinkernagel RM, Hangart-ner L. Recombination of retrotransposon and exogenousRNA virus results in nonretroviral cDNA integration.Science 2009; 323:393-6; PMID:19150848; http://dx.doi.org/10.1126/science.1167375 [28] Shimizu A, Nakatani Y, Nakamura T, Jinno-Oue A, Ishikawa O, Boeke JD, Takeuchi Y, Hoshino H.Characterisation of cytoplasmic DNA complementary to non-retroviral RNA viruses in human cells.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"BMC Evol Biol 2011; 11:276; PMID:21943216; http://dx.doi.org/10.1186/1471-2148-11-276 [30] Liu H, Fu Y, Jiang D, Li G, Xie J, Cheng J, Peng Y, Ghabrial SA, Yi X.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"J Virol 2010; 84:11876-87; PMID:20810725;http://dx.doi.org/10.1128/JVI.00955-10 [31] Feschotte C, Gilbert C. Endogenous viruses: insights into viral evolution and impact on host biology.",Non-OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
Nat Rev Genet 2012; 13:283-96; PMID:22421730; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
"Nature 1975; 256:471-3; PMID:51475; http://dx.doi.org/10.1038/256471a0 [33] Goic B, Vodovar N, Mondotte JA, Monot C, Frangeul L, Blanc H, Gausson V, Vera-Otarola J, Cristofari G, SalehM-C. RNA-mediated interference and reverse transcrip-tion control the persistence of RNA viruses in the insect model Drosophila.",OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
Nat Immunol 2013; 14:396-403; PMID:23435119; http://dx.doi.org/10.1038/ni.2542e1165785-6 T. HONDA AND K. TOMONAGA,OADS,/arxiv_data1/oa_pdf/13/d1/kmge-06-03-1165785.PMC4964890.pdf
birds visiting private garden feeding stations in the United Kingdom since the winter of 1970/71 (http://www.bto.org/volunteer-surveys/gbfs ).,Non-OADS,/arxiv_data1/oa_pdf/dd/0d/BIMJ-58-357.PMC4964939.pdf
"The ground frost covariate is an average number of days of ground frost obtained from the Met Ofﬁce’s UKCP09 gridded datasets ( http://ukclimateprojections.metoffice.gov.uk/ ) .T h e s ed a t aa r eam e a s u r e of the number of days of ground frost for each 5 km square across the United Kingdom, interpolated from Met Ofﬁce observation stations.",OADS,/arxiv_data1/oa_pdf/dd/0d/BIMJ-58-357.PMC4964939.pdf
Temperature 2016; 3:260-8;http://dx.doi.org/10.1080/23328940.2016.1148938 The human thermoregulatory apparatus has both autonomic and behavioral mechanisms at its disposal.,Non-OADS,/arxiv_data1/oa_pdf/a4/c3/ktmp-03-02-1168535.PMC4964988.pdf
"2, 195 –196 http://dx.doi.org/10.1080/23328940.2016.1168535",Non-OADS,/arxiv_data1/oa_pdf/a4/c3/ktmp-03-02-1168535.PMC4964988.pdf
"Temperature 2016; 3:260-8; http://dx.doi.org/10.1080/ 23328940.2016.1148938 [2] Kingma BR, Frijns AJ, Saris WH, van Steenhoven AA, van Marken Lichtenbelt WD.",OADS,/arxiv_data1/oa_pdf/a4/c3/ktmp-03-02-1168535.PMC4964988.pdf
"Acta Physiol (Oxf) 2011; 203:419-27;PMID:21707931; http://dx.doi.org/10.1111/j.1748-1716.2011.02336.x [3] Kenny GP, Sigal RJ, McGinn R. Body temperature regulation in diabetes.",Non-OADS,/arxiv_data1/oa_pdf/a4/c3/ktmp-03-02-1168535.PMC4964988.pdf
"Temperature 2016; 3:119-45; http://dx.doi.org/ 10.1080/23328940.2015.1131506 [4] Parkinson T, de Dear R. Thermal pleasure in built environments: physiology of alliesthesia.",Non-OADS,/arxiv_data1/oa_pdf/a4/c3/ktmp-03-02-1168535.PMC4964988.pdf
"Building Research & Information 2015; 43:288-301; http://dx.doi.org/10.1080/09613218.2015.989662 [5] Pallubinsky H, Schellen L, Rieswijk TA, Breukel CMGAM, Kingma BRM, van Marken Lichtenbelt WD.",Non-OADS,/arxiv_data1/oa_pdf/a4/c3/ktmp-03-02-1168535.PMC4964988.pdf
Energy and Buildings 2016; 113:15-22; http://dx.doi.org/10.1016/j.enbuild.2015.12.016 Boris R.M.,OADS,/arxiv_data1/oa_pdf/a4/c3/ktmp-03-02-1168535.PMC4964988.pdf
"Temperature 2015; 2:129-134; http://dx.doi.org/10.1080/23328940.2015.1014250 I thank the editors of Temperature for the opportunity to provide an editorial comment on the recent article by Solym /C19ar et al.1We have known for some time that, when endothermic animals are fasted, their energy expendi- ture pathways are altered in a way that results in a decrease in core body temperature during the inactive phaseof their daily activity cycle.",Non-OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"2, 197 –198 http://dx.doi.org/10.1080/23328940.2016.1139961",Non-OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"Temperature 2015; 2:129-34; http://dx.doi.org/10.1080/23328940.2015.1014250 [2] Overton JM, Williams TD.",OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"Physiol Behav 2004; 81:749-54; 8174954 PMID:15234180; http://dx.doi.org/10.1016/j.physbeh.2004.04.025 [3] Hetem RS, Maloney SK, Fuller A, Mitchell D. Heterothermy in large mammals: inevitable or implemented?",Non-OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"Biol Rev Camb Philos Soc 2016; 91(1):187-205; PMID:25522232; http://dx.doi.org/10.1111/brv.12166 [4] Maloney SK, Meyer LCR, Blache D, Fuller A.",OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"Phys- iol Rep 2013; 1e00118; PMID:24303185; http://dx.doi.org/10.1002/phy2.118 [5] Tanner JM, Kearns DT, Kim BJ, Sloan C, Jia Z, Yang T, Abel ED, Symons JD.",OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"Exp Biol Med 2010; 235:1489-97; http://dx.doi.org/10.1258/ ebm.2010.010171 [6] Swoap SJ, Weinshenker D. Norepinephrine controls both torpor initiation and emergence via distinct mechanisms in the mouse.",Non-OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"PLoS One 2008; 3:e4038; PMID:19107190; http://dx.doi.org/10.1371/journal.pone.0004038 [7] Ahren B, Mansson S, Gingerich RL, Havel PJ.",OADS,/arxiv_data1/oa_pdf/d3/27/ktmp-03-02-1139961.PMC4964989.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.TEMPERATURE 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"2, 252 –261 http://dx.doi.org/10.1080/23328940.2016.1176102",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"FrontBiosci 2010; 15:259-90; http://dx.doi.org/10.2741/3620 [2] Kondo N, Nishiyasu T, Inoue Y, Koga S. Non-thermal mod- iﬁcation of heat-loss responses during exercise in humans.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Eur J Appl Physiol 2010; 110:447-58; PMID:20512585;http://dx.doi.org/10.1007/s00421-010-1511-x [3] Taylor NAS, Machado-Moreira CA.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Extrem Physiol Med 2013; 2:4; PMID:23849497; http://dx.doi.org/10.1186/2046-7648-2-4 [4] van Beaumont W, Bullard RW.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
Science 1963; 141:643-6; PMID:13995960;http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Circulation Res 1991;69:228-38; PMID:2054936; http://dx.doi.org/10.1161/01.RES.69.1.228 [7] Amano T, Kato Y, Machado-Moreira CA, Taylor NAS, Inoue Y, Nishiyasu T, Kondo N. Changes in eccrine sweating on the glabrous skin of the palm and ﬁnger dur- ing isometric exercise.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Acta Physiologica 2011; 202:649-55; PMID:21457475; http://dx.doi.org/10.1111/j.1748-1716.2011.02299.x [8] Machado-Moreira CA, McLennan PL, Lillioja S, van Dijk W, Caldwell JN, Taylor NAS.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Exp Physiol 2012; 97:930-42; PMID:22496503; http://dx.doi.org/10.1113/expphysiol.2012.065037 [9] Machado-Moreira CA, Taylor NAS.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"ActaPhysiologica 2012; 204:571-81; PMID:21920031; http://dx.doi.org/10.1111/j.1748-1716.2011.02362.x [10] Machado-Moreira CA, Taylor NAS.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Psychophysiology 2012;49:369-74; PMID:22091709; http://dx.doi.org/10.1111/ j.1469-8986.2011.01309.x [11] Kondo N, Tominaga H, Shibasaki M, Aoki K, Okada S, Nishiyasu T. Effects of exercise intensity on the sweatingresponse to a sustained static exercise.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Acta Physiologica 2014; 212:86-96; PMID:24934867; http://dx.doi.org/10.1111/apha.12327 [15] Kondo N, Tominaga H, Shibasaki M, Aoki K, Koga S, Nishiyasu T. Modulation of the thermoregulatory sweat-ing response to mild hyperthermia during activation ofthe muscle metabore ﬂex in humans.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"J Physiol 1999; 515:591-598; PMID:10050024; http://dx.doi.org/10.1111/j.1469-7793.1999.591ac.x [16] Taylor NAS, Tipton MJ, Kenny GP.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"J Thermal Biol 2014; 46:72-101; PMID:25455943;http://dx.doi.org/10.1016/j.jtherbio.2014.10.006 [17] Shibasaki M, Secher NH, Selmer C, Kondo N, Crandall CG.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
J Physiol 2003; 553:999-1004; PMID:14555727; http://dx.doi.org/10.1113/jphysiol.,Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"J Appl Physiol 2006; 100:2065-72;PMID:16410380; http://dx.doi.org/10.1152/japplphysiol.01118.2005 [19] Eiken O, Mekjavic IB.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
Acta Physiologica Scandinavica 2004; 181:305-11; PMID:15196091; http://dx.doi.org/10.1111/j.1365-201X.2004.01289.x [20] Seals DR.,Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"J Physiol 1993; 462:147-59;PMID:8331581; http://dx.doi.org/10.1113/jphysiol.1993.sp019548 [21] Ray CA, Wilson TE.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"J ApplPhysiol 2004; 97:160-164; PMID:15033962; http://dx.doi.org/10.1152/japplphysiol.00699.2003 [22] Seals DR, Washburn RA, Hanson PG, Painter PL, Nagle FJ.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Acta Physiologica Scandinavica 1972;84:177-86; PMID:5015185; http://dx.doi.org/10.1111/j.1748-1716.1972.tb05168.x [25] Cotter JD, Patterson MJ, Taylor NAS.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Eur J Appl Physiol 2014; 114:1679-89; PMID:24819447; http://dx.doi.org/10.1007/s00421-014-2894-x [27] Caldwell JN, Matsuda-Nakamura M, Taylor NAS.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Eur J Appl Physiol 2016;116:343-52; PMID:26526291; http://dx.doi.org/10.1007/s00421-015-3288-4 [28] Taylor NAS, Patterson MJ, Cotter JD, Macfarlane DJ.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Eur J Appl Physiol 1997; 76:380-386; http://dx.doi.org/10.1007/s004210050265 [29] Mekjavic IB, Rempel ME.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Journal of Applied Physiology 1990; 69:376-9;PMID:2394660 [30] Lee J-Y, Wakabayashi H, Wijayanto T, Tochihara Y. Dif- ferences in rectal temperatures measured at depths of 4-19 cm from the anal sphincter during exercise and rest.Eur J Appl Physiol 2010; 109:73-80; PMID:19787368;http://dx.doi.org/10.1007/s00421-009-1217-0 [31] Keatinge WR, Sloan RE.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Eur J ApplPhysiol 1995; 71:549-54; http://dx.doi.org/10.1007/BF00238559[33] Hardy JD, DuBois EF.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Eur J Appl Physiol 1992;65:286-94; http://dx.doi.org/10.1007/BF00705095 [35] Vissing SF, Hjorts øEM.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
J Physiol 1996; 492:931-9; PMID:8735003;http://dx.doi.org/10.1113/jphysiol.1996.sp021359 [36] Borg GAV.,OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Lancet 1938; 1:299-303; http://dx.doi.org/ 10.1016/S0140-6736(00)62410-8 [38] Hertel H-C, Howaldt B, Mense S. Responses of group IV and group III muscle afferents to thermal stimuli.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"BrainRes 1976; 113:201-5; PMID:133748; http://dx.doi.org/10.1016/0006-8993(76)90020-2 [39] Kumazawa T, Mizumura K. Thin- ﬁbre receptors responding to mechanical, chemical, and thermal stimu-lation in the skeletal muscle of the dog.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"J Physiol 1977; 273:179-94; PMID:599419; http://dx.doi.org/10.1113/ jphysiol.1977.sp012088 [40] Christensen NJ, Galbo H. Sympathetic nervous activity during exercise.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Annu Rev Physiol 1983; 45:139-53;PMID:6342511; http://dx.doi.org/10.1146/annurev.ph.45.030183.001035 [41] Maciel BC, Gallo J /C19unior L, Marin Neto JA, Martins LE.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"P ﬂugers Archives 1987; 408:173-7; http://dx.doi.org/10.1007/BF00581348 [42] Schotzinger RJ, Landis SC.",Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"Nature 1988;335:637-9; PMID:3262829; http://dx.doi.org/10.1038/335637a0 [43] Machado-Moreira CA, Barry RJ, Vosselman MJ, Ruest RM, Taylor NAS.",OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
Temporal and thermal variations in site-speci ﬁc thermoregulatory sudomotor thresholds: precursor versus discharged sweat production.Psychophysiology 2015; 52:117-23; PMID:25048252;http://dx.doi.org/10.1111/psyp.12292TEMPERATURE 261,Non-OADS,/arxiv_data1/oa_pdf/4b/02/ktmp-03-02-1176102.PMC4964990.pdf
"2, 191 –194 http://dx.doi.org/10.1080/23328940.2016.1185206",Non-OADS,/arxiv_data1/oa_pdf/05/04/ktmp-03-02-1185206.PMC4964991.pdf
"Temperature 2015; 4:439-40; http://dx.doi.org/10.1080/23328940.2015.1106637 [2] Bain AR, Lesperance NC, Jay O.",OADS,/arxiv_data1/oa_pdf/05/04/ktmp-03-02-1185206.PMC4964991.pdf
J Appl Physiol 2014; 116:1088-95; PMID:24577060; http://dx.doi.org/10.1152/japplphysiol.01059.2013 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/05/04/ktmp-03-02-1185206.PMC4964991.pdf
"Med Sci Sports Exerc 2016; 48:114-22; PMID:26258857; http://dx.doi.org/10.1249/MSS.0000000000000746 [5] Schulze E, Daanen HAM, Levels K, Casadio JR, Plews DJ, Kilding AE, Siegel R, Laursen PB.",Non-OADS,/arxiv_data1/oa_pdf/05/04/ktmp-03-02-1185206.PMC4964991.pdf
"Int J Sports Physiol Perform, 2015; 10:655-63; PMID:25620399; http://dx.doi.org/10.1123/ijspp.2014-0281 [6] Tan PMS, Lee JKW.",OADS,/arxiv_data1/oa_pdf/05/04/ktmp-03-02-1185206.PMC4964991.pdf
"Scand J Med Sci Sports 2015; 25 Suppl 1:39-51; PMID:25943655; http://dx.doi.org/10.1111/sms.12366 Nathan B. Morris Thermal Ergonomics Laboratory, Faculty of Health Sciences University of Sydney, NSW, Australia Ollie Jay Thermal Ergonomics Laboratory, Faculty of Health Sciences, University of Sydney, NSW, Australia Charles Perkins Centre, University of Sydney, NSW, Australia ollie.jay@sydney.edu.au194 N. B. MORRIS AND O. JAY",Non-OADS,/arxiv_data1/oa_pdf/05/04/ktmp-03-02-1185206.PMC4964991.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.TEMPERATURE 2016, VOL.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"2, 220 –231 http://dx.doi.org/10.1080/23328940.2016.1174794",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Nat Neurosci 2000;3:184-90; PMID:10649575; http://dx.doi.org/10.1038/72131 [2] Davis KD, Pope GE, Crawley AP, Mikulis DJ.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Neurophysiol 2004; 92:1248-51; PMID:15277602; http://dx.doi.org/10.1152/jn.00084.2004 [3] Farrell MJ, Johnson J, McAllen RM, Zamarripa F, Denton DA, Fox PT, Egan GE.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Thermal Biol 2011; 36:57-63; http://dx.doi.org/10.1016/j.jtherbio.2010.11.003 [4] Kanosue K, Sadato N, Okada T, Yoda T, Nakai S, Yoshida K, Hosono T, Nagashima K, Yagishita T, Inoue O, et al.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Neurosci Lett 2002; 329:157-60;PMID:12165401; http://dx.doi.org/10.1016/S0304-3940(02)00621-3 [5] Davis KD, Moayedi M. Central mechanisms of pain revealed through functional and structural MRI.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Neuro- immune Pharmacol 2013; 8:518-34; PMID:22825710; http://dx.doi.org/10.1007/s11481-012-9386-8 [6] Farrell MJ, Laird AR, Egan GF.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Human brain mapping 2005;25:129-39; PMID:15846813; http://dx.doi.org/10.1002/hbm.20125 [7] Fredrikson M, Furmark T, Olsson MT, Fischer H, Andersson J, Langstrom B. Fu nctional neuroanatomi- cal correlates of electrodermal activity: a positronemission tomographic study .",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Psychophysiology 1998; 35:179-85; PMID:9529944; http://dx.doi.org/10.1111/1469-8986.3520179 [8] Nagai Y, Critchley HD, Featherstone E, Trimble MR, Dolan RJ.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"NeuroImage 2004; 22:243-51; PMID:15110014; http://dx.doi.org/10.1016/j.neuroimage.2004.01.019 [9] Patterson JC, 2nd, Ungerleider LG, Bandettini PA. Task- independent functional brain activity correlation withskin conductance changes: an fMRI study.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
NeuroImage2002; 17:1797-806; PMID:12498753; http://dx.doi.org/10.1006/nimg.2002.1306228 M. J. FARRELL,Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Neuroreport 2000; 11:3011-5; PMID:11006985; http://dx.doi.org/10.1097/00001756-200009110-00037 [11] SatputeAB,WagerTD,Cohen-AdadJ,BianciardiM,ChoiJK, Buhle JT, Wald LL, Barrett LF.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"NeuroImage 1999;9:526-33; PMID:10329292; http://dx.doi.org/10.1006/ nimg.1999.0435 [13] Fox PT, Raichle ME.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
Neurology 1988; 38:89-95; PMID:3257295; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Magn Reson Med 2003; 49:796-802; PMID:12704760; http://dx.doi.org/10.1002/mrm.10437 [18] Murphy K, Harris AD, Diukova A, Evans CJ, Lythgoe DJ, Zelaya F, Wise RG.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"MagnReson Imaging 2011; 29:1382-9; PMID:21546190; http://dx.doi.org/10.1016/j.mri.2011.02.030 [19] Fechir M, Klega A, Buchholz HG, Pfeifer N, Balon S, Schlereth T, Geber C, Breimhorst M, Maihofner C,Birklein F, et al.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Eur J Neurosci 2010; 31:2101- 11; PMID:20529117; http://dx.doi.org/10.1111/j.1460-9568.2010.07243.x [20] Nunneley SA, Martin CC, Slauson JW, Hearon CM, Nickerson LD, Mason PA. Changes in regional cerebral metabolism during systemic hyperthermia in humans.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Physiol Behav 2014; 128:99-107; PMID:24530482; http://dx.doi.org/10.1016/j.physbeh.2014.01.028 [22] Kalivas PW, Nemeroff CB, Miller JS, Prange AJ, Jr. Microinjection of neurotensin into the ventral teg-mental area produces hypothermia: evaluation ofdopaminergic mediation.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Brain Res 1985; 326:219-27;PMID:2982460; http://dx.doi.org/10.1016/0006-8993(85)90031-9 [23] Smith JE, Jansen AS, Gilbey MP, Loewy AD.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Brain Res 1998; 786:153-64; PMID:9554992; http://dx.doi.org/10.1016/S0006-8993(97)01437-6 [24] Zhang YH, Hosono T, Yanase-Fujiwara M, Chen XM, Kanosue K. Effect of midbrain stimulations on thermo-regulatory vasomotor responses in rats.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Physiol 1997;503 (Pt 1):177-86; PMID:9288685; http://dx.doi.org/10.1111/j.1469-7793.1997.177bi.x [25] McAllen RM, Tanaka M, Ootsuka Y, McKinley MJ.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Eur J Appl Physiol 2010; 109:27-33;PMID:19949811; http://dx.doi.org/10.1007/s00421-009-1295-z [26] Davison MA, Koss MC.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Neuroscience 1986;18:51-9; PMID:2874523; http://dx.doi.org/10.1016/0306-4522(86)90178-8 [28] Shafton AD, McAllen RM.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Am J Physiol Regul IntegrComp Physiol 2013; 304:R804-9; PMID:23467325; http://dx.doi.org/10.1152/ajpregu.00040.2013 [29] Bratincsak A, Palkovits M. Activation of brain areas in rat following warm and cold ambient exposure.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Neurosci-ence 2004; 127:385-97; PMID:15262329; http://dx.doi.org/10.1016/j.neuroscience.2004.05.016 [30] Kiyohara T, Miyata S, Nakamura T, Shido O, Nakashima T, Shibata M. Differences in Fos expression in the ratbrains between cold and warm ambient exposures.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
BrainRes Bull 1995; 38:193-201; PMID:7583347; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Brain ResBull 2000; 53:307-15; PMID:11113585; http://dx.doi.org/10.1016/S0361-9230(00)00346-4 [32] Yoshida K, Konishi M, Nagashima K, Saper CB, Kanosue K. Fos activation in hypothalamic neuronsduring cold or warm exposure: projections to peria- queductal gray matter.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
46; PMID:15927405; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Physiol 2000; 523 Pt 1:259-70; PMID:10673560;http://dx.doi.org/10.1111/j.1469-7793.2000.t01-1-00259.x [34] Owen DG, Bureau Y, Thomas AW, Prato FS, St Law- rence KS.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Am J Physiol Regul Integr Comp Physiol 2005; 289:R319-R25; PMID:15805097; http://dx.doi.org/10.1152/ajpregu.00123.2005 [36] Moulton EA, Keaser ML, Gullapalli RP, Greenspan JD.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Neurophysiol 2005; 93:2183-93;PMID:15601733; http://dx.doi.org/10.1152/jn.01025.2004 [37] Moulton EA, Pendse G, Becerra LR, Borsook D. BOLD responses in somatosensory cortices betterreﬂect heat sensation than pain.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Neurosci 2012; 32:6024-31; PMID:22539862; http://dx.doi.org/10.1523/JNEUROSCI.0006-12.2012 [38] Davis KD, Kwan CL, Crawley AP, Mikulis DJ.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
Quarterly Rev Biol 1979; 54:1-29; PMID:379894; http://dx.doi.org/10.1086/410981 [40] Mower GD.,Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
JComparative Physiol Psychol 1976; 90:1152-5;PMID:993393; http://dx.doi.org/10.1037/h0077284 [41] Attia M. Thermal pleasantness and temperature regula- tion in man.,Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
Neurosci Biobehavioral Rev 1984; 8:335-42; PMID:6504416; http://dx.doi.org/10.1016/0149-7634(84)90056-3 [42] Cabanac M. Physiological role of pleasure.,OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Science 1971; 173:1103-7; PMID:5098954; http://dx.doi.org/10.1126/science.173.4002.1103 [43] Sung EJ, Yoo SS, Yoon HW, Oh SS, Han Y, Park HW.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Int J Neurosci2007; 117:1011-27; PMID:17613111; http://dx.doi.org/10.1080/00207450600934432 [44] Kulkarni B, Bentley DE, Elliott R, Youell P, Watson A, Derbyshire SW, Frackowiak RS, Friston KJ, Jones AK.Attention to pain localization and unpleasantness discrimi-nates the functions of the medial and lateral pain systems.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
NeuroImage 2008; 41:1504-13; PMID:18468458;http://dx.doi.org/10.1016/j.neuroimage.2008.03.005 [46] Nakamura K. Central circuitries for body temperature regulation and fever.,Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Am J Physiol Regul Integr CompPhysiol 2011; 301:R1207-28; PMID:21900642; http://dx.doi.org/10.1152/ajpregu.00109.2011 [47] Brooks JC, Faull OK, Pattinson KT, Jenkinson M. Physio- logical noise in brainstem FMRI.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Front Hum Neurosci2013; 7:623; PMID:24109446; http://dx.doi.org/10.3389/fnhum.2013.00623 [48] Pattinson KT, Mitsis GD, Harvey AK, Jbabdi S, Dirckx S, Mayhew SD, Rogers R, Tracey I, Wise RG.Determination of the human brainstem respiratorycontrol network and its cortical connections in vivo using functional and structural imaging.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"NeuroImage 2009; 44:295-305; PMID:18926913; http://dx.doi.org/10.1016/j.neuroimage.2008.09.007 [49] McAllen RM, Farrell M, Johnson JM, Trevaks D, Cole L, McKinley MJ, Jackson G, Denton DA, Egan GF.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Proc Natl Acad Sci U S A 2006;103:809-13; PMID:16407125; http://dx.doi.org/10.1073/ pnas.0509862103 [50] Farrell MJ, Trevaks D, Taylor NA, McAllen RM.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Am J Physiol Regul Integr Comp Physiol2013; 304:R810-7; PMID:23535458; http://dx.doi.org/10.1152/ajpregu.00041.2013 [51] Farrell MJ, Trevaks D, Taylor NA, McAllen RM.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Neurophysiol 2015; 114:2578-87; PMID:26289468; http://dx.doi.org/10.1152/jn.00601.2015 [52] Critchley HD, Eccles J, Gar ﬁnkel SN.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Handbook Clin Neurol 2013; 117:59-77;PMID:24095116; http://dx.doi.org/10.1016/B978-0-444-53491-0.00006-7 [53] Farrell MJ, Trevaks D, McAllen RM.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Preoptic activation and connectivity during thermal sweating in humans.Temperature 2014; 1:135-41; http://dx.doi.org/10.4161/temp.29667 [54] Nedergaard J, Bengtsson T, Cannon B.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"N Engl J Med 2009; 360:1500-8; PMID:19357405;http://dx.doi.org/10.1056/NEJMoa0808718 [56] Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerback S,et al.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
N Engl J Med 2009; 360:1518-25; PMID:19357407; http://dx.doi.org/10.1056/NEJMoa0808949230 M. J. FARRELL,Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"NeuroImage 2011;54:142-7; PMID:20682349; http://dx.doi.org/10.1016/j.neuroimage.2010.07.058 [58] Miao Q, Zhao XL, Zhang QY, Zhang ZY, Guan YH, Ye HY, Zhang S, Zeng MF, Zuo CT, Li YM.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"AJNR Am J Neuroradiol 2012;33:1464-9; PMID:22576895; http://dx.doi.org/10.3174/ajnr.A3006 [59] Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, Powell L, Sternfeld B, Matthews K. Longitudinal analysisof the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women ’s health across the nation.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Am J Public Health 2006; 96:1226-35; PMID:16735636; http://dx.doi.org/10.2105/AJPH.2005.066936[60] Diwadkar VA, Murphy ER, Freedman RR.",Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Cereb Cortex 2014;24:3006-13; PMID:23787950; http://dx.doi.org/10.1093/cercor/bht155 [61] Freedman RR, Benton MD, Genik RJ, 2nd, Graydon FX.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"Fertil Steril 2006; 85:674-8; PMID:16500337; http://dx.doi.org/ 10.1016/j.fertnstert.2005.08.026 [62] Hajos M, Engberg G, Nissbrandt H, Magnusson T, Carls- son A. Capsaicin-sensitive vasodilatatory mechanisms inthe rat substantia nigra and striatum.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"J Neural Transm1988; 74:129-39; PMID:3210010; http://dx.doi.org/10.1007/BF01244779 [63] Hashimoto M, Arita J, Shibata M. Electrical stimulation of the lower midbrain around retrorubral ﬁeld decreases tem- peratures of brown fat and rectum in anesthetized Wistarrats.",OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
Neurosci Lett 1998; 246:129-32; PMID:9792609;http://dx.doi.org/10.1016/S0304-3940(98)00206-7TEMPERATURE 231,Non-OADS,/arxiv_data1/oa_pdf/09/b5/ktmp-03-02-1174794.PMC4964992.pdf
"2, 187 –190 http://dx.doi.org/10.1080/23328940.2016.1165786",Non-OADS,/arxiv_data1/oa_pdf/56/bd/ktmp-03-02-1165786.PMC4964993.pdf
"Sports Med 2011; 42:89-98; http://dx.doi.org/10.2165/11596870-000000000-00000 [2] Quod MJ, Martin DT, Laursen PB, Gardner AS, Halson SL, Marino FE, Tate MP, Mainwaring DE, Gore CJ, Hahn AG.",Non-OADS,/arxiv_data1/oa_pdf/56/bd/ktmp-03-02-1165786.PMC4964993.pdf
"J Sports Sci 2008; 26:1477-87; PMID:18949661;http://dx.doi.org/10.1080/02640410802298268 [3] Siegel R, Mate J, Brearley MB, Watson G, Nosaka K, Laursen PB.",OADS,/arxiv_data1/oa_pdf/56/bd/ktmp-03-02-1165786.PMC4964993.pdf
"Med Sci Sports Exercise 2010; 42:717-25; http://dx.doi.org/10.1249/MSS.0b013e3181bf257a [4] Yeo ZW, Fan PW, Nio AQ, Byrne C, Lee JK.",OADS,/arxiv_data1/oa_pdf/56/bd/ktmp-03-02-1165786.PMC4964993.pdf
"Int J Sports Med 2012; 33:859-66; PMID:22730052; http://dx.doi.org/10.1055/s-0032-1304643 [5] Stevens CJ, Dascombe B, Boyko A, Sculley D, Callister R. Ice slurry ingestion during cycling improves Olympic distance triath- lon performance in the heat.",Non-OADS,/arxiv_data1/oa_pdf/56/bd/ktmp-03-02-1165786.PMC4964993.pdf
"J Sports Sci 2013; 31:1271-9; PMID:23506436; http://dx.doi.org/10.1080/02640414.2013.779740 Paul B. Laursen High Performance Sport New Zealand Millennium Institute of Sport & Health 17 Antares Place, Mairangi Bay 0632, New Zealand paul.laursen@hpsnz.org.nz190 P. B. LAURSEN",Non-OADS,/arxiv_data1/oa_pdf/56/bd/ktmp-03-02-1165786.PMC4964993.pdf
"2, 240 –251 http://dx.doi.org/10.1080/23328940.2016.1179380",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Anticipatory regulation and avoidance of catastrophe during exercise-induced hyperthermia.Comp Biochem Physiol B Biochem Mol Biol 2004;139:561-9; PMID:15581788; http://dx.doi.org/10.1016/j.cbpc.2004.09.010 [2] Gonz /C19alez-Alonso J.,Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Exp Physiol 2012; 97:340-6; http://dx.doi.org/10.1113/expphysiol.2011.058701 [3] Parkin JM, Carey MF, Zhao S, Febbraio MA.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Appl Phys-iol 1999; 86:902-8; PMID:10066703; http://dx.doi.org/10.1063/1.370821 [4] Nybo L, Nielsen B.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Can J Physiol Pharma-col 1987; 65:1274-80; PMID:3621076; http://dx.doi.org/10.1139/y87-203 [6] Nybo L, Nielsen B. Hyperthermia and central fatigue during prolonged exercise in humans.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Exp Physiol 2003;88:783-90; PMID:14603378; http://dx.doi.org/10.1113/eph8802611 [8] Morrison S, Sleivert GG, Cheung SS.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Acta Physiol (Oxf) 2010; 199:63-70; PMID:20102344; http://dx.doi.org/10.1111/j.1748-1716.2010.02084.x [11] Nybo L, Moller K, Volianitis S, Nielsen B, Secher NH.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J ApplPhysiol 2002; 93:58-64; PMID:12070186; http://dx.doi.org/10.1152/japplphysiol.00049.2002 [12] Trangmar SJ, Chiesa ST, Stock CG, Kalsi KK, Secher NH, Gonz /C19alez-Alonso J. Dehydration affects cerebral blood ﬂow but not its metabolic rate for oxygen during maxi- mal exercise in trained humans.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Physiol 2014;592:3143-60; PMID:24835170; http://dx.doi.org/10.1113/jphysiol.2014.272104 [13] Brock-Utne J, Gaf ﬁn S, Wells M, Gathiram P, Sohar E, James M, Morrell D, Norman R. Endotoxaemia in exhausted runners after a long-distance race.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Scand J Gast 1992; 27:270-4;http://dx.doi.org/10.3109/00365529209000073 [15] Costa KA, Soares ADN, Wanner SP, Santos RdGCd, Fer- nandes SOA, Martins FdS, Nicoli JR, Coimbra CC, Cardoso VN.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Nutr 2014; 144:218-23; PMID:24259555; http://dx.doi.org/10.3945/jn.113.183186 [16] Starkie RL, Hargreaves M, Rolland J, Febbraio MA.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Brain Behav Immun 2005; 19:404-12; PMID:16061150; http://dx.doi.org/10.1016/j.bbi.2005.03.005TEMPERATURE 247,Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Ann NY Acad Sci 1997; 813:534-44; PMID:9100931; http://dx.doi.org/10.1111/j.1749-6632.1997.tb51743.x [19] Rowell LB.,OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Int J Sports Med 2008; 29:194-8; PMID:17614027; http://dx.doi.org/10.1055/s-2007-965163 [22] Lambert GP, Boylan M, Laventure JP, Bull A, Lanspa S. Effect of aspirin and ibuprofen on GI permeabilityduring exercise.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Int J Sports Med 2007; 28:722-6; PMID:17436199; http://dx.doi.org/10.1055/s-2007-964891 [23] Pedersen BK.,OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Immunol Cell Biol 2000; 78:532-5; PMID:11050536; http://dx.doi.org/ 10.1111/j.1440-1711.2000.t01-11-.x [24] Lambert P. In: Marino F, ed.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Curr Sports Med Rep 2012; 11:115-23; PMID:22580488; http://dx.doi.org/10.1249/ JSR.0b013e31825615cc [26] Vargas NT, Marino F. A neuroin ﬂammatory model for acute fatigue during exercise.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Sports Med 2014; 44:1479-87; PMID:25164464; http://dx.doi.org/10.1007/s40279-014-0232-4 [27] Robson-Ansley PJ, Milander Ld, Collins M, Noakes TD.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Can J Appl Physiol 2004; 29:411-8; PMID:15317982; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Cytokine2009; 45:111-6; PMID:19097916; http://dx.doi.org/10.1016/j.cyto.2008.11.006 [29] Lambert GP.,OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Br J Sports Med 2014; 48:980-6; PMID:23134759;http://dx.doi.org/10.1136 /bjsports-2012-091585 [31] Rowell LB, Brengelmann GL, Blackmon JR, Twiss RD, Kusumi F. Splanchnic blood ﬂow and metabolism inheat-stressed man.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Appl Physiol 2002;92:1750-61; PMID:11896046; http://dx.doi.org/10.1152/japplphysiol.00787.2001 [34] Somasundaram S, Hayllar H, Ra ﬁS, Wrigglesworth JM, Macpherson AJS, Bjarnason I.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Scand J Gast 1995; 30:289-99; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Interferon Cytokine Res 2011; 32:60-5; http://dx.doi.org/10.1089/jir.2011.0062 [37] Cheung SS, Sleivert GG.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Exerc Sport Sci Rev 2004;32:100-6; PMID:15243205; http://dx.doi.org/10.1097/00003677-200407000-00005 [38] Ryan AJ, Flanagan SW, Moseley PL, Gisol ﬁCV.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Eur J ApplPhysiol 2015; 115:1577-88; PMID:25736783; http://dx.doi.org/10.1007/s00421-015-3143-7 [40] King YT, Lin CS, Lin JH, Lee WC.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Can J Physiol Pharmacol 1998; 76:589-97; http://dx.doi.org/10.1139/y98-040 [42] Chesnokova V, Melmed S. Minireview: Neuro-immuno- endocrine modulation of the hypothalamic-pituitary- adrenal (HPA) axis by gp130 signaling molecules.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Endo- crinology 2002; 143:1571-4; PMID:11956136; http://dx.doi.org/10.1210/endo.143.5.8861 [43] Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsia- dis CS, Chrousos GP.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J ClinEndocrinol Metab 1997; 82:4167-70; PMID:9398733;http://dx.doi.org/10.1210/jcem.82.12.4422 [44] Jeukendrup AE, Wagenmakers AJM, Stegen JHCH, Gij- sen AP, Brouns F, Saris WHM.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Appl Physiol 2002;92:2648-55; PMID:12015385; http://dx.doi.org/10.1152/japplphysiol.01005.2001 [48] Abedelmalek S, Chtourou H, Aloui A, Aouichaoui C, Souissi N, Tabka Z.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Eur J Appl Physiol2013; 113:241-8; PMID:22677919; http://dx.doi.org/10.1007/s00421-012-2432-7 [49] Leggate M, Nowell MA, Jones SA, Nimmo MA.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Cell Stress Chap- erones 2010; 15:827-33; PMID:20396982; http://dx.doi.org/10.1007/s12192-010-0192-z [50] Ostrowski K, Schjerling P, Pedersen KB.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Eur J Appl Physiol 2000;83:512-5; PMID:11192058; http://dx.doi.org/10.1007/s004210000312 [51] Febbraio M, Steensberg A, Keller C, Starkie R, Nielsen H, Krustrup P, Ott P, Secher N, Pedersen B. GlucoseIngestion Attenuates Interleukin-6 Release from Con-tracting Skeletal Muscle in Humans.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Physiol 2003;549:607-12; PMID:12702735; http://dx.doi.org/10.1113/jphysiol.2003.042374 [52] Starkie R, Arkinstall M, Koukoulas I, Hawley J, Febbraio M. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin- 6 mRNA, during exercise in humans.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Physiol 2001;533:585-91; PMID:11389214; http://dx.doi.org/10.1111/j.1469-7793.2001.0585a.x [53] Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Physiol 2001; 529:237-42; http://dx.doi.org/10.1111/ j.1469-7793.2000.00237.x [54] Steensberg A, Toft AD, Schjerling P, Halkjær-Kristensen J, Pedersen BK.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Am J Physiol Endocrinol Metab2003; 285:E433-7; PMID:12857678; http://dx.doi.org/ 10.1152/ajpendo.00074.2003 [56] Rhind SG, Gannon GA, Shephard RJ, Buguet A, Shek PN, Radomski MW.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Int J Hyperth ermia 2004; 20:503-16; PMID:15277023; http://dx.doi.org/10.1080/ 02656730410001670651 [57] Fortes MB, Di Felice U, Dolci A, Junglee NA, Crockford MJ, West L, Hillier-Smith R, Macdonald JH, Walsh NP.Muscle-damaging exercise increases heat strain duringsubsequent exercise heat stress.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Med Sci Sports Exerc2013; 45:1915-24; PMID:23559121; http://dx.doi.org/10.1249/MSS.0b013e318294b0f8 [58] Lim CL, Mackinnon LT.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Sports Med 2006; 36:39-64; PMID:16445310;http://dx.doi.org/10.2165/00007256-200636010-00004 [59] Welc SS, Phillips NA, Oca-Cossio J, Wallet SM, Chen DL, Clanton TL.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Am J Physiol Cell Physiol 2012;303:C455-C66; PMID:22673618; http://dx.doi.org/ 10.1152/ajpcell.00028.2012 [60] Harden LM, Plessis Id, Poole S, Laburn HP.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Brain BehavImmun 2008; 22:838-49; PMID:18255258; http://dx.doi.org/10.1016/j.bbi.2007.12.006 [61] Hansen MK, Nguyen KT, Fleshner M, Goehler LE, Gay- kema RPA, Maier SF, Watkins LR.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Diabetes 2004; 53:1643-8; PMID:15220185; http://dx.doi.org/10.2337/diabetes.53.7.1643 [64] Nowell MA, Richards PJ, Horiuchi S, Yamamoto N, Rose- John S, Topley N, Williams AS, Jones SA.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Immunol2003; 171:3202-9; PMID:12960349; http://dx.doi.org/ 10.4049/jimmunol.171.6.3202 [65] Boettger MK, Leuchtweis J, Kummel D, Gajda M, Brauer R, Schaible HG.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Arthritis Res Ther 2010; 12:R140; PMID:20626857; http://dx.doi.org/10.1186/ar3079 [66] Zhang Y, Pilon G, Marette A, Baracos VE.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Pain 2005; 114:168-76; PMID:15733642; http://dx.doi.org/10.1016/j.pain.2004.12.020 [68] Andratsch M, Mair N, Constantin CE, Scherbakov N, Benetti C, Quarta S, Vogl C, Sailer CA, €Uceyler N, Brock- haus J, et al.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Neurosci 2009;29:13473-83; PMID:19864560; http://dx.doi.org/10.1523/JNEUROSCI.1822-09.2009 [69] Alexander GM, Peterlin BL, Perreault MJ, Grothusen JR, Schwartzman RJ.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Pain 2012; 13:10-20; PMID:22172450; http://dx.doi.org/10.1016/j.jpain.2011.10.003 [70] Roth J, Harre EM, Rummel C, Gerstberger R, Hubschle T. Signaling the brain in systemic in ﬂammation: role of sen- sory circumventricular organs.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Front Biosci 2004; 9:290-300; PMID:14766367; http://dx.doi.org/10.2741/1241 [71] Kovacs E. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Biomed Pharmacother 2001;55:391-6; PMID:11669502; http://dx.doi.org/10.1016/S0753-3322(01)00079-8 [72] Kallen KJ.,OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Biochim Bio-phys Acta Mol Cell Res 2002; 1592:323-43; http://dx.doi.org/10.1016/S0167-4889(02)00325-7 [73] Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA, Maihle NJ.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Cytokine1992; 4:96-100; PMID:1633265; http://dx.doi.org/10.1016/1043-4666(92)90043-Q [74] Horiuchi S, Koyanagiu Y, Zhouu Y, Miyamotou H, Tana- kau Y, Waki M, Matsumoto A, Yamamotou M, Yama-motof N. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated throughan alternative splicing mechanism.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Eur J Immun 1994;24:1945-8; http://dx.doi.org/10.1002/eji.1830240837 [75] M €ulberg J, Schooltink H, Stoyan T, G €unther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S. Thesoluble interleukin-6 receptor is generated by shedding.Eur J Immunol 1993; 23:473-80; PMID:8436181; http:// dx.doi.org/10.1002/eji.1830230226 [76] Rose-John S, Neurath MF.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Immunity 2004; 20:2-4; PMID:14738759; http://dx.doi.org/10.1016/S1074-7613(04)00003-2 [77] Emery P, Keystone E, Tony HP, Cantagrel A, van Vollen- hoven R, Sanchez A, Alecock E, Lee J, Kremer J. IL-6receptor inhibition with tocilizumab improves treatmentoutcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.Ann Rheum Dis 2008; 67:1516-23; PMID:18625622; http://dx.doi.org/10.1136/ard.2008.092932 [78] Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic in ﬂammatory proliferative disease.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Cyt Growth Factor Rev 2002; 13:357-68; http://dx.doi.org/10.1016/S1359-6101(02)00027-8 [79] Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Cli n Sci (Lond) 2012; 122:143-59; PMID:22029668; http://dx.doi.org/10.1042/CS20110340 [80] Kawasaki Y, Zhang L, Cheng JK, Ji RR.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Neurosci 2008; 28:5189- 94; PMID:18480275; http://dx.doi.org/10.1523/ JNEUROSCI.3338-07.2008 [81] Jostock T, Mullberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath M, Rose-John S. Soluble gp130 isthe natural inhibitor of soluble interleukin-6 receptortrans signalling responses.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Cytokine 2009; 47:98-102; PMID:19527938; http://dx.doi.org/10.1016/j.cyto.2009.05.011 [83] Gray SR, Robinson M, Nimmo MA.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Eur JAppl Physiol 2007; 99:353-60; PMID:17165057; http://dx.doi.org/10.1007/s00421-006-0354-y [85] Robinson M, Gray SR, Watson MS, Kennedy G, Hill A, Belch JJ, Nimmo MA.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Scand J Med Sci Sports 2010;20:282-90; PMID:19422646; http://dx.doi.org/10.1111/j.1600-0838.2009.00895.x [86] Patterson S, Reid S, Gray S, Nimmo M. The response of plasma interleukin-6 and its soluble receptors toexercise in the cold in humans.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"J Pysiol 2006; 574:905-15; http://dx.doi.org/ 10.1113/jphysiol.2005.101733 [89] Gonz /C19alez-Alonso J, Teller C, Andersen S, Jensen F, Hyldig T, Nielsen B.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Evidence for neuromuscular fatigue dur- ing high-intensity cycling in warm, humid conditions.Eur J Appl Physiol 2001; 84:115-21; PMID:11394239;http://dx.doi.org/10.1007/s004210000340 [91] Coderre TJ, Melzack R. Central neural mediators of sec- ondary hyperalgesia following heat injury in rats: Neuro-peptides and excitatory amino acids.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
Neurosci Lett 1991;131:71-4; PMID:1686478; http://dx.doi.org/10.1016/ 0304-3940(91)90339-U [92] Yunus MB.,OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Best Prac Res Clin Rheumatol 2007;21:481-97; http://dx.doi.org/10.1016/j.berh.2007.03.006[93] Romanovsky AA, Ivanov AI, Sz /C19ekely M. Neural route of pyrogen signaling to the brain.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Clin Infect Dis2000; 31:S162-S7; PMID:11113019; http://dx.doi.org/10.1086/317515 [94] Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, De Clerck LS.",OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"Eur J Clin Invest 2012; 42:203-12; PMID:21793823; http://dx.doi.org/10.1111/j.1365-2362.2011.02575.x [95] Taylor JL, Gandevia S. In: Marino F, ed.",Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
J NeurolNeurosurg Psychiatry 1959; 22:113-6; PMID:13655099; http://dx.doi.org/10.1136/jnnp.22.2.113 [97] Marino FE.,Non-OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
IntJ Hyperth 2009; 25:34-40; http://dx.doi.org/10.1080/02656730802294020TEMPERATURE 251,OADS,/arxiv_data1/oa_pdf/9f/89/ktmp-03-02-1179380.PMC4964994.pdf
"2, 262 –270 http://dx.doi.org/10.1080/23328940.2016.1148526",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Eur J Appl Physiol 2009; 105:607-13;PMID:19037655; http://dx.doi.org/10.1007/s00421-008-0940-2 [2] Northington WE, Suyama J, Goss FL, Randall C, Gal- lagher M, Hostler D. Physiological responses during graded treadmill exercise in chemical-resistant per- sonal protective equipment.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Prehosp Emerg Care2007; 11:394-8; PMID:17907022; http://dx.doi.org/10.1080/10903120701536933 [3] Morley J, Beauchamp G, Suyama J, Guyette FX, Reis SE, Callaway CW, Hostler D. Cognitive function followingtreadmill exercise in thermal protective clothing.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Int J OccupSafety Ergon 2012; 19:443-53; http://dx.doi.org/10.1080/10803548.2013.11077000 [5] Zwoli /C19nska M, Bogdan A.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Appl Ergon 2012;43:1096-104; PMID:22575493; http://dx.doi.org/10.1016/ j.apergo.2012.03.011 [6] Langø T, Nesbakken R, Færevik H, Holbø K, Reitan J, Yavuz Y, Ma /C14rvik R. Cooling vest for improving surgeons ’ thermal comfort: A multidisciplinary design project.Minim Invasive Ther Allied Technol 2009; 18:20-9;http://dx.doi.org/10.1080/13645700802649383 [7] McLellan TM, Daanen HA, Cheung SS.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Am J Physiol Regul Integr Comp Physiol 2015; 308:R847-54; PMID:25786484; http://dx.doi.org/10.1152/ajpregu.00010.2015 [11] Caldwell JN, Patterson MJ, Taylor NA.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Exertional thermal strain, protective clothing and auxiliary cooling in dry heat: evidence for physiological but not cognitive impairment.Eur J Appl Physiol 2012; 112:3597-606; PMID:22328005;http://dx.doi.org/10.1007/s00421-012-2340-x [12] Schlader ZJ, Lucas RA, Pearson J, Crandall CG.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Exp Physiol 2013; 98:1597-607; PMID:23851918; http://dx.doi.org/10.1113/ expphysiol.2013.074104 [13] Simmons SE, Saxby BK, McGlone FP, Jones DA.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"The effect of passive heating and head cooling on perception, cardio-vascular function and cognitive performance in the heat.Eur J Appl Physiol 2008; 104:271-80; PMID:18214520;http://dx.doi.org/10.1007/s00421-008-0677-y [14] Gaoua N, Racinais S, Grantham J, El Massioui F. Alterations in cognitive performance during passive hyperthermia are task dependent.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Int J Hyperthermia 2011; 27:1-9; PMID:21070137; http://dx.doi.org/10.3109/02656736.2010.516305 [15] Racinais S, Gaoua N, Grantham J. Hyperthermia impairs short-term memory and peripheral motor drive trans-mission.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"J Physiol 2008; 586:4751-62; PMID:18703579;http://dx.doi.org/10.1113/jphysiol.2008.157420 [16] McMorris T, Swain J, Smith M, Corbett J, Delves S, Sale C, Harris RC, Potter J.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Int J Psy- chophysiol 2006; 61:204-15; PMID:16309771; http://dx.doi.org/10.1016/j.ijpsycho.2005.10.002 [17] Cian C, Barraud PA, Melin B, Raphel C. Effects of ﬂuid ingestion on cognitive function after heat stress or exer-cise-induced dehydration.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Int J Psychophysiol 2001;42:243-51; PMID:11812391; http://dx.doi.org/10.1016/ S0167-8760(01)00142-8 [18] Gaoua N, Grantham J, El Massioui F, Girard O, Racinais S. Cognitive decrements do not follow neuromuscularalterations during passive heat exposure.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Int J Hyperther-mia 2011; 27:10-9; PMID:21070138; http://dx.doi.org/10.3109/02656736.2010.519371 [19] Gaoua N, Grantham J, Racinais S, El Massioui F. Sensory displeasure reduces complex cognitive performance in the heat.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"JSaf Res 1983; 14:105-14; http://dx.doi.org/10.1016/0022-4375(83)90021-X [21] Froom P, Caine Y, Shochat I, Ribak J.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"J Occup Environ Med 1993; 35:720-32; http://dx.doi.org/10.1097/00043764- 199307000-00016 [22] Caldwell JN, Patterson MJ, Taylor NA.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"J Human Environ Sys 2006; 9:13-8; http://dx.doi.org/10.1618/jhes.9.13 [23] Christian MS, Bradley JC, Wallace JC, Burke MJ.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"J Appl Psychol 2009; 94:1103; PMID:19702360; http://dx.doi.org/10.1037/a0016172 [24] Bain AR, Jay O.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
Eur J Appl Physiol 2011; 111:1197-205;PMID:21127900; http://dx.doi.org/10.1007/s00421-010-1743-9 [25] Ramanathan NL.,Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Percept Mot Skills 2014; 119:183-90; PMID:25153748; http://dx.doi.org/10.2466/27.06.PMS.119c10z2 [27] Goss FL, Robertson RJ, Gallagher Jr M, Haile L, Mor- ley J, Suyama J, Hostler D. Validation of the OMNI scale of thermal sensations.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Percept Mot Skills 2013;116:773-83; PMID:24175452; http://dx.doi.org/10.2466/27.29.PMS.116.3.773-783 [28] Gallagher M, Robertson RJ, Goss FL, Nagle-Stilley EF, Schafer MA, Suyama J, Hostler D. Development of a per-ceptual hyperthermia index to evaluate heat strain duringtreadmill exercise.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Eur J Appl Physiol 2012; 112:2025-34; PMID:21947408; http://dx.doi.org/10.1007/s00421-011- 2173-z[29] Lejuez CW, Read JP, Kahler CW, Richards JB, Ramsey S E ,S t u a r tG L ,S t r o n gD R ,B r o w nR A .E v a l u a t i o no fabehavioral measure of ris k taking: the Balloon Ana- logue Risk Task (BART).",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
J Exp Psychol Appl 2002;8:75-84; PMID:12075692; http://dx.doi.org/10.1037/1076-898X.8.2.75 [30] Watkins JL.,Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Med Sci Sport Exer1993; 25:71-80; http://dx.doi.org/10.1249/00005768- 199301000-00011 [32] Black AC, Hochman E, Rosen MI.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"J Appl Sport Psychol 2013;25:175-9; PMID:24761127; http://dx.doi.org/10.1080/10413200.2012.704621 [33] Charness G, Gneezy U.",Non-OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"J Econo Behav Organizat 2012; 83:50-8; http://dx.doi.org/10.1016/j.jebo.2011.06.007 [34] Montain SJ, Sawka MN, Cadarette BS, Quigley MD, McKay JM.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"J TherBiol 2015; 49:16-32; PMID:25774023; http://dx.doi.org/10.1016/j.jthe rbio.2015.01.007 [37] Reinertsen RE, Faerevik H, Holbo K, Nesbakken R, Rei- tan J, Royset A, Le Thi MS. Optimizing the performanceof phase-change materials in personal protective clothingsystems.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Int J Occup Safety Ergon 2008; 14:43; http://dx.doi.org/10.1080/10803548.2008.11076746 [38] Weinger MB, Ancoli-Israel S. Sleep deprivation and clini- cal performance.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Jama 2002; 287:955-7; PMID:11866625;http://dx.doi.org/10.1001/jama.287.8.955 [39] Acheson A, Richards JB, de Wit H. Effects of sleep depri- vation on impulsive behaviors in men and women.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"Phys-iol Behav 2007; 91:579-87; PMID:17477941; http://dx.doi.org/10.1016/j.physbeh.2007.03.020 [40] Killgore WD, Grugle NL, Killgore DB, Leavitt BP, Wat- lington GI, McNair S, Balkin TJ.",OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
Aviat Space Environ Med 2008; 79:867-74; PMID:18785355; http://dx.doi.org/ 10.3357/ASEM.2259.2008270 Z. J. SCHLADER ET AL.,OADS,/arxiv_data1/oa_pdf/1a/92/ktmp-03-02-1148526.PMC4964995.pdf
"2, 232 –239 http://dx.doi.org/10.1080/23328940.2016.1157665",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Handb Exp Pharmacol 2014; 222:547-79;PMID:24756721; http://dx.doi.org/10.1007/978-3-642-54215-2_22 [3] Almeida MC, Hew-Butler T, Soriano RN, Rao S, Wang W, Wang J, Tamayo N, Oliveira DL, Nucci TB, Aryal P,et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Neuro- sci 2012; 32:2086-99; PMID:22323721; http://dx.doi.org/10.1523/JNEUROSCI.5606-11.2012 [4] Andrew D, Craig AD.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"JPhysiol 2001; 537:489-95; PMID:11731580; http://dx.doi.org/10.1111/j.1469-7793.2001.00489.x [5] Banet M, Hensel H. The interaction between cutaneous and spinal therman inputs in the control of oxygen con- sumption in the rat.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Physiol 1976; 260:461-73;PMID:978543; http://dx.doi.org/10.1113/jphysiol.1976.sp011525 [6] Carlisle HJ, Ingram DL.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
J Physiol 1973; 231:353-64;PMID:4720937; http://dx.doi.org/10.1113/jphysiol.1973.,OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Transient receptor potential ion channels as participants in thermosensation and thermoregulation.Am J Physiol Regul Integr Comp Physiol 2007; 292:R64-76; PMID:16973931; http://dx.doi.org/10.1152/ajpregu.00446.2006 [8] Craig AD, Krout K, Andrew D. Quantitative response characteristics of thermoreceptive and nociceptive lamina I spinothalamic neurons in the cat.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Comp Neurol 1979; 185:203-9; PMID:429614; http://dx.doi.org/10.1002/cne.901850112 [11] Dostrovsky JO, Hellon RF.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"JPhysiol 1978; 277:29-47; PMID:650531; http://dx.doi.org/10.1113/jphysiol.1978.sp012258 [12] Fawley JA, Hofmann ME, Largent-Milnes TM, Andresen MC.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
PloS one 2015; 10:e0127764; PMID:25992717;http://dx.doi.org/10.1371/journal.pone.0127764 [13] Glitsch MD.,OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Cell calcium 2008; 43:9-15; PMID:17382386;http://dx.doi.org/10.1016/j.ceca.2007.02.008 [14] Heath ME, Jessen C. Thermosensitivity of the Goats Brain.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
J Physiol-London 1988; 400:61-74; PMID:3418538; http://dx.doi.org/10.1113/jphysiol.1988.sp017-110 [15] Hensel H. Neural processes in thermoregulation.,Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Ann Rev Physiol 1974; 36:233-49; PMID:19400663; http://dx.doi.org/10.1146/ annurev.ph.36.030174.001313 [17] Hensel H, Schafer K. Static an dynamic activity of cold receptors in cats after long-term exposure to various tem-peratures.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
P ﬂugers Arch 1982; 392:291-4; PMID: 7070961; http://dx.doi.org/10.1007/BF00584313 [18] Iggo A. Cutaneous thermoreceptors in primates and sub- primates.,OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Physiol 1969; 200:403-30; PMID:4974402;http://dx.doi.org/10.1113/jphysiol.1969.sp008701 [19] Jessen C. Temperature Regulation in Humans and Other Mammals, Berlin: Springer-Verlag, 2001.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Physiol-ogy 2011; 26:45-53; PMID:21357902; http://dx.doi.org/10.1152/physiol.00040.2010 [21] Kirillova-Woytke I, Baron R, Janig W. Re ﬂex inhibition of cutaneous and muscle vasoconstrictor neurons during stimulation of cutaneous and muscle nociceptors.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Neurophysiol 2014; 111:1833-45; PMID:24501261; http://dx.doi.org/10.1152/jn.00798.2013 [22] Largent-Milnes TM, Hegarty DM, Aicher SA,Andresen MC.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Neuro- physiol 2014; 111:2222-31; PMID:24598529; http://dx.doi.org/10.1152/jn.00912.2013 [23] Mercer JB, Jessen C. Central thermosensitivity in con- scious goats: hypothalamus and spinal cord versus resid-ual inner body.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"P ﬂugers Arch 1978; 374:179-86; PMID:566426; http://dx.doi.org/10.1007/BF00581299 [24] Mercer JB, Simon E. A comparison between total body thermosensitivity and local thermosensitivity in mam-mals and birds.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"P ﬂugers Arch 1984; 400:228-34; PMID:6728643; http://dx.doi.org/10.1007/BF00581552 [25] Morrison SF, Nakamura K. Central neural pathways for thermoregulation.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
Frontiers in bioscience 2011; 16:74-104; http://dx.doi.org/10.2741/3677 [26] Mower GD.,OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"JComp Physiol Psychol 1976; 90:1152-5; PMID:993393;http://dx.doi.org/10.1037/h0077284 [27] Nagel A, Herold W, Roos U, Jessen C. Skin and core tem- peratures as determinants of heat production and heat loss in the goat.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"P ﬂugers Arch 1986; 406:600-7; PMID:3714458; http://dx.doi.org/10.1007/BF00584027 [28] Nakamura K, Morrison SF.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Nat Neurosci 2008; 11:62-71; PMID:18084288; http://dx.doi.org/10.1038/nn2027 [30] Neuhuber WL, Sandoz PA, Fryscak T. The central projections of primary afferent neurons of greatersplanchnic and intercostal nerves in the rat.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Physiol 1997;498(Pt 2):483-95; PMID:9032695; http://dx.doi.org/10.1113/jphysiol.1997.sp021874 [32] Rawson RO, Quick KP.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Physiol 1972; 222:665-7;PMID:5033027; http://dx.doi.org/10.1113/jphysiol.1972.sp009820 [33] Rawson RO, Quick KP, Coughlin RF.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
Science1969; 165:919-20; PMID:5798318; http://dx.doi.org/10.1126/science.165.3896.919 [34] Riedel W. Warm receptors in the dorsal abdominal wall of the rabbit.,Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"P ﬂugers Arch 1976; 361:205-6; PMID:129763; http://dx.doi.org/10.1007/BF00583468 [35] Riedel W, Siaplauras G, Simon E. Intra-abdominal ther- mosensitivity in the rabbit as compared with spinalthermosensitivity.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"P ﬂugers Arch 1973; 340:59-70; PMID: 4735964; http://dx.doi.org/10.1007/BF00592197 [36] Roos U, Jessen C. No dynamic effector responses to fast changes of core temperature at constant skin tempera-ture.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Can J Physiol Pharmacol 1987; 65:1339-46;PMID:3621082; http://dx.doi.org/10.1139/y87-212 [37] Shoudai K, Peters JH, McDougall SJ, Fawley JA, Andre- sen MC.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Neurosci 2010;30:14470-5; PMID:20980604; http://dx.doi.org/10.1523/JNEUROSCI.2557-10.2010 [38] Simon E. Temperature regulation: the spinal cord as a site of extrahypothalamic thermoregulatory functions.Rev Physiol Biochem Pharmacol 1-76, 1974; PMID:4616314 [39] Simon E. Temperature signals from skin and spinal cord converging on spinothalamic neurons.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"P ﬂugers Arch 1972; 337:323-32; PMID:4674881; http://dx.doi.org/10.1007/BF00586649 [40] Simon E, Iriki M. Sensory transmission of spinal heat and cold sensitivity in ascending spinal neurons.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"P ﬂugers Arch 1971; 328:103-20; PMID:4328518; http://dx.doi.org/10.1007/BF00592439 [41] Simon E, Pierau FK, Taylor DC.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Neurosci 2007; 27:14147-57; PMID:18094254; http://dx.doi.org/ 10.1523/JNEUROSCI.4578-07.2007 [43] Takashima Y, Ma L, McKemy DD.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Neuroscience 2010; 169:828-42; PMID:20580783;http://dx.doi.org/10.1016/j.neuroscience.2010.05.039 [44] Teliban A, Bartsch F, Struck M, Baron R, Janig W. Axo- nal thermosensitivity and mechanosensitivity of cutane- ous afferent neurons.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"Eur J Neurosci 2011; 33:110-8; PMID:21050282; http://dx.doi.org/10.1111/j.1460-9568.2010.07471.x [45] Teliban A, Bartsch F, Struck M, Baron R, Janig W. Responses of intact and injured sural nerve ﬁbers to cool- ing and menthol.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Neurophysiol 2014; 111:2071-83;PMID:24572095; http://dx.doi.org/10.1152/jn.00287.2013 [46] Tsuzuki K, Xing H, Ling J, Gu JG.",OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"J Neurosci 2004; 24:762-71; PMID:14736862; http://dx.doi.org/10.1523/JNEUR-OSCI.4658-03.2004 [47] Wrigley PJ, Jeong HJ, Vaughan CW.",Non-OADS,/arxiv_data1/oa_pdf/a7/c4/ktmp-03-02-1157665.PMC4964996.pdf
"2, 328 –339 http://dx.doi.org/10.1080/23328940.2016.1153360",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"The RyR1 variants c.742G>A, p.Gly248Arg and c.7354C >T, p.Arg24- 52Trp were used as positive controls as the formerhas been validated as an MH-causative mutation bythe EMHG (https://emhg.org/genetics/mutations-in-ryr1/) and the latter was shown to be causative usingour system.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
Sequences were aligned to the RYR1 cDNA (NM_000540.2) using the web based tool nee-dle through EMBOSS (http://www.ebi.ac.uk/Tools/psa/emboss_needle/nucleotide.html).,OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
Ann N Y Acad Sci 1993; 707:294-304; PMID:9137560; http://dx.doi.org/10.1111/ j.1749-6632.1993.tb38060.x [2] Hopkins PM.,OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Br J Anaesth 2011; 107:48-56; PMID:21624965; http://dx.doi.org/10.1093/bja/aer132 [3] Vukcevic M, Broman M, Islander G, Bodelsson M, Ran- klev-Twetman E, Muller CR, Treves S. Functional prop-erties of RYR1 mutations identi ﬁed in Swedish patients with malignant hyperthermia and central core disease.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Am J Physiol Cell Physiol 2007:292:C1591-8 Epub2006 Dec 20; PMID:17182726; http://dx.doi.org/10.1152/ ajpcell.00133.2006 [5] Eltit JM, Bannister RA, Moua O, Altamirano F, Hopkins PM, Pessah IN, Molinski TF, Lopez JR, Beam KG, AllenPD.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Eur J Anaesthesiol 2001; 18:632-52; PMID:11553240; http://dx.doi.org/10.1097/00003643-200110000-00002 [7] Lopez JR, Allen P, Alamo L, Ryan JF, Jones DE, Sreter F. Dantrolene prevents the malignant hyperthermic syn-drome by reducing free intracellular calcium concentra-tion in skeletal muscle of susceptible swine.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
CellCalcium 1987; 8:385-96; PMID:3427616; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Br JAnaesth 2009; 102:642-9; PMID:19346234; http://dx.doi.org/10.1093/bja/aep061 [9] Robinson R, Carpenter D, Shaw MA, Halsall J, HopkinsP.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Hum Mutat 2006: 27:977-89; PMID:16917943; http://dx.doi.org/10.1002/humu.20356 [10] Stewart SL, Hogan K, Rosenberg H, Fletcher JE.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Skelet Muscle2015: 5:23; PMID:26203350; http://dx.doi.org/10.1186/s13395-015-0049-3 [12] Gilchrist JS, Palahniuk C, Abrenica B, Rampersad P, Mutawe M, Cook T. RyR1/SERCA1 cross-talk regulationof calcium transport in heavy sarcoplasmic reticulumvesicles.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Can J Physiol Pharmacol 2003: 81:220-33;PMID:12733821; http://dx.doi.org/10.1139/y03-035 [13] Hopkins PM, Ruffert H, Snoeck MM, Girard T, Glahn KP, Ellis FR, Muller CR, Urwyler A. European MalignantHyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Br J Anaesth 2015: 115:531-539; PMID:26188342; http://dx.doi.org/10.1093/bja/aev225 [14] Stowell KM, Brown R, James D, Couchman K, Hodges M, Pollock N. Malignant Hyperthermia in New Zealand.NZ BioScience 1999.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Jama 2005; 293:2918-24; PMID:15956637; http://dx.doi.org/ 10.1001/jama.293.23.2918 [16] Rosenberg H, Rueffert H. Clinical utility gene card for: malignant hyperthermia.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Eur J Hum Genet 2011; 19;PMID:21248738; http://dx.doi.org/10.1038/ejhg.2010.248 [17] Robinson RL, Anetseder MJ, Brancadoro V, van Broek- hoven C, Carsana A, Censier K, Fortunato G, Girard T,Heytens L, Hopkins PM, et al.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Eur J Hum Genet 2003; 11:342-8; PMID:12700608; http://dx.doi.org/10.1038/sj.ejhg.5200964 [18] Urwyler A, Deufel T, McCarthy T, West S. Guidelines for molecular genetic detection of susceptibility tomalignant hyperthermia.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Br J Anaesth 2001; 86:283-7;PMID:11573677; http://dx.doi.org/10.1093/bja/86.2.283 [19] Robinson R, Curran JL, Hall WJ, Halsall PJ, Hopkins PM, Markham AF, Stewart AD, West SP, Ellis FR.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"J Med Genet 1998; 35:196-201;PMID:9541102; http://dx.doi.org/10.1136/jmg.35.3.196 [20] Girard T, Treves S, Voronkov E, Siegemund M, Urwy- ler, A. Molecular genetic testing for malignant hyper-thermia susceptibility.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"An esthesiology 2004; 100:1076- 80; PMID:15114203; http://dx.doi.org/10.1097/ 00000542-200405000-00008[21] Fiszer D, Shaw MA, Fisher NA, Carr IM, Gupta PK, Wat- kins EJ, Roiz de Sa D, Kim JH, Hopkins PM.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Anesthesiol-ogy 2015; 122:1033-46; PMID:25658027; http://dx.doi.org/10.1097/ALN.0000000000000610 [22] Sambuughin N, McWilliams S, de Bantel A, Sivakumar K, Nelson TE.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Am J HumGenet 2001; 69:204-8; PMID:11389482; http://dx.doi.org/10.1086/321270 [23] Grievink H, Stowell KM.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Anal Biochem 2008; 374:396-404 Epub 2007 Nov 21; PMID:18082125; http://dx.doi.org/10.1016/j.ab.2007.11.019 [24] Roesl C, Sato K, Schiemann AH, Pollock N, Stowell KM.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Cell Calcium 2014; 56:1950201; http://dx.doi.org/10.1016/j.ceca.2014.07.004 [25] Tong J, Oyamada H, Demaurex N, Grinstein S, McCarthy TV, MacLennan DH.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"J BiolChem 1997; 272:26332-26339; PMID:9334205; http://dx.doi.org/10.1074/jbc.272.42.26332 [26] Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heffron JJ, Heytens L, et al.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
Acta Anaes-thesiol Scand 1997; 41:955-66; PMID:9311391; http://dx.doi.org/10.1111/j.1399-6576.1997.tb04820.x [27] Ording H. Diagnosis of susceptibility to malignant hyper- thermia in man.,Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Br J Anaesth 1988; 60:287-302; PMID:3279989; http://dx.doi.org/10.1093/bja/60.3.287 [28] Pollock N, Langton EE, Stowell KM, Bulger TF.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Anesth Analg 2000; 91:452-7;PMID:10910867; http://dx.doi.org/10.1213/00000539-200008000-00042 [30] Tung CC, Lobo PA, Kimlicka L, Van Petegem F. The amino-terminal disease hotspot of ryanodine receptorsforms a cytoplasmic vesti bule.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
Nature 2010; 468:585- 8; PMID:21048710; http://dx.doi.org/10.1038/nature 09471338 J. STEPHENS ET AL.,OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Am J HumGenet 2001; 69:204-8 Epub 2001 May 29; PMID:11389482; http://dx.doi.org/10.1086/321270 [32] Yan Z, Bai XC, Yan C, Wu J, Li Z, Xie T, Peng W, Yin CC, Li X, Scheres, SH, et al.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"Nature2015; 517:50-5; PMID:25517095; http://dx.doi.org/10.1038/nature14063 [33] Tong J, McCarthy TV, MacLennan DH.",Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"J Biol Chem 1999; 274:693-702; PMID:9873004; http:// dx.doi.org/10.1074/jbc.274.2.693 [34] Ikemoto N, Yamamoto T. Regulation of calcium release by interdomain interaction within ryanodine receptors.Front Biosci 2002; 7:d671-83; PMID:11861212; http://dx.doi.org/10.2741/ikemoto [35] Avila G, Dirksen RT.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"J Gen Physiol 2001; 118:277-90; PMID:11524458; http://dx.doi.org/10.1085/jgp.118.3.277 [36] Murayama T, Oba T, Hara H, Wakebe K, Ikemoto N, Ogawa Y. Postulated role of interdomain interactionbetween regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.Biochem J 2007; 402:349-57; PMID:17107340; http://dx.doi.org/10.1042/BJ20061040 [37] Yamamoto T, El-Hayek R, Ikemoto N. Postulated role of interdomain interaction within the ryanodine receptor inCa 2Cchannel regulation.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
Neuromuscul Disord 2015; 25:567-76;PMID:25958340; http://dx.doi.org/10.1016/j.nmd.2015.,OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"J Med Genet 2004; 41:e33; PMID:14985404; http://dx.doi.org/10.1136/jmg.2003.014274 [40] Sato K, Pollock N, Stowell KM.",OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
Anesthesi- ology 2010; 112:1350-4; PMID:20461000; http://dx.doi.org/10.1097/ALN.0b013e3181d69283TEMPERATURE 339,Non-OADS,/arxiv_data1/oa_pdf/4b/04/ktmp-03-02-1153360.PMC4964997.pdf
"2, 286 –297 http://dx.doi.org/10.1080/23328940.2016.1156215",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Hypertension 1986; 8:37-44; PMID: 3080370; http://dx.doi.org/10.1161/01.HYP.8.1.37 [4] Laughlin MH, Newcomer SC, Bender SB.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
J Appl Physiol2008; 104:588-600; PMID:18063803; http://dx.doi.org/ 10.1152/japplphysiol.01096.2007294 K. N. THOMAS ET AL.,OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Hypertension2009; 54:278-85; PMID:19546 374; http://dx.doi.org/ 10.1161/HYPERTENSIONAHA.109.134361 [6] Tinken TM, Thijssen DH, Black MA, Cable NT, Green DJ.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"JPhysiol 2008; 586:5003-12; PMID:18755749; http://dx.doi.org/10.1113/jphysiol.2008.158014 [7] Tinken TM, Thijssen DH, Hopkins N, Dawson EA, Cable NT, Green DJ.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Hypertension 2010;55:312-8; PMID:20048193; http://dx.doi.org/10.1161/ HYPERTENSIONAHA.109.146282 [8] Birk GK, Dawson EA, Atkinson C, Haynes A, Cable NT, Thijssen DH, Green DJ.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J ApplPhysiol 2012; 112:1653-8; PMID:22403347; http://dx.doi.org/10.1152/japplphysiol.01489.2011 [9] Carter HH, Dawson EA, Birk GK, Spence AL, Naylor LH, Cable NT, Thijssen DH, Green DJ.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Hyperten- sion 2013; 61:143-50; PMID:23150517; http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.197277 [10] Naylor LH, Carter H, Fitzsimons MG, Cable NT, Thijs- sen DH, Green DJ.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Med SciSports Exerc 2009; 41:1072-9; PMID:19346980; http://dx.doi.org/10.1249/MSS.0b013e3181923957 [12] Carter HH, Spence AL, Atkinson CL, Pugh CJ, Naylor LH, Green DJ.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Am Coll Cardiol2001; 38:1083-8; PMID:11583886; http://dx.doi.org/10.1016/S0735-1097(01)01467-X [15] Kihara T, Biro S, Imamura M, Yoshifuku S, Takasaki K, Ikeda Y, Otuji Y, Minagoe S, Toyama Y, Tei C. Repeatedsauna treatment improves vascular endothelial and car- diac function in patients with chronic heart failure.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Jpn Circ J 2001;65:434-8; PMID:11348049; http://dx.doi.org/10.1253/ jcj.65.434 [17] Akasaki Y, Miyata M, Eto H, Shirasawa T, Hamada N, Ikeda Y, et al.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Sci Med Sport 2007; 10:259-62; PMID:16877041; http://dx.doi.org/10.1016/j.jsams.2006.06.009 [19] Convertino VA, Greenleaf JE, Bernauer EM.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Appl Physiol 2009; 107:1612- 21; PMID:19556452; http://dx.doi.org/10.1152/japplphysiol.91651.2008 [21] Yamane M, Teruya H, Nakano M, Ogai R, Ohnishi N, Kosaka M. Post-exercise leg and forearm ﬂexor muscle cooling in humans attenuates endurance and resistancetraining effects on muscle performance and on circula- tory adaptation.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Eur J Appl Physiol 2006; 96:572-80; PMID:16372177; http://dx.doi.org/10.1007/s00421-005-0095-3 [22] Gupte AA, Bomhoff GL, Touchberry CD, Geiger PC.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Appl Physiol 2011;110:451-7; PMID:21148343; http://dx.doi.org/10.1152/japplphysiol.00849.2010 [23] Morton JP, Kayani AC, McArdle A, Drust B.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Sports Med 2009; 39:643-62; PMID:19769414; http://dx.doi.org/10.2165/00007256-200939080-00003 [24] Iguchi M, Littmann AE, Chang SH, Wester LA, Knipper JS, Shields RK.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
Am J Physiol Regul Integr CompPhysiol 2007; 292:R432-9; PMID:16990482; http://dx.doi.org/10.1152/ajpregu.00895.2005 [26] Laughlin MH.,Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Acta Physiol (Oxf)2010; 199:407-23; PMID:20345414; http://dx.doi.org/10.1111/j.1748-1716.2010.02119.x [29] Crandall CG, Wilson TE, Marving J, Vogelsang TW, Kjaer A, Hesse B, Secher NH.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"JPhysiol 2008; 586:293-301; PMID:17962331; http://dx.doi.org/10.1113/jphysiol.2007.143057 [30] Kihara T, Biro S, Ikeda Y, Fukudome T, Shinsato T, Masuda A, Miyata M, Hamasaki S, Otsuji Y, Minagoe S,et al.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Circ J 2004; 68:1146-51; PMID:15564698; http://dx.doi.org/ 10.1253/circj.68.1146 [31] Tei C, Horikiri Y, Park JC, Jeong JW, Chang KS, Toyama Y, Tanaka N. Acute hemodynamic improvement by ther-mal vasodilation in congestive heart failure.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Circulation1995; 91:2582-90; PMID:7743620; http://dx.doi.org/10.1161/01.CIR.91.10.2582 [32] Miyamoto H, Kai H, Nakaura H, Osada K, Mizuta Y, Matsumoto A, Imaizumi T. Safety and ef ﬁcacy of repeated sauna bathing in patients with chronic systolicheart failure: a preliminary report.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Card Fail 2005;11:432-6; PMID:16105634; http://dx.doi.org/10.1016/j.cardfail.2005.03.004 [33] Joyeux-Faure M, Arnaud C, Godin-Ribuot D, Ribuot C. Heat stress preconditioning and delayed myocar-dial protection: what is new?",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"JAMA Intern Med 2015;175:542-8; PMID:25705824; http://dx.doi.org/10.1001/jamainternmed.2014.8187 [35] Thijssen DH, Rowley N, Padilla J, Simmons GH, Laugh- lin MH, Whyte G, Cable NT, Green DJ.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Appl Physiol 2011; 111:244-50; PMID:21512151; http://dx.doi.org/10.1152/japplphysiol.00290.2011 [36] Dawson EA, Green DJ, Cable NT, Thijssen DH.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
J Appl Physiol (1985) 2013; 115:1589-98; PMID:24030665; http://dx.doi.org/ 10.1152/japplphysiol.00450.2013 [37] McMillan DE.,Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
Stroke 1985; 16:582-7; PMID:2411027;http://dx.doi.org/10.1161/01.STR.16.4.582 [38] 2008 Physical Activity Guidelines for Americans.,Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Circulation2004; 109:2507-10; PMID:15136499; http://dx.doi.org/ 10.1161/01.CIR.0000128207.26863.C4 [40] Hijmering ML, de Lange DW, Lorsheyd A, Kraaijenha- gen RJ, van de Wiel A.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Clin Sci (Lond)2005; 109:55-60; PMID:15799717; http://dx.doi.org/10.1042/CS20040358 [42] Adkisson EJ, Casey DP, Beck DT, Gurovich AN, Martin JS, Braith RW.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Environ Res 1969; 2:209-29; PMID:5788908; http://dx.doi.org/10.1016/0013-9351(69)90037-1 [45] Pyke KE, Dwyer EM, Tschakovsky ME.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Appl Physiol 2004;97:499-508; PMID:15064302; http://dx.doi.org/10.1152/japplphysiol.01245.2003 [46] Gemignani V, Bianchini E, Faita F, Giannarelli C, P l a n t i n g aY ,G h i a d o n iL ,D e m iM .U l t r a s o u n dm e a -surement of the brachial artery ﬂow-mediated dilation without ECG gating.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"IEEE Trans Med Imaging 2007; 26:393-404; PMID:17354644; http://dx.doi.org/10.1109/TMI.2006.891477 [48] Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, TschakovskyME, Green DJ.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Am J Physiol Heart Circ Physiol 2011; 300:H2- 12; PMID:20952670; http://dx.doi.org/10.1152/ ajpheart.00471.2010 [49] Taylor NAS, Cotter JD.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
Atheroscleros is 2013; 226:425-7; PMID: 23261170; http://dx.doi.org/ 10.1016/j.atherosclerosis.,OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Vasc Med 2013; 18:354-65; PMID:24172228; http://dx.doi.org/10.1177/1358863X13508446 [52] Atkinson G, Batterham AM, Thijssen DH, Green DJ.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Hypertens 2013; 31:287-91; PMID:23169234; http://dx.doi.org/10.1097/HJH.0b013e32835b8164 [53] Newcomer SC, Thijssen DH, Green DJ.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Magn Reson Imaging 2004; 19:188-93;PMID:14745752; http://dx.doi.org/10.1002/jmri.10441 [55] Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Acta PhysiolScand 2000; 169:115-24; PMID:10848641; http://dx.doi.org/10.1046/j.1365-201x.2000.00728.x [57] Hopper MK, Coggan AR, Coyle EF.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Med Sci Sports Exerc 1994;26:503-9; PMID:7515456; http://dx.doi.org/10.1249/00005768-199404000-00016 [59] Berger NJ, Campbell IT, Wilkerson DP, Jones AM.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Appl Physiol (1985) 2006; 101:707-14; PMID:16690793; http://dx.doi.org/10.1152/japplphysiol.00154.2006 [60] Dawson EA, Whyte GP, Black MA, Jones H, Hopkins N, Oxborough D, Gaze D, Shave RE, Wilson M, George KP,et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Appl Physiol 2008; 105:1562-8; PMID:18719231; http://dx.doi.org/ 10.1152/japplphysiol.90837.2008 [61] Rognmo O, Bjornstad TH, Kahrs C, Tjonna AE, Bye A, Haram PM, Stølen T, Slørdahl SA, Wisløff U.Endothelial function in highly endurance-trained men:effects of acute exercise.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Am J Physiol HeartCirc Physiol 2012; 303:H533-8; PMID:22730390; http://dx.doi.org/10.1152/ajpheart.00272.2012 [63] Hwang IC, Kim KH, Choi WS, Kim HJ, Im MS, Kim YJ, Kim SH, Kim MA, Sohn DW, Zo JH.",OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Cardiovasc Ultrasound 2012; 10:39;PMID:23031621; http://dx.doi.org/10.1186/1476-7120-10-39 [64] Finaud J, Lac G, Filaire E. Oxidative stress : relationship with exercise and training.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"Sports Med 2006; 36:327-58;PMID:16573358; http://dx.doi.org/10.2165/00007256-200636040-00004 [65] Tei C, Shinsato T, Miyata M, Kihara T, Hamasaki S. Waon therapy improves peripheral arterial disease.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"J Am Coll Cardiol 2007; 50:2169-71; PMID:18036456; http://dx.doi.org/10.1016/j.jacc.2007.08.025 [66] Shinsato T, Miyata M, Kubozono T, Ikeda Y, Fujita S, Kuwahata S, Akasaki Y, Hamasaki S, Fujiwara H, Tei C.Waon therapy mobilizes CD34 Ccells and improves peripheral arterial disease.",Non-OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
J Cardiol 2010; 56:361-6;PMID:20843662; http://dx.doi.org/10.1016/j.jjcc.2010.,OADS,/arxiv_data1/oa_pdf/cd/8e/ktmp-03-02-1156215.PMC4964998.pdf
"2, 318 –327 http://dx.doi.org/10.1080/23328940.2016.1159772",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Curr Opin Clin Nutr Metab Care 1999; 6:515-20; http://dx.doi.org/10.1097/00075197-199911000-00015 [2] Vandenbogaerde TJ, Hopkins WG.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Sports Med 2011; 41:773-92; PMID:21846165; http://dx.doi.org/10.2165/11590520-000000000-00000 [3] Sawka MN, Burke LM, Eichner ER, Maughan RJ, Montain SJ, Stachenfeld NS.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Med Sci Sports Exerc 2007; 39:377-90; PMID:17277604;http://dx.doi.org/10.1249/01.mss.0000272779.34140.3b [4] Hawley JA, Burke LM, Angus DJ, Fallon KE, Martin DT, Febbraio MA.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
Br J Nutr 2000; 84:829-38; PMID:11177199; http://dx.doi.org/10.1017/S0007114500002440 [5] Burke LM.,Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Comp Biochem Physiol A Mol Integr Physiol 2001;128:735-48; PMID:11282317; http://dx.doi.org/10.1016/S1095-6433(01)00279-3 [ 6 ] W e n d tD ,v a nL o o nL J ,L i c h t e n b e l tW D .T h e r m o r e g u - lation during exercise in the heat: strategies for main- taining health and perf ormance.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
Sports Med 2007; 37:669-82; PMID:17645370; http://dx.doi.org/10.2165/00007256-200737080-00002 [7] Febbraio MA.,Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
Sports Med 2001; 31:47-59;PMID:11219501; http://dx.doi.org/10.2165/00007256-200131010-00004 [8] Jeukendrup AE.,OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Biochem SocTrans 2003; 31:1270-3; PMID:14641041; http://dx.doi.org/10.1042/bst0311270[9] Yaspelkis BB, Ivy JL.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
J ApplPhysiol 2002; 92:1562-72; PMID:11896023; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"MedSci Sports Exerc 1995; 27:200-10; PMID:7723643; http://dx.doi.org/10.1249/00005768-199502000-00009 [12] Carter J, Jeukendrup AE, Mundel T, Jones DA.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"P ﬂug Arch 2003; 446:211-9; PMID:12739159; http://dx.doi.org/10.1007/s00424-003-1020-4 [13] Febbraio MA, Murton P, Selig SE, Clark SA, Lambert DL, Angus DJ, Carey MF.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
Med Sci Sports Exerc 1996; 28:1380-7;PMID:8933488; http://dx.doi.org/10.1097/00005768-199 611000-00006 [14] Abd-Aziz S. Sago starch and its utilisation.,Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"J Biosci Bio- eng 2002; 94:526-9; PMID:16233345; http://dx.doi.org/10.1016/S1389-1723(02)80190-6 [15] Singhal RS, Kennedy JF, Gopalakrishnan SM, Kaczmarek A.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Carbohyd Polym 2008;72:1-20; http://dx.doi.org/10.1016/j.carbpol.2007.07.043 [16] Goodpaster BH, Costill DL, Fink WJ, Trappe TA, Jozsi AC, Starling RD, Trappe SW.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Int J SportsMed 1996; 17:366-72; PMID:8858409; http://dx.doi.org/10.1055/s-2007-972862 [17] Saris WH, Goodpaster BH, Jeukendrup AE, Brouns F, Halliday D, Wagenmakers AJ.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Am J Agric Biol Sci 2008; 3:639-46;http://dx.doi.org/10.3844/ajabssp.2008.639.646 [19] Sands AL, Leidy HJ, Hamaker BR, Maguire P, Campbell WW.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Nutr Res 2009; 29:383-90; PMID:19628104; http://dx.doi.org/10.1016/j.nutres.2009.05.009 [20] Ahmad H, Singh R, Ghosh AK.",OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
2015; 25 Suppl 1:296-301; PMID:25943681; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Med Sci SportsExerc 1996; 28:266-70; PMID:8775164; http://dx.doi.org/10.1097/00005768-199602000-00017 [23] Rodriguez NR, Di Marco NM, Langley S. American College of Sports Medicine position stand.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
Med Sci Sports Exerc 2009; 41:709-31; PMID:19225360; http://dx.doi.org/10.1249/MSS.0b013e31890eb86 [24] Ramanathan NL.,Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
Int J Sports Med 2005; 26 (Suppl 1):S28-37;PMID:15702454; http://dx.doi.org/10.1055/s-2004-830512 [26] Borg GA. Psychophysical bases of perceived exertion.,OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"Int JSport Med 1991; 12:180-6; PMID:1860741; http://dx.doi.org/10.1055/s-2007-1024664 [29] Stannard SR, Constantini NW, Miller JC.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"J Appl Physiol2010; 108:245-50; PMID:19940093; http://dx.doi.org/10.1152/japplphysiol.91275.2008 [32] Vist GE, Maughan RJ.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
J Physiol 1995; 486:523-31; PMID:7473216; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"J Nutr 1948; 36:41-57; PMID:18868796 [37] Horswill CA, Stofan JR, Lovett SC, Hannasch C. Core temperature and metabolic responses after carbohydrateintake during exercise at 30 degrees C. J Athl Train 2008;43:585-91; PMID:19030136; http://dx.doi.org/10.4085/1062-6050-43.6.585 [38] Fortney SM, Wenger CB, Bove JR, Nadel ER.",Non-OADS,/arxiv_data1/oa_pdf/ee/bf/ktmp-03-02-1159772.PMC4964999.pdf
"2, 199 –207 http://dx.doi.org/10.1080/23328940.2016.1157668",Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Lancet Neurol 2014; 13:924-35;PMID:25142459; http://dx.doi.org/10.1016/S1474-4422(14)70102-4 [2] Lorenz J, Cross DJ, Minoshima S, Morrow TJ, Paulson PE, Casey KL.",OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Neuron 2002; 35:383-93; PMID:12160755; http://dx.doi.org/10.1016/S0896-6273(02)00767-5 [3] Le Bars D, Gozariu M, Cadden SW.",OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"J Pharmacol Methods 1985; 13:351-7; PMID:3927065; http://dx.doi.org/10.1016/0160-5402 (85)90017-8 [5] Ga /C14rdmark M, H €oglund AU, Hammarlund-Udenaes M. Aspects on tail- ﬂick, hot-plate and electrical stimulation tests for morphine antinociception.",OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Pharmacol Toxicol1998; 83:252-8; http://dx.doi.org/10.1111/j.1600-0773.1998.tb01478.x [6] Yalcin I, Charlet A, Freund-Mercier MJ, Barrot M, Pois- beau P. Differentiating thermal allodynia and hyperalge- sia using dynamic hot and cold plate in rodents.",Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"J Pain 2009; 10:767-73; PMID:19409860; http://dx.doi.org/10.1016/j.jpain.2009.01.325 [7] Tj ;lsen A, Rosland JH, Berge OG, Hole K. The increas- ing-temperature hot-plate test: an improved test of noci-ception in mice and rats.",OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"J Pharmacol Methods 1991;25:241-50; PMID:2056753; http://dx.doi.org/10.1016/0160-5402(91)90014-V [8] Hargreaves K, Dubner R, Brown F, Flores C, Joris J.",OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
Pain 1988; 32:77-88;PMID:3340425; http://dx.doi.org/10.1016/0304-3959(88)90026-7 [9] McCarson KE.,Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Neurosci Lett 1998; 254:25-8; PMID:9780083;http://dx.doi.org/10.1016/S0304-3940(98)00648-X [11] Gris G, Merlos M, Vela JM, Zamanillo D, Portillo-Salido E. S1RA, a selective sigma-1 receptor antagonist, inhibitsinﬂammatory pain in the carrageenan and complete Freund ’s adjuvant models in mice.",Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Behav Pharmacol 2014; 25:226-35; PMID:24776490; http://dx.doi.org/10.1097/FBP.0000000000000038 [12] Pertovaara A, Kauppila T, H €am€al€ainen MM.",Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
ExpBrain Res 1996; 107:497-503; PMID:8821389; http://dx.doi.org/10.1007/BF00230429206 J. R. DEUIS AND I. VETTER,Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Experimental diabetes research 2011;2011:848307; PMID:22144990; http://dx.doi.org/10.1155/2011/848307 [14] Harvey VL, Dickenson AH.",Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Molecular Pain 2009; 5:18; PMID:19379487; http://dx.doi.org/10.1186/1744-8069-5-18 [15] O ’Brien DE, Brenner DS, Gutmann DH, Gereau RWT.",Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"J Pain 2013; 14:628- 37; PMID:23578956; http://dx.doi.org/10.1016/j.jpain.2013.01.770 [16] Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions.",OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
Drug discovery today 2015;20:122-8; PMID:25450771; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"Physiol Behav 2001; 72:271-81; PMID:11240006; http://dx.doi.org/10.1016/S0031-9384(00)00405-4 [18] Chillingworth NL, Donaldson LF.",Non-OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"J Neurosci Methods 2003; 128:45-52;PMID:12948547; http://dx.doi.org/10.1016/S0165-0270(03)00147-X [19] Carbone ET, Lindstrom KE, Diep S, Carbone L. Duration of action of sustained-release buprenorphine in 2 strainsof mice.",OADS,/arxiv_data1/oa_pdf/10/10/ktmp-03-02-1157668.PMC4965000.pdf
"2, 208 –219 http://dx.doi.org/10.1080/23328940.2016.1171281",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Br J Sports Med 2007; 41:126-33; PMID:17178778;http://dx.doi.org/10.1136/bjsm.2006.026344 [2] Gant N, Atkinson G, Williams C. The validity and reliabil- ity of intestinal temperature during intermittent running.Med Sci Sports Exerc 2006; 38:1926-31; PMID:17095925; http://dx.doi.org/10.1249/01.mss.0000233800.69776.ef [3] Casa DJ, Becker SM, Ganio MS, Brown CM, Yeargin SW, Roti MW, Siegler J, Blowers JA, Glaviano NR, HugginsRA, et al.",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
J Therm Biol 2007; 32:78-86; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Therm Biol 2012; 37:351-4; http://dx.doi.org/10.1016/j.jtherbio.2011.08.006 [6] Low DA, Vu A, Brown M, Davis SL, Keller DM, Levine BD, Crandall CG.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
Med Sci SportsExerc 2007; 39:1029-35; PMID:17596768; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Br J Sports Med 2006;40:133-8; PMID:16432000; http://dx.doi.org/10.1136/ bjsm.2005.021980 [8] Chapon PA, Gauthier A, Bulla J, Moussay S. Calibration and performance assessment of a temperature sensorprototype using a 1-point calibration procedure.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Rev SciInstrum 2012; 83:114907; PMID:23206089; http://dx.doi.org/10.1063/1.4767244 [9] Chapon PA, Bessot N, Gauthier A, Besnard S, Moussay S. Performance testing of an innovative telemetric tempera- ture sensor in animals.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Therm Biol 2012; 37:255-9; http://dx.doi.org/10.1016/j.jtherbio.2011.08.004 [10] Pearson J, Ganio MS, Seifert T, Overgaard M, Secher NH, Crandall CG.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Med Sci SportsExerc 2012; 44:857-62; PMID:22015711; http://dx.doi.org/10.1249/MSS.0b013e31823d7a2b [11] Teunissen LP, de Haan A, de Koning JJ, Daanen HA.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Physiol Meas 2012; 33:915-24; PMID:22551669;http://dx.doi.org/10.1088/0967-3334/33/6/915 [12] McKenzie JE, Osgood DW.",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Therm Biol 2004; 29:605-11; http://dx.doi.org/10.1016/j.jtherbio.2004.08.020 [13] Drust B, Reilly T, Cable NT.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Sports Sci 2000; 18:885-92; PMID:11144865;http://dx.doi.org/10.1080/026404100750017814 [14] Clarke ND, Maclaren DP, Reilly T, Drust B. Carbohydrate ingestion and pre-cooling improves exercise capacity fol-lowing soccer-speci ﬁc intermittent exercise performed in the heat.",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Eur J Appl Physiol 2011; 111:14471455; http://dx.doi.org/10.1007/s00421-010-1771-5 [15] Bland JM, Altman DG.",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Statistical methods for assessing agreement between two methods of clinical agreement.Lancet 1986; 8:307-10; http://dx.doi.org/10.1016/S0140-6736(86)90837-8 [16] Shrout PE, Fleiss JL.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
Psychol Bull 1979; 86:420-8; PMID:18839484; http://dx.doi.org/10.1037/0033-2909.86.2.420 [17] Hopkins WG.,Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Sports Med 2000; 30:1-15; PMID:10907753;http://dx.doi.org/10.2165/00007256-200030010-00001 [18] Lee SM, Williams WJ, Schneider SM.",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Chronobio Int 2002; 19:579-97; http://dx.doi.org/10.1081/CBI-120004227 [20] Kolka MA, Levine L, Stephenson LA.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Therm Biol 1997; 22:343-9; http://dx.doi.org/10.1016/S0306-4565(97)00032-6 [21] Kolka MA, Quigley MD, Blanchard LA, Toyota DA.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Therm Biol 1993; 18:203-10;http://dx.doi.org/10.1016/0306-4565(93)90004-D [22] Ruddock AD, Tew GA, Purvis AJ.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Strength Cond Res2014; 28:861-9; PMID:24561595; http://dx.doi.org/10.1519/JSC.0b013e3182aa5dd0 [23] Domitrovich JW, Cuddy JS, Ruby BC.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"JAthletic Train 2010; 45:594-600; http://dx.doi.org/ 10.4085/1062-6050-45.6.594 [24] Kenney WL, Stanhewicz AE, Bruning RS, Alexander LM.",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"Eur J Appl Physiol 2014; 114:467-79;PMID:23636697; http://dx.doi.org/10.1007/s00421-013- 2652-5 [25] Rowell LB, Blackmon JR, Bruce RA.",Non-OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"J Clin Invest 1964;43:1677-90; PMID:14201551; http://dx.doi.org/10.1172/JCI105043 [26] Sparling PB, Snow TK, Millard-Stafford M. Monitoring core temperature during exercise: Ingestible sensor vs. rectal thermistor.",OADS,/arxiv_data1/oa_pdf/9e/89/ktmp-03-02-1171281.PMC4965001.pdf
"2, 271 –285 http://dx.doi.org/10.1080/23328940.2016.1148938",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Epidemiol 2009; 20:205; http://dx.doi.org/10.1097/EDE.0b013e318190ee08 [3] Wilson TE, Klabunde RE, Monahan KD.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Therm Biol 2014; 43:24-32; PMID:24956954; http://dx.doi.org/10.1016/j.jtherbio.2014.03.003 [4] To ﬂer GH, Muller JE.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Circulation2006; 114:1863-72; PMID:17060396; http://dx.doi.org/10.1161/CIRCULATIONAHA.105.596189 [5] Kenney WL, Craighead DH, Alexander LM.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Med Sci Sport Exer 2014; 46:1891-9; http://dx.doi.org/10.1249/MSS.0000000000000325 [6] De Blois J, Kjellstrom T, Agewall S, Ezekowitz J, Arm- strong P, Atar D. The effects of climate change on cardiachealth.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Cardiology 2015; 131:209-17; PMID:25997478;http://dx.doi.org/10.1159/000398787 [7] Schlader ZJ, Stannard SR, Mundel T. Human thermoreg- ulatory behavior during rest and exercise - a prospective review.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
Physiol Behav 2010; 99:269-75; PMID:20006632;http://dx.doi.org/10.1016/j.physbeh.2009.12.003 [8] Hardy JD.,OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Eur J Appl Physiol2013; 113:1291-301; PMID:23179204; http://dx.doi.org/ 10.1007/s00421-012-2544-0[12] Schlader ZJ, Prange HD, Mickleborough TD, Stager JM.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
Physiol Behav 2009; 98:557-62;PMID:19748517; http://dx.doi.org/10.1016/j.physbeh.2009.09.002 [13] Romanovsky AA.,OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Am J Physiol Regul Integr Comp Physiol 2007; 292:R37-46; PMID:17008453; http://dx.doi.org/10.1152/ajpregu.00668.2006 [14] Savage MV, Brengelmann GL.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
ArchIntern Med 1916; 73:863-71; http://dx.doi.org/10.1001/archinte.1916.00080130010002 [17] Siri WE.,Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Br J Nutr 1978; 40:497-504;PMID:718832; http://dx.doi.org/10.1079/BJN19780152 [19] Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"The Journal of physiology 2009; 587:3383-92;PMID:19417092; http://dx.doi.org/10.1113/jphysiol.2009.170381 [23] Gobel FL, Norstrom L, Nelson RR, Jorgensen CR, Wang Y.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Circulation 1978; 57:549-56; PMID:624164; http://dx.doi.org/10.1161/01.CIR.57.3.549 [24] Schlader ZJ, Mundel T, Barnes MJ, Hodges LD.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Clin PhysiolFunct Imaging 2010; 30:480 - 4; PMID:20718806; http://dx.doi.org/10.1111/j.1475-097X.2010.00959.x [25] Johnson J, Pergola P, Liao F, Kellogg D, Crandall C. Skin of the dorsal aspect of human hands and ﬁngers possesses an active vasodilator system.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Eur J Appl Physiol2002; 88:141-5; PMID:12436282; http://dx.doi.org/10.1007/s00421-002-0692-3 [27] Rubinstein EH, Sessler DI.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Anesthesiology 1990; 73:541-5; PMID:2393139; http://dx.doi.org/10.1097/00000542-199009000-00027 [28] Hardy CJ, Rejeski WJ.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Environ Res 1967; 1:1-20; PMID:5614624; http://dx.doi.org/10.1016/0013-9351(67) 90002-3 [30] Gagnon D, Kenny GP.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Physiol 2012; 590:5963-73; PMID:23045336;http://dx.doi.org/10.1113/jphysiol.2012.240739 [31] Bain AR, Jay O.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Eur J Appl Physiol 2011; 111:1197-205; PMID:21127900; http://dx.doi.org/10.1007/s00421-010-1743-9 [32] Schlader ZJ, Stannard SR, Mundel T. Evidence for ther- moregulatory behavior during self-paced exercise in theheat.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Therm Biol 2011; 36:390-6; http://dx.doi.org/10.1016/j.jtherbio.2011.07.002 [33] Barber BJ, Crawford EC.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Physiol Zool 1979; 52:250-63; http://dx.doi.org/10.1086/physzool.52.2.30152568 [34] Crandall CG, Wilson TE.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Am J Physiol Regul IntegrComp Physiol 2011; 301:R1510-6; PMID:21832209;http://dx.doi.org/10.1152/ajpregu.00247.2011 [36] Schlader ZJ, Gagnon D, Lucas RA, Pearson J, Crandall CG.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Appl Physiol2015; 118:449-54; PMID:25525210; http://dx.doi.org/ 10.1152/japplphysiol.00800.2014 [37] Dostrovsky JO, Hellon RF.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"JPhysiol 1978; 277:29-47; PMID:650531; http://dx.doi.org/10.1113/jphysiol.1978.sp012258 [38] Minson CT, Wladkowski SL, Cardell AF, Pawelczyk JA, Kenney WL.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Med Sci Sports Exer 2008; 40:2063;PMID:18981943; http://dx.doi.org/10.1249/MSS.0b013e3-18180bc98 [41] Wilson TE, Sauder CL, Kearney ML, Kuipers NT, Leuen- berger UA, Monahan KD, Ray CA.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Appl Physiol 2007; 103:1257-62;PMID:17673561; http://dx.doi.org/10.1152/japplphysiol.00401.2007 [42] Cui J, Durand S, Levine BD, Crandall CG.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Am J Physiol-Heart Circulat Physiol 2005; 289:H2429-H33; PMID:16024573; http://dx.doi.org/10.1152/ajpheart.00383.2005 [43] Greaney JL, Stanhewicz AE, Kenney WL, Alexander LM.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Appl Physiol2014; 117:648-57; PMID:25103970; http://dx.doi.org/10.1152/japplphysiol.00516.2014 [44] Wilson TE, Gao Z, Hess KL, Monahan KD.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
Effect of aging on cardiac function during cold stress in humans.Am J Physiol Regul Integr Comp Physiol 2010; 298:R1627-R33; PMID:20375268; http://dx.doi.org/10.1152/ajpregu.00099.2010 [45] Werner J. Bene ﬁcial and detrimental effects of thermal adaptation.,Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Int J Biometeorol 1992; 36:1-4;PMID:1582717; http://dx.doi.org/10.1007/BF01208726 [47] Charkoudian N. Skin blood ﬂow in adult human thermo- regulation: how it works, when it does not, and why.Mayo Clin Proc 2003; 78:603-12; PMID:12744548;http://dx.doi.org/10.4065/78.5.603 [48] Kamijo Y-I, Lee K, Mack GW.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J ApplPhysiol 2005; 98:829-37; PMID:15489258; http://dx.doi.org/10.1152/japplphysiol.00235.2004 [49] Cranston W, Gerbrandy J, Snell E. Oral, rectal and oeso- phageal temperatures and some factors affecting them inman.",Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Physiol 1954; 126:347; PMID:13222289; http://dx.doi.org/10.1113/jphysiol.1954.sp005214 [50] Nielsen M, Herrington LP, Winslow C-E.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Therm Biol 2006; 31:53-9; http://dx.doi.org/10.1016/j.jtherbio.2005.11.028 [52] Arens E, Zhang H, Huizenga C. Partial- and whole-body thermal sensation and comfort - Part II: Non-uniform284 Z. J. SCHLADER ET AL.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Therm Biol 2006; 31:60-6; http://dx.doi.org/10.1016/j.jtherbio.2005.11.027 [53] Schlader ZJ, Simmons SE, Stannard SR, Mundel T. The independent roles of temperature and thermal perceptionin the control of human thermoregulatory behavior.Physiol Behav 2011; 103:217-24; PMID:21315099; http://dx.doi.org/10.1016/j.physbeh.2011.02.002 [54] Cotter JD, Taylor NA.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Physiol2005; 565:335-45; PMID:15760945; http://dx.doi.org/10.1113/jphysiol.2004.081562 [55] Nakamura M, Yoda T, Crawshaw LI, Yasuhara S, Saito Y, Kasuga M, Nagashima K, Kanosue K. Regional differencesin temperature sensation and thermal comfort in humans.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Appl Physiol 2008; 105:1897-906; PMID:18845785; http://dx.doi.org/10.1152/japplphysiol.90466.2008 [56] Shibasaki M, Wilson TE, Bundgaard-Nielsen M, Seifert T, Secher NH, Crandall CG.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Am J Physiol RegulIntegr Comp Physiol 2011; 300:R486-R91; PMID:21084673;http://dx.doi.org/10.1152/ajpregu.00505.2010 [57] M €undel T, Carter JM, Wilkinson DM, Jones DA.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Build Environ 2011; 46:478-88; http://dx.doi.org/10.1016/j.buildenv.2010.08.011 [59] Mitchell D, Wyndham CH.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"J Physiol 1976; 257:275-91;PMID:985881; http://dx.doi.org/10.1113/jphysiol.1976.sp011368 [62] Gerrett N, Ouzzahra Y, Redortier B, Voelcker T, Havenith G. Female thermal sensitivity to hot and cold during rest and exercise.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Physiol Behav 2015; 152:11-9; PMID:26343771; http://dx.doi.org/10.1016/j.physbeh.2015.08.032 [63] Gerrett N, Ouzzahra Y, Coleby S, Hobbs S, Redortier B, Voelcker T, Havenith G. Thermal sensitivity to warmthduring rest and exercise.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Acta Physiol 2014; 210:498-507; http://dx.doi.org/ 10.1111/apha.12231 [65] Bratincsak A, Palkovits M. Evidence that peripheral rather than intracranial thermal signals induce thermoregulation.Neuroscience 2005; 135:525-32; PMID:16125855; http://dx.doi.org/10.1016/j.neuroscience.2005.06.028 [66] Flouris AD, Cheung SS.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Microcirculation 2011; 18:56-62; PMID:21166926; http://dx.doi.org/10.1111/j.1549-8719.2010.00068.x [67] Almeida M, Vizin R, Carrettiero D. Current understand- ing on the neurophysiology of behavioral thermoregula-tion.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"Temperature 2015; 2:483-90; http://dx.doi.org/10.1080/23328940.2015.1095270 [68] Kenny GP, Yardley J, Brown C, Sigal RJ, Jay O.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"CMAJ 2010; 182:1053-60; PMID:19703915; http://dx.doi.org/10.1503/cmaj.081050 [69] Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, SallisJF, et al.",OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
Med Sci Sports Exerc2003; 35:1381-95; PMID:12900694; http://dx.doi.org/10.1249/01.MSS.0000078924.61453.FBTEMPERATURE 285,Non-OADS,/arxiv_data1/oa_pdf/de/e3/ktmp-03-02-1148938.PMC4965002.pdf
"2, 298 –306 http://dx.doi.org/10.1080/23328940.2016.1156214",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
The relative overlooking of human behav- ioral temperature regulation –A paradox worth resolving Temperature 2014; 1:20-1; http://dx.doi.org/10.4161/ temp.29235[5] Anonymous.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"J Therm Biol 2011; 36:390-6; http://dx.doi.org/ 10.1016/j.jtherbio.2011.07.002 [8] Caputa M, Cabanac M. Muscular work as thermal behav- ior in humans.",OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Physiol Behav 2010; 99:269-75; PMID:20006632;http://dx.doi.org/10.1016/j.physbeh.2009.12.003 [10] Wyss CR, Brengelmann GL, Johnson JM, Rowell LB, Nie- derberger M. Control of skin blood ﬂow, sweating, and heart rate: role of skin vs. core temperature.",OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
Acta Physiol 2014; 210:498-507; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Am J Physiol Regul Integr Comp Physiol 2007;292:R37-46; PMID:17008453; http://dx.doi.org/10.1152/ajpregu.00668.2006 [15] Schlader ZJ, Simmons SE, Stannard SR, M €undel T. Skin temperature as a thermal controller of exercise intensity.",OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Eur J Appl Physiol 2011; 111:1631-9; PMID:21197543; http://dx.doi.org/10.1007/s00421-010-1791-1 [16] Schlader ZJ, Simmons SE, Stannard SR, M €undel T. The independent roles of temperature and thermal perceptionin the control of human thermoregulatory behavior.Physiol Behav 2011; 103:217-24; PMID:21315099; http://dx.doi.org/10.1016/j.physbeh.2011.02.002 [17] Arens E, Zhang H, Huizenga C. Partial-and whole-body thermal sensation and comfort –Part I: Uniform environ- mental conditions.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"J Therm Biol 2006; 31:53-9; http://dx.doi.org/10.1016/j.jtherbio.2005.11.028 [18] Nakamura M, Yoda T, Crawshaw LI, Yasuhara S, Saito Y, Kasuga M, Nagashima K, Kanosue K. Regional differencesin temperature sensation and thermal comfort in humans.J Appl Physiol 2008; 105:1897-906; PMID:18845785;http://dx.doi.org/10.1152/japplphysiol.90466.2008 [19] Nakamura M, Yoda T, Crawshaw LI, Kasuga M, Uchida Y, Tokizawa K, Nagashima K, Kanosue K. Relative importanceTEMPERATURE 305",OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Eur J Appl Physiol 2013; 113:63-76; PMID:22569893; http://dx.doi.org/10.1007/s00421-012-2406-9 [20] Cotter JD, Taylor NAS.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"J Physiol2005; 565:335-45; PMID:15760945; http://dx.doi.org/ 10.1113/jphysiol.2004.081562 [21] Dubois D, Dubois EF.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
ArchsIntern Med 1916; 17:863-71; http://dx.doi.org/10.1001/archinte.1916.00080130010002 [22] Siri WE.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
Br J Nutr 1978; 40:497-504;PMID:718832; http://dx.doi.org/10.1079/BJN19780152 [24] Kenney WL.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
Int J Sports Med 1998; 19:S92-95; PMID:9694407; http://dx.doi.org/10.1055/s-2007-971966 [25] Ramanathan NL.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Environ Res 1967; 1:1-20; PMID:5614624; http://dx.doi.org/10.1016/0013-9351(67) 90002-3 [28] Barcroft J, Verzar F. The effect of exposure to cold on the pulse rate and respiration of man.",OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"J Physiol 1931; 71:373-80; PMID:16994186; http://dx.doi.org/10.1113/jphysiol.1931.sp002742 [29] Cabanac M, Bleichert R, Massonnet B.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
Physiol Behav 2009; 98:557-62;PMID:19748517; http://dx.do i.org/10.1016/j.physbeh.,OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Eur J Appl Physiol2013; 113:1291-301; PMID:23179204; http://dx.doi.org/10.1007/s00421-012-2544-0 [32] Cabanac M, Cunningham DJ, Stolwijk JA.",OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
JComp Physiol Psychol 1971; 76:94-102; PMID:5571306;http://dx.doi.org/10.1037/h0031050 [33] Satinoff E. Behavioral thermoregulation in the cold.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
Ann N YAcad Sci 2011; 1225:72-82; PMID:21534994; http://dx.doi.org/10.1111/j.1749-6632.2011.05990.x [35] Cabanac M. Sensory pleasure.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Q Rev Biol 1979; 54:l-29; http://dx.doi.org/10.1086/410981 [36] Cabanac M, Caputa M. Natural selective cooling of the human brain: evidence of its occurrence and magnitude.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
J Physiol 1979; 286:255-64; PMID:439025; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"JPhysiol 1979; 286:163-74; http://dx.doi.org/10.1113/jphysiol.1979.sp012730 [38] White MD, Greiner JG, McDonald PLL, Nybo L, Secher NH.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
J Appl Physiol 2011; 110:569-74; PMID:20798268; http://dx.doi.org/10.1152/japplphysiol.00992.2010 [39] Simon E. Tympanic temperature is not suited to indicate selective brain cooling in humans: a re-evaluation of thethermophysiological basics.,Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"Eur J Appl Physiol 2007;101:19-30; PMID:17534647; http://dx.doi.org/10.1007/s00421-007-0449-0 [40] M €undel T, Carter JM, Wilkinson DM, Jones DA.",Non-OADS,/arxiv_data1/oa_pdf/6a/eb/ktmp-03-02-1156214.PMC4965003.pdf
"2, 307 –317 http://dx.doi.org/10.1080/23328940.2016.1156801",Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Military Med 2004; 169:184-6; PMID:15080235; http://dx.doi.org/10.7205/MILMED.169.3.184 [3] Rav-Acha M, Hadad E, Epstein Y, Heled Y, Moran DS.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
Am J Med Sci 2004; 328:84-7; PMID:15311166; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
Occup Med 1996; 46:304-12; PMID:8854710; http://dx.doi.org/10.1093/occmed/46.4.304 [5] Goldman RF.,Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"J Thermal Biol 1997; 22:331-42; http://dx.doi.org/10.1016/S0306-4565 (97)00031-4 [11] Montain SJ, Sawka MN, Cadarette BS, Quigley MD, McKay JM.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Med Sci Sports Exerc 2001; 33:422-30;PMID:11252069; http://dx.doi.org/10.1097/00005768-200103000-00014 [13] Sawka MN, Young AJ, Latzka WA, Neufer PD, Quigley MD, Pandolf KB.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Eur J Appl Physiol 1990; 61:419-27; http://dx.doi.org/10.1007/BF00236062 [15] Lisman P, Kazman JB, O ’Connor F, Heled Y, Duester PA. Heat tolerance testing: Association between heat intoler- ance and anthropometric and ﬁtness measurements.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Mil Med 2014; 179:1339-46; PMID:25373064; http://dx.doi.org/10.7205/MILMED-D-14-00169 [16] Coso JD, Hamouti N, Ortega J, Fernandez-Elias V, Mora-Rodriguez R. Relevance of individual character-istics for thermoregulation during exercise in a hot-dry environment.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Eur J Appl Physiol 2011; 111:2173-81; PMID:21305382; http://dx.doi.org/10.1007/s00421- 011-1847-x [17] Ely BR, Ely MR, Cheuvront SN, Kene ﬁck RW, DeGroot DW, Montain SJ.",Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"J Appl Physiol2009; 107:1519-25; PMID:19713430; http://dx.doi.org/10.1152/japplphysiol.00577.2009 [18] Nolte HW, Noakes TD, van Vuuren B.",Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"J Sports Sci 2011; 29:1233-41; PMID:21780852; http://dx.doi.org/10.1080/02640414.2011.587195 [19] Lee JKW, Nio AQX, Lim CL, Teo EYN, Bryne C. Ther- moregulation, pacing and ﬂuid balance during mass par- ticipantion distance running in a warm and humidevnrionment.",Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Eur J Appl Physiol 2010; 109:887-98;PMID:20237797; http://dx.doi.org/10.1007/s00421-010-1405-y [20] Ramsbottom R, Brewer J, Williams C. A progressive shuttle run test to estimate maximal oxygen uptake.",Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
Sports Med 1988; 22:141-4; PMID:3228681; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Mi litary Psychol 1994; 6:215- 33; http://dx.doi.org/10.1207/s15327876mp0604_2 [25] Gonzalez-Alonso J, Teller C, Andersen SL, Jensen FB, Hyldig T, Nielsen B.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"J Thermal Biol 2003;28:381-4; http://dx.do i.org/10.1016/S0306-4565(03) 00021-4 [27] Fukazawa T, Havenith G. Differences in comfort percep- tion in relation to local and whole body skin wettedness.Eur J Appl Physiol 2009; 106:15-24; PMID:19159949;http://dx.doi.org/10.1007/s00421-009-0983-z[28] Greenleaf JE.",Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Med Sci Sports Exerc 1992;24:645-56; PMID:1602937; http://dx.doi.org/10.1249/00005768-199206000-00007 [29] Wessely S, Nickson J, Cox B.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
Med Sci SportsExerc 1999; 31:224-8; PMID:10063810; http://dx.doi.org/10.1097/00005768-199902000-00004 [31] Wyndham CH.,Non-OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Ergonomics 1978; 21:455-62; PMID:679933; http://dx.doi.org/ 10.1080/00140137808931742 [33] Buller MJ, Welles AP, Stevens M, Leger J, Gribok A, Jen- kins OC, Friedl KE, Rumpler W. Automated guidancefrom phsyiological sensing to reduce thermal-work strainlevels on a novel task.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"Comp Biochem Physiol A Mol Integr Physiol 2001;128:691-700; http://dx.doi.org/10.1016/S1095-6433(01)00275-6 [35] Wallace RF, Kriebel D, Punnett L, Wegman DH, Wenger CB, Gardner JW, Kark JA.",OADS,/arxiv_data1/oa_pdf/41/4b/ktmp-03-02-1156801.PMC4965006.pdf
"2, 340 –353 http://dx.doi.org/10.1080/23328940.2016.1163452",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
Biol Rev 2009; 84:413 –29; PMID:19485986; http://dx.doi.org/10.1111/j.1469-185X.2009.00080.x [2] Gates DM.,OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"J Animal Ecol 1987;56:751 –61; http://dx.doi.org/10.2307/4946 [7] Austin MP, Nicholls AO, Margules CR.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Ecological Monographs 1990; 60:161 –77; http://dx.doi.org/10.2307/1943043 [8] Kearney M, Porter WP.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Ecology 2004; 85:3119 –31; http://dx.doi.org/ 10.1890/03-0820 [9] Elith J, Graham CH, Anderson RP, Dud /C19ık M, Ferrier S, Guisan A, Hijmans RJ, Huettmann F, Leathwick JR, Leh-mann A, et al.",OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
Ecogeography 2006; 29:129 –51; http://dx.doi.org/10.1111/j.2006.0906- 7590.04596.x [10] Dawson T. Kangaroos.,Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Australian Mammal2004; 26:135 –44; http://dx.doi.org/10.1071/AM04135 [12] McCarron HCK, Buffenstein R, Fanning FD, Dawson TJ.",OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"J Comparative Physiol B- Biochem Systemic Environmental Physiol 2001; 171:401 –11; http://dx.doi.org/10.1007/s003600100189 [13] Brown GD, Dawson TJ.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Comparative Biochem Physiology Part A:Physiology 1977; 56:59 –67; http://dx.doi.org/10.1016/ 0300-9629(77)90442-X [14] Munn AJ, Skeers P, Kalkman L, McLeod SR, Dawson TJ.",OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"JZool 2010; 282:226 –37; http://dx.doi.org/10.1111/j.1469- 7998.2010.00740.x [17] McCullough DR, McCullough Y. Kangaroos in outback Australia: comparative ecology and behavior of three co-existing species.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Biogeography 1990; 17:279 –89; http://dx.doi.org/ 10.2307/2845124 [20] Ritchie EG, Bolitho EE.",OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
Physiol BiochemZool 2008; 81:880 –90; PMID:18937565; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"J Mammal 1964;45:429 –36; http://dx.doi.org/10.2307/1377416 [22] Dawson TJ, Denny MJS, Russell EM, Ellis B.",OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"JZool 1975; 177:1 –23; http://dx.doi.org/10.1111/j.1469- 7998.1975.tb05968.x [23] Dawson TJ, McTavish KJ, Munn AJ, Holloway J.",OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
Wildlife Res 1986;13:113 –20; http://dx.doi.org/10.1071/WR9-860113 [27] Dawson TJ.,Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
Com-parative Biochem Physiol 1973; 46:153 –69; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Ecology 1969; 50:328&; http://dx.doi.org/10.2307/1934861 [29] Dawson TJ, McTavish KJ, Ellis BA.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Canberra, Australia, Centre for Australian Weather and ClimateResearch (Bureau of Meteorology and CSIRO) Availableat http://www.csiro.au/awap Accessed June 2011; 22:2011 [33] Jones DA, Wang W, Fawcett R. High-quality spatial cli- mate data-sets for Australia.",OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Australian Wildlife Res 1984; 11:1 – 10; http://dx.doi.org/10.1071/WR9840001 [39] Mykytowycz R, Nay T. Studies of the cutaneous glands and hair follicles of some species of Macropodidae.CSIRO Wildlife Res 1964; 9:200 –17; http://dx.doi.org/ 10.1071/CWR9640200 [40] Coulson G, MacFarlane A, Parsons S, Cutter J. Evolution of sexual segregation in mammalian herbivores:352 J.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Australian J Zool 2006; 54:217 –24; http://dx.doi.org/10.1071/ZO05062 [41] Mayland H, Mertens D, Taylor T, Burns J, Fisher D, Gregorini P, Ciavarella T, Smith K, Shewmaker G, GriggsT.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/ktmp-03-02-1163452.PMC4965007.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume:8, Issue:6, Pages:2458-2465,DOI:http://dx.doi.org/10.19082/ 2458 Corresponding author: Assistant Professor Dr. Mohammad Khammarnia, Department of Public Health, Zahedan University of Medical Sciences, Zahedan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/05/90/epj-08-2458.PMC4965194.pdf
"http://www.ephysician.ir Page2460trustworthiness and rigor, their credibility was ensured by using peer check (check data by other researchers) and member check (check data by other participants) and continuous data analysis (transcribing interviews on paper and reviewing them to develop the mai n themes).",OADS,/arxiv_data1/oa_pdf/05/90/epj-08-2458.PMC4965194.pdf
http://www.ephysician.ir Page24623.2.1.,Non-OADS,/arxiv_data1/oa_pdf/05/90/epj-08-2458.PMC4965194.pdf
http://www.ephysician.ir Page2464and creating and fostering a culture of manager training in hospi tals and universities are recommended to promote hospital managers’ skills.,Non-OADS,/arxiv_data1/oa_pdf/05/90/epj-08-2458.PMC4965194.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician .ir June2016, Volume: 8, Issue:6, Pages:2466-2474,DOI:http://dx.doi.org/10.19082/ 2466 Corresponding author: Associate Professor Dr. Seyed Mohammad Jazayeri, Clinical Virologist, Hepatitis B Lab -Dept.",Non-OADS,/arxiv_data1/oa_pdf/4d/fd/epj-08-2466.PMC4965195.pdf
http://www.ephysician.ir Page2468virological response.,Non-OADS,/arxiv_data1/oa_pdf/4d/fd/epj-08-2466.PMC4965195.pdf
http://www.ephysician.ir Page24703.3.,Non-OADS,/arxiv_data1/oa_pdf/4d/fd/epj-08-2466.PMC4965195.pdf
"http://www.ephysician.ir Page2472patients who responded partially to the sequential administration of LAM and ADV, LAM and ADV in combination, and monotherapy treatment regimens.",Non-OADS,/arxiv_data1/oa_pdf/4d/fd/epj-08-2466.PMC4965195.pdf
"http://www.ephysician.ir Page247431)Ghany MG, Feld JJ, Zhao X, Heller T, Doo E, Rotman Y, et al.",OADS,/arxiv_data1/oa_pdf/4d/fd/epj-08-2466.PMC4965195.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2475-2482,DOI:http://dx.doi.org/10.19082/ 2475 Corresponding author: Associate Professor Dr. Amir Shahram Yousefi Kashi, Shohada -e-Tajrish Hospital, Department of Radiation Oncology, Faculty of Medicine, Shahid Behesht i University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
"http://www.ephysician.ir Page2476differences were st atistically significant (p<0.001, p<0.001, respectively).",OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
Clinical Trial Registration: The study was registered in the Iranian Clinical Trial Registry Center (http://www.irct.ir) with the registration code: IRCT2015081423426N1.,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
"Analysis of the characteristics and composition of processed honey and royal jelly was done in Kimiafaam (http://en.kimiafaam.com/bee.php), which is the reference laboratory of the ministry of health.",OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
http://www.ephysician.ir Page2478randomly into the two groups: 26 participants to processed honey and royal jelly and 26 participants to pure honey group of the same shape.,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
"http://www.ephysician.ir Page2480Coenzyme Q 10, L -Carnitine and guarana have been evaluated in placebo -controlled trials for CRF; however, they have been found to be no more helpful than placebos (31).",Non-OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
Clinical Trial Registration: The study was registered i n the Iranian Clinical Trial Registry Center (http://www.irct.ir) with the registration code: IRCT2015081423426N1.,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
"http://www.ephysician.ir Page248222)Oka H, Emori Y, Kobayashi N, Hayashi Y, Nomoto K.Suppression of allergic reactions by royal jelly in association wit h the restoration of macrophage function and the improvement of Th1/Th2 cell responses.",Non-OADS,/arxiv_data1/oa_pdf/2b/d4/epj-08-2475.PMC4965196.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2483-2488,DOI:http://dx.doi.org/10.19082/ 2483 Corresponding author: Dr. Sameh Abou Zeid, Department of Nephrology, Theodor Bilharz Research Institute, Cairo, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/a2/7f/epj-08-2483.PMC4965197.pdf
http://www.ephysician.ir Page2484(3).,Non-OADS,/arxiv_data1/oa_pdf/a2/7f/epj-08-2483.PMC4965197.pdf
"http://www.ephysician.ir Page2486the 1α-hydroxylase enzyme in the kidney converts into 1,25(OH) 2vitamin D, the active form of vitamin D. Declining renal function is associated with reduction of renal production of 1,25(OH) 2vitamin D. However, it was discovered later that, apart from the kidney, many other organs are also able to produce 1,25(OH) 2vitamin D locally, which clearly depends on availability of the substrate vitamin D (20).",Non-OADS,/arxiv_data1/oa_pdf/a2/7f/epj-08-2483.PMC4965197.pdf
"http://www.ephysician.ir Page248818)Pecovnik-Balon B, Jakopin E, B evc S, Knehtl M, Gorenjak M. Vitamin D as a Novel Nontraditional Risk Factor for Mortality in Hemodialysis Patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/7f/epj-08-2483.PMC4965197.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2489-2496,DOI:http://dx.doi.org/10.19082/ 2489 Corresponding author: Professor Dr. Masoumeh Simbar, Department of Midwifery & Reproductive Health, School of Nursing & Midwifery, Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/35/2d/epj-08-2489.PMC4965198.pdf
"http://www.ephysician.ir Page2490promotion of sexual health should enhance sexual and emotional well -being and help people to reduce the risk of sexually-transmitted diseases (STDs), HIV, and unw anted pregnancies (4).",Non-OADS,/arxiv_data1/oa_pdf/35/2d/epj-08-2489.PMC4965198.pdf
http://www.ephysician.ir Page2492participants’ perspectives and experiences revealed that the definition of sexual health from the view of participants was having sexual intercourse without the risk of contracting sexually -transmitted disease.,Non-OADS,/arxiv_data1/oa_pdf/35/2d/epj-08-2489.PMC4965198.pdf
"http://www.ephysician.ir Page2494build a website for sexual health education; then, ordinary people can safely use it"" (a 32 -year-old man, Master of electronics, employee).",Non-OADS,/arxiv_data1/oa_pdf/35/2d/epj-08-2489.PMC4965198.pdf
"Available from: http://www.who.int/healthpromotion/conferences/previous/ottawa/en/ 8)Haberland N, Rogow D. Sexuality education: emerging trends in evidence and practice.",Non-OADS,/arxiv_data1/oa_pdf/35/2d/epj-08-2489.PMC4965198.pdf
"http://www.ephysician.ir Page249613)DeJong J, Jawad R, Mortagy I, Shepard B.",Non-OADS,/arxiv_data1/oa_pdf/35/2d/epj-08-2489.PMC4965198.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2497-2505,DOI:http://dx.doi.org/10.19082/ 2497 Corresponding author: Assistant Professor Dr. Abbas Shahsavani, Environmental and Occupational Hazards Control Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6e/27/epj-08-2497.PMC4965199.pdf
http://www.ephysician.ir Page24981.,Non-OADS,/arxiv_data1/oa_pdf/6e/27/epj-08-2497.PMC4965199.pdf
http://www.ephysician.ir Page2500Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/27/epj-08-2497.PMC4965199.pdf
http://www.ephysician.ir Page250214.36 Bq/m3and the effective annual dose was 2.11 mSv.,Non-OADS,/arxiv_data1/oa_pdf/6e/27/epj-08-2497.PMC4965199.pdf
http://www.ephysician.ir Page25042)UNSCAR.,Non-OADS,/arxiv_data1/oa_pdf/6e/27/epj-08-2497.PMC4965199.pdf
Available from: http://www.ama r.org.ir/Portals/1/Iran/Atlas_Census_2011.pdf.,OADS,/arxiv_data1/oa_pdf/6e/27/epj-08-2497.PMC4965199.pdf
"Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2506-2514,DOI:http://dx.doi.org/10.19082/ 2506 Corresponding author: AssociateProfessor Dr. Batoul Ahmadi, Department of Health Management and Ec onomics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/15/71/epj-08-2506.PMC4965200.pdf
http://www.ephysician.ir Page25082.,Non-OADS,/arxiv_data1/oa_pdf/15/71/epj-08-2506.PMC4965200.pdf
"http://www.ephysician.ir Page2510variables, and the relationships between them were adjusted as the software suggested, thereby improving the fit index.",OADS,/arxiv_data1/oa_pdf/15/71/epj-08-2506.PMC4965200.pdf
"http://www.ephysician.ir Page2512health for citizens, which some authors have emphasized (17, 30, 39).",Non-OADS,/arxiv_data1/oa_pdf/15/71/epj-08-2506.PMC4965200.pdf
Available from: http://www.who.int/hpr/archive/docs/almaata.html 3)Department of Health.,OADS,/arxiv_data1/oa_pdf/15/71/epj-08-2506.PMC4965200.pdf
"Available from: http://www.uhs.nhs.uk/ 14)Maloff B, Bilan D, Thurston W. Enhancing public input into decision making: Development of the Calgary Regional Health Authority public participation model.",Non-OADS,/arxiv_data1/oa_pdf/15/71/epj-08-2506.PMC4965200.pdf
"http://www.ephysician.ir Page251430)Barnes M, Coelho VS. Social participa tion in health in Brazil and England: inclusion, representation and authority.",Non-OADS,/arxiv_data1/oa_pdf/15/71/epj-08-2506.PMC4965200.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.e physician.ir June2016, Volume: 8, Issue:6, Pages:2515-2523,DOI:http://dx.doi.org/10.19082/ 2515 Corresponding author: Akbar Babaei Heydarabadi, Department of Public Health, School of Health, Student’s Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
"http://www.ephysician.ir Page2516time spent were 20 km and 50 minutes, respectively (8).",OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
http://www.ephysician.ir Page2518active participation of people are some examples of participation that are very effective in the success and efficiency of a program.,Non-OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
http://www.ephysician.ir Page2520neglecting the audience's views in planning (34).,Non-OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
[Cited 2013 Sept 28]; Available from: http://en.wikipedia.org/wiki/Commuting.,Non-OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
[Cited 2013 Sept 1]; Available from: http://www.oxforddictionaries.com/definition/englis h/commute.,Non-OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
[Cit ed 2013 Sept 28]; Available from: http://ilna.ir/news/news.cfm?id=131332.,OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
"http://www.ephysician.ir Page252217)Ohrling K, Hal lberg IR.",Non-OADS,/arxiv_data1/oa_pdf/66/8d/epj-08-2515.PMC4965201.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2524-2530,DOI:http://dx.doi.org/10.19082/ 2524 Corresponding author: Zahra Sadat Dibaji F orooshani, Department of Nursing, School of Nursing and Midwifery, Tehran University of Medical Sciences, International Campus (TUMS-IC), Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b5/dc/epj-08-2524.PMC4965202.pdf
http://www.ephysician.ir Page2526depending on its flow.,OADS,/arxiv_data1/oa_pdf/b5/dc/epj-08-2524.PMC4965202.pdf
http://www.ephysician.ir Page2528problems of the nursing profession.,Non-OADS,/arxiv_data1/oa_pdf/b5/dc/epj-08-2524.PMC4965202.pdf
"2009, Available from: http://www.ils.unc.edu/~yanz/Content%20analysis.pdf 18)Rezaei-Adaryani M, Salsali M, Mohammadi E. Nursing image: an evolutionary concept analysis.",Non-OADS,/arxiv_data1/oa_pdf/b5/dc/epj-08-2524.PMC4965202.pdf
"http://www.ephysician.ir Page253020)Ravari A, Bazargan M, Vanaki Z, Mirzaei T. Job satisfaction among Iranian hospital -based practicing nurses: examining the influence of self -expectation, social interaction and organisational situations.",Non-OADS,/arxiv_data1/oa_pdf/b5/dc/epj-08-2524.PMC4965202.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephys ician.ir June2016, Volume: 8, Issue:6, Pages:2531-2538,DOI:http://dx.doi.org/10.19082/ 2531 Corresponding author: Assistant Professor Dr. Zahra Hadian, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/d8/10/epj-08-2531.PMC4965203.pdf
"http://www.ephysician.ir Page2532Diverse methods can be used to improve the barrier properties of natural polymers, including the use of polymer blends, high -barrier coating materials, and multi -layered films that cont ain a high -barrier film (5).",Non-OADS,/arxiv_data1/oa_pdf/d8/10/epj-08-2531.PMC4965203.pdf
http://www.ephysician.ir Page2534products due to false estimation of product condition during storage.,Non-OADS,/arxiv_data1/oa_pdf/d8/10/epj-08-2531.PMC4965203.pdf
"http://www.ephysician.ir Page2536Acknowledgments: The authors thank the staff at the National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences for their incredible support.",Non-OADS,/arxiv_data1/oa_pdf/d8/10/epj-08-2531.PMC4965203.pdf
"http://www.ephysician.ir Page253844)Liau S, Read D, P ugh W, Furr J, Russell A. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterialaction of silver ions.",OADS,/arxiv_data1/oa_pdf/d8/10/epj-08-2531.PMC4965203.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2539-2542,DOI:http://dx.doi.org/10.19082/ 2539 Corresponding author: Associate Professor Dr. Mojga n Safari, Department of Immunology and Allergy, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/a8/ba/epj-08-2539.PMC4965204.pdf
http://www.ephysician.ir Page2540from the patient (1).,Non-OADS,/arxiv_data1/oa_pdf/a8/ba/epj-08-2539.PMC4965204.pdf
"http://www.ephysician.ir Page254212)Taskapan O, Kutlu A, KarabudakO.Evaluation of autologous serum skin test results in patients with chronic idiopathic urticaria, allergic ⁄ non-allergic asthma or rhinitis and healthy people.",Non-OADS,/arxiv_data1/oa_pdf/a8/ba/epj-08-2539.PMC4965204.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysi cian.ir June2016, Volume: 8, Issue:6, Pages:2543-2545,DOI:http://dx.doi.org/10.19082/ 2543 Corresponding author: Assistant Professor Dr. Saeed Safari, Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/01/0a/epj-08-2543.PMC4965205.pdf
http://www.ephysician.ir Page25442.,Non-OADS,/arxiv_data1/oa_pdf/01/0a/epj-08-2543.PMC4965205.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8,Issue:6, Pages:2546-2550,DOI:http://dx.doi.org/10.19082/ 2546 Corresponding author: Assistant Professor Dr. Abdel Hakeem Abdel Mohsen, Department of Pediatrics, Faculty of Medicine, Al Minia University, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/8b/1b/epj-08-2546.PMC4965206.pdf
http://www.ephys ician.ir Page2548for the need for CS.,Non-OADS,/arxiv_data1/oa_pdf/8b/1b/epj-08-2546.PMC4965206.pdf
Available from: http://www.update.com.search.sti.eg:2048.,Non-OADS,/arxiv_data1/oa_pdf/8b/1b/epj-08-2546.PMC4965206.pdf
Available from: http://emedicine.medscape.com/article/262679 -overview.,Non-OADS,/arxiv_data1/oa_pdf/8b/1b/epj-08-2546.PMC4965206.pdf
"http://www.ephys ician.ir Page25508)LeRoith D, Werner H, Beitner -Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin - Like growth factor I receptor.",OADS,/arxiv_data1/oa_pdf/8b/1b/epj-08-2546.PMC4965206.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2551-2556,DOI:http://dx.doi.org/10.19082/ 2551 Corresponding author: Professor Dr. Abolghasem Pourreza, Department of Management & Health Economic, School of Public Health, Tehran University of Medical Science, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/25/01/epj-08-2551.PMC4965207.pdf
"http://www.ephysician.ir Page2552migration, and, ove rall, the size and structure of the population of a country (2).",OADS,/arxiv_data1/oa_pdf/25/01/epj-08-2551.PMC4965207.pdf
http://www.ephysician.ir Page2554Table 3.Results of panel least squares of fixed effects (Dependent variable: LTFR) Variables Coefficient t-Statistic Prob.,OADS,/arxiv_data1/oa_pdf/25/01/epj-08-2551.PMC4965207.pdf
Available from: https://data.oecd.org/pop/fertility -rates.htm.,OADS,/arxiv_data1/oa_pdf/25/01/epj-08-2551.PMC4965207.pdf
Available from: http://www.un.org/esa/population/publications/wpp2006/wpp2006.htm.,Non-OADS,/arxiv_data1/oa_pdf/25/01/epj-08-2551.PMC4965207.pdf
http://www.ephysician.ir Page25567)Statistical Center of Iran.,Non-OADS,/arxiv_data1/oa_pdf/25/01/epj-08-2551.PMC4965207.pdf
Available from: https://www.amar.org.ir/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/25/01/epj-08-2551.PMC4965207.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2557-2567,DOI:http://dx.doi.org/10.19082/ 2557 Corresponding author: Assistant Professor Dr. Mona Fattouh Mohamed Shalaby, Department of Medical Microbiology and Immunology, Faculty of Medicine, Sohag University, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/ef/a6/epj-08-2557.PMC4965208.pdf
http://www.ephysician.ir Page2558disseminated disease.,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/epj-08-2557.PMC4965208.pdf
"http://www.ephysician.ir Page2560To obtain a sample for microscopic fungal identification, a small piece of clear acetate tape was gently touched to the surface of the fungal colony, and then the ta pe was carefully applied to a glass slide over of a drop of methylene blue stain; the slide was examined under 10X and 40X magnification to identify the characteristic dermatophyte conidia and fungal hyphae (Figures 4 -7).",Non-OADS,/arxiv_data1/oa_pdf/ef/a6/epj-08-2557.PMC4965208.pdf
http://www.ephysician.ir Page25622.5.,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/epj-08-2557.PMC4965208.pdf
http://www.ephysician.ir Page2564Table6.Distribution of antifungal susceptibility pattern of different dermatophy tespecies The tested antifungal drugMicrosporum canisMicrosporum gypseumT.,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/epj-08-2557.PMC4965208.pdf
http://www.ephysician.ir Page25665.,Non-OADS,/arxiv_data1/oa_pdf/ef/a6/epj-08-2557.PMC4965208.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2568-2575,DOI:http://dx.doi.org/10.19082/ 2568 Corresponding author: Assistant Professor Dr. Sepideh Miraj.",Non-OADS,/arxiv_data1/oa_pdf/04/2f/epj-08-2568.PMC4965209.pdf
http://www.ephysician.ir Page2570abortificient effects of Lawsonia inermis leaves was found.,OADS,/arxiv_data1/oa_pdf/04/2f/epj-08-2568.PMC4965209.pdf
http://www.ephysician.ir Page2572case groups.,Non-OADS,/arxiv_data1/oa_pdf/04/2f/epj-08-2568.PMC4965209.pdf
"http://www.ephysician.ir Page257414)Pradhan R, Dandawate P, Vyas A, Padhye S, Biersack B, Schobert R, et al.",Non-OADS,/arxiv_data1/oa_pdf/04/2f/epj-08-2568.PMC4965209.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2576-2585,DOI:http://dx.doi.org/10.19082/ 2576 Correspondi ng author: Maryam Erfanmanesh, Department of Agriculture and Plant Breeding, Faculty of Agriculture, Zanjan University, Zanjan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/1a/61/epj-08-2576.PMC4965210.pdf
http://www.ephysician.ir Page25782.3.,Non-OADS,/arxiv_data1/oa_pdf/1a/61/epj-08-2576.PMC4965210.pdf
http://www.ephysician.ir Page2580 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/1a/61/epj-08-2576.PMC4965210.pdf
http://www.ephysician.ir Page2582The LAMP assay is a highly sensitive and specific approach to detect EHEC O157:H7 in which facilitated laboratories are not needed to conduct the test.,Non-OADS,/arxiv_data1/oa_pdf/1a/61/epj-08-2576.PMC4965210.pdf
"http://www.ephysician.ir Page258427)Meng J, Zhao S, Doyle MP, Mitchell SE, Kresovich S. Polymerase chain reaction for detecting Escherichia coli O157: H7.",Non-OADS,/arxiv_data1/oa_pdf/1a/61/epj-08-2576.PMC4965210.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2586-2590,DOI:http://dx.doi.org/10.19082/ 2586 Corresponding author: Professor Dr. Bhargav Dave, 2804 Field Hollow Dr, Pearland, Texas, USA 77584.",Non-OADS,/arxiv_data1/oa_pdf/83/df/epj-08-2586.PMC4965211.pdf
http://www.ephysician.ir Page25882.6.,Non-OADS,/arxiv_data1/oa_pdf/83/df/epj-08-2586.PMC4965211.pdf
"http://www.ephysician.ir Page2590Acknowledgments: Andrea Braakhuis (ISAK level 3 criterion anthropometrist) and Manish Patel (President, Manish Therapy Services) .",Non-OADS,/arxiv_data1/oa_pdf/83/df/epj-08-2586.PMC4965211.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir June2016, Volume: 8, Issue:6, Pages:2591-2594,DOI:http://dx.doi.org/10.19082/ 2591 Corresponding author: Dr. Amir Anushiravani, Department of Internal Medicine, Faculty of Medicine, Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b6/a0/epj-08-2591.PMC4965212.pdf
http://www.ephysician.ir Page2592ventilation/perfusion rates.,Non-OADS,/arxiv_data1/oa_pdf/b6/a0/epj-08-2591.PMC4965212.pdf
"http://www.ephysician.ir Page25944)Vinton DT, Capp R, Rooks SP, Abbott JT, Ginde AA.",OADS,/arxiv_data1/oa_pdf/b6/a0/epj-08-2591.PMC4965212.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/27/2d/prbm-9-171.PMC4965219.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/27/2d/prbm-9-171.PMC4965219.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/27/2d/prbm-9-171.PMC4965219.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 171–178Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 171 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S108036 A psychometric appraisal of the Jefferson Scale of  Empathy using law students Brett Williams1  Adiva Sifris2  Marty Lynch1 1Department of Community  Emergency Health and Paramedic  Practice, Faculty of Medicine, Nursing and Health Sciences,  2Faculty of Law,   Monash University, Frankston, VIC,  AustraliaBackground: A growing body of literature indicates that empathic behaviors are positively  linked, in several ways, with the professional performance and mental well-being of lawyers  and law students.",Non-OADS,/arxiv_data1/oa_pdf/27/2d/prbm-9-171.PMC4965219.pdf
"Theorists within allied health and helping professions have long accepted Correspondence: Brett Williams Department of Community Emergency Health and Paramedic Practice, Monash University – Peninsula Campus, McMahons Road, PO Box 527, Frankston, VIC 3199, Australia Tel +61 3 9904 4283   Fax +61 3 9904 4168   Email brett.williams@monash.eduJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Williams et alRunning head recto: JSE-L-S as a reliable measure of empathyDOI: http://dx.doi.org/10.2147/PRBM.S108036",Non-OADS,/arxiv_data1/oa_pdf/27/2d/prbm-9-171.PMC4965219.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/27/2d/prbm-9-171.PMC4965219.pdf
Available from: http://www.stat-help.com/notes.html.,OADS,/arxiv_data1/oa_pdf/27/2d/prbm-9-171.PMC4965219.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/c4/copd-11-1647.PMC4965220.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1647–1655International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1647OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10869 8 an antagonist of the platelet-activating factor  receptor inhibits adherence of both nontypeable  Haemophilus influenzae  and Streptococcus  pneumoniae  to cultured human bronchial epithelial  cells exposed to cigarette smoke shakti D shukla1,* rory l Fairbairn1,* David a gell1 roger D latham1 sukhwinder s sohal1,2 eugene h Walters1 ronan F O’T oole1 1Breathe Well Centre, school of  Medicine, Faculty of health, University  of Tasmania, hobart, T as, australia;   2school of health sciences, Faculty  of health, University of Tasmania,   launceston, T as, australia *These authors contributed equally  to this workBackground:  COPD is emerging as the third largest cause of human mortality worldwide  after heart disease and stroke.",Non-OADS,/arxiv_data1/oa_pdf/2f/c4/copd-11-1647.PMC4965220.pdf
"It is emerging as the third largest cause of  human mortality after heart disease and stroke, killing over 3 million people worldwide  each year.1 Tobacco smoking is the most important causative factor of COPD.2–4 Expo - sure to cigarette smoke has been shown to significantly increase invasive respiratory Correspondence: ronan F O’Toole Breathe Well Centre, school of Medicine,  Faculty of health, University of Tasmania,  Medical science 1, 17 liverpool street,  hobart, Tas 7000, australia Tel +61 3 6226 6974 email ronan.otoole@utas.edu.a u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Shukla et al Running head recto: PAFr inhibitor of NTHi and S. pneumoniae  infection DOI: http://dx.doi.org/10.2147/COPD.S108698",Non-OADS,/arxiv_data1/oa_pdf/2f/c4/copd-11-1647.PMC4965220.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2f/c4/copd-11-1647.PMC4965220.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/c4/copd-11-1647.PMC4965220.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/b9/jpr-9-515.PMC4965221.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Effectiveness of the World Health Organization  cancer pain relief guidelines: an integrative review Cathy L Carlson School of Nursing, Northern Illinois  University, DeKalb, IL, USA Correspondence: Cathy L Carlson   School of Nursing, Northern Illinois  University, 1240 Normal Road, DeKalb,  IL 60115, USA   T el +1 815 753 6573   Fax +1 815 753 0814   Email clcarlson@niu.ed uAbstract:  Inadequate cancer pain relief has been documented extensively across historical  records.",Non-OADS,/arxiv_data1/oa_pdf/07/b9/jpr-9-515.PMC4965221.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/07/b9/jpr-9-515.PMC4965221.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/b9/jpr-9-515.PMC4965221.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/64/ijwh-8-325.PMC4965222.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 325–340International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  325OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S10591 3 Middlemore Hospital experience with tubo-ovarian  abscesses: an observational retrospective study antoine Y oussef Habboub Middlemore Hospital, counties  Manukau District Health Board,   auckland, new ZealandAim:  The aim of this paper was to study the characteristics of patients presenting to Middlemore  Hospital with tubo-ovarian abscess (TOA) and to compare the outcomes of conservative medical  management versus medical management with surgical drainage and medical management with  radiological drainage.",Non-OADS,/arxiv_data1/oa_pdf/46/64/ijwh-8-325.PMC4965222.pdf
govt.n zJournal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Habboub Running head recto: Middlemore Hospital experience with TOA DOI: http://dx.doi.org/10.2147/IJWH.S105913,Non-OADS,/arxiv_data1/oa_pdf/46/64/ijwh-8-325.PMC4965222.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/46/64/ijwh-8-325.PMC4965222.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/64/ijwh-8-325.PMC4965222.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/af/ijn-11-3317.PMC4965223.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3317–3330International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3317OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10316 2radiolabeling, whole-body single photon emission  computed tomography/computed tomography  imaging, and pharmacokinetics of carbon  nanohorns in mice Minfang Zhang,1,2 Dhifaf a   Jasim,1 cécilia Ménard-Moyon,3   antonio Nunes,1 sumio Iijima,2  alberto Bianco,3 Masako  Yudasaka,2 Kostas Kostarelos1 1Nanomedicine laboratory, Faculty  of Medical and human sciences  and National graphene Institute,   University of Manchester, Manchester,   United Kingdom; 2Institute of  advanced science and Industrial  T echnology (aIsT), Tsukuba, Ibaraki,   Japan; 3cNrs, Institute of Molecular  and cellular Biology, laboratory of  Immunopathology and Therapeutic  chemistry, strasbourg, FranceAbstract:  In this work, we report that the biodistribution and excretion of carbon nanohorns  (CNHs) in mice are dependent on their size and functionalization.",Non-OADS,/arxiv_data1/oa_pdf/37/af/ijn-11-3317.PMC4965223.pdf
"ac.uk Masako Yudasaka National Institute of advanced Industrial  science and Technology (aIsT), central  5, 1-1-1 higashi, Tsukuba, Ibaraki  305-8565, Japan Tel +81 29 861 4818 Fax +81 29 861 6290 email m-yudasaka@aist.go.j p alberto Bianco cNrs, Institut de Biologie Moléculaire et  cellulaire, Immunopathologie et chimie  Thérapeutique, 67000 strasbourg, France Tel +33 388 417088 Fax +33 388 610680 email a.bianco@ibmc-cnrs.unistra.f r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Radiolabeling whole-body images of carbon nanohorns in mice DOI: http://dx.doi.org/10.2147/IJN.S103162",Non-OADS,/arxiv_data1/oa_pdf/37/af/ijn-11-3317.PMC4965223.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/37/af/ijn-11-3317.PMC4965223.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/af/ijn-11-3317.PMC4965223.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/ef/copd-11-1657.PMC4965225.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1657–1662International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1657OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10834 3 sex differences of COPD phenotypes in  nonsmoking patients Y oonki hong1 Wonjun Ji2 soojeong an3 seon-sook han1 seung-Joon lee1 Woo Jin Kim1 1Department of Internal Medicine,   environmental health Center,   Kangwon national University  hospital, Chuncheon, south Korea,   2Department of Pulmonary and  Critical Care Medicine, asan Medical  Center, University of Ulsan College  of Medicine, seoul, south Korea,   3Department of statistics, Kangwon  national University, Chuncheon,   south KoreaBackground:  There is growing evidence about sex-related phenotypes of COPD.",Non-OADS,/arxiv_data1/oa_pdf/12/ef/copd-11-1657.PMC4965225.pdf
"Males were associated with a broader extent of emphysema in relation  to the cumulative smoking history,10,11 whereas, among smokers, females had higher  wall area percentage (WA%) in anatomically matched airways than males.12 Sex differences in COPD phenotypes may be more complicated because these  studies did not clearly differentiate the effects of sex from the effects of cigarette Correspondence: Woo Jin Kim Department of Internal Medicine,  school of Medicine, Kangwon national  University, 1 Kangwondaehak-gil,  Chuncheon, 200-701, south Korea Tel +82 32 258 9364 Fax +82 32 258 2404 email pulmo2@kangwon.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hong et al Running head recto: Sex differences in nonsmoking COPD DOI: http://dx.doi.org/10.2147/COPD.S108343",Non-OADS,/arxiv_data1/oa_pdf/12/ef/copd-11-1657.PMC4965225.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/12/ef/copd-11-1657.PMC4965225.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/ef/copd-11-1657.PMC4965225.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/de/48/imcrj-9-207.PMC4965226.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/de/48/imcrj-9-207.PMC4965226.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).A case of optic-nerve hypoplasia and anterior  segment abnormality associated with facial cleft T omoko Miyake1 Shota Kojima1 T etsuya Sugiyama2 Mari Ueki1 Jun Sugasawa1 Hidehiro Oku1 Kensuke Tajiri1 Yuka Shigemura3 Koichi Ueda3 Atsuko Harada4 Mami Yamasaki4 Takumi Yamanaka4 Hidetsuna Utsunomiya5 Tsunehiko Ikeda1 1Department of Ophthalmology,   Osaka Medical College, Takatsuki City,   2Nakano Eye Clinic of Kyoto Medical  Co-operative, Kyoto, 3Department of  Plastic and Reconstructive Surgery,   Osaka Medical College, Takatsuki  City, 4Department of Pediatric  Neurosurgery, Takatsuki General  Hospital, Takatsuki City, 5Department  of Radiological Science, International  University of Health and Welfare,   Graduate School, Fukuoka, Japan Correspondence: Shota Kojima   Department of Ophthalmology,  Osaka Medical College, 2-7 Daigaku-cho,  Takatsuki City, Osaka 569-8686, Japan   T el +81 72 683 1221   Fax +81 72 684 6339   Email shota@poh.osaka-med.ac.j pIntroduction:  The incidence of facial cleft is rare and ranges between 1.43 and 4.85 per 100,000  births.",Non-OADS,/arxiv_data1/oa_pdf/de/48/imcrj-9-207.PMC4965226.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/de/48/imcrj-9-207.PMC4965226.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/48/imcrj-9-207.PMC4965226.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 401–405Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 401 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //10.2147/AMEP .S101698 Exploring residents’ spontaneous collaborative  skills in a simulated setting context: an  exploratory study on CanMEDS collaborator role Kathleen Ouellet1 Robert Sabbagh2 Linda Bergeron3 Sandeep Kumar Mayer2 Christina St-Onge4 1Center for Health Profession  Education, Faculty of Medicine  and Health Sciences, Université de Sherbrooke,  2Department of Surgery,   Faculty of Medicine and Health Sciences, Université de Sherbrooke,   3Research Chair in Medical Education,   Paul Grand’Maison of the Société des médecins, Université de Sherbrooke,  4Department of Medicine,   Faculty of Medicine and Health Sciences, Université de Sherbrooke,  Sherbrooke, Québec, CanadaBackground: Collaboration is an important competence to be acquired by residents.",Non-OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
Available from: https://www.afmc.ca/pdf/CACMS_Standards_and_Elements_June_2014_Effective_July12015.pdf.,OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 405 Exploring residents’ spontaneous collaborative skills  7.,Non-OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
Available from: http://fhs.mcmaster.ca/tosce/.,Non-OADS,/arxiv_data1/oa_pdf/0c/c2/amep-7-401.PMC4965227.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/a9/ijn-11-3331.PMC4965228.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3331–3346International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3331OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10691 2 exposure to nickel oxide nanoparticles induces  pulmonary inflammation through NLRP3  inflammasome activation in rats Zhengwang Cao1 Yiliang Fang1 Y onghui Lu1 Fenghua Qian2 Qinglong Ma1 Mingdi He1 Huifeng Pi1 Zhengping Yu1 Zhou Zhou1 1Department of Occupational Health,   2Department of Haematology,   Southwest Hospital, Third Military  Medical University, Chongqing,   People’s Republic of ChinaAbstract:  With recent advances in the manufacture and application of nickel oxide nanoparticles  (NiONPs), concerns about their adverse effects on the respiratory system are increasing.",Non-OADS,/arxiv_data1/oa_pdf/63/a9/ijn-11-3331.PMC4965228.pdf
"Correspondence: Zhou Zhou Department of Occupational Health,  Third Military Medical University, No 30,  Gaotanyan Street, Chongqing 400038,  People’s Republic of China Tel/fax +86 23 6875 2289 email lunazhou00@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Cao et al Running head recto: Exposure to nickel oxide nanoparticles induces pulmonary inflammation DOI: http://dx.doi.org/10.2147/IJN.S106912",Non-OADS,/arxiv_data1/oa_pdf/63/a9/ijn-11-3331.PMC4965228.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/63/a9/ijn-11-3331.PMC4965228.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/a9/ijn-11-3331.PMC4965228.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/fa/81/ceg-9-181.PMC4965261.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fa/81/ceg-9-181.PMC4965261.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fa/81/ceg-9-181.PMC4965261.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 181–189Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  181 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S87205How do patients’ clinical phenotype and the  physiological mechanisms of the operations  impact the choice of bariatric procedure?",Non-OADS,/arxiv_data1/oa_pdf/fa/81/ceg-9-181.PMC4965261.pdf
"It remains unclear whether these mechanisms alone or in combination with others are necessary or sufficient for reduced food intake or body weight loss.Correspondence: Marco Bueter Division of Visceral and Transplantation Surgery, University Hospital Zurich, Rämistrasse 100, CH – 8091 Zürich, SwitzerlandTel +41 44 255 8895Fax +41 44 255 8942Email marco.bueter@usz.chJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Bächler et alRunning head recto: Impact of patients’ clinical phenotype on bariatric surgeryDOI: http://dx.doi.org/10.2147/CEG.S87205",Non-OADS,/arxiv_data1/oa_pdf/fa/81/ceg-9-181.PMC4965261.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/fa/81/ceg-9-181.PMC4965261.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 189 Impact of patients’ clinical phenotype on bariatric surgery  76.,Non-OADS,/arxiv_data1/oa_pdf/fa/81/ceg-9-181.PMC4965261.pdf
Weaver’s source code is freely available at:  https://github.com/ma-compbio/Weaver .,OADS,/arxiv_data1/oa_pdf/bc/cb/nihms792109.PMC4965314.pdf
"Expression quantitative trait data and coexpression patterns (data sets V –IX) Data set V was based on ﬁbroblast data from the MuTHER resource and assessed through the Genevar database (GENe Expression VARiation, TheWellcome Trust Sanger Institute; http://www.sanger.ac.uk/resources/software/genevar).",OADS,/arxiv_data1/oa_pdf/15/a1/mp2015186a.PMC4965332.pdf
The replication data set (VI) was based on lymphoblastoidcell lines from all unrelated subjects of the HapMap3 population (SNPexp v1.2; http://app3.titan.uio.no/biotools/help.php?app = snpexp).,OADS,/arxiv_data1/oa_pdf/15/a1/mp2015186a.PMC4965332.pdf
"To study coexpression ofSNX7 ,CASP8 ,IL1B and TDO2 (data set VIII), we used a post-mortem brain tissue collection deposited in the Braincloud database (http://braincloud.jhmi.edu).",OADS,/arxiv_data1/oa_pdf/15/a1/mp2015186a.PMC4965332.pdf
"All analyses were done using the statistical software programs R (RDevelopment Core Team, Vienna, Austria), IBM SPSS Statistics 20.0 (IBMSPSS, Chicago, IL, USA), the script PROCESS for SPSS (percentilebootstrap = 20 000) and Graph-Pad prism 6.0 (http://www.graphpad.com/).",OADS,/arxiv_data1/oa_pdf/15/a1/mp2015186a.PMC4965332.pdf
"Non-parametric bootstrap method, the PROCESS script for SPSS (see http://afhayes.com/spss-sas-and-mplus-macros-and-code.html).",OADS,/arxiv_data1/oa_pdf/15/a1/mp2015186a.PMC4965332.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)A GWAS of KYNA in CSF CM Sellgren et al 1350 Molecular Psychiatry (2016), 1342 –1350",Non-OADS,/arxiv_data1/oa_pdf/15/a1/mp2015186a.PMC4965332.pdf
"Published studies, including the National Heart, Lung, and  Blood Institute-sponsored Coronary Artery Surgery Study and  the Women’s Ischemia Syndrome Evaluation (WISE) study have  reported that as many as 50% of women undergoing coronary  angiography for suspected IHD are found to have normal or  nonobstructed epicardial coronary arteries.3-5) Moreover, women exhibit a greater symptom burden, more  functional disability, and a higher prevalence of no obstructive  CAD compared to men when evaluated for signs and symptoms of Review Article http://dx.doi.org/10.4070/kcj.2016.46.4.433 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Women and Ischemic Heart Disease: Recognition, Diagnosis and   Management Seong-Mi Park, MD1, and C. Noel Bairey Merz, MD2 1Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea, 2Barbra Streisand Women’s Heart Center, Cedars-Sinai Heart  Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA Cardiovascular disease is one of the most frequent causes of death in both males and females throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
"434  Women and Ischemic Heart Disease http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org myocardial ischemia.6-10) Among many clinical cohorts, paradoxical  sex differences have been observed in patients with symptoms and  outcomes of CAD.",Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org Recognition The initial step to improve the outcome of women’s IHD is  recognition of at-risk women.,Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
"436  Women and Ischemic Heart Disease http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org not approach intermediate risk of IHD until the fifth decade of  life, whereas women in their 70s and those who are older may  be categorized as high risk.",Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org wall motion abnormalities during stress echocardiography and  are independently predictive of death from CAD or nonfatal MI  above and beyond presenting symptoms, clinical risk factors,  and a patient’s medical history.38) Women with multiple inducible  wall motion abnormalities, especially if they encumber varying  vascular territories or are in the anterior wall, are at particularly  high risk, with annual event rates of 5% or higher and even as  high as 10% per year for those undergoing dobutamine stress  echocardiography.39-41) Exercise and pharmacologic stress gated myocardial perfusion  imaging with SPECT is commonly used diagnostic imaging  procedure and useful for risk stratification in higher risk  women.42-44) Recently, the prognostic value of resting/stress 82Rb  Positron Emission Tomography (PET) was published from a large  multicenter cohort of women and men.45) From this report, 5-year  CAD mortality ranged from 0.9-13% for women with 0-≥15%  abnormal myocardium at stress PET (p<0.0001), which comparable  to death rates were reported for men.",Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
"438  Women and Ischemic Heart Disease http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org between the sexes,16) although event rates were predictably lower in  this stable lower risk population and therefore the sensitivity to detect  differences may be limited compared with an ACS population.",Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org signs and symptoms of myocardial ischemia.,Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
440  Women and Ischemic Heart Disease http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org management of coronary artery disease.,Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org College of Cardiology Foundation/American Heart Association Task  Force on Practice Guidelines, and the American College of Physicians,  American Association for Thoracic Surgery, Preventive Cardiovascular  Nurses Association, Society for Cardiovascular Angiography and  Interventions, and Society of Thoracic Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
442  Women and Ischemic Heart Disease http://dx.doi.org/10.4070/kcj.2016.46.4.433 www.e-kcj.org converting enzyme inhibition reduces plasma asymmetric  dimethylarginine and improves endothelial nitric oxide bioavailability  and coronary microvascular function in patients with syndrome X.,Non-OADS,/arxiv_data1/oa_pdf/95/b2/kcj-46-433.PMC4965421.pdf
"Functional Anatomy of Tricuspid Valve The TV is the largest and most caudally located among the four Review Article http://dx.doi.org/10.4070/kcj.2016.46.4.443 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Revisit of Functional Tricuspid Regurgitation; Current Trends in the   Diagnosis and Management Denisa Muraru,  MD, Elena Surkova,  MD, and Luigi Paolo Badano, MD  Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, School of Medicine, Padua, Italy Current knowledge of functional tricuspid regurgitation (FTR) as a progressive entity, worsening the prognosis of patients irrespective of  its aetiology, has led to renewed interest in the pathophysiology and assessment of FTR.",Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
444  Current Management of Functional Tricuspid Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org cardiac valves.,Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org outward.,Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
"446  Current Management of Functional Tricuspid Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org imaging of TV, right heart chambers size and function, interventricular  septal motion and inferior vena cava (IVC), as well as Doppler  parameters of regurgitation severity 2DE combined with spectral  and color flow Doppler is the main modality used for detection and  quantitation of TR.19) “Physiological” FTR is a frequent finding in  healthy subjects and is typically associated with normal TV leaflet  morphology, normal RV and RA size.20) The color jet is localized in a  small region adjacent to the valve closure, is thin, central and often  limited to early-systole.",Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org A B C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
448  Current Management of Functional Tricuspid Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org aliasing.,Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org available for assessing RV volumes and function, cardiac magnetic  resonance (CMR) is the technique of choice to assess patients with  significant TR.32) CMR is not limited by an acoustic window and can  image the whole heart in any plane providing excellent myocardial  definition.",Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
450  Current Management of Functional Tricuspid Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org and its extension into the RA can be used as a semi-quantitative  parameter of TR severity by CMR.,OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org failure (diuretics, ACE inhibitors) and in patients with chronic  atrial fibrillation, to control the heart rate (digitalis) and reduce  the thrombo-embolic risk (warfarin).",Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
452  Current Management of Functional Tricuspid Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org of the TV and the incomplete understanding of the mechanisms/ pathophysiology of FTR in different cardiac conditions (e.g.,Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org functional, since it is secondary to anatomical abnormalities of a TV  apparatus, such as dilation and change in shape of TA, papillary muscle  displacement, and leaflet remodelling and tethering.",Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
454  Current Management of Functional Tricuspid Regurgitation http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org 21.,Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.443 www.e-kcj.org 50.,Non-OADS,/arxiv_data1/oa_pdf/13/dd/kcj-46-443.PMC4965422.pdf
"Indeed, the probability of cardiovascular events increases, along Review Article http://dx.doi.org/10.4070/kcj.2016.46.4.456 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Systemic Hemodynamic Atherothrombotic Syndrome and Resonance   Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events Kazuomi Kario, MD1,2,3 1Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, 2Jichi Medical University Center of Excellence, Cardiovascular  Research and Development (JCARD), 3Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network, Tochigi, Japan  Blood pressure (BP) exhibits different variabilities and surges with different time phases, from the shortest beat-by-beat to longest yearly  changes.",OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
"457 Kazuomi Kario http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org with increase in BP; however, we are not able to predict when and  where the cardiovascular events will occur.",Non-OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
458  Systemic Hemodynamic Atherothrombotic Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org hemodynamic stress (increased variability of BP and blood flow)  and vascular disease that damages organs and contributes to  cardiovascular events: SHATS (Fig.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
"459 Kazuomi Kario http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org in the elderly,52) and are found to be advanced in patients with  increased pulse wave velocity.",OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
460  Systemic Hemodynamic Atherothrombotic Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org occur in the morning even among high-risk hypertensives whose  home and ambulatory BP levels are well-controlled.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
"461 Kazuomi Kario http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org The HONEST Study: Latest home BP monitoring  evidence  We recently published the main results of the Home Blood  Pressure Measurement with Olmesartan-Na ïve Patients to Establish  Standard Target Blood Pressure (HONEST) study, the largest-scale  prospective, real-world observational study of 21,591 outpatients  with essential hypertension in Japan.66) The results of the study  demonstrated that on-treatment morning home BP is much more  important than office BP during antihypertensive treatment.",Non-OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
462  Systemic Hemodynamic Atherothrombotic Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org angina pectoris with coronary intervention) and sudden death.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
463 Kazuomi Kario http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org morning and nocturnal phases.,OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
464  Systemic Hemodynamic Atherothrombotic Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org of RDN on the nocturnal BP profile in OSAS patients who were  already enrolled in the SPREAD study.84) The results of the HTN-J  study demonstrated that catheter-based RDN significantly reduced  hypoxia-induced nocturnal systolic BP peaks by 10 mmHg.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
465 Kazuomi Kario http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org reduction.,OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
466  Systemic Hemodynamic Atherothrombotic Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org Surge-Home Blood Pressure (J-HOP) Study Group.,Non-OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
467 Kazuomi Kario http://dx.doi.org/10.4070/kcj.2016.46.4.456 www.e-kcj.org 3-year report of the Symplicity HTN-1 study.,OADS,/arxiv_data1/oa_pdf/f0/3c/kcj-46-456.PMC4965423.pdf
Lowering concentrations of plasma lipoproteins  and fibrinogen can reduce blood viscosity that may improve blood  flow (particularly in the microvasculature) which can be important Editorial http://dx.doi.org/10.4070/kcj.2016.46.4.468 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of  Statins or Effect of LDL-cholesterol Reduction?,Non-OADS,/arxiv_data1/oa_pdf/00/17/kcj-46-468.PMC4965424.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.468 www.e-kcj.org in cardio- and cerebro- vascular diseases.3) Plaque stabilization,  changes to transmembrane ion channel conduction, antioxidant  and antiproliferative effect, and decrease in the parasympathetic  tone may potentially account for antiarrhythmic effect of statins.",Non-OADS,/arxiv_data1/oa_pdf/00/17/kcj-46-468.PMC4965424.pdf
"470  Pre-treatment with Statins for Coronary Intervention http://dx.doi.org/10.4070/kcj.2016.46.4.468 www.e-kcj.org analysis and tested the following variables: pravastatin, stent size,  maximum balloon inflation pressure, diabetes mellitus, C-reactive  protein level, IVUS plaque burden, and creatinine level.",Non-OADS,/arxiv_data1/oa_pdf/00/17/kcj-46-468.PMC4965424.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.468 www.e-kcj.org Interv  2011;4:513-20.,OADS,/arxiv_data1/oa_pdf/00/17/kcj-46-468.PMC4965424.pdf
"Furthermore, recent  studies have raised controversy over the effects of high dose  statins in the prevention of peri-procedural myocardial injury and  the improvement of clinical outcome.7)8) The Index of microcirculatory resistance (IMR) is an invasive  physiologic index which interrogates the status of coronary  microvasculture.9) IMR can be reliably measured in a cardiac Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.472 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular  Dysfunction after Percutaneous Coronary Intervention in Patients with  Acute Coronary Syndrome?",Non-OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org catheterization laboratory and is not influenced by hemodynamic  conditions, unlike coronary flow reserve (CFR).",Non-OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
474  Atorvastatin Loading and Post-Percutaneous Coronary Intervention Microvascular Dysfunction http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org expanded formula (IMR=PaxTmnx[Pd-Pw]/[Pa-Pw]) was applied to  calculate the true IMR that incorporates coronary Pw to account  for collateral flow.13)  Endpoints and definition  The primary end point was the post PCI IMR.,OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org prevalence of cardiovascular risk factors, current medications,  metabolic profiles, left ventricular function, and clinical presentation.",Non-OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
"476  Atorvastatin Loading and Post-Percutaneous Coronary Intervention Microvascular Dysfunction http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org Determinants for microcirculatory impairment after   percutaneous coronary intervention By univariate analyses, high dose atorvastatin loading (odd ratio  [OR] 0.117, 95% confidence interval [CI] 0.014 to 0.999; p=0.050)  and pre-dilatation balloon pressure (OR 1.353, 95% CI 0.945 to 1.938; p=0.099) were explored as potential predictors of post- PCI microcirculatory impairment.",Non-OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org Table 3.,OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
"478  Atorvastatin Loading and Post-Percutaneous Coronary Intervention Microvascular Dysfunction http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org with low left ventricular function at three month follow-up and  reduced long-term survival.14) Furthermore, Pepine et al.",Non-OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org 3.,Non-OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
480  Atorvastatin Loading and Post-Percutaneous Coronary Intervention Microvascular Dysfunction http://dx.doi.org/10.4070/kcj.2016.46.4.472 www.e-kcj.org atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave  acute myocardial infarction.,Non-OADS,/arxiv_data1/oa_pdf/80/5f/kcj-46-472.PMC4965425.pdf
"These  effects appear to be mediated by antithrombogenic or triglyceride- lowering activities, alteration or interference in adhesion molecule  metabolism, and the suppression of inflammatory mediators.1–3)  Another study has shown a relationship between a lower ω-3  PUFA serum content and the presence of lipid-rich atherosclerotic Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.481 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary  Atherosclerosis in Statin Treated Patients Undergoing Percutaneous  Coronary Intervention Jinhee Ahn, MD1, Seo Kwang Park, RT1, Tae Sik Park, RT1, Jin Hee Kim, MD2, Eunyoung Yun, PhD3, Sang-Pil Kim, MD4,  Hye Won Lee, MD1, Jun-Hyok Oh, MD1, Jung Hyun Choi, MD1, Kwang Soo Cha, MD1, Taek Jong Hong, MD1,    Sang Yeoup Lee, MD,5,6 and Han Cheol Lee, MD1 1Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, 2Department of Internal Medicine, Busan Medical Center, 3Department of  Biostatistics, Pusan National University Hospital, 4Department of Cardiovascular Surgery, Pusan National University Hospital, Busan, 5Family Medicine Clinic and Research  Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, 6Medical Education Unit and Medical Research Institute,  Pusan National University School of Medicine, Yangsan, Korea Background and Objectives:  Statins remain the mainstay of secondary coronary artery disease (CAD) prevention, but n-3 polyunsaturated  fatty acids ( ω-3 PUFA) display biological effects that may also reduce the risk of atherosclerosis and CAD.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
"482  Additional Effect of n-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org plaques using integrated backscatter intravascular ultrasound  (IVUS).4) Moreover, Nozue et al.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org volume divided by the length of the measured atheroma, whereas  percent atheroma volume was calculated as the ratio of atheroma  volume to vessel volume×100.",OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
"484  Additional Effect of n-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org Discussion The main results of this study can be summarized as follows:  addition of ω-3 PUFA to statin therapy in CAD patients requiring  stent implantation did not have any effect on atheroma volume  index, change in percent atheroma volume, neointimal volume  index, late loss, and in-stent restenosis rates.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org Table 2.,OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
"486  Additional Effect of n-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org risk of acute coronary syndrome.4) Other study5) demonstrated that  low serum ω-3 PUFA was associated with atheroma progression  in patients who achieved very low levels of LDL cholesterol during statin therapy.5) In contrast, in this study we hypothesized that  elevation of serum ω-3 PUFA by ω-3 PUFA supplementation could  induce the regression of coronary atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org reported that orally administrated EPA induces the regression of  atherosclerosis in LDL receptor-deficient mice, and that this effect  was possibly mediated by alteration of dendritic cell functions and  decrease in circulating T-lymphocytes.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
"488  Additional Effect of n-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org Limitations First, although we designed this study to investigate the benefits  of adding ω-3 PUFA to statin therapy, we did not compare the  differences between the statin group and the placebo group in  the same patient population.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.481 www.e-kcj.org 17.,Non-OADS,/arxiv_data1/oa_pdf/91/7f/kcj-46-481.PMC4965426.pdf
"It is defined as a state  of myocardial hypoperfusion in the presence of a patent epicardial  coronary artery.1)2) No reflow negatively affects the clinical  outcome in patients with acute myocardial infarction (AMI),3-6) and  it is associated mainly with increased mortality or left ventricular  remodeling, despite its relatively low incidence.7) The pathomechanism of no reflow includes ischemia-reperfusion  injury, myocardial edema, endothelial swelling, capillary obstruction,   vasospasm, inflammatory response, and distal coronary embolization.1)  Although interventional cardiologists try to overcome no reflow using Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.490 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Long-Term Clinical Outcomes of Transient and Persistent No Reflow  Phenomena following Percutaneous Coronary Intervention in Patients  with Acute Myocardial Infarction Min Chul Kim, MD1, Jae Yeong Cho, MD1, Hae Chang Jeong, MD1, Ki Hong Lee, MD1, Keun Ho Park, MD1,  Doo Sun Sim, MD1, Nam Sik Yoon, MD1, Hyun Joo Youn, MD1, Kye Hun Kim, MD1, Young Joon Hong, MD1,  Hyung Wook Park, MD1, Ju Han Kim, MD1, Myung Ho Jeong, MD1, Jeong Gwan Cho, MD1, Jong Chun Park, MD1,  Ki-Bae Seung, MD2, Kiyuk Chang, MD2, and Youngkeun Ahn, MD1 1Department of Cardiology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, 2Department of Cardiology,   Seoul St Mary’s Hospital, The Catholic University School of Medicine, Seoul, Korea Background and Objectives:  There is limited information on the transient or persistent no reflow phenomenon in patients with acute  myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org various methods and drugs,2) persistent no reflow often remains  despite adequate revascularization of coronary stenosis.",Non-OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
492  Transient and Persistent No Reflow in Acute Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org Statistical analysis Continuous variables are presented as the means ±standard  deviations and were compared using the Student’s t-test or  Mann-Whitney U-test.,OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
"494  Transient and Persistent No Reflow in Acute Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org serum glucose, low-density lipoprotein-cholesterol, left ventricular  ejection fraction, and were more likely to include patients who  were prescribed a beta blocker and angiotensin-converting enzyme  inhibitor or angiotensin-II receptor blocker (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org Table 3.,OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
496  Transient and Persistent No Reflow in Acute Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org Discussion This study investigated the long-term clinical outcomes of  transient or persistent no reflow in patients with AMI who  underwent PCI.,Non-OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org be related to overfitting in the multivariate analysis.,Non-OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
498  Transient and Persistent No Reflow in Acute Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.4.490 www.e-kcj.org pooled analysis from the SPIRIT (clinical evaluation of the XIENCE V  everolimus eluting coronary stent system) and COMPARE (second- generation everolimus-eluting and paclitaxel-eluting stents in real- life practice) randomized trials.,Non-OADS,/arxiv_data1/oa_pdf/70/44/kcj-46-490.PMC4965427.pdf
"Previous  studies have shown that OCT can detect TCFAs, plaque ruptures, Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.499 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Multimodality Intravascular Imaging Assessment of Plaque Erosion  versus Plaque Rupture in Patients with Acute Coronary Syndrome Jee Eun Kwon, MD1, Wang Soo Lee, MD1, Gary S. Mintz, MD2, Young Joon Hong, MD3, Sung Yun Lee, MD4, Ki Seok Kim, MD5,  Joo-Yong Hahn, MD6, Kaup Sharath Kumar, MD1, Hoyoun Won, MD1, Seong Hyeop Hyeon, MD1, Seung Yong Shin, MD1,   Kwang Je Lee, MD1, Tae Ho Kim, MD1, Chee Jeong Kim, MD1, and Sang Wook Kim, MD1 1Heart Research Institute, Cardiovascular-Arrhythmia Center, College of Medicine, Chung-Ang University Hospital, Seoul, Korea,2Cardiovascular Research Foundation,  New York, USA,3Chonnam National University Hospital, Gwangju, 4Inje University Ilsan Paik Hospital, Koyang, 5Jeju National University Hospital, Jeju, 6Samsung Medical  Center, Seoul, Korea Background and Objectives:  We assessed plaque erosion of culprit lesions in patients with acute coronary syndrome in real world practice.",Non-OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
"500  Plaque Erosion in Acute Coronary Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.499 www.e-kcj.org plaque erosions, and intracoronary thrombus with greater accuracy  than IVUS, although the limited penetration of OCT especially in the  setting of high-risk plaques with superimposed red thrombus can  affect the quantitative assessment of lipid and remodeling.7-13) We  hypothesized that combined imaging with OCT and radiofrequency  (virtual histology [VH])-IVUS would overcome the limitation of each  imaging modality.",Non-OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.499 www.e-kcj.org performed retrograde back to the aorto-ostial junction using an  ECG-gated automatic pullback device.,OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
502  Plaque Erosion in Acute Coronary Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.499 www.e-kcj.org Distributions of continuous variables were evaluated.,OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.499 www.e-kcj.org Intravascular ultrasound analysis of plaque ruptures and  plaque erosions At the site of plaque erosion or plaque rupture, EEM area was  larger in plaque ruptures (p=0.0359) with larger plaque burden  (p<0.0001), more positive remodeling (p=0.029) and larger NC  (p<0.0001).",Non-OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
"504  Plaque Erosion in Acute Coronary Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.499 www.e-kcj.org rupture was 23.54 ±18.42  mm, similar to the distance from the  coronary artery ostium to the site of plaque erosion (23.37±17.82  mm, p=0.96).",Non-OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.499 www.e-kcj.org VH-IVUS analysis was reduced in the setting of intracoronary  thrombus.,Non-OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
506  Plaque Erosion in Acute Coronary Syndrome http://dx.doi.org/10.4070/kcj.2016.46.4.499 www.e-kcj.org 17.,Non-OADS,/arxiv_data1/oa_pdf/21/11/kcj-46-499.PMC4965428.pdf
"Subjects and Methods Annual mortality data were obtained from the Korean Statistical Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.507 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea Seung Won Lee, MPH1,2, Hyeon Chang Kim, MD2,3, Hye Sun Lee, PhD 4, and Il Suh, MD3 1Department of Public Health, Yonsei University Graduate School, 2 Cardiovascular and Metabolic Diseases Etiology Research Center, 3Department of Preventive Medicine,  4 Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea Background and Objectives:  Cerebrovascular disease is a leading cause of mortality and morbidity in Korea.",OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
508  Cerebrovascular Disease Mortality Trends in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org Information Service managed by Statistics Korea (former the Korea  National Statistical Office).,OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org until 2002.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
510  Cerebrovascular Disease Mortality Trends in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org reversed since 1991.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org Crude and age-adjusted mortality rates from cerebral  infarction Crude mortality rate from cerebral infarction increased until  2004.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
512  Cerebrovascular Disease Mortality Trends in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org mortality since 1950.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org Korea.,OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
514  Cerebrovascular Disease Mortality Trends in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org 9.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org Seung Won Lee, et al.",OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
516  Cerebrovascular Disease Mortality Trends in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.507 www.e-kcj.org Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/21/kcj-46-507.PMC4965429.pdf
"515 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Introduction Atrial fibrillation (AF) is a common arrhythmia and an important  cause of cardiovascular morbidity and mortality.1) AF is also associated with a 4 to 5-fold increased risk of stroke and is  responsible for approximately 15% of all strokes.2)3) The incidence  and prevalence of AF increase with older age4)5) and are higher in  men than in women.6)7) The prevalence of AF in the United States is  estimated at 2.3 million and is expected to increase to 5.6 million  by 2050.4) In the Rotterdam Study, the prevalence of AF was 5.5% in  subjects aged≥55 years, and the incidence rate in subjects aged 80- 84 years was 21 per 1000 person-years.8) Assessment of Medicare  beneficiaries in the United States showed that the incidence of AF  over a 14-year period ranged from 27.3 to 28.3 per 1000 person- years; moreover, AF was associated with various co-morbidities  and mortality, and its incidence rates were consistently higher in  men than in women and in whites than non-whites.9) In Asia, the  prevalence of AF is approximately 1%, lower than in Caucasians (1- 2%).4)10) Moreover, it is estimated that by 2050,72 million individuals  in Asia will be diagnosed with AF, which is more than double the  combined numbers of patients in Europe and the United States,  due to proportionally larger number of aged individuals in Asian Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.515 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Incidence and Risk Factors for Atrial Fibrillation in Korea: the National  Health Insurance Service Database (2002–2010) Mi Kyoung Son, MS1, Nam-Kyoo Lim, PhD1, Myeong-Chan Cho, MD2, and Hyun-Young Park, MD1 1Division of Cardiovascular and Rare Diseases, Center for Biomedical Science, Korea National Institute of Health, 2Department of Internal Medicine, College of Medicine,  Chungbuk National University, Cheongju, Korea Background and Objectives:  Atrial fibrillation (AF) is a common arrhythmia that is known as an important independent risk factor for  stroke.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
"516  Atrial Fibrillation in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.515 www.e-kcj.org countries.11-13) To date, few epidemiologic studies have assessed the prevalence  of AF in Korea, and none have examined its incidence.14)15) The Korean  Genome and Epidemiology Study reported that the prevalence  of AF was 0.4% in adults aged 40-69 years, increasing to 1.0%  in individuals aged 60-69 years.14) Another study found that the  prevalence of AF was 0.7% in subjects aged≥40 years and 2.1%  in those aged≥65 years.15) These studies may have underestimated  the prevalence of AF because they enrolled study population aged  40-69 years14) or healthy individuals.15) Many studies have reported that risk factors for AF include  increased age, male sex, hypertension, diabetes mellitus, obesity,  heart failure, valve disease, myocardial infarction and alcohol  consumption.7)16-18) The Copenhagen City Heart Study reported  that AF was a much more pronounced risk factor for stroke and  cardiovascular death in women than in men.19) The prevalence of AF is expected to increase in proportion to  the aging of the Korean population and thus likely to become a  greater public health problem.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.515 www.e-kcj.org Results During the 6-year follow-up period, 3517(1.7%) individuals  aged≥30 years in South Korea were newly diagnosed with AF,  including 2043(58.1%) males and 1474(41.9%) females.",OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
518  Atrial Fibrillation in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.515 www.e-kcj.org and 95% CIs for AF.,OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.515 www.e-kcj.org Table 4.,OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
"520  Atrial Fibrillation in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.515 www.e-kcj.org and 11.54 per 1000 person-years, in men and women aged≥80  years, respectively.",OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.,Non-OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.515 www.e-kcj.org and stroke prevention: the AnTicoagulation and Risk Factors in Atrial  Fibrillation (ATRIA) Study.,Non-OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
"522  Atrial Fibrillation in Korea http://dx.doi.org/10.4070/kcj.2016.46.4.515 www.e-kcj.org Mi Kyoung Son, et al.",OADS,/arxiv_data1/oa_pdf/13/a4/kcj-46-515.PMC4965430.pdf
"Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.522 Print ISSN 1738-5520  • On-line ISSN 1738-5555 The Relat ionship between P & QT D ispersions and Presence & Sever ity  of Stable Coronary Artery D isease Bingül Dilekci Şahin, MD1, Erkan Yıldırım, MD1, Emrah Ipek, MD1, Mahir Cengiz, MD2, Kursat Aslan, MD1,   Esra Poyraz, MD3, Selami Demirelli, MD1, Murat Bayantemur, MD1, Emrah Ermis, MD1, and Cavlan Ciftci, PhD4 1Department of Cardiology, Erzurum Region Training and Research Hospital, Erzurum ,2Department of Internal Medicine, Cerrahpa şa Faculty of Medicine, Istanbul  University, Istanbul, 3Department of Cardiology, Istanbul Siyami Ersek Training and Research Hospital, Istanbul ,4Department of Cardiology, Istanbul Bilim University,  Istanbul , Turkey Background and Objectives:  The study aimed to evaluate the correlation between electrocardiographic (ECG) parameters and presence  and extent of coronary artery disease (CAD) to indicate the usefulness of these parameters as predictors of severity in patients with stable  CAD.",Non-OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.522 www.e-kcj.org QTd is a parameter measured non-invasively on the surface ECG  and indicates heterogeneity of ventricular repolarization.,OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
524  Electrocardiography and Coronary Artery  Disease http://dx.doi.org/10.4070/kcj.2016.46.4.522 www.e-kcj.org least 9 out of the 12 derivations.,Non-OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.522 www.e-kcj.org Table 3.,OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
526  Electrocardiography and Coronary Artery  Disease http://dx.doi.org/10.4070/kcj.2016.46.4.522 www.e-kcj.org of the patients.,Non-OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.522 www.e-kcj.org Discussion In our study, we identified that ECG parameters including PWD,  Pmax, QTd, QTcd, QTdR had significant correlations with Gensini  score.",OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
528  Electrocardiography and Coronary Artery  Disease http://dx.doi.org/10.4070/kcj.2016.46.4.522 www.e-kcj.org patients with CAD.,Non-OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.522 www.e-kcj.org Health Organization MONICA Project.,Non-OADS,/arxiv_data1/oa_pdf/58/97/kcj-46-522.PMC4965431.pdf
"P-wave dispersion (PWD) in  electrocardiography and atrial electrocardiographic delay measured  by echocardiography are the latest promising markers.6)7) Intra-atrial and inter-atrial conduction times in patients with LP  have been assessed based on only PWD on electrocardiography  up to now.8) However, studies which enrolled patients with isolated  atrial fibrillation and paroxysmal atrial fibrillation revealed that,  measurement of echocardiographic delay was more useful than  electrocardiography measurement of PWD in the prediction Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.530 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Atrial Electromechanical Coupling in Patients with Lichen Planus Mehmet Yaman, MD1, Uğur Arslan, MD1, Osman Beton, MD2, Lale Din ç Asarcıklı, MD2, Aytekin Aksakal, MD1,   and Orhan Dogdu, MD3 1Department of Cardiology , Samsun Education and Research Hospital, Samsun,2Department of Cardiology , Diskapi Education and Research Hospital, Ankara , 3Department  of Cardiology , Firat University, Faculty of Medicine, Elazig, Turkey Background and objectives:  A chronic inflammatory disease, lichen planus may cause disturbance of atrial electromechanical coupling  and increase the risk of atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/97/29/kcj-46-530.PMC4965432.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.530 www.e-kcj.org of atrial fibrillation.9) In this study, we aimed to evaluate, for  the first time, intra-atrial and inter-atrial conduction times  with both electrocardiographic PWD and echocardiographic  electromechanical delay in patients with LP.",Non-OADS,/arxiv_data1/oa_pdf/97/29/kcj-46-530.PMC4965432.pdf
532  Atrial Electromechanical Coupling in Lichen Planus http://dx.doi.org/10.4070/kcj.2016.46.4.530 www.e-kcj.org three measurements was taken.13) Atrial electromechanical coupling  Continuous ECG recording was performed from a single lead.,OADS,/arxiv_data1/oa_pdf/97/29/kcj-46-530.PMC4965432.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.530 www.e-kcj.org Table 2.,OADS,/arxiv_data1/oa_pdf/97/29/kcj-46-530.PMC4965432.pdf
"534  Atrial Electromechanical Coupling in Lichen Planus http://dx.doi.org/10.4070/kcj.2016.46.4.530 www.e-kcj.org onset of P-wave on surface ECG to the beginning of A-wave  (PA), representing atrial electromechanical delay (Fig.",Non-OADS,/arxiv_data1/oa_pdf/97/29/kcj-46-530.PMC4965432.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.530 www.e-kcj.org delay has been shown to be correlated with the development of  AF in several patient groups.18)19) Therefore, according to our study  results, we can only hypothesize that LP patients with ongoing  inflammation might have atrial electro-mechanical delay with a  risk of AF development.",Non-OADS,/arxiv_data1/oa_pdf/97/29/kcj-46-530.PMC4965432.pdf
"Subjects and Methods Study population and protocol The present study included 4261 Koreans (male:female ratio 7:3), Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.536 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Prehypertension and Left Ventricular Diastolic Dysfunction   in Middle-Aged Koreans Shin Yi Jang, PhD1, Sujin Kim, BSN1, Chang Kwan Lee, PhD2, Eun Jeong Cho, MD3, Soo Jin Cho, MD4, and Sang-Chol Lee, MD1 1Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, 2Department of  Nursing, KC University, Seoul, 3Division of Cardiology, Department of Internal Medicine, Cardiology Clinic, National Cancer Center, Goyang, 4Health Promotion Center,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background and Objectives:  Left ventricular diastolic dysfunction is known to be a marker of myocardial damage, in particular myocardial  fibrosis resulting from hypertension (HT).",Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.536 www.e-kcj.org 45 to 64 years of age with no previous history of HT, diabetes  mellitus, malignancy, proven coronary artery disease, or valvular  heart disease, who underwent routine health examinations  including echocardiography at the Health Promotion Center of  Samsung Medical Center from January 2009 to June 2010.",Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
538  Prehypertension and Diastolic Dysfunction http://dx.doi.org/10.4070/kcj.2016.46.4.536 www.e-kcj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.536 www.e-kcj.org Approximately 40% of our subjects were prehypertensive.,Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
540  Prehypertension and Diastolic Dysfunction http://dx.doi.org/10.4070/kcj.2016.46.4.536 www.e-kcj.org diastolic dysfunction and preHT according to gender have  been presented.,Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
Supplementary Materials  The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.4.536.,Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.536 www.e-kcj.org prehypertension with an angiotensin-receptor blocker.,Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
"542  Prehypertension and Diastolic Dysfunction http://dx.doi.org/10.4070/kcj.2016.46.4.536 www.e-kcj.org Shin Yi Jang, et al.",Non-OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.536 www.e-kcj.org Shin Yi Jang, et al.",OADS,/arxiv_data1/oa_pdf/c1/c0/kcj-46-536.PMC4965433.pdf
"The Kobayashi,5) Egami,6) and Sano7) scoring systems have  identified factors such as patient age, fever duration, proportion  of neutrophils, platelet count, and the serum levels of sodium, Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.542 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Non-Responders to Intravenous Immunoglobulin and Coronary Artery  Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children Bo Young Kim, MD, Dongwan Kim, MD, Yong Hyun Kim, MD, Eell Ryoo, MD, Yong Han Sun, MD, In-sang Jeon, MD,  Mi-Jin Jung, MD, Hye Kyung Cho, MD, Hann Tchah, MD, Deok Young Choi, MD, and Na Yeon Kim, MD * Department of Pediatrics, Gachon University Gil Medical Center, Incheon, Korea Background and Objectives:  In Kawasaki disease (KD), high dose intravenous immunoglobulin (IVIG) significantly lowers the coronary  complications.",Non-OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.542 www.e-kcj.org C-reactive protein (CRP), total bilirubin, aspartate aminotransferase  (AST), and alanine aminotransferase (ALT).5-7) Nevertheless, there is  no current consensus regarding the factors for predicting patients  not responsive to IVIG.",Non-OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
544  Intravenous Immunoglobulin Unresponsiveness and Coronary Artery Dilatation in Kawasaki Disease http://dx.doi.org/10.4070/kcj.2016.46.4.542 www.e-kcj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.542 www.e-kcj.org Table 3.,OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
546  Intravenous Immunoglobulin Unresponsiveness and Coronary Artery Dilatation in Kawasaki Disease http://dx.doi.org/10.4070/kcj.2016.46.4.542 www.e-kcj.org where illness day 1 was defined as the first day of fever.,Non-OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.542 www.e-kcj.org Prediction of coronary artery dilatation CAD was found in 234 patients (33.3%) in the acute phase  and in 32 patients (4.6%) in the convalescent phase.,Non-OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
"548  Intravenous Immunoglobulin Unresponsiveness and Coronary Artery Dilatation in Kawasaki Disease http://dx.doi.org/10.4070/kcj.2016.46.4.542 www.e-kcj.org reported that low albumin, low sodium, and a high proportion of  neutrophils were significantly related to IVIG resistance.",OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.542 www.e-kcj.org 2.,Non-OADS,/arxiv_data1/oa_pdf/98/a0/kcj-46-542.PMC4965434.pdf
"Subjects and Methods We retrospectively reviewed the medical records of 239 patients Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.550 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Clinical Characteristics of Kawasaki Disease in Infants Younger than  Six Months: A Single-Center Study You Min Yoon, MD, Hye Won Yun, MD, and Sung Hye Kim, MD Department of Pediatrics, Hallym University Sacred Heart Hospital, Anyang, Korea Background and Objectives:  Kawasaki disease (KD) is the leading cause of acquired heart disease, which predominantly occurs in children  under the age of 5 years.",Non-OADS,/arxiv_data1/oa_pdf/23/80/kcj-46-550.PMC4965435.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.550 www.e-kcj.org with KD admitted to the Hallym University Sacred Heart Hospital  from January 2013 to June 2015.,Non-OADS,/arxiv_data1/oa_pdf/23/80/kcj-46-550.PMC4965435.pdf
552  Clinical Characteristics of Infantile Kawasaki Disease http://dx.doi.org/10.4070/kcj.2016.46.4.550 www.e-kcj.org Table 2.,Non-OADS,/arxiv_data1/oa_pdf/23/80/kcj-46-550.PMC4965435.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.550 www.e-kcj.org fever duration before the IVIG administration and the total fever  duration were longer in Group A, without statistical significance.",OADS,/arxiv_data1/oa_pdf/23/80/kcj-46-550.PMC4965435.pdf
"554  Clinical Characteristics of Infantile Kawasaki Disease http://dx.doi.org/10.4070/kcj.2016.46.4.550 www.e-kcj.org mg/L of CRP, p=0.167).",Non-OADS,/arxiv_data1/oa_pdf/23/80/kcj-46-550.PMC4965435.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.550 www.e-kcj.org KD patients, thereby causing difficulties in statistical comparison.",Non-OADS,/arxiv_data1/oa_pdf/23/80/kcj-46-550.PMC4965435.pdf
"Extra anatomic bypass grafts from the ascending to descending  aorta are used formerly following different routes around the  cardiac structure for the repair of coarctation accompanied by a  congenital or an acquired heart disease in single stage procedure.4)5) In this paper, we will share our surgical experience in 7 adult Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.556 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Single Stage Repair for Aortic Coarctation associated with Intracardiac  Defects Using Extra-Anatomic Bypass Graft in Adults Ibrahim Duvan, MD1, Mehmet Sanser Ates, MD1, Burak Emre Onuk, MD1, Beyhan Bakkaloglu, MD2, Umit Pinar Sungur, MD1,  Murat Kurtoglu, MD1, and Yahya Halidun Karagoz, MD1 1Department of Cardiovascular Surgery, 2Department of Cardiovascular Anaesthesiology, Guven Hospital, Ankara, Turkey Background and Objectives:  Coarctation of the aorta in adulthood is generally associated with other cardiovascular disorders requiring  surgical management.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/kcj-46-556.PMC4965436.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.556 www.e-kcj.org patients with previously uncorrected, postductal aortic coarctation  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/kcj-46-556.PMC4965436.pdf
558  Single Stage Repair of Coactation and Cardiac Defect http://dx.doi.org/10.4070/kcj.2016.46.4.556 www.e-kcj.org where CT angiography was not carried out.,Non-OADS,/arxiv_data1/oa_pdf/fe/12/kcj-46-556.PMC4965436.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.556 www.e-kcj.org margin of the heart above the inferior vena cava (IVC), which was  used in 2 of our patients.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/kcj-46-556.PMC4965436.pdf
"560  Single Stage Repair of Coactation and Cardiac Defect http://dx.doi.org/10.4070/kcj.2016.46.4.556 www.e-kcj.org angiotensin II receptor antagonist or an angiotensin converting  enzyme inhibitor in 3 patients, rest of the patients were treated  by a β-blocker only.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/kcj-46-556.PMC4965436.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.556 www.e-kcj.org safer as being very far away from fragile collateral blood vessels.,Non-OADS,/arxiv_data1/oa_pdf/fe/12/kcj-46-556.PMC4965436.pdf
"Among K+ channels in the  cardiovascular system, the adenosine triphosphate (ATP)-sensitive  potassium channels (KATP channels), the first to be discovered in  cardiomyocytes,3) have a structure analogous to the inwardly Original Article http://dx.doi.org/10.4070/kcj.2016.46.4.562 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Influence of Thromboxane A2 on the Regulation of Adenosine   Triphosphate-Sensitive Potassium Channels in Mouse Ventricular Myocytes In Seok Jeong, MD1, Hwa Jin Cho, MD2, Jeong Gwan Cho, MD3, Sang Hyung Kim, MD1, Kook Joo Na, MD1,  and Jong-Keun Kim, MD4 1Department of Thoracic and Cardiovascular Surgery, 2Department of Pediatrics, 3Department of Internal Medicine, 4Department of Pharmacology, Chonnam National  University Medical School, Gwangju, Korea Background and Objectives:  Adenosine triphosphate (ATP)-sensitive potassium (KATP) channels play an important role in myocardial  protection.",Non-OADS,/arxiv_data1/oa_pdf/d3/db/kcj-46-562.PMC4965437.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.562 www.e-kcj.org rectifying potassium channel superfamily, and their activity is  regulated by the concentration of intracellular ATP metabolites.4) The activity of KATP channels is regulated by the ratio of ATP/ Adenosine Driphosphate or ATP concentration, which is an indicator  of intracellular metabolism.",OADS,/arxiv_data1/oa_pdf/d3/db/kcj-46-562.PMC4965437.pdf
"564  Thromboxane A2 and ATP-Sensitive Potassium Channel Regulation http://dx.doi.org/10.4070/kcj.2016.46.4.562 www.e-kcj.org they were then coated with Sylgard (Dow Corning Co., Midland,  MI, USA) up to the area around the microelectrode’s terminal, and  dried with a laboratory-made coiled heater.",Non-OADS,/arxiv_data1/oa_pdf/d3/db/kcj-46-562.PMC4965437.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.562 www.e-kcj.org the channel activity reached similar levels to those seen just after the  excised inside-out patch procedure.,OADS,/arxiv_data1/oa_pdf/d3/db/kcj-46-562.PMC4965437.pdf
"566  Thromboxane A2 and ATP-Sensitive Potassium Channel Regulation http://dx.doi.org/10.4070/kcj.2016.46.4.562 www.e-kcj.org differences between the two groups, and U46619 had no effect on  channel conductance (Fig.",Non-OADS,/arxiv_data1/oa_pdf/d3/db/kcj-46-562.PMC4965437.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.562 www.e-kcj.org white rats.,OADS,/arxiv_data1/oa_pdf/d3/db/kcj-46-562.PMC4965437.pdf
568  Thromboxane A2 and ATP-Sensitive Potassium Channel Regulation http://dx.doi.org/10.4070/kcj.2016.46.4.562 www.e-kcj.org aspects.,Non-OADS,/arxiv_data1/oa_pdf/d3/db/kcj-46-562.PMC4965437.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2016.46.4.569 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Remnant Pacemaker Lead Tips after Lead Extractions in Pacemaker  Infections Daehoon Kim, MD, Yong-Soo Baek, MD, Misol Lee, MD, Jae-Sun Uhm, MD, Hui-Nam Pak, MD, Moon-Hyoung Lee, MD,  and Boyoung Joung, MD Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Complete hardware removal is recommended in the case of patients with cardiovascular implantable electronic device (CIED) infections.",Non-OADS,/arxiv_data1/oa_pdf/49/6c/kcj-46-569.PMC4965438.pdf
570  Remnant Pacemaker Lead Tips http://dx.doi.org/10.4070/kcj.2016.46.4.569 www.e-kcj.org Patients with localized pocket infections Case 1 A 93-year-old female was admitted for skin erosion at the  site of the generator pocket (Patient 1 in Table 1-1).,Non-OADS,/arxiv_data1/oa_pdf/49/6c/kcj-46-569.PMC4965438.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.569 www.e-kcj.org via the right subclavian vein 14 days after the device removal  (18 days after the blood cultures were confirmed to be negative).,Non-OADS,/arxiv_data1/oa_pdf/49/6c/kcj-46-569.PMC4965438.pdf
572  Remnant Pacemaker Lead Tips http://dx.doi.org/10.4070/kcj.2016.46.4.569 www.e-kcj.org Case 5 A 54-year-old female was admitted due to continuous fever  for a month (Patient 5 in Table 1-1).,Non-OADS,/arxiv_data1/oa_pdf/49/6c/kcj-46-569.PMC4965438.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.569 www.e-kcj.org complications after the reimplantation, suggesting that the  remaining lead fragments were not an absolute contraindication  for the implantation of a new intracardiac device.",Non-OADS,/arxiv_data1/oa_pdf/49/6c/kcj-46-569.PMC4965438.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2016.46.4.574 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Spontaneous Transition of Double Tachycardias with Atrial Fusion   in a Patient with Wolff-Parkinson-White Syndrome Dongmin Kim, MD and Myung-Yong Lee, MD Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University, Cheonan, Korea Among patients with Wolff-Parkinson-White syndrome, atrioventricular reciprocating tachycardia (AVRT) and atrioventricular nodal  reentrant tachycardia (AVNRT) can coexist in a single patient.",Non-OADS,/arxiv_data1/oa_pdf/a4/1e/kcj-46-574.PMC4965439.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.574 www.e-kcj.org Tachycardia characteristics Tachycardia with CL varying from 393 to 420 msec was  reproducibly induced by single atrial extra-stimulation with AH  prolongation (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a4/1e/kcj-46-574.PMC4965439.pdf
576  Direct Transition of Double Tachycardias http://dx.doi.org/10.4070/kcj.2016.46.4.574 www.e-kcj.org were quite different and the difference was greater than 25 msec.,OADS,/arxiv_data1/oa_pdf/a4/1e/kcj-46-574.PMC4965439.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.574 www.e-kcj.org H H H H  421 msec  VA interval: 56 msec 418 msec 418 msec 416 msec  414 msec 418 msec 421 msec 414 msec 418 msec I II III V1 RA-HRA4 RA3 RA2RA-LHISpHISdCSpCS7-8CS5-6CS3-4CSdRVA200 msec  Fig.,Non-OADS,/arxiv_data1/oa_pdf/a4/1e/kcj-46-574.PMC4965439.pdf
578  Direct Transition of Double Tachycardias http://dx.doi.org/10.4070/kcj.2016.46.4.574 www.e-kcj.org slow pathway.,Non-OADS,/arxiv_data1/oa_pdf/a4/1e/kcj-46-574.PMC4965439.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.574 www.e-kcj.org double paroxysmal supraventricular tachycardias.,Non-OADS,/arxiv_data1/oa_pdf/a4/1e/kcj-46-574.PMC4965439.pdf
"580 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Case Report http://dx.doi.org/10.4070/kcj.2016.46.4.580 Print ISSN 1738-5520  • On-line ISSN 1738-5555Introduction Left atrial intramural hematoma (LAIH) is an exceedingly rare  occurrence.1) It is defined as a false, blood-filled cavity or lumen  in the left atrial (LA) walls or interatrial septum, creating a new  chamber which may or may not be connected with the true LA  chamber.2) The few reports available in the existing literature  relate LAIH primarily to cardiac procedures such as transcatheter  arrhythmia ablation and cardiac surgeries.",Non-OADS,/arxiv_data1/oa_pdf/27/e6/kcj-46-580.PMC4965440.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.580 www.e-kcj.org in the posterior LA regions.,Non-OADS,/arxiv_data1/oa_pdf/27/e6/kcj-46-580.PMC4965440.pdf
582  Left Atrial Hematoma after Catheter Ablation http://dx.doi.org/10.4070/kcj.2016.46.4.580 www.e-kcj.org follow-up TTE in an outpatient clinic 50 days after discharge  revealed significant resolution of the hematoma (Fig.,Non-OADS,/arxiv_data1/oa_pdf/27/e6/kcj-46-580.PMC4965440.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.580 www.e-kcj.org Left atrial dissection: an almost unknown entity.,Non-OADS,/arxiv_data1/oa_pdf/27/e6/kcj-46-580.PMC4965440.pdf
584 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Case Report http://dx.doi.org/10.4070/kcj.2016.46.4.584 Print ISSN 1738-5520  • On-line ISSN 1738-5555Introduction Central venous catheterization with a large-bore catheter is  widely used to gain vascular access while performing hemodialysis  or continuous renal replacement therapy.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/kcj-46-584.PMC4965441.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.584 www.e-kcj.org general anesthesia and the need for thoracotomy or partial removal  of the first rib during surgery, the patient was referred to us for  endovascular repair of the subclavian artery.",Non-OADS,/arxiv_data1/oa_pdf/71/d2/kcj-46-584.PMC4965441.pdf
586  Percutaneous Closure Device and Subclavian Artery http://dx.doi.org/10.4070/kcj.2016.46.4.584 www.e-kcj.org close to the origin of the left vertebral artery (Fig.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/kcj-46-584.PMC4965441.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.4.584 www.e-kcj.org Using angiography, an observation study reported significant  stenosis (20%) and occlusion (12%) during a 10-year period.6)  In addition, long-term antiplatelet therapy could increase the  bleeding risk in patients with recent massive bleeding and liver  transplantation.",Non-OADS,/arxiv_data1/oa_pdf/71/d2/kcj-46-584.PMC4965441.pdf
Sequential implementation of suture- mediated closure devices with a temporary balloon tamponade  backup can be considered as a reasonable alternative for poor  surgical candidates with inadvertent arterial catheterization at  non-compressible sites.Supplementary Materials  The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.4.584.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/kcj-46-584.PMC4965441.pdf
Available from: http://www.abbottvascular.com/ifu.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/kcj-46-584.PMC4965441.pdf
"588 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2016.46.4.588 Print ISSN 1738-5520  • On-line ISSN 1738-5555A 71-year-old woman had severe aortic stenosis (AS) (aortic valve  area, 0.6 cm2; mean valve gradient, 47 mmHg; and peak velocity, 4.2  m/s) and cardiac symptoms.",Non-OADS,/arxiv_data1/oa_pdf/6f/5e/kcj-46-588.PMC4965442.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop - erly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/5e/kcj-46-588.PMC4965442.pdf
http://dx.doi.org/10.4070/kcj.2016.46.4.588 www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/6f/5e/kcj-46-588.PMC4965442.pdf
"590 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Erratum http://dx.doi.org/10.4070/kcj.2016.46.4.590 Print ISSN 1738-5520  • On-line ISSN 1738-5555Korean Circ J 2016;46:207-212 http://dx.doi.org/10.4070/kcj.2016.46.2.207 In the article, “Right Cardiac Catheterization Using the Antecubital Fossa Vein in Korean Patients” in Volume 46(2),  page 207-212, the 9th author’s name was misspelled.",Non-OADS,/arxiv_data1/oa_pdf/95/5f/kcj-46-590.PMC4965443.pdf
"Copyright © 2016 The Korean Society of Cardiology591 Korean Circulation Journal Erratum http://dx.doi.org/10.4070/kcj.2016.46.4.591 Print ISSN 1738-5520  • On-line ISSN 1738-5555Korean Circ J 2016;46:394-401 http://dx.doi.org/10.4070/kcj.2016.46.3.394 In the article, “Obesity and Hypertension in Association with Diastolic Dysfunction Could Reduce Exercise Capacity”  in Volume 46(3), page 394-401, the 3rd author’s affiliation was misspelled.",Non-OADS,/arxiv_data1/oa_pdf/28/46/kcj-46-591.PMC4965444.pdf
Available from: http://evs.nci.nih.gov/ftp1/ CTCAE/About.html.,OADS,/arxiv_data1/oa_pdf/90/82/JCB-8-27720.PMC4965495.pdf
Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx  12.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/JCB-8-27749.PMC4965497.pdf
G*power (version 3.1) was used to calculat-ed the sample size (http://www.softpedia.com/get/ Science-CAD/G-Power.shtml).,OADS,/arxiv_data1/oa_pdf/6d/01/JCB-8-27760.PMC4965499.pdf
"National Comprehensive Cancer Network, Squamous Cell  Skin Cancer Version 1.2015 2015. http://www.nccn.org/ professionals/physician_gls/pdf/squamous.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/8f/2b/JCB-8-27942.PMC4965504.pdf
"However,	Received:	March	4,	2016 Accepted:	April	6,	2016 Corresponding	 author:	Dr.	Masahiro	 Goto,	Division	of	 Endocrinology	 and	Metabolism,	 Tokyo	Metropolitan 	 Children’s	 Medical	Center,	2-8-29	Musashidai, 	Fuchu,	 Tokyo	183-8561,	Japan E-mail:	masahiro_gotou@tmhp.jp This	is	an	open-access	 article	distributed	 under	the	terms	 of	the	Creative	Commons 	Attribution 	Non-Commercial 	No	 Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/ licenses/by-nc-nd/4.0/>.Clin	Pediatr	Endocrinol	2016;	25(3),	83–89 Copyright©	2016	by	The	Japanese	Society	for	Pediatric	Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/5f/0a/cpe-25-083.PMC4965507.pdf
"Some authors have suggested that pathogenic Received: December 19, 2015 Accepted: March 31, 2016 Corresponding author: Dr. Koji Muroya, Department of  Endocrinology and Metabolism, Kanagawa Children’s  Medical Center, Mutsukawa 2-138-4, Minami-ku,  Yokohama-shi, Kanagawa 232-8555, Japan E-mail address: kmuroya@kcmc.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Clin Pediatr Endocrinol 2016; 25(3), 91–98 Copyright© 2016 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/29/a2/cpe-25-091.PMC4965508.pdf
"Seattle (WA): University of Washington, Seattle: 1993-2015 http://www.ncbi.nlm.nih.gov/books/NBK3789/.",Non-OADS,/arxiv_data1/oa_pdf/29/a2/cpe-25-091.PMC4965508.pdf
"reported the  identification of 6q24 uniparental disomy in three  patients with childhood-onset non-autoimmune Received: January 15, 2016 Accepted: March 8, 2016 Corresponding author: Dr. Maki Fukami; Department  of Molecular Endocrinology, National Research Insti- tute for Child Health and Development, 2-10-1 Okura,  Setagaya, Tokyo 157-8535, Japan E-mail: fukami-m@ncchd.go.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Clin Pediatr Endocrinol 2016; 25(3), 99–102 Copyright© 2016 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/59/97/cpe-25-099.PMC4965509.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Clin Pediatr Endocrinol 2016; 25(3), 103–106 Copyright© 2016 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/28/55/cpe-25-103.PMC4965510.pdf
The identified mutation is novel and has not been  registered in the Human Genome Mutation Database (http://www.hgmd.cf.ac.uk/ac).,Non-OADS,/arxiv_data1/oa_pdf/28/55/cpe-25-103.PMC4965510.pdf
"To date, 48 COL10A1 mutations have been reported  in families with SMCD of different ethnic origin  (Human Gene Mutation Database; http://www.hgmd.cf.ac.uk/ac).",Non-OADS,/arxiv_data1/oa_pdf/d4/1e/cpe-25-107.PMC4965511.pdf
"Clinical findings  Received: December 15, 2015 Accepted: April 6, 2016 Corresponding author: Dr. Yukihiro Hasegawa, Depart- ment of Endocrinology and Metabolism, Tokyo Metro- politan Children’s Medical Center, 2-8-29 Musashidai,  Fuchu-shi, Tokyo 183-8561, Japan E-mail: yhaset@gmail.com This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Clin Pediatr Endocrinol 2016; 25(3), 107–110 Copyright© 2016 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/d4/1e/cpe-25-107.PMC4965511.pdf
"At the age of 3 mo, she presented  with failure to thrive and frequent vomiting once  again, and she was admitted to our hospital at  Received: October 6, 2015 Accepted: April 8, 2016 Corresponding author: Dr. Toshiki Tsunogai, Depart- ment of Pediatrics, The Jikei University Kashiwa  Hospital, 163-1 Kashiwa-shimo, Chiba 277-8567, Japan E-mail: tsunogait@gmail.com This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Clin Pediatr Endocrinol 2016; 25(3), 111–114 Copyright© 2016 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/7f/36/cpe-25-111.PMC4965512.pdf
"Her father’s height was 160 cm (–1.9 SD) and  her maternal grandmother had short stature  Received: February 29, 2016 Accepted: May 7, 2016 Corresponding author: Masatsune Itoh, Department of  Pediatrics, Kanazawa Medical University, Daigaku 1-1,  Uchinada-machi, Kahoku-gun, Ishikawa 920-0293, Japan E-mail: p-itou@kanazawa-med.ac.jp This is an open-access article distributed under the terms  of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Clin Pediatr Endocrinol 2016; 25(3), 115–118 Copyright© 2016 by The Japanese Society for Pediatric Endocrinology",Non-OADS,/arxiv_data1/oa_pdf/52/fd/cpe-25-115.PMC4965513.pdf
"E-mail:  nkawano@seitoku.ac.jp ©2016 BMFH Press This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Full Paper Bioscience of Microbiota, Food and Health Vol.",Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmfh-35-105.PMC4965514.pdf
"(section 5.3, Expert report, at ftp://ftp.fao.org/es/esn/food/Reid.pdf.",Non-OADS,/arxiv_data1/oa_pdf/19/fc/bmfh-35-105.PMC4965514.pdf
"E-mail:  suzuki@gifu-u.ac.jp ©2016 BMFH Press This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Full Paper Bioscience of Microbiota, Food and Health Vol.",Non-OADS,/arxiv_data1/oa_pdf/b1/61/bmfh-35-113.PMC4965515.pdf
Sequences were obtained from the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov/nuccore/).,OADS,/arxiv_data1/oa_pdf/b1/61/bmfh-35-113.PMC4965515.pdf
"CLUSTAL W 2.1 (http://clustalw.ddbj.nig.ac.jp) was used for sequence alignment [27], and FigTree 1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/) was used for visualization.",OADS,/arxiv_data1/oa_pdf/b1/61/bmfh-35-113.PMC4965515.pdf
Amino acid sequence similarities were determined with BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.cgi) [28].,OADS,/arxiv_data1/oa_pdf/b1/61/bmfh-35-113.PMC4965515.pdf
"E-mail: lab@ nichinichi-phar.co.jp ©2016 BMFH Press This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Full Paper Bioscience of Microbiota, Food and Health Vol.",Non-OADS,/arxiv_data1/oa_pdf/f3/53/bmfh-35-123.PMC4965516.pdf
"Phone: +81-96- 242-7742, Fax: +81-96-249-1002, E-mail:   tomooki@affrc.go.jp ©2016 BMFH Press This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Full Paper Bioscience of Microbiota, Food and Health Vol.",Non-OADS,/arxiv_data1/oa_pdf/00/cf/bmfh-35-129.PMC4965517.pdf
"Mailing address: Takashi Kuda, Depart- ment of Food Science and Technology, Tokyo University of  Marine Science and Technology, 4-5-7 Konan, Minato-ku, Tokyo  108-8477, Japan E-mail: kuda@kaiyodai.ac.jp ©2016 BMFH Press This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Note Bioscience of Microbiota, Food and Health Vol.",Non-OADS,/arxiv_data1/oa_pdf/3e/47/bmfh-35-137.PMC4965518.pdf
"Mailing address: Shuzo Orikasa, Next  Generation Science Institute, Morinaga Milk Industry Co., Ltd.,  5-1-83 Higashihara, Zama, Kanagawa 252-8583, Japan ©2016 BMFH Press This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Note Bioscience of Microbiota, Food and Health Vol.",Non-OADS,/arxiv_data1/oa_pdf/b2/b4/bmfh-35-141.PMC4965519.pdf
"   Case Rep Dermatol 2016;8:189 –192  DOI: 10.1159/000447482   Published online: July 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/9c/89/cde-0008-0189.PMC4965525.pdf
"04-01, MD3, 16 Medical Drive   Singapore 117600 (Singapore)   E-Mail phccclh   @   nus.edu.sg www.karger.com/dee DOI: 10.1159/000445050  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/77/8e/dee-0006-0276.PMC4965526.pdf
"   Case Rep Neurol 2016;8:151 –155  DOI: 10.1159/000447120   Published online: July 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/37/5d/crn-0008-0151.PMC4965527.pdf
"   Case Rep Neurol 2016;8:145 –150  DOI: 10.1159/000447296   Published online: July 7, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/3a/dc/crn-0008-0145.PMC4965528.pdf
"   Case Rep Nephrol Dial 2016;6:89 –95  DOI: 10.1159/000448025   Published online: July 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cnd   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Servi ces/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/b3/8d/cnd-0006-0089.PMC4965529.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: July 15, 2016 EXTRA  Annika Öhrfelt   Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry   Institute of Neuroscience and Physiology, Sahlgrenska University Hospital Mölndal   Sahlgrenska Academy, University of Gothenburg, SE–431 80 Mölndal (Sweden)   E-Mail annika.ohrfelt   @   neuro.gu.se www.karger.com/dee DOI: 10.1159/000447239  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/00/19/dee-0006-0283.PMC4965532.pdf
"   Case Rep Ophthalmol 2016;7:345 –353  DOI: 10.1159/000447086   Published online: July 11, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommerc ial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/90/17/cop-0007-0345.PMC4965533.pdf
"   Case Rep Dermatol 2016;8:193 –196  DOI: 10.1159/000447234   Published online: July 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/3f/81/cde-0008-0193.PMC4965534.pdf
"   Case Rep Dermatol 2016;8:179 –184  DOI: 10.1159/000446836   Published online: July 11, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c3/ad/cde-0008-0179.PMC4965536.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: July 19, 2016 EXTRA  Prof. Anne Marja Remes, MD, PhD   Department of Neurology, Institute of Clinical Medicine   University of Eastern Finland   PO Box 1627, FI–70211 Kuopio (Finland)   E-Mail anne.remes   @   uef.fi www.karger.com/dee DOI: 10.1159/000446425  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/de/52/dee-0006-0303.PMC4965537.pdf
"Similar results are p ublished for Argentina, Brazil  Published online: July 16, 2016 EXTRA  Cecilia Albala, MD, MPH   INTA, University of Chile   El Libano 5524 Macul   Santiago (Chile)   E-Mail calbala   @   uchile.cl www.karger.com/dee DOI: 10.1159/000447447  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/35/1a/dee-0006-0295.PMC4965539.pdf
"   Case Rep Gastroenterol 2016;10:360 –365  DOI: 10.1159/000447485   Published online: July 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/92/71/crg-0010-0360.PMC4965541.pdf
"   Case Rep Dermatol 2016;8:185 –188  DOI: 10.1159/000447256   Published online: July 11, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons A ttribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/74/6b/cde-0008-0185.PMC4965542.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: July 6, 2016   Sébastien Menzinger   Hôpitaux Universitaires de Genève   4, rue Gabrielle-Perret-Gentil   CH–1205 Geneva (Switzerland)   E-Mail Sebastien.Menzinger   @   hcuge.ch www.karger.com/dpa DOI: 10.1159/000446699  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/91/c0/dpa-0003-0061.PMC4965543.pdf
"   Case Rep Gastroenterol 2016;10:352 –359  DOI: 10.1159/000447486   Published online: July 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crg   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International Lic ense (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/f3/e5/crg-0010-0352.PMC4965544.pdf
- Korean J Orthod 2016;46:180-5 http://dx.doi.org/10.4041/kjod.2016.46.4.187187www.e-kjo.orgpIssN 2234-7518 eIssN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/ab/23/kjod-46-187.PMC4965589.pdf
"While Suresmile ® provides  finishing customized archwires, and thus the utilization of these robot-bent wires should be limited to the stage after  www.e-kjo.org http://dx.doi.org/10.4041/kjod.2016.46.4.187This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.achieving complete leveling and alignment with no spaces.",Non-OADS,/arxiv_data1/oa_pdf/ab/23/kjod-46-187.PMC4965589.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.4.189",Non-OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
Choi et al • Stress with different insertion angles www.e-kjo.org 190 http://dx.doi.org/10.4041/kjod.2016.46.4.189 INTRODUCTION   Miniscrews have been used to provide temporary  skeletal anchorage during orthodontic treatment.,Non-OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
Choi et al • Stress with different insertion angles www.e-kjo.org 191 http://dx.doi.org/10.4041/kjod.2016.46.4.189 1.5 mm.,OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
Choi et al • Stress with different insertion angles www.e-kjo.org 192 http://dx.doi.org/10.4041/kjod.2016.46.4.189 fixed in all directions as boundary conditions.,OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
"Choi et al • Stress with different insertion angles www.e-kjo.org 193 http://dx.doi.org/10.4041/kjod.2016.46.4.189 en-masse  retraction of anterior teeth based on previous  studies.26,27   The von Mises stresses were measured in the roots and  PDLs of the maxillary second premolars, first molars, cortical bone, and cancellous bone during miniscrew insertion and after orthodontic force loading at placement angles of 30 o, 60o, and 90o.",Non-OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
Choi et al • Stress with different insertion angles www.e-kjo.org 194 http://dx.doi.org/10.4041/kjod.2016.46.4.189 Cylindrical TaperedD M773.539551 12979.069878 25184.600206 37390.130534 49595.660862 61801.191 189 74006.721517 86212.251845 98417.782172 110623 60 90 30DM5219.798828 12566.405382 19913.01 1936 27259.61849 34606.225043 41952.831597 49299.438151 56646.044705 63992.651259 71339.25781210548.69043 17219.947917 23891.205404 30562.462891 37233.720378 43904.977865 50576.235352 57247.492839 63918.750326 70590.007812 1581.968384 18740.155924 35898.343465 53056.531006 70214.718547 87372.906087 104531 121689 138847 1560065265.750488 18557.205295 31848.660102 45140.1 14909 58431.569716 71723.024523 85014.479329 98305.934136 111597 12488917874.802734 31415.614583 44956.426432 58497.238281 72038.05013 85578.861979 99119.673828 112660 126201 139742 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
"Choi et al • Stress with different insertion angles www.e-kjo.org 195 http://dx.doi.org/10.4041/kjod.2016.46.4.189 Stress distributions during force application Roots and PDLs (Table 4)   The maximum von Mises stresses from cylindrical  and tapered miniscrews were near zero, regardless of insertion angle.",OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
"Choi et al • Stress with different insertion angles www.e-kjo.org 196 http://dx.doi.org/10.4041/kjod.2016.46.4.189 stress might attract more inflammatory mediators to the  site and could possibly result in bone resorption and remodeling, which may cause miniscrew failure.",Non-OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
Choi et al • Stress with different insertion angles www.e-kjo.org 197 http://dx.doi.org/10.4041/kjod.2016.46.4.189 length of the miniscrew was longer at 30o than at other  insertion angles.,OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
Choi et al • Stress with different insertion angles www.e-kjo.org 198 http://dx.doi.org/10.4041/kjod.2016.46.4.189 Implants 2010;25:777-83.,OADS,/arxiv_data1/oa_pdf/5f/32/kjod-46-189.PMC4965590.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.4.199",Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 200 http://dx.doi.org/10.4041/kjod.2016.46.4.199 INTRODUCTION   Several occlusal indices have been developed to  assess the outcome of orthodontic treatment in an objective and quantitative manner in order to ensure improvements in treatment quality.,Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
"Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 201 http://dx.doi.org/10.4041/kjod.2016.46.4.199 ments [upper and lower anterior segments, upper right  and left segments, lower right and left segments] for teeth alignment: 2 occlusion measurements [right and left buccal occlusion] on molar relationship, and measurement of overjet, over-bite, and centerline; Table 1).",OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 202 http://dx.doi.org/10.4041/kjod.2016.46.4.199 Dental relationship · Arch length discrepancy (ALD; mm; dental model):  the amount of crowding in the maxillary and  mandibular arches.,OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 203 http://dx.doi.org/10.4041/kjod.2016.46.4.199 Table 5.,Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
"Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 204 http://dx.doi.org/10.4041/kjod.2016.46.4.199 (U1-SN) (o, lateral cephalogram): if the inclination  of the maxillary incisor is normal (Korean standard,  107.8o ± 5.9o), it indicates balance and harmony of  the upper lip and nasolabial angle.",Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 205 http://dx.doi.org/10.4041/kjod.2016.46.4.199 individuals.,OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
"Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 206 http://dx.doi.org/10.4041/kjod.2016.46.4.199 can be measured in both directions; however, their  scoring depends on the absolute measurement value.",Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
"Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 207 http://dx.doi.org/10.4041/kjod.2016.46.4.199 value of −4 mm (“3” points) and an Irregularity value  of 6 (‘2’ points), which was primarily due to excess maxillary tooth mass according to the anterior Bolton ratio (75.5%).",Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
"Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 208 http://dx.doi.org/10.4041/kjod.2016.46.4.199 to be proclined, which was challenging.",Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
"Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 209 http://dx.doi.org/10.4041/kjod.2016.46.4.199 the assessment scope, visualization with consecutive  monitoring, and a comprehensive scoring system.",Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 210 http://dx.doi.org/10.4041/kjod.2016.46.4.199 of ‘Irregularity’.,Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
Hong et al • ICO index for orthodontic treatment quality www.e-kjo.org 211 http://dx.doi.org/10.4041/kjod.2016.46.4.199 dissertation].,Non-OADS,/arxiv_data1/oa_pdf/eb/64/kjod-46-199.PMC4965591.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.4.212",Non-OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
Yu et al • Mandibular total arch distalization using plate www.e-kjo.org 213 http://dx.doi.org/10.4041/kjod.2016.46.4.212 INTRODUCTION   The achievement of a pleasing profile with non- surgical treatment of Class III patients has always been challenging.,Non-OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
"Yu et al • Mandibular total arch distalization using plate www.e-kjo.org 214 http://dx.doi.org/10.4041/kjod.2016.46.4.212 missing or extracted third molars, and (4) no syndrome  or systemic disease.",Non-OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
"Yu et al • Mandibular total arch distalization using plate www.e-kjo.org 215 http://dx.doi.org/10.4041/kjod.2016.46.4.212 RESULTS   In the evaluation of tooth movement in relation to the  FH and VFH as the craniofacial reference lines, there was a significant 3.2 mm ( p < 0.001) distalization of the  mandibular first molars, while their roots were distalized 2.0 mm with distal tipping of 4.6 o (p < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
Yu et al • Mandibular total arch distalization using plate www.e-kjo.org 216 http://dx.doi.org/10.4041/kjod.2016.46.4.212 Table 2.,OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
"Yu et al • Mandibular total arch distalization using plate www.e-kjo.org 217 http://dx.doi.org/10.4041/kjod.2016.46.4.212 buccal shelf mini-implant was successful in distalizing  the mandibular arch,20 the force vector resulted in  greater rotation of the mandibular occlusal plane.",Non-OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
"Yu et al • Mandibular total arch distalization using plate www.e-kjo.org 218 http://dx.doi.org/10.4041/kjod.2016.46.4.212 no significant change in the vertical position of the  mandibular molars nor in the MP angle; however, the amount of root distalization was not statistically signifi-cant.",Non-OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
Yu et al • Mandibular total arch distalization using plate www.e-kjo.org 219 http://dx.doi.org/10.4041/kjod.2016.46.4.212 25.,Non-OADS,/arxiv_data1/oa_pdf/20/8b/kjod-46-212.PMC4965592.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.4.220",Non-OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
"Aglarci et al • Turkish version of PIDAQ www.e-kjo.org 221 http://dx.doi.org/10.4041/kjod.2016.46.4.220 INTRODUCTION   Oral health affects people physically, as it is closely  related to appearance, enjoyment, eating, speech, taste, and growth.",Non-OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
Aglarci et al • Turkish version of PIDAQ www.e-kjo.org 222 http://dx.doi.org/10.4041/kjod.2016.46.4.220 original and back-translated versions.,Non-OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
Aglarci et al • Turkish version of PIDAQ www.e-kjo.org 223 http://dx.doi.org/10.4041/kjod.2016.46.4.220 variance for the entire scale was 62.94% (Table 1).,OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
Aglarci et al • Turkish version of PIDAQ www.e-kjo.org 224 http://dx.doi.org/10.4041/kjod.2016.46.4.220 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
"Aglarci et al • Turkish version of PIDAQ www.e-kjo.org 225 http://dx.doi.org/10.4041/kjod.2016.46.4.220 DISCUSSION   Quality of life is commonly assessed via questionnaires,  which should be verified for cross-cultural adaptation when the original and translated versions are comparable.",Non-OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
"Aglarci et al • Turkish version of PIDAQ www.e-kjo.org 226 http://dx.doi.org/10.4041/kjod.2016.46.4.220 consistency, relative to that of the original version, could  be explained by the disarrangement of items in the psychological impact subscale.",Non-OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
Aglarci et al • Turkish version of PIDAQ www.e-kjo.org 227 http://dx.doi.org/10.4041/kjod.2016.46.4.220 5.,Non-OADS,/arxiv_data1/oa_pdf/56/4b/kjod-46-220.PMC4965593.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.4.228",Non-OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
"Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 229 http://dx.doi.org/10.4041/kjod.2016.46.4.228 INTRODUCTION   Orthodontic root resorption (ORR) is one of the most  difficult procedure-related adverse events to predict in cases of orthodontic tooth movement (OTM), and may cause permanent loss of the dental structure at the root apex.",Non-OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 230 http://dx.doi.org/10.4041/kjod.2016.46.4.228 was ligated to the maxillary first molar with ligature  wire.,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
"Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 231 http://dx.doi.org/10.4041/kjod.2016.46.4.228 tension side during tooth movement (Figure 3).11 In  both areas, positive cells were counted manually.",OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 232 http://dx.doi.org/10.4041/kjod.2016.46.4.228 with few multinucleated odontoclasts were observed  on palatal root surfaces (Figure 4s and 4v).,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
"Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 233 http://dx.doi.org/10.4041/kjod.2016.46.4.228 K-positive and MMP-9-positive multinucleated  odontoclasts were observed (Figures 5, 6n, and 6o).",OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
"Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 234 http://dx.doi.org/10.4041/kjod.2016.46.4.228 and RANKL-positive cells were observed in PDL tissues  on day 7 in the A areas of the roots, while increased numbers were observed on days 14 and 21 (Figures 7, 8, and 9m–9o).",OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 235 http://dx.doi.org/10.4041/kjod.2016.46.4.228 A and B areas on day 21 ( p < 0.01) (Figure 11C–11E).,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 236 http://dx.doi.org/10.4041/kjod.2016.46.4.228 roots of rat molars bucco-palatally once a week for 21  days in vivo .,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 237 http://dx.doi.org/10.4041/kjod.2016.46.4.228 species and the magnitudes and intervals of the applied  forces.,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 238 http://dx.doi.org/10.4041/kjod.2016.46.4.228 Eross et al.15 concluded that jiggling forces applied  alternately in different directions with a short interval of  reactivation are critically important in inducing severe root resorption.,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 239 http://dx.doi.org/10.4041/kjod.2016.46.4.228 Positivecells/area 0 Control12 10 8 6 4 2ACathepsin-K JF HF OF Control JF HF OFPositivecells/area 014 10 8 6 4 2BMMP-9 Positivecells/area Positivecells/area0 0Control Control35 30 25 201510 5 25 201510 5C EIL-6 RANKLJF JFHF HFOF OFControl ControlJF JFHF HFOF OFPositivecells/area Positivecells/area0 045 40 35 3025 20 1510 5 4.5 4.03.5 3.0 2.5 2.0 1.51.00.5D FCINC-1 OPG**12 **** **** *** * ** ** ** **** ** ** ** ** ** **** ******** **** **Control JF HF OF Control JF HF OF Control JF HF OF Control JF HF OF Control JF HF OF Control JF HF OFAarea Barea Aarea Barea Aarea BareaAarea Barea Aarea Barea Aarea Barea Figure 11.,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 240 http://dx.doi.org/10.4041/kjod.2016.46.4.228 were increased in the JF group on day 21 compared with  the HF group (50 g) and the OF group (10 g).,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
Hikida et al • A jiggling force aggravates root resorption www.e-kjo.org 241 http://dx.doi.org/10.4041/kjod.2016.46.4.228 2015;147:738-46.,OADS,/arxiv_data1/oa_pdf/14/95/kjod-46-228.PMC4965594.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.4.242",Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"Song et al • High OMI retraction www.e-kjo.org 243 http://dx.doi.org/10.4041/kjod.2016.46.4.242 INTRODUCTION   En-masse  retraction is beneficial because it does not  require complicated techniques such as wire bending,  but it provides little room for the orthodontist to adjust, except for the length of the anterior retraction hook (ARH), thereby making it difficult to obtain various tooth movement patterns.",Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
Song et al • High OMI retraction www.e-kjo.org 244 http://dx.doi.org/10.4041/kjod.2016.46.4.242 from the main arch wire towards the root apex area  (low OMI traction) or at 12 mm from the mesial second maxillary premolar (high OMI traction).,Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"Song et al • High OMI retraction www.e-kjo.org 245 http://dx.doi.org/10.4041/kjod.2016.46.4.242 on the mesiobuccal cusp tip and root apex, with the  X-, Y-, and Z-axis coordinate values and displacements measured in each.",OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"Song et al • High OMI retraction www.e-kjo.org 246 http://dx.doi.org/10.4041/kjod.2016.46.4.242 the maxillary anterior crowns, root apexes, each cusp,  and the root apex of the maxillary first molar, regardless of the ARH height.",Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
Song et al • High OMI retraction www.e-kjo.org 247 http://dx.doi.org/10.4041/kjod.2016.46.4.242 1mm 1mm mm 3mm mmM1 M2 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"Song et al • High OMI retraction www.e-kjo.org 248 http://dx.doi.org/10.4041/kjod.2016.46.4.242   To overcome this limitation, Kojima and Fukui13 intro- duced a repeated finite element experiment method.",OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"Song et al • High OMI retraction www.e-kjo.org 249 http://dx.doi.org/10.4041/kjod.2016.46.4.242 element experiment, considering the tooth movement  caused by biologic factors such as periodontal ligament and alveolar bone remodeling, it seemed valid to assume no deformation in the tooth and bracket by the external force and to increase the arch wire property in order to avoid arch wire bowing.",Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
Song et al • High OMI retraction www.e-kjo.org 250 http://dx.doi.org/10.4041/kjod.2016.46.4.242 incisor was compared under low and high OMI traction  conditions.,OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"Song et al • High OMI retraction www.e-kjo.org 251 http://dx.doi.org/10.4041/kjod.2016.46.4.242 the extraction space, if the retraction force continued for  several months, then the intrusion force could affect the entire maxillary arch and cause intrusion of the maxillary molars.",Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"Song et al • High OMI retraction www.e-kjo.org 252 http://dx.doi.org/10.4041/kjod.2016.46.4.242 dimensional dental model analysis of treatment  outcomes for protrusive maxillary dentition: comparison of headgear, miniscrew, and miniplate skeletal anchorage.",Non-OADS,/arxiv_data1/oa_pdf/ca/25/kjod-46-242.PMC4965595.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSCase Report pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.4.253",Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
"Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 254 http://dx.doi.org/10.4041/kjod.2016.46.4.253 INTRODUCTION   In the adult Chinese population, skeletal Class II  malocclusion is often accompanied by a prognathic maxilla and a retrognathic mandible with clockwise rotation, resulting in a convex facial profile, an excessive lower facial height, and compromised facial esthetics.",Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
"Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 255 http://dx.doi.org/10.4041/kjod.2016.46.4.253 overjet and overbite, establishment of Class I canine  and molar relationships, and correction of the gummy smile and facial profile.",Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 256 http://dx.doi.org/10.4041/kjod.2016.46.4.253 elastics to achieve a compromised result without skeletal  correction.,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 257 http://dx.doi.org/10.4041/kjod.2016.46.4.253 palatal miniscrew to the maxillary left second molar for  correction of the scissor bite between the maxillary and mandibular left second molars and for avoiding mesial movement of the maxillary left first molar (Figures 4 and 5A).,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 258 http://dx.doi.org/10.4041/kjod.2016.46.4.253 the maxillary and mandibular central and lateral incisors  (Figure 7).,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 259 http://dx.doi.org/10.4041/kjod.2016.46.4.253 achieved.,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 260 http://dx.doi.org/10.4041/kjod.2016.46.4.253 and overbite were achieved.,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
"Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 261 http://dx.doi.org/10.4041/kjod.2016.46.4.253 Evidence of these changes was further provided by  cephalometric analysis; the MP/SN decreased by 3.3o,  the sella−nasion−B (SNB) point angle increased by 2.8o,  the ANB angle decreased by 3.2o, and U1/L1 decreased  by 14.4o (Figures 10 and 11, Table 1).",OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 262 http://dx.doi.org/10.4041/kjod.2016.46.4.253 steel wires with a reverse curve of Spee are often used to  correct a deep overbite in the conventional straight-wire technique based on sliding mechanics.,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 263 http://dx.doi.org/10.4041/kjod.2016.46.4.253 molar intrusion in this high-angle case provided a  force system that effectively controlled her posterior dentoalveolar dimensions and significantly improved her chin projection and overall facial profile.,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 264 http://dx.doi.org/10.4041/kjod.2016.46.4.253 be strictly maintained to minimize the degree of root  resorption.,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
Wang et al • Nonsurgical correction of gummy smile www.e-kjo.org 265 http://dx.doi.org/10.4041/kjod.2016.46.4.253 21.,Non-OADS,/arxiv_data1/oa_pdf/98/91/kjod-46-253.PMC4965596.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):243-250 http://dx.doi.org/10.3341/kjo.2016.30.4.243 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.243 Original ArticlePatients complained of repeated epiphora need to evalu - ate nasolacrimal drainage system because the common -est cause of epiphora is nasolacrimal duct obstruction  (NLDO).",Non-OADS,/arxiv_data1/oa_pdf/fb/16/kjo-30-243.PMC4965598.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):251-257 http://dx.doi.org/10.3341/kjo.2016.30.4.251 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.251 Original ArticleAnterior segment morphometry and intraocular pressure  (IOP) can change after intraocular surgery.",Non-OADS,/arxiv_data1/oa_pdf/62/99/kjo-30-251.PMC4965599.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):258-264 http://dx.doi.org/10.3341/kjo.2016.30.4.258 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.258 Original ArticleToxocariasis is one of the most common zoonotic infec - tions caused by larvae of Toxocara canis  or Toxocara cati .",Non-OADS,/arxiv_data1/oa_pdf/58/a4/kjo-30-258.PMC4965600.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):265-271 http://dx.doi.org/10.3341/kjo.2016.30.4.265 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.265 Original ArticleAge-related macular degeneration (AMD) is the most  common cause of irreversible visual impairments [1,2].",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/kjo-30-265.PMC4965601.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):272-279 http://dx.doi.org/10.3341/kjo.2016.30.4.272 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.272 Original ArticlePolypoidal choroidal vasculopathy (PCV) is a disorder  of the eyes characterized by branching vascular networks and terminating polypoidal lesions on indocyanine green  angiography (ICGA).",Non-OADS,/arxiv_data1/oa_pdf/89/27/kjo-30-272.PMC4965602.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):280-288 http://dx.doi.org/10.3341/kjo.2016.30.4.280 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.280 Original ArticleAfter the introduction of phacoemulsification by Kelman  [1] in the 1960s, surgeons have continually refined this  technique to make it even safer and more effective.",Non-OADS,/arxiv_data1/oa_pdf/d0/2d/kjo-30-280.PMC4965603.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):289-294 http://dx.doi.org/10.3341/kjo.2016.30.4.289 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.289 Original ArticleUnilateral optic nerve dysfunction with optic disc swell - ing has been reported in various disorders, such as nonar - teritic anterior ischemic optic neuropathy (NAION), optic  neuritis (ON), compressive optic neuropathy, infiltrative optic neuropathy, and retinal vein occlusion.",Non-OADS,/arxiv_data1/oa_pdf/ce/66/kjo-30-289.PMC4965604.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):295-301 http://dx.doi.org/10.3341/kjo.2016.30.4.295 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.295 Original ArticlePituitary adenoma (PA) is a common benign monoclonal  neoplasm that accounts for approximately 15% to 20% of primary intracranial tumors [1].",Non-OADS,/arxiv_data1/oa_pdf/f7/55/kjo-30-295.PMC4965605.pdf
Internet  J Ophthalmol Vis Sci  2007;4. http://faculty.ksu.edu.sa/68905/ Lectures/mhtml%20file%20F%20Pituitary%20Adenomas.,Non-OADS,/arxiv_data1/oa_pdf/f7/55/kjo-30-295.PMC4965605.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2016;30(4):302-308 http://dx.doi.org/10.3341/kjo.2016.30.4.302 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.302 Original ArticleDry eye (DE) syndrome is one of the most frequent dis - eases encountered by ophthalmologists, and has a preva - lence of 30% to 50% in the entire population [1-3] and a  significant impact on daily life [4-6].",Non-OADS,/arxiv_data1/oa_pdf/92/82/kjo-30-302.PMC4965606.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2016 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.309Verrucous Carcinoma of the Eyelid Dear Editor, Verrucous carcinoma (VC) is a rare variant of squamous  cell carcinoma with low grade, well-differentiated, and  very slow-growing malignancy.",Non-OADS,/arxiv_data1/oa_pdf/a6/c5/kjo-30-309.PMC4965607.pdf
"Macroscopically, VC shows exophytic growth as a pro -Korean J Ophthalmol 2016;30(4):309-310 http://dx.doi.org/10.3341/kjo.2016.30.4.309Correspondence  Fig.",OADS,/arxiv_data1/oa_pdf/a6/c5/kjo-30-309.PMC4965607.pdf
"Based on these findings, Tse Korean J Ophthalmol 2016;30(4):311-312 http://dx.doi.org/10.3341/kjo.2016.30.4.311 Fig.",Non-OADS,/arxiv_data1/oa_pdf/67/8c/kjo-30-311.PMC4965608.pdf
"Af - ter 2 hours, IOP in the right eye decreased to 24 mmHg,  and visual acuity increased to 20 / 100; however, fundus Korean J Ophthalmol 2016;30(4):312-313 http://dx.doi.org/10.3341/kjo.2016.30.4.312",Non-OADS,/arxiv_data1/oa_pdf/67/8c/kjo-30-311.PMC4965608.pdf
"Af - ter 2 hours, IOP in the right eye decreased to 24 mmHg,  and visual acuity increased to 20 / 100; however, fundus Korean J Ophthalmol 2016;30(4):312-313 http://dx.doi.org/10.3341/kjo.2016.30.4.312",Non-OADS,/arxiv_data1/oa_pdf/59/88/kjo-30-312.PMC4965609.pdf
Brain magnetic resonance images Korean J Ophthalmol 2016;30(4):314-315 http://dx.doi.org/10.3341/kjo.2016.30.4.314 Fig.,Non-OADS,/arxiv_data1/oa_pdf/00/ac/kjo-30-314.PMC4965610.pdf
Surv Ophthalmol  2016  Mar 12. http://dx.doi.org/10.1016/j.survophthal.2016.02.007.,OADS,/arxiv_data1/oa_pdf/6e/44/kjo-30-316.PMC4965611.pdf
Korean J Ophthalmol 2016;30(4):316-317 http://dx.doi.org/10.3341/kjo.2016.30.4.316,Non-OADS,/arxiv_data1/oa_pdf/6e/44/kjo-30-316.PMC4965611.pdf
"Documentation, source code and binaries for MacOS, Windows and Ubuntu Linux can be downloaded from http://smeagol.sourceforge.net.",OADS,/arxiv_data1/oa_pdf/f8/15/btw109.PMC4965627.pdf
"2394 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/btw109.PMC4965627.pdf
"2313 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/08/btw121.PMC4965629.pdf
"2402 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/ff/btw310.PMC4965637.pdf
"Received: April 27, 2015    Revised: October 30, 2015 Accepted:  December 16, 2015    Available online: March 28, 2016  Correspondence: Min-Sup Shin, PhD Department of Psychiatry, Seoul National University College of Medicine, 101  Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea Tel: +82-2-2072-2454, Fax: +82-2-744-7241, E-mail: shinms@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.373",Non-OADS,/arxiv_data1/oa_pdf/d3/8f/pi-13-373.PMC4965646.pdf
"Received: September 1, 2014    Revised: January 22, 2015 Accepted:  June 20, 2015    Available online: April 6, 2016  Correspondence: Sun-Mi Cho, PhD  Department of Psychiatry & Behavioral Science, Ajou University School of  Medicine, 206 World cup-ro, Y eongtong-gu, Suwon 16499, Republic of Korea Tel: +82-31-219-5180, Fax: +82-31-219-5179, E-mail: smcho@ajou.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.383",Non-OADS,/arxiv_data1/oa_pdf/ae/f1/pi-13-383.PMC4965647.pdf
Avail - able at: http://www.child-encycolpedia.com/documents/BoivinANGxp.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/f1/pi-13-383.PMC4965647.pdf
"Received:  June 22, 2015    Revised:  October 19, 2015 Accepted:  November 8, 2015    Available online:  March 23, 2016  Correspondence:  Jong-Ik Park, MD, PhD, LLM Department of Psychiatry, Kangwon National University School of Medicine,  Advisor at Korea Suicide Prevention Center, 1 Kangwondaehak-gil, Chun - cheon 24341, Korea Tel: +82-33-258-9171, Fax: +82-33-258-2146, E-mail:  lugar@kangwon.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.389",Non-OADS,/arxiv_data1/oa_pdf/6c/5b/pi-13-389.PMC4965648.pdf
"2, Nei-Hu District, Taipei 114, Taiwan Tel: +011-886-2-8792-7220, Fax: +011-886-2-8792-7221 E-mail:  chang.ha@mail.ndmctsgh.edu.tw cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.397",Non-OADS,/arxiv_data1/oa_pdf/1f/23/pi-13-397.PMC4965649.pdf
"Received: August 19, 2015    Revised: October 13, 2015 Accepted:  October 31, 2015    Available online: March 23, 2016  Correspondence: Suk-Hoon Kang, MD Department of Psychiatry, Veteran Health Service Medical Center, 53 Jinhwang- do-ro 60-gil, Gangdong-gu, Seoul 05368, Republic of Korea Tel: +82-2-2225-1330, Fax: +82-2-477-6190, E-mail: sleepkang@bohun.or.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.406",Non-OADS,/arxiv_data1/oa_pdf/10/ba/pi-13-406.PMC4965650.pdf
"Received:  October 25, 2015    Revised:  December 28, 2015 Accepted:  December 31, 2015    Available online:  March 23, 2016  Correspondence:  Seiichiro Tarutani, MD Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical  Psychiatry, 4-10-1, Nasahara, Takatsuki-shi, Osaka 569-1041, Japan Tel: +81-72-693-1881, Fax: +81-72-693-3029, E-mail:  dtarutan@gmail.com Department of Neuropsychiatry, Osaka Medical College, 2-7, Daigakumachi,  Takatsuki-shi, Osaka 569-8686, Japan Tel: +81-72-683-1221, Fax: +81-72-683-4810, E-mail:  dtarutan@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.413",Non-OADS,/arxiv_data1/oa_pdf/a7/74/pi-13-413.PMC4965651.pdf
Available at: http://www.bps.org.uk/ contact-details/contact-details.,Non-OADS,/arxiv_data1/oa_pdf/a7/74/pi-13-413.PMC4965651.pdf
Available at: http://www.apa.org/ support/.,Non-OADS,/arxiv_data1/oa_pdf/a7/74/pi-13-413.PMC4965651.pdf
"Received: May 19, 2015    Revised: September 6, 2015 Accepted:  September 17, 2015    Available online: February 17, 2016  Correspondence: Süleyman Demir, MD Department of Psychiatry, Dicle University, Diyarbakir 21280, Turkey Tel: +90 (506) 4972567, Fax: +90 (412) 2488523 E-mail: drsuleymandemir@hotmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.420",Non-OADS,/arxiv_data1/oa_pdf/03/64/pi-13-420.PMC4965652.pdf
"Received:  September 20, 2015    Revised:  December 26, 2015 Accepted:  December 30, 2015    Available online:  January 29, 2016  Correspondence:  Dilek Unal, MD Department of Child and Adolescent Psychiatry, Hacettepe University School  of Medicine, Ankara 06100, Turkey Tel: +90-312-305-1150, Fax: +90-312-3091430 E-mail:  dilekunal.beu@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.427",Non-OADS,/arxiv_data1/oa_pdf/c8/79/pi-13-427.PMC4965653.pdf
"Restriction enzyme digestion was carried out us - ing MspI and Hsp92 II (New England Biolabs, MA, USA) to  genotype DNA samples for the rs1800544 variation in  ADRA2A  and rs4680 variation in COMT , respectively, using  a protocol modified from previous studies.34,35 Allele designa - tions for ADRA2A  and COMT  are according to the NCBI  reference sequences and the dbSNP database (NM_000681.3  and NM_001135162.1, respectively) (http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/c8/79/pi-13-427.PMC4965653.pdf
"Received:  June 10, 2015    Revised:  October 6, 2015 Accepted:  October 12, 2015    Available online:  March 23, 2016  Correspondence:  Girish Gulab Meshram, MD Department of Pharmacology, Vardhman Mahavir Medical College and Safdar - jung Hospital, Inner Ring Road, New Delhi 110029, India Tel: +918376010560, E-mail:  drgirish23@yahoo.co.in  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.434",Non-OADS,/arxiv_data1/oa_pdf/c0/79/pi-13-434.PMC4965654.pdf
"Received:  May 6, 2015    Revised:  September 12, 2015 Accepted:  October 24, 2015    Available online:  March 23, 2016  Correspondence:  Sung-Gon Kim, MD, PhD Department of Psychiatry, Pusan National University College of Medicine, 20  Geumo-ro, Meulgeum-eup, Y angsan 50612, Republic of Korea Tel: +82-55-360-2461, Fax: +82-51-366-7224, E-mail:  sungkim@pusan.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.440",Non-OADS,/arxiv_data1/oa_pdf/24/fb/pi-13-440.PMC4965655.pdf
"Received:  June 24, 2015    Revised:  October 27, 2015 Accepted:  October 27, 2015    Available online:  March 23, 2016  Correspondence:  Bon-Hoon Koo, MD, PhD  Department of Psychiatry, Y eungnam University College of Medicine, 170 Hy - eonchung-ro, Nam-gu, Daegu 42415, Republic of Korea Tel: +82-53-620-3343, Fax: +82-53-629-0256, E-mail:  vijnana@chol.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.447",Non-OADS,/arxiv_data1/oa_pdf/b2/92/pi-13-447.PMC4965656.pdf
"Received:  November 30, 2015    Revised:  February 2, 2016 Accepted:  February 5, 2016    Available online:  March 23, 2016  Correspondence:  Heon-Jeong Lee, MD, PhD  Department of Psychiatry, Korea University Hospital, Korea University College  of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Republic of Korea Tel: +82-2-920-6721, Fax: +82-2-929-7679, E-mail:  leehjeong@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.453",Non-OADS,/arxiv_data1/oa_pdf/52/b3/pi-13-453.PMC4965657.pdf
"Received: January 15, 2016    Revised: February 12, 2016 Accepted:  March 7, 2016    Available online: June 1, 2016  Correspondence: Won-Myong Bahk, MD, PhD  Department of Psychiatry, Y eouido St. Mary’s Hospital, College of Medicine,  The Catholic University of Korea, 10 63-ro, Y eongdeungpo-gu, Seoul 07345,  Republic of KoreaTel: +82-2-3779-1250, Fax: +82-2-780-6577, E-mail: wmbahk@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.4.458ORIGINAL ARTICLE 458  Copyright © 2016 Korean Neuropsychiatric Association",Non-OADS,/arxiv_data1/oa_pdf/93/db/pi-13-458.PMC4965658.pdf
"Received:  September 20, 2015    Revised:  October 27, 2015 Accepted:  October 27, 2015    Available online:  March 23, 2016  Correspondence:  Jae-Min Kim, MD, PhD Department of Psychiatry, Chonnam National University Medical School, 160  Baekseo-ro, Dong-gu, Gwangju 61469, Republic of Korea Tel: +82-62-220-6143, Fax: +82-62-225-2351, E-mail:  jmkim@chonnam.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.4.468",Non-OADS,/arxiv_data1/oa_pdf/86/08/pi-13-468.PMC4965659.pdf
Available at: http://www.nice.org.uk/guidance/ipg242.,Non-OADS,/arxiv_data1/oa_pdf/86/08/pi-13-468.PMC4965659.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 19, Number 4, 2016Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0101 284",Non-OADS,/arxiv_data1/oa_pdf/a3/50/pop.2015.0101.PMC4965702.pdf
1995. http://www.who.int/governance/ eb/who_constitution_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/pop.2015.0101.PMC4965702.pdf
2009. http://wbi.meyou health.com/ﬁles/GallupHealthwaysWBI-Methodology.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a3/50/pop.2015.0101.PMC4965702.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 19, Number 4, 2016Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0097 248",Non-OADS,/arxiv_data1/oa_pdf/a6/c3/pop.2015.0097.PMC4965703.pdf
https://www.camdenhealth .org/annualreport/CCHP_AnnualReport_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a6/c3/pop.2015.0097.PMC4965703.pdf
http://www.camdenhealth.org/americorps- resource-library/.,Non-OADS,/arxiv_data1/oa_pdf/a6/c3/pop.2015.0097.PMC4965703.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY Volume 29, Number 4, 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/63/1b/jamp.2015.1255.PMC4965704.pdf
Available from: http://www.ginasthma.org/local/ uploads/ﬁles/GINA_Report_2014_Aug12.pdf.,OADS,/arxiv_data1/oa_pdf/63/1b/jamp.2015.1255.PMC4965704.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.02.002,Non-OADS,/arxiv_data1/oa_pdf/7a/b7/main.PMC4965806.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/b7/main.PMC4965806.pdf
"International Journal of Preventive Medicine 2016, 7:92 http://www.ijpvmjournal.net/content/7/1/92divided into five types including original research article,  review article, brief report or short communication, case  report, and letter to the editor.",Non-OADS,/arxiv_data1/oa_pdf/c4/f2/IJPVM-7-92.PMC4966197.pdf
"International Journal of Preventive Medicine 2016, 7:92 http://www.ijpvmjournal.net/content/7/1/92According to the first overview, through an up‑to‑down  framework, monitoring and management processes start  from the highest level of the system.",Non-OADS,/arxiv_data1/oa_pdf/c4/f2/IJPVM-7-92.PMC4966197.pdf
"International Journal of Preventive Medicine 2016, 7:92 http://www.ijpvmjournal.net/content/7/1/92They should be exactly committed to the guidelines  and instructions of the Committee on Publication  Ethics.",Non-OADS,/arxiv_data1/oa_pdf/c4/f2/IJPVM-7-92.PMC4966197.pdf
"International Journal of Preventive Medicine 2016, 7:92 http://www.ijpvmjournal.net/content/7/1/92research system evaluation in I.R.",Non-OADS,/arxiv_data1/oa_pdf/c4/f2/IJPVM-7-92.PMC4966197.pdf
"International Journal of Preventive Medicine 2016, 7:89 http://www.ijpvmjournal.net/content/7/1/898.",Non-OADS,/arxiv_data1/oa_pdf/92/c5/IJPVM-7-89.PMC4966198.pdf
"International Journal of Preventive Medicine 2016, 7:90 http://www.ijpvmjournal.net/content/7/1/90METHODS This case–control study was conducted on 180 patients  in 2013.",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/IJPVM-7-90.PMC4966199.pdf
"International Journal of Preventive Medicine 2016, 7:90 http://www.ijpvmjournal.net/content/7/1/90including daily energy had been supplied by the hospital  meals alone.",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/IJPVM-7-90.PMC4966199.pdf
"International Journal of Preventive Medicine 2016, 7:90 http://www.ijpvmjournal.net/content/7/1/90the patients by one unit and reduced the prevalence of  malnutrition by 17%.",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/IJPVM-7-90.PMC4966199.pdf
"International Journal of Preventive Medicine 2016, 7:90 http://www.ijpvmjournal.net/content/7/1/9014.",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/IJPVM-7-90.PMC4966199.pdf
"International Journal of Preventive Medicine 2016, 7:91 http://www.ijpvmjournal.net/content/7/1/91experience, and the second five students were excluded  because they had failed to attend the exercise sessions  consistently [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/a9/10/IJPVM-7-91.PMC4966200.pdf
"International Journal of Preventive Medicine 2016, 7:91 http://www.ijpvmjournal.net/content/7/1/91criterion.",Non-OADS,/arxiv_data1/oa_pdf/a9/10/IJPVM-7-91.PMC4966200.pdf
"International Journal of Preventive Medicine 2016, 7:91 http://www.ijpvmjournal.net/content/7/1/91Post hoc paired t‑tests indicated statistical significant  differences in trampoline group between the two  measurements about calf girth ( t = −4.35,  P = 0.001), fat%  (t = 5.87,  P = 0.001), vertical jump ( t = −5.53,  P = 0.001),  and long jump ( t = −10.00,  P = 0.001).",Non-OADS,/arxiv_data1/oa_pdf/a9/10/IJPVM-7-91.PMC4966200.pdf
"International Journal of Preventive Medicine 2016, 7:91 http://www.ijpvmjournal.net/content/7/1/91Effects of different resistance training protocols on upper‑body strength and  endurance development in children.",Non-OADS,/arxiv_data1/oa_pdf/a9/10/IJPVM-7-91.PMC4966200.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/09/08/JSTCR-7-32.PMC4966202.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/09/08/JSTCR-7-32.PMC4966202.pdf
Fact Sheet Number 339: Tobacco; July  2015. http://www.who.int/mediacentre/factsheets/fs339/en/.,Non-OADS,/arxiv_data1/oa_pdf/9a/6d/ATM-11-183.PMC4966220.pdf
"World Health Organization, Global Health Observatory Data  Repository, 2015. http://apps.who.int/ghodata.",OADS,/arxiv_data1/oa_pdf/9a/6d/ATM-11-183.PMC4966220.pdf
Avaialble from: http://www.nice.org.uk/ page.aspx?o=CG033NICEguideline.,Non-OADS,/arxiv_data1/oa_pdf/71/4b/ATM-11-197.PMC4966222.pdf
Available from: http://www.nice.org.uk/ nicemedia/live.,Non-OADS,/arxiv_data1/oa_pdf/71/4b/ATM-11-197.PMC4966222.pdf
Available from: http://www.ecdc.europa.edu/en/ publications.,Non-OADS,/arxiv_data1/oa_pdf/71/4b/ATM-11-197.PMC4966222.pdf
"Silver Spring (MD): U.S. Food and  Drug Administration; This Week in FDA History; 26 October,  1951; Available from: http://www.fda.gov/AboutFDA/ WhatWeDo/History/ThisWeek/ucm117875.htm.",Non-OADS,/arxiv_data1/oa_pdf/a2/7c/JRPP-5-149.PMC4966231.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/JRPP-5-149.PMC4966231.pdf
Available from: http://www.fda.gov/Drugs/ResourcesForYou/ Consumers/ucm143547.htm.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/JRPP-5-149.PMC4966231.pdf
Available from: http://www.fda.gov/drugs/ emergencypreparedness/bioterrorismanddrugpreparedness/ ucm133411.htm.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/JRPP-5-149.PMC4966231.pdf
Available from: http://www.usatoday.com/story/money/ business/2014/05/28/cialis-over -the-counter/9681243/.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/JRPP-5-149.PMC4966231.pdf
http://www.fda.gov/AboutFDA/Transparency/ Basics/ucm319836.htm.,Non-OADS,/arxiv_data1/oa_pdf/a2/7c/JRPP-5-149.PMC4966231.pdf
Available from: http://irimc.org/ FileManager/IRIMCLaw.pdf?Lang=EN.,OADS,/arxiv_data1/oa_pdf/1e/ce/JRPP-5-155.PMC4966232.pdf
Available from: http://www.wipo.int/wipolex/en/details.,OADS,/arxiv_data1/oa_pdf/1e/ce/JRPP-5-155.PMC4966232.pdf
Available from: http://www.wipo.int/edocs/lexdocs/laws/en/ ir/ir008en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/JRPP-5-155.PMC4966232.pdf
Available from: http://www.iran-investment.org/fippaen.,Non-OADS,/arxiv_data1/oa_pdf/1e/ce/JRPP-5-155.PMC4966232.pdf
Available from: http://www.indiaoppi.com/OPPI%20 %Code%20of%20Marketing%202012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/66/JRPP-5-162.PMC4966233.pdf
Available from: http://www.iium.edu.my/pharmacy/ programmes‑courses/undergraduate/bachelor‑pharmacy/ course‑structure/elective‑course.,Non-OADS,/arxiv_data1/oa_pdf/0f/b5/JRPP-5-193.PMC4966239.pdf
Available from:  http://www.fda.gov/downloads/AboutFDA/CentersOffices/ CDER/UCM148055.pdf  [Last retrieved on 2007 Oct 9].,OADS,/arxiv_data1/oa_pdf/b6/7a/JRPP-5-200.PMC4966240.pdf
Available from: http://www.random.org.,Non-OADS,/arxiv_data1/oa_pdf/b6/7a/JRPP-5-200.PMC4966240.pdf
Available  from: http://www.acpm.org/?MedAdhereTTProviders.,Non-OADS,/arxiv_data1/oa_pdf/37/83/JRPP-5-205.PMC4966241.pdf
Available from: http://www.apps.who.int/medicinedocs/pdf/ s4882e/s4882e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8e/2c/JRPP-5-212.PMC4966242.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/8e/2c/JRPP-5-212.PMC4966242.pdf
http://www.uptodate.com/contents/ganciclovir- systemic‑drug‑information.,Non-OADS,/arxiv_data1/oa_pdf/8e/2c/JRPP-5-212.PMC4966242.pdf
Available from: http://www.apps.who.int/medicinedocs/ documents/s22114en/s22114en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8e/2c/JRPP-5-212.PMC4966242.pdf
Available from: http://www.pcne.org/ upload/files/11_PCNE_classification_V6-2.pdf.,OADS,/arxiv_data1/oa_pdf/90/74/JRPP-5-222.PMC4966245.pdf
Methods Literature was collected using PubMed ( https://www.ncbi.,OADS,/arxiv_data1/oa_pdf/04/fc/pyw002.PMC4966271.pdf
http://data.world- bank.org/indicator/NY.GDP.MKTP.KD.ZG/countries/1W- EE?display  = graph .,OADS,/arxiv_data1/oa_pdf/c9/d5/pyw013.PMC4966275.pdf
Invega Trinza Prescribing Information (2015) http://www.jans- sencns.com/shared/product/invegatrinza/prescribing-infor - mation.pdf  last updated in May 2015.,Non-OADS,/arxiv_data1/oa_pdf/23/86/pyw018.PMC4966278.pdf
Available from: http://www.isccm.org/ images/Section4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/IJA-60-449.PMC4966346.pdf
[Ahead of Print] Available from:  http://dx.doi.org/10.1016/j.bjane.,OADS,/arxiv_data1/oa_pdf/dc/2c/IJA-60-525.PMC4966365.pdf
Available from: https://www.nlm.nih.gov/pubs/factsheets/j_sel_faq.html#a2.,Non-OADS,/arxiv_data1/oa_pdf/40/b8/IJO-64-331.PMC4966368.pdf
We scanned  37 previous reported cataract‑related genes[5] and 15 additional  cataract‑related genes obtained from OMIM (http://omim.org/)  to find whether there were variants located in these genes.,OADS,/arxiv_data1/oa_pdf/6b/5b/IJO-64-364.PMC4966373.pdf
"Sorting Intolerant From Tolerant (SIFT) (http://sift.jcvi.org/),  PolyPhen‑2 (http://genetics.bwh.harvard.edu/pph 2/index.",Non-OADS,/arxiv_data1/oa_pdf/6b/5b/IJO-64-364.PMC4966373.pdf
5 shtml) and MutationTaster (http://www.mutationtaster.org/)  were used to predict whether the variants are harmful[11] and  Genomic Evolutionary Rate Profiling (GERP) was used to  predict the conservation of the variants.,OADS,/arxiv_data1/oa_pdf/6b/5b/IJO-64-364.PMC4966373.pdf
Mutations  in this gene are the cause of certain genetically‑related  cataract disorders (http://www.ncbi.nlm.nih.gov/gene/1969).,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/IJO-64-364.PMC4966373.pdf
Available from: http://www.censusindia.gov.,OADS,/arxiv_data1/oa_pdf/02/38/IJO-64-387.PMC4966377.pdf
Available  from: http://www.socialjustice.nic.in/consd.php.,Non-OADS,/arxiv_data1/oa_pdf/02/38/IJO-64-387.PMC4966377.pdf
A  search of the medical  literature and online resources such as the Online Mendelian  Inheritance in Man (OMIM: http://www.ncbi.nlm.nih.gov/ omim) did not show any previously described link between  all of the features.,OADS,/arxiv_data1/oa_pdf/3e/c5/IJO-64-399.PMC4966382.pdf
"To explore this possibility  one can use available databases  (e.g., http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/3e/c5/IJO-64-399.PMC4966382.pdf
"The international Scientific Forum on  Home Hygiene (iFH) (http://www.ifh- homehygiene.org) was established in  1997 with the aim of developing and promoting a more effective approach to hygiene, based on scientific principles and the growing database of evidence  about pathogen transmission.",Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.ifh- homehygiene.org/review/global-burden- hygiene-related-diseases-relation-home-and- community  11.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.parliament.uk/ documents/post/pn193.pdf  12.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.food.gov.uk  13.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.who.int/gpsc/ country_work/gpsc_ccisc_fact_sheet_en.pdf  17.,OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online  at: https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/340851/ Clostridium_difficile_infection_how_to_deal_ with_the_problem.pdf  18.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
"Available online at: http://www.kingsfund.org.uk/sites/files/kf/briefing-healthcare-associated- infections-stemming-rise-of-superbug-rachel- turner-kings-fund-july-2008.pdf  20. eyre Dw , Cule ML, w ilson DJ, Griffiths D,  Vaughan A, O’Connor L et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at:  http://www.hpa.org.uk/webc/HPAwebFile/ HPAweb_C/1284473407318  22.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://apps.who.int/ iris/bitstream/10665/68998/1/wHO_CDS_ CSr_GiP_2005.5.pdf  24.,OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://ecdc.europa.eu/en/ activities/diseaseprogrammes/TATFAr/ Documents/210911_TATFAr_report.pdf  27.,OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.ifh-homehygiene.org/review/spread-antibiotic- resistant-strains-home-and-community  28.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.ifh-homehygiene.org/best-practice-review/ hygiene-hypothesis-and-implications-home- hygiene  47.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.nhs.uk/ Conditions/pregnancy-and-baby/pages/ caesarean-section.aspx  51.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.pfma.org.uk/ pet-population/  61.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://data.worldbank.org/ indicator/SP .UrB.TOTL.iN.ZS  72. indoor Air Quality UK.,OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at:  http://www.iaquk.org.uk/  73.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online  at: http://www.ifh-homehygiene.org/review/are- antibiotics-contributory-factor-rise-allergic-and- other-chronic-inflammatory-diseases  90.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: http://www.ifh-home   hygiene.org/review/chain-infection-transmission- home-and-everyday-life-settings-and-role- hygiene-reducing-risk  117.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at:  http://www.nhs.uk/Livewell/homehygiene/Pages/Homehygienehub.aspx  130.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
Available online at: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
133. http://www.thetimes.co.uk/tto/health/article4602687.ece  134. http://www.dailymail.co.uk/sciencetech/ article-3398553/Don-t-wash-hands-bit-dirt- good-experts-say-cleaning-protect-against- allergies-allowing-helpful-bacteria-body.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/10.1177_1757913916650225.PMC4966430.pdf
"While such efﬁcacy biomarkers show whether the treatment is working or not, they © Philippe Gatault, Guillaume Brachet, David Ternant, Danielle Degenne, Guillaume R /C19ecipon, Christelle Barbet, Emmanuel Gyan, Val /C19erie Gouilleux-Gruart, C /C19ecile Bordes, Alexandra Farrell, Jean Michel Halimi,and Herv /C19e Watier *Correspondence to: Philippe Gatault; Email: philippe.gatault@univ-tours.frSubmitted: 03/27/2015; Revised: 08/15/2015; Accepted: 08/17/2015 http://dx.doi.org/10.1080/19420862.2015.1086049 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Mol Immunol 1996; 33:1389-401; PMID:9171898; http://dx.doi.org/10.1016/S0161-5890(96)00078-8 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
"Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria Nat Biotechnol 2007;25:1256-64; PMID:17989688; http://dx.doi.org/ 10.1038/nbt1344 3.",Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Blood 2014; 124:3502-3; PMID:25431478; http://dx.doi.org/ 10.1182/blood-2014-07-589366 4.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
N Engl J Med 2006; 355:1233-43; PMID:16990386; http://dx.doi.org/10.1056/NEJMoa061648 5.,OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
N Engl J Med 2013; 368:2169-81; PMID:23738544; http://dx.doi.org/10.1056/NEJMoa1208981 6.,OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Br J Haematol 2013; 162:62-73; PMID:23617322; http://dx.doi.org/ 10.1111/bjh.12347 7.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Am J Kidney Dis 2014; 63:40-8; PMID:24021908; http://dx.doi.org/10.1053/j.ajkd.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Available at: http://www.thetimes.co.uk/tto/ health/news/article3775905.ece 9.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Blood 2014; 124: 1715-26; PMID:25037630; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
N Engl J Med 2014; 370:632-9; PMID:24521109; http://dx.doi.org/10.1056/NEJMoa1311084 11.,OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
N Engl J Med 2013; 369: 1377-80; PMID:24088106; http://dx.doi.org/10.1056/NEJMc 1308826 12.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Pediatr Blood Cancer 2014; 61:1544-50; PMID:24777716; http://dx.doi.org/10.1002/ pbc.25068 14.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
J Thromb Haemost 2014; 12: 1440-8; PMID:24853860; http://dx.doi.org/10.1111/jth.12615 15.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Clin Kid- ney J 2013; 6: 243-4; PMID:26019860; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
J Pharmacokinet Pharmacodyn 2009; 36: 341-51;PMID:19578985; http://dx.doi.org/10.1007/s10928- 009-9125-9 17.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
Clin Phar- macokinet 2010; 49:633-59; PMID:20818831;http://dx.doi.org/10.2165/11535960-000000000- 00000 www.tandfonline.com 1211 mAbs,Non-OADS,/arxiv_data1/oa_pdf/8c/29/kmab-07-06-1086049.PMC4966484.pdf
"3In fact, BoNT/A and BoNT/B are considered to be the most toxic substances known, with a human LD 50estimated between 1 and 10 ng.kg¡1by intravenous, subcutaneous, intra-peritoneal and intramuscularroutes; between 10 and 21 ng.kg ¡1by pulmonary route and at 1mg.kg¡1by oral route.3-9To date, 7 subtypes of BoNT/B (BoNT/B1 to B7) have been identiﬁed.10,11The analysis of 53 © Christine Rasetti-Escargueil, Arnaud Avril, Siham Chahboun, Rob Tierney, Nicola Bak, Sebastian Miethe, Christelle Mazuet, Michel R Popoff, Phil ippe Thullier, Michael Hust, Thibaut Pelat, and Dorothea Sesardic*Correspondence to: Dorothea Sesardic; Email: thea.sesardic@nibsc.orgSubmitted: 03/16/2015; Revised: 08/05/2015; Accepted: 08/05/2015 http://dx.doi.org/10.1080/19420862.2015.1082016 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
"DNAs were extracted by the Nucleobond AX100 kit (Macherey-Nagel, Duren, Ger-many) or the QIA cube apparatus (Qiagen, Hilden, Germany)and then sequenced by Beckman Coulter Genomics(Takeley, UK) using the primers MHLacZ-Pro_f(5 0_GGCTCGTATGTTGTGTGG_30) and MHgIII_r (50_CTAAAGTTTTGTCGTCTTTCC_30).59The DNA sequences were then translated to amino acid sequences (http://web.expasy.org/translate/) to identify and eliminate the redun-dant and the recombined sequences.",OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
"Computational analysis The sequences of interest were analyzed with IMGT/V-QUEST and IMGT/DomainGapAlign tools, available on-line from theInternational ImmunoGeneTics Information system (IMGT)(http://imgt.imgt.org), 53,63-65to identify the human germline sequences that are the most similar to the isolated scFvs and to cal-culate the GI.",OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
"52,53A second evaluation of immunoge- nicity relied on the G-score (http://www.bioinf.org.uk).",Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Mol Biol 1999; 291:1091-104; PMID:10518945; http://dx.doi.org/10.1006/jmbi.1999.2945 2.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Infect Immun 2005; 73:5450-7; PMID:16113261; http://dx.doi.org/10.1128/ IAI.73.9.5450-5457.2005 3.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
JAMA 2001; 285: 1059-70; PMID:11209178; http://dx.doi.org/10.1001/jama.285.8.1059 4.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Appl Toxicol 1999; 19 Suppl 1:S35-8; PMID:10594898; http://dx.doi.org/ 10.1002/(SICI)1099-1263(199912)19:1 C%3cS35::AI D-JAT612%3e3.0.CO;2-9 5.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
MovDisord 1988; 3:333-5; PMID:3211180; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Toxicol Pathol 2005; 33:336-42;PMID:15814363; http://dx.doi.org/10.1080/ 01926230590922884 8.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Bacteriol 2007; 189:818-32; PMID:17114256; http://dx.doi.org/10.1128/JB.01180-06 11.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Anal Bioanal Chem 2012; 403:215-26;PMID:22395449; http://dx.doi.org/10.1007/s00216- 012-5767-3 12.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Cell Biol 1986; 103:535-44; PMID:3015983; http://dx.doi.org/10.1083/jcb.103.2.535 14.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Handb Exp Pharmacol 2008;184:129-70; PMID:18064414; http://dx.doi.org/ 10.1007/978-3-540-74805-2_6 15.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Nature 1992; 359:832-5; PMID:1331807; http://dx.doi.org/10.1038/359832a0 16.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Clin Neurosci 2000; 7:389-94; PMID:10942658; http://dx.doi.org/10.1054/ jocn.2000.0684 18.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Neu- rol Neurosurg Psychiatry 2013; 84:1014-9;PMID:23687362; http://dx.doi.org/10.1136/jnnp- 2012-303608 19.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Nat Rev Neurol 2010; 6:624-36; PMID:21045798; http://dx.doi.org/10.1038/nrneurol.2010.149 20.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
JAMA 1997; 278:399-411; PMID:9244332; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
N Engl J Med 2006; 354:462-71; PMID:16452558; http://dx.doi.org/10.1056/NEJMoa051926 22.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Am J Med 1980; 69:567-70; PMID:7191633; http://dx.doi.org/10.1016/0002- 9343(80)90469-6 23.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
BMC Biochem 2011; 12:58; PMID:22085466; http://dx.doi.org/10.1186/1471-2091-12-58 24.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
JImmunol Methods 2008; 333:156-66; PMID:18313069; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Vac- cine 2002; 20:1640-8; PMID:11858873; http://dx.doi.org/10.1016/S0264-410X(01)00482-0 26.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Toxicon 2011; 57:1008- 16; PMID:21513727; http://dx.doi.org/10.1016/j.toxicon.2011.04.00327.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Toxicon 2006; 48:246-54; PMID:16870221; http://dx.doi.org/10.1016/j.toxicon.2006.05.007 28.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Selection and characterization of a human monoclonal neutralizing antibody for clostridium botulinum neuro-toxin serotype B. Bioorg Med Chem Lett 2009; 19:662-4; PMID:19112017; http://dx.doi.org/ 10.1016/j.bmcl.2008.12.055 29.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
"Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin, Protein Eng Des Sel 2011; 24:321-31;PMID:21149386; http://dx.doi.org/10.1093/protein/ gzq111 30.",Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
MAbs 2010; 2:528-38; PMID:20562531;http://dx.doi.org/10.4161/mabs.2.5.12545 31.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
BMC Biotechnol 2011; 11:113; PMID:22111995; http://dx.doi.org/10.1186/1472-6750-11-113 32.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Toxicon 2009; 53:503-11; PMID:19673096; http://dx.doi.org/10.1016/j.toxicon.2009.01.019 33.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Botulinum J 2011; 2:30-48; http://dx.doi.org/ 10.1504/TBJ.2011.041814 34.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Protein J 2004; 23:39-52; PMID:15115181; http://dx.doi.org/10.1023/B:JOPC.0000016257.91979.06 35.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
FEBS letters 2004; 572:299-306; PMID:15304366; http://dx.doi.org/ 10.1016/j.febslet.2004.06.094 36.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
PLoS ONE 2008; 3:e3023;PMID:18714390; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Mol Biol 2010; 396:1439-50; PMID:20043919; http://dx.doi.org/10.1016/j.jmb.2009.12.041 39.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
BMC Biotechnol 2009; 9:60; PMID:19563687; http://dx.doi.org/10.1186/1472-6750-9-6040.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Anti- microb Agents Chemother 2005; 49:3414-20; PMID:16048955; http://dx.doi.org/10.1128/ AAC.49.8.3414-3420.2005 41.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
PloS ONE 2012; 7:e37242; PMID:22666347; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Nat Biotechnol2007; 25:107-16; PMID:17173035; http://dx.doi.org/ 10.1038/nbt1269 43.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
PloS ONE 2009; 4:e5355; PMID:19399171; http://dx.doi.org/10.1371/journal.pone.0005355 44.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
"Kalb SR, Garcia-Rodriguez C, Lou J, Baudys J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR. Extractionof BoNT/A, /B, /E, and /F with a single, high afﬁnity monoclonal antibody for detection of botulinum neu- rotoxin by Endopep-MS. PLoS ONE 2010; 5:e12237; PMID:20808925; http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Molecular evolution ofantibody afﬁnity for sensitive detection of botulinum neurotoxin type A. J Mol Biol 2005;351:158-69; PMID:16002090; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Potent neutralization of botuli- num neurotoxin by recombinant oligoclonal antibody.Proc Natl Acad Sci U S A 2002; 99:11346-50; PMID:12177434; http://dx.doi.org/10.1073/ pnas.172229899 47.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Infect Immun 2010; 78:756-763; PMID:19917718; http://dx.doi.org/10.1128/IAI.01084-09 48.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
PLoS ONE 2012; 7: e29941; PMID:22238680; http://dx.doi.org/10.1371/ journal.pone.0029941 49.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
PLoS ONE 2014; 9:87089; http://dx.doi.org/10.1371/journal.pone.0087089 50.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
mAbs 2014; 6:446- 459; PMID:24492304; http://dx.doi.org/10.4161/ mabs.27773 51.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Mol Biol 2007; 369:852-62; PMID:17442342; http://dx.doi.org/10.1016/j.jmb.2007.02.100 1176 Volume 7 Issue 6 mAbs,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Mini Rev Med Chem 2009; 9:1633-8; PMID:20105119; http://dx.doi.org/10.2174/138955709791012283 53.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Mol Biol2008; 384:1400-7; PMID:18976662; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
PLoS ONE 2010; 5:e12416; PMID:20865035; http://dx.doi.org/ 10.1371/journal.pone.0012416 55.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Anal Biochem 2011; 410:281-288; PMID:21134347; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
PloS ONE 2009; 4:e6625; PMID:19675673; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Methods Mol Biol 2014;1060:215-43; PMID:24037844; http://dx.doi.org/10.1007/978-1-62703-586-6_12 60.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Antimicrob Agents Chemother 2007; 51:2758-64; PMID:17517846; http://dx.doi.org/10.1128/AAC.01528-06 61.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Analysis of mass transport-lim- ited binding kinetics in evenescent wave biosensors.Anal Biochem 1996; 240:262-272; PMID:8811920; http://dx.doi.org/10.1006/abio.1996.0356 63.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Methods Mol Biol 2012; 882:569-604;PMID:22665256; http://dx.doi.org/10.1007/978-1- 61779-842-9_32 64.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Meth-ods Mol Biol 2012; 882:605-33; PMID:22665257; http://dx.doi.org/10.1007/978-1-61779-842-9_33 65.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Methods Mol Biol 2012; 907:3-37; PMID:22907343; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
J Immunol Methods 2008; 329:92-101;PMID:17976638; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Pharmacol Toxicol 1996; 78:283-8; PMID:8737961; http://dx.doi.org/10.1111/j.1600-0773.1996.tb01376.x 68.,Non-OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
Mov Disord 2004; 19:85-91; http://dx.doi.org/ 10.1002/mds.20021 www.tandfonline.com 1177 mAbs,OADS,/arxiv_data1/oa_pdf/91/be/kmab-07-06-1082016.PMC4966489.pdf
"*Correspondence to: Baolin Zhang; Email: baolin.zhang@fda.hhs.govSubmitted: 07/07/2015; Revised: 08/20/2015; Accepted: 08/24/2015 http://dx.doi.org/10.1080/19420862.2015.1087636 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
PDA J Pharm Sci Technol 2013; 67:186-200; PMID:23752747; http://dx.doi.org/10.5731/pdajpst.,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
J Pharm Sci 2009; 98:1201-5; PMID:18704929; http://dx.doi.org/10.1002/jps.21530 3.,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
JPEN J Parenter Enteral Nutr 1996; 20:81-7; PMID:8788269; http://dx.doi.org/10.1177/014860 719602000181 6.,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Intensive Care Med 2010; 36:707- 11; PMID:20165942; http://dx.doi.org/10.1007/ s00134-010-1775-y 7.,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
BMC Pediatr 2013; 13:21; PMID:23384207; http://dx.doi.org/10.1186/1471-2431-13-21 8.,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Intensive Care Med 2012; 38:1008-16; PMID:22527062; http://dx.doi.org/10.1007/s00134-012-2539-7 9 .,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Pediatrics 2009; 123:e609-e613; PMID:19289450; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
1988; 296:968-9; PMID:3129111; http://dx.doi.org/10.1136/ bmj.296.6627.968-a 13.,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
mAbs 2013; 5:491-500; PMID:23571158; http://dx.doi.org/10.4161/mabs.24245 14.,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
mAbs 2009; 1:142-50; PMID:20061815; http://dx.doi.org/ 10.4161/mabs.1.2.7632 1 5 .,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
mAbs 2013; 5:162-70; PMID:23255057;http://dx.doi.org/10.4161/mabs.22873 16.,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Curr Opin Immunol 1995; 7:41-7; PMID:7772281; http://dx.doi.org/10.1016/0952- 7915(95)80027-1 19.,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
J Chromatogr B Biomed Sci Appl 2001; 752:233-45;PMID:11270864; http://dx.doi.org/10.1016/S0378- 4347(00)00548-X 20.,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Biochemistry 1999; 38:13960-7; PMID:10529242; http://dx.doi.org/ 10.1021/bi9905516 21.,Non-OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Nat Med 2013; 19:452-7; PMID:23524342; http://dx.doi.org/10.1038/nm.3107 22.,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Anal Biochem 2006; 350:233-8; PMID:16336940; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
Free Radic Biol Med 2014; 75:84-94; PMID:25058340; http://dx.doi.org/10.1016/j.freeradbiomed.2014.07.018 www.tandfonline.com 1103 mAbs,OADS,/arxiv_data1/oa_pdf/e0/9e/kmab-07-06-1087636.PMC4966494.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/4c/ott-9-4533.PMC4966496.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4533–4538OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4533Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10876 9 The effect of clove-based herbal mouthwash on  radiation-induced oral mucositis in patients with  head and neck cancer: a single-blind randomized  preliminary study Moonkyoo Kong1 Deok-sang hwang2 seong Woo Y oon3 Jinsung Kim4 1Department of radiation Oncology,   Kyung hee University Medical center,   Kyung hee University school of  Medicine, 2Department of Korean  Medicine Obstetrics & gynecology,   Kyung hee University Medical  center, 3Department of Korean  internal Medicine, Korean Medicine  cancer center, Kyung hee University  hospital at gangdong, 4Department of  Korean internal Medicine, Kyung hee  University Medical center, college  of Korean Medicine, Kyung hee  University, seoul, republic of KoreaPurpose:  This study was performed to evaluate the efficacy and safety of clove-based herbal  mouthwash in ameliorating radiation-induced oral mucositis in patients with head and neck cancer.",Non-OADS,/arxiv_data1/oa_pdf/63/4c/ott-9-4533.PMC4966496.pdf
"Radiation-induced oral mucositis is the most common complication  of RT and causes clinical and economic problems, in patients with head and neck  cancer.1–4 Although many clinical studies attempting to reduce radiation-induced oral  mucositis have been reported, there is no widely accepted effective agent for treatment  of radiation-induced oral mucositis.5–13correspondence: seong Woo Yoon Department of Korean internal Medicine,  Korean Medicine cancer center,  Kyung hee University hospital at  gangdong, 149 sangil-dong, gangdong-gu,  seoul 130-090, republic of Korea Tel +82 2 440 7272 Fax +82 2 440 7287 email stepano212@hanmail.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kong et al Running head recto: Clove-based herbal mouthwash for radiation-induced oral mucositis DOI: http://dx.doi.org/ 10.2147/OTT.S108769",Non-OADS,/arxiv_data1/oa_pdf/63/4c/ott-9-4533.PMC4966496.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/63/4c/ott-9-4533.PMC4966496.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/4c/ott-9-4533.PMC4966496.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/c9/ppa-10-1299.PMC4966497.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1299–1307Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1299Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10682 1 Poor medication adherence in type 2 diabetes:  recognizing the scope of the problem and its key  contributors william H Polonsky1,2 Robert R Henry2,3 1Behavioral Diabetes institute, San  Diego, 2University of California,   San Diego, 3Center for Metabolic  Research, vA San Diego Healthcare  System, San Diego, CA, USAAbstract:  At least 45% of patients with type 2 diabetes (T2D) fail to achieve adequate glycemic  control (HbA1c 7%).",Non-OADS,/arxiv_data1/oa_pdf/67/c9/ppa-10-1299.PMC4966497.pdf
"Keywords:  glycemic control, HbA1c, hypoglycemia, medication adherence, psychosocial,  type 2 diabetes Introduction The prevalence of type 2 diabetes (T2D) is at epidemic proportions worldwide,1,2 and  the incidence and prevalence of T2D continue to increase (Figure 1).3,4 Indeed, the  worldwide prevalence of T2D is expected to increase from 382 million individuals  (2013) to 417 million individuals by 2035.1 This is of critical concern because T2D  represents the largest budget item in many health care systems,5,6 primarily due to  the high rates of morbidity and mortality associated with the disease.7–9 Even worse,  it has been well documented that this cost burden has been inexorably growing  worldwide.10 A key contributor to the remarkably high rates of morbidity and mortality is chronic  poor metabolic control, especially poor glycemic control.7 Although a wide array of  options are now available for treating T2D, including several new pharmacological  classes of drugs that are included in the current American Diabetes Assocation/Euro - pean Association for the Study of Diabetes (ADA/EASD) and American Association of  Clinical Endocrinologists (AACE) recommendations,11,12 ~50% of patients with T2D fail  to achieve adequate glycemic control (glycated hemoglobin [HbA1c] 7%).13,14 Using  data from the National Health and Nutrition Examination Survey, targets for glycemic Correspondence: william H Polonsky Behavioral Diabetes institute,  PO Box 2148, Del Mar, CA 92014, USA Tel +1 760 525 5256 email whp@behavioraldiabetes.or g Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Polonsky and Henry Running head recto: Poor medication adherence in type 2 diabetes DOI: http://dx.doi.org/10.2147/PPA.S106821",Non-OADS,/arxiv_data1/oa_pdf/67/c9/ppa-10-1299.PMC4966497.pdf
"Available from: https://www.cdc.gov/diabetes/.../statsreport14/ national-diabetes-report-web.pd f. Accessed April 7, 2015.",OADS,/arxiv_data1/oa_pdf/67/c9/ppa-10-1299.PMC4966497.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/ppa-10-1299.PMC4966497.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/77/31/ott-9-4527.PMC4966498.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4527–4531OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4527Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10594 9 Efficacy of pemetrexed-based regimen in relapsed  advanced thymic epithelial tumors and its  association with thymidylate synthetase level Xinyu Qian1,* Zhengbo Song2,3,* 1Department of chemotherapy,   hangzhou First People’s hospital,   hangzhou cancer hospital, hangzhou,   2Key Laboratory Diagnosis and  Treatment Technology on Thoracic  Oncology, Zhejiang Province,   3Department of chemotherapy,   Zhejiang cancer hospital, hangzhou,   People’s Republic of China *These authors contributed equally  to this workPurpose:  Due to the rarity of thymic epithelial tumors (TET), no standard chemotherapy regimen  has been identified in the relapsed setting.",Non-OADS,/arxiv_data1/oa_pdf/77/31/ott-9-4527.PMC4966498.pdf
"The results of randomized Correspondence: Zhengbo Song Department of chemotherapy,  Zhejiang cancer hospital, 38  guangji road 310022, hangzhou,  People’s Republic of China Tel +86 571 8812 2182  Fax +86 571 8812 2188 email songzhengbo83@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Qian and Song Running head recto: Pemetrexed-based regimen in relapsed advanced thymic epithelial tumors DOI: http://dx.doi.org/10.2147/OTT.S105949",Non-OADS,/arxiv_data1/oa_pdf/77/31/ott-9-4527.PMC4966498.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/77/31/ott-9-4527.PMC4966498.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/31/ott-9-4527.PMC4966498.pdf
"Available from: https://www.nccn.org/professionals/physician_gls/pdf/ thymic.pd f. Accessed June 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/77/31/ott-9-4527.PMC4966498.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/38/ndt-12-1809.PMC4966499.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1809–1816Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1809OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10734 9 subgrouping of risky behaviors among iranian  college students: a latent class analysis saeid safiri1,2 afarin rahimi-Movaghar3 Masud Yunesian4,5 homayoun sadeghi- Bazargani6 Mansour shamsipour5 Mohammad ali Mansournia1 akbar Fotouhi1 1Department of epidemiology  and Biostatistics, school of Public  health, T ehran University of Medical  sciences, T ehran, 2Department of  Public health, school of Nursing and  Midwifery, Maragheh University of  Medical sciences, Maragheh, 3iranian  National center for addiction  studies ( iNcas), iranian institute for  reduction of high-risk Behaviors,   T ehran University of Medical sciences,   T ehran, 4Department of environmental  health engineering, school of Public  health, 5Department of research  Methodology and Data analysis,   institute for environmental research,   T ehran University of Medical sciences,   T ehran, 6road Traffic injury research  center, Department of statistics &  epidemiology, Tabriz University of  Medical sciences, Tabriz, iranBackground:  Risky behaviors may interrupt development or cause considerable morbidity or  mortality.",Non-OADS,/arxiv_data1/oa_pdf/33/38/ndt-12-1809.PMC4966499.pdf
"Keywords:  alcohol drinking, sexual behavior, latent class analysis, risk behaviors, drug abuse,  substance abuse Introduction Risky behavior means a “specific form of behavior, which is proven to be associated  with increased susceptibility to a specific disease or ill-health”.1 According to the  report of the Y outh Risk Behavior Surveillance in the US,2 tobacco and substance  use and sexual behaviors that contribute to sexually transmitted infections, including  extramarital sex, are priority health risky behaviors, which may interrupt develop - ment or cause considerable morbidity or mortality.3 Drug use, alcohol use, and sexual  behaviors are responsible for 2%, 7%, and 4%, respectively, of the global disability- adjusted life years among 15- to 24-year-old age groups.4 Community health can be considerably improved through controlling risky behav - iors in young people, since 15·5% of total disability-adjusted life years for all age  groups are devoted to people aged 15–24 years.4 Determining subgroups of young people based on risky behaviors provides the  opportunity for health service managers and policy makers to recognize people who  have identical characteristics based on risky behavior patterns.5correspondence: akbar Fotouhi Department of epidemiology and  Biostatistics, school of Public health,  Tehran University of Medical sciences,  enghelab sq., Pour sina street,  PO Box 14155-6446, Tehran, iran email afotouhi@tums.ac.i r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Safiri et al Running head recto: Subgrouping of risky behaviors DOI: http://dx.doi.org/10.2147/NDT.S107349",Non-OADS,/arxiv_data1/oa_pdf/33/38/ndt-12-1809.PMC4966499.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/33/38/ndt-12-1809.PMC4966499.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/38/ndt-12-1809.PMC4966499.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e9/14/ppa-10-1289.PMC4966500.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1289–1298Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1289OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9913 6 connection between self-stigma, adherence to  treatment, and discontinuation of medication Dana Kamaradova1 Klara latalova1 Jan Prasko1 radim Kubinek1 Kristyna Vrbova1 Barbora Mainerova1 Andrea cinculova1 Marie Ociskova1 Michaela holubova2 Jarmila smoldasova1 Anezka Tichackova1 1Department of Psychiatry,   University hospital Olomouc,    2Faculty of Medicine and Dentistry,   Palacky University Olomouc,   Olomouc, czech republicIntroduction:  Self-stigma plays a role in many areas of the patient’s life.",Non-OADS,/arxiv_data1/oa_pdf/e9/14/ppa-10-1289.PMC4966500.pdf
"Pavlova 6,  Olomouc, 779 00, czech republic Tel +420 588 44 3519 email dana.kamaradova@fnol.c z Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kamaradova et al Running head recto: Self-stigma, adherence to treatment, and discontinuation of medication DOI: http://dx.doi.org/10.2147/PPA.S99136",Non-OADS,/arxiv_data1/oa_pdf/e9/14/ppa-10-1289.PMC4966500.pdf
"Available from: http://www.ema.europa.eu/pdfs/human/ ich/013595en.pd f. Accessed March 20, 2009.",Non-OADS,/arxiv_data1/oa_pdf/e9/14/ppa-10-1289.PMC4966500.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e9/14/ppa-10-1289.PMC4966500.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/7b/ndt-12-1849.PMC4966501.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1849–1860Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1849OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11038 3 Depression and pain: testing of serial multiple  mediators Tinakon Wongpakaran1 Nahathai Wongpakaran1 sitthinant Tanchakvaranont2 Putipong Bookkamana3 Manee Pinyopornpanish1 Kamonporn Wannarit4 sirina satthapisit5 Daochompu Nakawiro6 Thanita hiranyatheb6 Kulvadee Thongpibul7 1Department of Psychiatry, Faculty  of Medicine, chiang Mai University,   chiang Mai, Kingdom of Thailand;   2Department of Psychiatry, Queen  savang Vadhana Memorial hospital,   chonburi, Kingdom of Thailand;   3Department of statistics, Faculty  of science, chiang Mai University,   chiang Mai, Kingdom of Thailand;   4Department of Psychiatry, Faculty  of Medicine, siriraj hospital, Mahidol  University, Bangkok, Kingdom of  Thailand; 5Department of Psychiatry,   Khon Kaen regional hospital,   Khon Kaen, Kingdom of Thailand;   6Department of Psychiatry, Faculty  of Medicine, ramathibodi hospital,   Mahidol University, Bangkok,   Kingdom of Thailand; 7Department  of Psychology, Faculty of humanities,   chiang Mai University, chiang Mai,   Kingdom of ThailandPurpose:  Despite the fact that pain is related to depression, few studies have been conducted  to investigate the variables that mediate between the two conditions.",Non-OADS,/arxiv_data1/oa_pdf/5a/7b/ndt-12-1849.PMC4966501.pdf
"Multiple factors  are involved in the depression–pain linkage, including neurobiological, genetic, and  precipitating environmental factors, as well as psychological, social, and cognitive  influences.7–12 Another important model in medical and psychiatric contexts is Engel’s  biopsychosocial model.13 Even though the term “biopsychosocial” is rather broad, its  name helps remind clinicians of the components involved in the relationship between  depression and pain.14–17 On the basis of this approach, cognitive abilities, which are the correspondence: Tinakon Wongpakaran Department of Psychiatry, Faculty  of Medicine, chiang Mai University, 110  intawaroros rd., T. sripoom, a. Meung,  chiang Mai 50200, Kingdom of Thailand email tinakon.w@cmu.ac.t h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wongpakaran et al Running head recto: A serial mediation model of depression on pain DOI: http://dx.doi.org/10.2147/NDT.S110383",Non-OADS,/arxiv_data1/oa_pdf/5a/7b/ndt-12-1849.PMC4966501.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5a/7b/ndt-12-1849.PMC4966501.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/7b/ndt-12-1849.PMC4966501.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/a0/ijn-11-3371.PMC4966502.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3371–3383International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3371OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10863 6 Inhibition of autophagy contributes to the  toxicity of cadmium telluride quantum dots in  Saccharomyces cerevisiae Junpeng Fan1–4 Ming shao1–4 lu lai3–5 Yi liu3–5 Zhixiong Xie1–4,6 1college of life sciences, Wuhan  University, 2hubei Provincial  cooperative Innovation center  of Industrial Fermentation,3state  Key laboratory of Virology, 4Key  laboratory of analytical chemistry  for Biology and Medicine (MOe),   5college of chemistry and Molecular  sciences, Wuhan University,   Wuhan, 6school of life science  and T echnology, hubei engineering  University, Xiaogan, People’s  republic of chinaAbstract:  Cadmium telluride quantum dots (CdTe QDs) are used as near-infrared probes in  biologic and medical applications, but their cytological effects and mechanism of potential  toxicity are still unclear.",Non-OADS,/arxiv_data1/oa_pdf/2e/a0/ijn-11-3371.PMC4966502.pdf
"Previous studies have demonstrated the toxicity of CdTe QDs in mammalian  cells6–8 and revealed that this toxicity is dependent on their physicochemical proper - ties, such as size, charge, concentration, and outer coating.9 It has been suggested  that the toxicity of CdTe QDs is related to oxidative stress, which can lead to  lysosome enlargement,8 mitochondrial network fragmentation,7 and activation of  autophagy.10 The toxicity and related mechanisms of CdTe QDs have been well correspondence: Zhixiong Xie college of life sciences, Wuhan  University, 266 Bayi road, Wuhan  430072, People’s republic of china Tel +86 27 6875 2090 Fax +86 27 6875 2560 email zxxie@whu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Fan et al Running head recto: Inhibition of autophagy contribues to the toxicity of CdTe QDs DOI: http://dx.doi.org/10.2147/IJN.S108636",Non-OADS,/arxiv_data1/oa_pdf/2e/a0/ijn-11-3371.PMC4966502.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2e/a0/ijn-11-3371.PMC4966502.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/a0/ijn-11-3371.PMC4966502.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/73/37/ndt-12-1795.PMC4966503.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1795–1807Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1795Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9387 3 Current and emerging treatment strategies for  Duchenne muscular dystrophy Jean K Mah Department of Pediatrics and Clinical  Neurosciences, Cumming School  of Medicine, University of Calgary,   Calgary, Alberta, CanadaAbstract:  Duchenne muscular dystrophy (DMD) is the most common form of muscular  dystrophy in childhood.",Non-OADS,/arxiv_data1/oa_pdf/73/37/ndt-12-1795.PMC4966503.pdf
"His parents want to know more  about the diagnosis and available treatment options.Correspondence: Jean K Mah Alberta Children’s Hospital,  2888 Shaganappi Trail Nw, Calgary,  Alberta, Canada T3B 6A8 Tel +1 403 955 2296 Fax +1 403 955 7649 email jean.mah@albertahealthservices.c a Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Mah Running head recto: DMD emerging treatment DOI: http://dx.doi.org/10.2147/NDT.S93873",Non-OADS,/arxiv_data1/oa_pdf/73/37/ndt-12-1795.PMC4966503.pdf
"As well, assessment for wheelchair, lifts, and  other adaptive technology should be included as part of the  comprehensive treatment plan.3,35 Therapeutic strategies for DMD Recent scientific advances have led to new disease-modifying  treatments for many neuromuscular diseases including  DMD.74–76 Identification of coordination centers and patients eli - gible for specific DMD trials has been greatly facilitated by the  establishment of TREAT-NMD and other international DMD  disease registries.15 Regularly updated information about DMD  clinical trials is available at https://www.ClinicalTrials.go v. A  significant proportion of the active studies are enrolling par - ticipants by invitation only; as well, many of the studies listed  are either Phase I safety or smaller Phase II pilot studies, with  a fewer number of Phase III double-blind randomized trials.",Non-OADS,/arxiv_data1/oa_pdf/73/37/ndt-12-1795.PMC4966503.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/73/37/ndt-12-1795.PMC4966503.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/37/ndt-12-1795.PMC4966503.pdf
"© Li Peng, Melissa M. Damschroder, Kimberly E. Cook, Herren Wu, and William F. Dall ’Acqua *Correspondence to: William Dall ’Acqua; Email: dallacquaw@medimmune.com Submitted: 07/08/2015; Revised: 10/19/2015; Accepted: 10/21/2015 http://dx.doi.org/10.1080/19420862.2015.1113359 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Science1996; 272:872–77; PMID:8629022; http://dx.doi.org/ 10.1126/science.272.5263.872 2.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nature 1996; 382:829–33; PMID:8752280; http://dx.doi.org/10.1038/382829a0 3.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nature 1998; 393:595–99; PMID:9634238; http://dx.doi.org/10.1038/31269 5.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Dev Biol 1999; 213:442–56; PMID:10479460; http://dx.doi.org/10.1006/dbio.1999.9405 7.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nature 1996; 382:635–38; PMID:8757135; http://dx.doi.org/10.1038/382635a08.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Annu Rev Immunol 1994;12:593–633; PMID:8011292; http://dx.doi.org/ 10.1146/annurev.iy.12.040194.003113 9.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Immunol Res 1997; 16:15–28; PMID:9048206; http://dx.doi.org/ 10.1007/BF02786321 10.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Immunol 2000; 165:6590–98; PMID:11086103; http://dx.doi.org/ 10.4049/jimmunol.165.11.6590 11.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nature 2001; 410:50–56; PMID:11242036; http://dx.doi.org/10.1038/35065016 12.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nat Rev Cancer 2004; 4:540–50; PMID:15229479; http://dx.doi.org/10.1038/nrc1388 13.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Pathol 2008; 215:211–13; PMID:18523970; http://dx.doi.org/10.1002/path.2350 14.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Curr Oncol Rep 2009; 11:125–31; PMID:19216844; http://dx.doi.org/10.1007/s11912- 009-0019-1 15.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Clin Cancer Res 2010; 16:2927– 31; PMID:20484021; http://dx.doi.org/10.1158/ 1078-0432.CCR-09-2329 16.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Semin Cancer Biol2004; 14:171–79; PMID:15246052; http://dx.doi.org/ 10.1016/j.semcancer.2003.10.003 17.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Curr Med Chem 2011; 18:497–512; PMID:21143114; http://dx.doi.org/10.2174/092986711794480159 19.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Cancer Lett2014; 352:36–53; PMID:24141062; http://dx.doi.org/ 10.1016/j.canlet.2013.10.006 20.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Clin Cancer Res 2013; 19:357–66; PMID:23213054;http://dx.doi.org/10.1158/1078-0432.CCR-12-2333 21.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nat Rev Drug Discov 2003; 2:581–87; PMID:12815382; http://dx.doi.org/10.1038/nrd1134 24.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Med 1998; 4:72–7; PMID:9427609; http://dx.doi.org/ 10.1038/nm0198-072 25.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Immunol 2001; 167:4686–92; PMID:11591799; http://dx.doi.org/10.4049/jimmunol.167.8.4686 26.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Blood 2003; 102:2728–30;PMID:12855591; http://dx.doi.org/10.1182/blood- 2003-02-0663 28.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Neoplasia 2012; 14:709–18; PMID:22952424; http://dx.doi.org/10.1593/neo.12324 29.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Pharmacol Ther 2010; 128:509–18; PMID:20826182; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Pharmacotherapy 2010; 30:485–92; PMID:20411999; http://dx.doi.org/ 10.1592/phco.30.5.485 31.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Ann Pharmacother 2010; 44:117–26; PMID:20009003; http://dx.doi.org/ 10.1345/aph.1M380 32.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Exp Med 1997; 186:1389–93; PMID:9334379; http://dx.doi.org/10.1084/jem.186.8.1389 33.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Org Biomol Chem 2003; 1:3663–69; PMID:14649897; http://dx.doi.org/10.1039/b306613b 36.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Org Biomol Chem 2005; 3:4392–94; PMID:16327900;http://dx.doi.org/10.1039/b513145f 37.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Biochem Biophys Res Commun 1998; 253:877–82; PMID:9918823; http://dx.doi.org/10.1006/bbrc.1998.9871 39.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Exp Biol Med (Maywood) 2011; 236:844–50; PMID:21697335; http://dx.doi.org/10.1258/ ebm.2011.010345 40.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Science 2010; 330:1066–71; PMID:20929726; http://dx.doi.org/ 10.1126/science.1194396 41.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Bioorg Med Chem Lett 2012; 22:2146– 50; PMID:22365757; http://dx.doi.org/10.1016/j.bmcl.2012.01.134 42.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Biol Chem 2000; 275:23736–44; PMID:10825158; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Neoplasia 2006; 8:290–301; PMID:16756721; http://dx.doi.org/10.1593/neo.05694 46.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Clin Exp Metastasis 2009; 26:261–68; http://dx.doi.org/10.1007/s10585-009-9240-4 47.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Hybridoma (Larchmt) 2009; 8:33–41; http://dx.doi.org/10.1089/hyb.2008.0069 48.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Virol 2001; 75:11534–43; PMID:11689635; http://dx.doi.org/10.1128/ JVI.75.23.11534-11543.2001 49.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Virol 2005; 79:1930–33;PMID:15650218; http://dx.doi.org/10.1128/ JVI.79.3.1930-1933.2005 50.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Immunol 2007; 179:2408–18; PMID:17675502; http://dx.doi.org/ 10.4049/jimmunol.179.4.2408 51.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nature 1989; 342:877–83;PMID:2687698; http://dx.doi.org/10.1038/342877a0 54.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Mol Biol 1992; 227:799–817; PMID:1404389; http://dx.doi.org/10.1016/0022-2836(92)90224-8 55.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Mol Biol 1997; 273:927–48; PMID:9367782; http://dx.doi.org/10.1006/jmbi.1997.1354 56.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Mol Biol 1992; 224:487–99;PMID:1560463; http://dx.doi.org/10.1016/0022- 2836(92)91010-M 57.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Exp Med 2006; 203:2201–13; PMID:16940167; http://dx.doi.org/10.1084/jem.20052144 60.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Proteins 2011; 79:3050–66; PMID:21935986; http://dx.doi.org/10.1002/prot.23130 61.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
FEBS Lett1999; 455:188–97; PMID:10428499; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Proteins 2008; 73:608–20; PMID:18473362; http://dx.doi.org/10.1002/prot.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Comp Chem 1983; 4:187–217; http://dx.doi.org/10.1002/jcc.540040211 64.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Comp Chem 2009; 30:1545– 1614; http://dx.doi.org/10.1002/jcc.21287 65.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Proteins 2003; 52: 80–7;PMID:12784371; http://dx.doi.org/10.1002/prot.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Proteins 2003; 53:693–707; PMID:14579360; http://dx.doi.org/10.1002/prot.10460 67.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
EMBO J 1997; 16:6996– 7007; PMID:9384579; http://dx.doi.org/10.1093/emboj/16.23.6996 68.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Immunol Lett 2001; 78:29–34; PMID:11470148; http://dx.doi.org/10.1016/S0165- 2478(01)00228-0 70.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
PNAS 2014; 111:E5363–E5372; PMID:25468967; http://dx.doi.org/10.1073/ pnas.1417037111 73.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Science 2015; 347:1117–22; PMID:25612609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
PNAS 2010; 107:20565–70; http://dx.doi.org/ 10.1073/pnas.1012865107 75.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Gene Ther 2001; 8:408–18;PMID:11313818; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Virol 2001; 75:8957–67; PMID:11533159; http://dx.doi.org/10.1128/JVI.75.19.8957-8967.2001 77.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Virology 2007; 363:280–7; PMID:17331556; http://dx.doi.org/10.1016/j.virol.2007.01.031 78.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Virol 2000; 74:4404–13; PMID:10756055; http://dx.doi.org/10.1128/ JVI.74.9.4404-4413.2000 79.,Non-OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
J Mol Biol 2009; 393:672–92; PMID:19699208; http://dx.doi.org/10.1016/j.jmb.2009.08.032 81.,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
Nucleic Acids Res 2000; 28:235–42; http://dx.doi.org/10.1093/nar/28.1.235 www.tandfonline.com 175 mAbs,OADS,/arxiv_data1/oa_pdf/92/bb/kmab-08-01-1113359.PMC4966504.pdf
"3For example, percentages of © Merck Sharp & Dohme Corp. *Correspondence to: Kalpit Vora; Email: kalpit.vora@merck.comSubmitted: 08/12/2015; Revised: 10/05/2015; Accepted: 10/12/2015 http://dx.doi.org/10.1080/19420862.2015.1109757 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Science 2002; 298:2199- 202; PMID:12481138; http://dx.doi.org/10.1126/ science.1076071 2.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/10.1128/ CVI.00131-10 3.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
N Engl J Med 2007; 357:1903-15; PMID:17989383; http://dx.doi.org/10.1056/NEJMoa066092 4 .,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Immunol 2008; 180:2165-73; http://dx.doi.org/10.4049/jimmunol.180.4.2165 5.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
PLoS Pathogens 2014; 10:e1004461; PMID:25330199; http://dx.doi.org/10.1371/journal.ppat.1004461 6.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Eur J Immunol 1999; 29:1406-17; PMID:10229109; http://dx.doi.org/10.1002/(SICI)1521-4141(199904)29:04%3c1406:: AID-IMMU1406%3e3.0.CO;2-P 7.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Nature 2008; 453:667-71; PMID:18449194; http://dx.doi.org/ 10.1038/nature06890 8.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Virol 2014; 88:12233-41;PMID:25100837; http://dx.doi.org/10.1128/ JVI.00247-14 10.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Nat Proto 2013; 8:1907-15; PMID:24030440; http://dx.doi.org/10.1038/ nprot.2013.117 11.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Adv Virus Res 2003; 59:141-75; PMID:14696329; http://dx.doi.org/10.1016/S0065-3527(03)59005-4 12.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Vaccine 2011; 29:7267-75; PMID:21777637; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Immunol Methods 2006; 317:175- 85; PMID:17055526; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Eur J Immunol 1997; 27:2073-9; PMID:9295047; http://dx.doi.org/10.1002/ eji.1830270835 15.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Nucl Acids Res 2015; 43:D405-12;PMID:25300482; http://dx.doi.org/10.1093/nar/ gku938 17.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Proc Natl Acad Sci U S A 2013; 110:18662-7; PMID:24158478; http://dx.doi.org/ 10.1073/pnas.1310962110 18.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
EMBO J 2012; 31:767-79; PMID:22139356; http://dx.doi.org/ 10.1038/emboj.2011.43919.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Virol 2010; 84:9227-39; PMID:20592088; http://dx.doi.org/10.1128/ JVI.01087-10 20.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Cell 2002; 108:717-25; PMID:11893341; http://dx.doi.org/10.1016/S0092-8674(02)00660-8 21.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Nat Struct Mol Biol 2013; 20:105-10; PMID:23241927; http://dx.doi.org/10.1038/nsmb.2463 22.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Proc Natl Acad Sci U S A 2014; 111:1939-44; PMID:24385585; http://dx.doi.org/ 10.1073/pnas.1317350111 23.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Science 2015; 349:88-91; PMID:26138979; http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Virology 2009; 392:103-13; PMID:19631955; http://dx.doi.org/10.1016/j.virol.2009.06.037 26.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Virol 2013; 87:52-66; PMID:23077306; http://dx.doi.org/ 10.1128/JVI.02273-12 27.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Vaccine 2010; 28:2705-15; PMID:20097152; http://dx.doi.org/10.1016/j.vaccine.2010.01.022 31.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Virology 2008; 380:234-42; PMID:18789807; http://dx.doi.org/ 10.1016/j.virol.2008.08.00432.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
JImmunol Methods 2009; 343:65-7; PMID:19100741; http://dx.doi.org/10.1016/j.jim.2008.11.012 33.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Immunol 2007; 179:8180-90; http://dx.doi.org/10.4049/jimmunol.179.12.8180 34.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Immunol2005; 175:7867-79; http://dx.doi.org/10.4049/ jimmunol.175.12.7867 35.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Nat Med 2010; 16:123-8; PMID:20023635; http://dx.doi.org/10.1038/nm.207136.,OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Immunol Methods 2004; 286:111-22; PMID:15087226; http://dx.doi.org/10.1016/j.jim.2003.12.015 37.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Nat Proto 2009; 4:372-84; PMID:19247287;http://dx.doi.org/10.1038/nprot.2009.3 38.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
J Immunol 2009; 183:6338-45; http://dx.doi.org/10.4049/ jimmunol.0901373 39.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Immunology 2014; 143:13-20; PMID:24854488;http://dx.doi.org/10.1111/imm.12323 40.,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
Proc Natl Acad Sci U S A 2003; 100:6986-91; PMID:12759475; http://dx.doi.org/10.1073/ pnas.0832193100 140 Volume 8 Issue 1 mAbs,Non-OADS,/arxiv_data1/oa_pdf/97/41/kmab-08-01-1109757.PMC4966506.pdf
"Winter, Tracy Pandina, Alan Jonason, Maria Scrivens, Leslie Balch, Holm Bussler, Sebold Torno, J ennifer Seils, Loretta Mueller, He Huang, Ekaterina Klimatcheva, Alan Howell, Renee Kirk, Elizabeth Evans, Mark Paris, John E. Leonard, Ernest S. Smith, and Mauric e Zauderer *Correspondence to: Maurice Zauderer; Email: mzauderer@vaccinex.comSubmitted: 07/06/2015; Revised: 09/10/2015; Accepted: 09/25/2015 http://dx.doi.org/10.1080/19420862.2015.1102813 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Mol Cancer 2010; 9:251; PMID:20858260; http://dx.doi.org/10.1186/1476-4598-9-251 3.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Immu-nol Res 2011 Jan 4; 50:10-21; PMID: 21203905; http://dx.doi.org/10.1007/s12026-010-8201-y4.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Cell Mol Immunol 2012 Dec 24; 10:97-8; PMID: 23262975;http://dx.doi.org/10.1038/cmi.2012.65 5.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Nat Immunol 2008 Jan; 9:17-23; PMID: 18087252; http://dx.doi.org/10.1038/ni1553 6.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Proc Natl Acad Sci U.S.A 1996 Oct 15;93:11780-5; PMID: 8876214; http://dx.doi.org/ 10.1073/pnas.93.21.11780 7.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Cell Mol Immunol 2010 Mar; 7:83-8; PMID: 20118971; http://dx.doi.org/10.1038/cmi.2009.111 8.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Proc Natl Acad Sci U.S.A2007 Jan 23; 104:1621-6; http://dx.doi.org/10.1073/ pnas.0606344104 www.tandfonline.com 161 mAbs,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Neurobiol Dis 2014; 73:254-68; http://dx.doi.org/10.1016/j.nbd.2014.10.008 11.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Cell 1999 Oct 1; 99:71-80; PMID: 10520995; http://dx.doi.org/10.1016/S0092- 8674(00)80063-X 12.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Nat Cell Biol 2002 Sep; 4:720-4; PMID: 12198496; http://dx.doi.org/ 10.1038/ncb843 13.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
JImmunol 2004 Jan 15; 172:1246-55; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
2012 Aug 14; 37:314-25; http://dx.doi.org/10.1016/j.immuni.2012.05.026 15.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
2000 No v; 13:621-31; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
2001 Dec; 22:670-6; PMID: 11738997; http://dx.doi.org/10.1016/S1471-4906(01)02087-7 17.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
J Immunol 2001 Apr 1; 166:4341-7; http://dx.doi.org/ 10.4049/jimmunol.166.7.4341 20.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
2000Nov; 13:633-42; http://dx.doi.org/10.1016/S1074- 7613(00)00063-7 21.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Mol Cancer Ther 2015 Apr; 14:964-72; PMID: 25657333; http://dx.doi.org/ 10.1158/1535-7163.MCT-14-0924 22.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Nat Immu-nol 2010 May 30; 11:594-600; PMID: 20512151; http://dx.doi.org/10.1038/ni.1885 23.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
J Biol Chem 2009 Sep 17; 284:32066-74; PMID: 19762474; http://dx.doi.org/10.1074/jbc.M109.057166 26.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Can- cer Immunol Res 2015 Jan 22; 3:689-701; PMID: 25614511; http://dx.doi.org/10.1158/2326-6066.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
J Immunol 2010Feb 1; 184:1499-506; PMID: 20038643; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Curr Opin Immunol 2008 Aug; 20:479-85; http://dx.doi.org/ 10.1016/j.coi.2008.05.010 31.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Nat Biotechnol 2009Aug; 27:767-71; http://dx.doi.org/10.1038/nbt.1553 32.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
N Engl J Med 2006 Sep 7; 355:1018-28; http://dx.doi.org/10.1056/NEJMoa063842 33.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Blood 2011 Sep 19; 118:6772-82; PMID: 21931118;http://dx.doi.org/10.1182/blood-2010-12-319780 34.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Nat Struct Biol 2003 Oct; 10:843-8; http://dx.doi.org/10.1038/nsb977 35.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Nature 2010 Sep 26; 467:1118-22; PMID: 20877282; http://dx.doi.org/ 10.1038/nature09468 36.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Blood 2010 Jun 24; 115:5191-201; PMID:20223920; http://dx.doi.org/10.1182/blood-2010-01- 263533 38.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Neurobiol Dis 2015 Feb 3; 76:46-56; http://dx.doi.org/10.1016/j.nbd.2015.01.002 39.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Tumours can act as adjuvants for humoral immunity.Immunology 2001 Apr; 102:486-97; http://dx.doi.org/ 10.1046/j.1365-2567.2001.01213.x 40.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Prostate 2002 May 15; 51:153-65; PMID: 11967950; http://dx.doi.org/10.1002/pros.10071 41.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Mol Immunol 2009 Oct; 46:3488- 94; PMID: 19683345; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
J Mol Recognit2007 Sep; 20:283-99; http://dx.doi.org/10.1002/ jmr.846 43.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
2015 Feb 23; 67:1481-90;PMID: 25707877; http://dx.doi.org/10.1002/ art.39086 44.,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
2012 Mar; 33:127-35; http://dx.doi.org/ 10.1016/j.it.2012.01.008 45.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Nat Med 2011 Oct 23; 17:1473-80; PMID: 22019888; http://dx.doi.org/10.1038/nm.2489 46.,OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Arthritis Res Ther 2011; 13:219; PMID:21635718; http://dx.doi.org/ 10.1186/ar3323 4 7 .,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
Blood 2011 Oct 13; 118:4159-68; PMID: 21795744; http://dx.doi.org/10.1182/blood-2011-04-351932 162 Volume 8 Issue 1 mAbs,Non-OADS,/arxiv_data1/oa_pdf/75/61/kmab-08-01-1102813.PMC4966508.pdf
"15,16Although mAbs produced by transgenic animals or transgenic plants have not been approved for therapeutic © Minoru Tada, Ken-ichiro Tatematsu, Akiko Ishii-Watabe, Akira Harazono, Daisuke Takakura, Noritaka Hashii, Hideki Sezutsu, and Nana Kawasaki *Correspondence to: Minoru Tada; Email: m-tada@nihs.go.jpSubmitted: 03/19/2015; Revised: 07/20/2015; Accepted: 07/22/2015 http://dx.doi.org/10.1080/19420862.2015.1078054 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Rev Immunol 2010;10:301-16; PMID:20414204; http://dx.doi.org/ 10.1038/nri2761 2.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Rev Drug Discov 2010; 9:767-74;PMID:20811384; http://dx.doi.org/10.1038/nrd3229 3.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
MAbs 2012; 4:413-5; PMID:22531442; http://dx.doi.org/10.4161/mabs.199314.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/nrc3236 5.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Biotechnol Genet Eng Rev 2012; 28:147-75; PMID:22616486; http://dx.doi.org/10.5661/bger- 28-147 6.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Methods Mol Biol 2012; 907:341-58; PMID:22907362; http://dx.doi.org/10.1007/978-1-61779-974-7_207.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Appl Microbiol Biotechnol 2012; 93:917-30; PMID:22159888; http://dx.doi.org/10.1007/s00253-011-3758-5 8.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Biotechnol Adv 2009; 27:879-94; PMID:19647060; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Clin Appl Thromb Hemost 2009; 15:645-51; PMID:19850586; http://dx.doi.org/10.1177/ 1076029609339748 14.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Biotechnol 2009; 27:302-4; PMID:19352350; http://dx.doi.org/10.1038/nbt0409-302 15.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Drugs Today (Barc) 2012; 48:525- 32; PMID:22916340; http://dx.doi.org/10.1358/dot.2012.48.4.1788435 16.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Mol Genet Metab 2014; 112:1- 8; PMID:24630271; http://dx.doi.org/10.1016/j.ymgme.2014.02.011 17.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Immu- nol Methods 1999; 231:147-57; PMID:10648934; http://dx.doi.org/10.1016/S0022-1759(99)00151-9 18.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Biotechnol 2005; 23:1159-69; PMID:16127450;http://dx.doi.org/10.1038/nbt1132 19.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Meth- ods Mol Biol 2012; 907:389-408; PMID:22907365; http://dx.doi.org/10.1007/978-1-61779-974-7_23 20.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Plant Biotechnol J2013; 11:53-65; PMID:23046448; http://dx.doi.org/ 10.1111/pbi.12006 21.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Biotechnol J 2007; 2:700-8; PMID:17427997; http://dx.doi.org/10.1002/biot.200600255 22.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
MAbs 2012; 4:532-41; PMID:22665069; http://dx.doi.org/ 10.4161/mabs.20577 23.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Biotechnol 2006; 24:1591-7; PMID:17128273; http://dx.doi.org/10.1038/nbt1260 25.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Appl Microbiol Biotechnol 2010; 85:459-70; PMID:19830419; http://dx.doi.org/10.1007/s00253- 009-2267-2 27.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
CurrPharm Biotechnol 2010; 11:246-50; PMID:20210748; http://dx.doi.org/10.2174/138920110791112013 28.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Biotechnol Lett 2011; 33:645-54; PMID:21184136; http://dx.doi.org/ 10.1007/s10529-010-0498-z 29.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Biochem 2011; 149:219-27; PMID:21113054; http://dx.doi.org/10.1093/jb/mvq138 30.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Interferon Cytokine Res 2000; 20:1015-22;PMID:11096459; http://dx.doi.org/10.1089/ 10799900050198462 32.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Biotechnol 2000; 18:81-4; PMID:10625397; http://dx.doi.org/10.1038/71978 33.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Biotechnol 2003; 21:34-5; PMID:12511906; http://dx.doi.org/10.1038/nbt0103-34 34.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Bio- technol 2003; 21:52-6; PMID:12483223; http://dx.doi.org/10.1038/nbt771 35.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Biotechnol2007; 128:531-44; PMID:17166611; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
FEBS J 2009; 276:5806-20; PMID:19740109; http://dx.doi.org/10.1111/j.1742- 4658.2009.07262.x 38.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Transgenic Res 2010; 19:473-87; PMID:19789990; http://dx.doi.org/10.1007/ s11248-009-9328-2 39.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Rev Immunol 2008; 8:34-47; PMID:18064051; http://dx.doi.org/10.1038/ nri220640.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
MAbs 2011; 3:422-30; PMID:22048693; http://dx.doi.org/10.4161/mabs.3.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Clin Immunol 2013; 33 Suppl 1:S9-17; PMID:22948741; http://dx.doi.org/10.1007/s10875-012-9768-y 42.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Immunol 2010;184:1968-76; PMID:20083659; http://dx.doi.org/ 10.4049/jimmunol.0903296 43.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
N Engl J Med 2012; 366:2008-16; PMID:22621628; http://dx.doi.org/10.1056/ NEJMct1114348 44.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
PLoS One 2014; 9: e95787; PMID:24752341; http://dx.doi.org/10.1371/journal.pone.0095787 45.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Biol Pharm Bull 2009; 32:796-800; PMID:19420744; http://dx.doi.org/10.1248/bpb.32.796 46.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Bio-Drugs 2010; 24:9-21; PMID:20055529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Rev Drug Discov 2009; 8:226-34; PMID:19247305; http://dx.doi.org/10.1038/nrd2804 50.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Mol Biotechnol 2013; 54:1056-68; PMID:23097175; http://dx.doi.org/10.1007/s12033-012-9612-x 51.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Biol Chem 2002; 277:26733-40; PMID:11986321; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Biol Chem 2003; 278:3466-73; PMID:12427744; http://dx.doi.org/ 10.1074/jbc.M210665200 53.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Mol Immu-nol 1995; 32:1311-8; PMID:8643100; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Biotechnol Prog 2005; 21:1644-52; PMID:16321047; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Curr Opin Immunol 2008; 20:471-8; PMID:18606225; http://dx.doi.org/ 10.1016/j.coi.2008.06.007 56.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Biotechnol 2009; 139:108-14; PMID:18984019;http://dx.doi.org/10.1016/j.jbiotec.2008.09.013 57.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
"J Immunol 2008; 180:2294-8; PMID:18250438;http://dx.doi.org/10.4049/jimmunol.180.4.2294 59. van der Kolk LE, Grillo-Lopez AJ, Baars JW, Hack CE, van Oers MH.",OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Br J Haema- tol 2001; 115:807-11; PMID:11843813; http://dx.doi.org/10.1046/j.1365-2141.2001.03166.x 60.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Eur J Biochem 1990; 194:457-62;PMID:2269277; http://dx.doi.org/10.1111/j.1432- 1033.1990.tb15639.x 62.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Nat Biotechnol 2003; 21:414-21; PMID:12612588; http://dx.doi.org/ 10.1038/nbt799 63.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Glycobiology2003; 13:305-13; PMID:12626384; http://dx.doi.org/ 10.1093/glycob/cwg034 64.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Curr Drug Targets 2007; 8:1116-25; PMID:17979671; http://dx.doi.org/10.2174/138945007782151360 67.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
J Immunol Methods 2002; 263:133-47; PMID:12009210; http://dx.doi.org/ 10.1016/S0022-1759(02)00036-4 68.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Glycobiol- ogy 2007; 17:104-18; PMID:17012310; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Glycobiology 2011; 21:949-59;PMID:21421994; http://dx.doi.org/10.1093/glycob/ cwr027 70.,Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
"MAbs 2012; 4:509-20; PMID:22669558; http://dx.doi.org/ 10.4161/mabs.20450 71. van Beers MM, Bardor M. Minimizing immunogenic- ity of biopharmaceuticals by controlling critical quality attributes of proteins.",Non-OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
Biotechnol J 2012; 7:1473-84; PMID:23027660; http://dx.doi.org/10.1002/biot.201200065 72.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
SpringerPlus 2014; 3:136; PMID:25674439; http://dx.doi.org/10.1186/2193-1801-3-136 74.,OADS,/arxiv_data1/oa_pdf/1d/cc/kmab-07-06-1078054.PMC4966511.pdf
"While cyto-intrabodies block targets© Andrea LJ Marschall, Stefan D €ubel, and Thomas B €oldicke *Correspondence to: Andrea LJ Marschall; Email: andrea.marschall@gmx.net Submitted: 06/24/2015; Revised: 07/19/2015; Accepted: 07/20/2015http://dx.doi.org/10.1080/19420862.2015.1076601 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Immunity 2015; 42:850-63; PMID:25979419; http://dx.doi.org/10.1016/j.immuni.2015.04.008 2.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2004; 340:525-42; PMID:15210352; http://dx.doi.org/ 10.1016/j.jmb.2004.04.062 3.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Cell Mol Med 2007; 11:54-70; PMID:17367501; http://dx.doi.org/10.1111/j.1582-4934.2007.00002.x 4.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cell Mol Biol Lett 2013; 18:433-46; PMID:23893288; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
"J Gen Virol 2010; 91:643-52; PMID:19889923; http://dx.doi.org/10.1099/vir.0.016063-0 7 .C o l b yD W ,C h uY ,C a s s a d yJ P ,D u e n n w a l dM , Z a z u l a kH ,W e b s t e rJ M ,M e s s e rA ,L i n d q u i s tS , Ingram VM, Wittrup KD.",OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2004;342:901-12; PMID:15342245; http://dx.doi.org/ 10.1016/j.jmb.2004.07.054 9.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2007; 368:1132-44; PMID: 17391701; http://dx.doi.org/10.1016/j.jmb.2007.02.089 10.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2009; 387:584-606; PMID:19361429; http://dx.doi.org/10.1016/j.jmb.2009.01.061 11.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Oncogene 2003; 22:1557-67; PMID:12629519; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Mol Cancer Ther 2005; 4:1801-9; PMID:16276002; http://dx.doi.org/ 10.1158/1535-7163.MCT-05-0174 13.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Breast Cancer Res 2013; 15:R116;PMID:24330716; http://dx.doi.org/10.1186/bcr3585 15.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cytotechnology 1991; 5:49-50; PMID:AMBIG- UOUS; http://dx.doi.org/10.1007/BF00736806 16.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Intracellular antibodies and challenges facing their use as therapeutic agents.Trends Mol Med 2003; 9:390-6; PMID:13129705; http://dx.doi.org/10.1016/S1471-4914(03)00163-1 19.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Curr Opin Chem Biol 2005; 9:359-65; PMID:15979379; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nature 1993; 366:469- 72; PMID:8247156; http://dx.doi.org/10.1038/366469a0 21.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Mol Ther 2003;8:355-66; PMID:12946308; http://dx.doi.org/ 10.1016/S1525-0016(03)00183-7 22.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
mAbs 2013; 5:518-22; PMID:23765067; http://dx.doi.org/10.4161/mabs.25084 23.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
mAbs 2011; 3:3-16; PMID:21099369; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
mAbs 2014; 6:943- 56; PMID:24848507; http://dx.doi.org/10.4161/mabs.29268 25.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biotechnology (N Y) 1995; 13:1110-5;PMID:9636285; http://dx.doi.org/10.1038/nbt1095- 1110 26.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2001; 305:989-1010; PMID:11162109; http://dx.doi.org/ 10.1006/jmbi.2000.4265 27.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
397:1106-18; PMID:20138889; http://dx.doi.org/ 10.1016/j.jmb.2010.01.070 29.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Toxi- con 2010; 56:990-8; PMID:20637220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochim Biophys Acta 2014; 1844:1933-42; PMID:24792387; http://dx.doi.org/10.1016/j.bbapap.2014.04.019 32.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Exp Cell Res 2013; 319:838-49; PMID:23353833; http://dx.doi.org/ 10.1016/j.yexcr.2013.01.011 33.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2002; 317:73-83;PMID:11916379; http://dx.doi.org/10.1006/jmbi.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Protein Eng Des Sel 2007; 20:413-6; http://dx.doi.org/10.1093/protein/gzm037 35.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochim Biophys Acta 2014; 1844:1983-2001; PMID:25065345; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Annu Rev Biochem 2013; 82:775-97; PMID:23495938; http://dx.doi.org/10.1146/ annurev-biochem-063011-092449 37.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
PloS one 2013; 8:e59812; PMID:23555790; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
EMBO Mol Med 2012; 4:1015-28; PMID:22837174; http://dx.doi.org/10.1002/emmm.201201379 39.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Protein Eng Des Sel 2011; 24:873-81; http://dx.doi.org/10.1093/protein/gzr049 40.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Biotechnol 2006; 24:79-88; PMID:16369541; http://dx.doi.org/ 10.1038/nbt1172 41.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Immunol Methods 2005; 303:19-39; PMID:16045924; http://dx.doi.org/10.1016/j.jim.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods 2004; 34:179- 83; PMID:15312671; http://dx.doi.org/10.1016/j.ymeth.2004.04.00343.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2003; 330:323-32;PMID:12823971; http://dx.doi.org/10.1016/ S0022-2836(03)00530-8 44.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
PloS One 2013; 8:e76834; PMID:24116173; http://dx.doi.org/10.1371/journal.pone.0076834 45.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
BMC Bio- technol 2007; 7:81; PMID:18034894; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biol Chem 2000; 275:2795-803; PMID:10644744; http://dx.doi.org/ 10.1074/jbc.275.4.2795 47.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 1998; 275:245-53; PMID:9466907; http://dx.doi.org/10.1006/ jmbi.1997.1457 48.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
"Bio- chemistry 2014; 53:4034-46; PMID:24896852;http://dx.doi.org/10.1021/bi5004102 50. van Anken E, Braakman I.",OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Crit Rev Bio- chem Mol Biol 2005; 40:191-228; PMID:16126486; http://dx.doi.org/10.1080/10409230591008161 51.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cell 1992; 68:353-64; PMID:1310258; http://dx.doi.org/10.1016/0092- 8674(92)90476-S 53.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem J 2005; 387:897-903; PMID:15610068; http://dx.doi.org/10.1042/BJ20041312 54.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Cell Biol 2005; 7:766-72; PMID:16056268; http://dx.doi.org/ 10.1038/ncb0805-766 55.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Trafﬁc 2004; 5:89-101; PMID:14690498; http://dx.doi.org/10.1111/j.1600-0854.2004.00159.x 56.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods 2012; 56:338-50; PMID:22037249; http://dx.doi.org/10.1016/j.ymeth.2011.10.008 57.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Immunol Methods1994; 175:89-95; PMID:7930642; http://dx.doi.org/ 10.1016/0022-1759(94)90334-4 58.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene 1991; 104:147-53; PMID:1916287; http://dx.doi.org/10.1016/0378-1119(91)90244-6 60.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Biotechnol 2011; 29:245-54; PMID:21390033; http://dx.doi.org/10.1038/nbt.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biotechnol 2002; 96:129-54; PMID:12039531; http://dx.doi.org/10.1016/S0168-1656(02)00043-3 64.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biotechnol 2009; 144:253- 8; PMID:19818816; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Methods 2011; 8:551-8; PMID:21572409; http://dx.doi.org/10.1038/nmeth.1607 66.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Genome Biol 2007; 8:R254; PMID:18047641; http://dx.doi.org/10.1186/gb- 2007-8-11-r254 67.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
FEBS Lett 2012; 586:2778-9; PMID:22664378; http://dx.doi.org/10.1016/j.febslet.2012.05.044 68.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods Mol Biol 2014; 1101:305-20; PMID:24233787; http://dx.doi.org/10.1007/978-1-62703-721-1_14 69.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
N Biotechnol 2010; 27:118-28; PMID:19883803; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Biotechnol 2005; 23:1105-16; PMID:16151404; http://dx.doi.org/ 10.1038/nbt1126 71.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods Mol Biol 2012; 907:85-107; PMID:22907347; http://dx.doi.org/10.1007/978-1- 61779-974-7_5 72.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2008; 376:1182-200;PMID:18191144; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Biotechnol 2005; 23:344-8; PMID:15723048; http://dx.doi.org/10.1038/nbt1067 75.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Immunol Methods 1994;173:33-9; PMID:8034983; http://dx.doi.org/ 10.1016/0022-1759(94)90280-1 80.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene 1997; 187:1-8; PMID:9073060; http://dx.doi.org/10.1016/S0378-1119(96)00627-0 82.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Yeast 2003; 20:1071-84; PMID:12961755; http://dx.doi.org/10.1002/yea.1027 85.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
BMC Biotechnol 2007; 7:14; PMID:17346344; http://dx.doi.org/10.1186/1472-6750-7-14 86.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
mAbs 2012; 4:182-97;PMID:22453100; http://dx.doi.org/10.4161/ mabs.4.2.19000 87.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biol Chem 2003; 278:47812-9; PMID:12947084; http://dx.doi.org/10.1074/jbc.M307002200 88.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Int J Cancer 2014; 134:2547-59; PMID:24243620; http://dx.doi.org/10.1002/ijc.28585 90.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
PloS One 2014; 9:e98178; PMID:24892548; http://dx.doi.org/10.1371/journal.pone.0098178 91.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
mAbs 2014; 6:219-35; PMID:24423624; http://dx.doi.org/10.4161/mabs.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Biophys Res Commun 1993; 197:422-7; PMID:8267576; http://dx.doi.org/ 10.1006/bbrc.1993.2496 93.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cell 1984; 36:847- 56; PMID:6323023; http://dx.doi.org/10.1016/ 0092-8674(84)90034-5 94.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nature 1982; 300:71-4; PMID:7133132; http://dx.doi.org/ 10.1038/300071a0 95.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
PloS one 2009; 4:e5727; PMID:19492089; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Arch Biochem Biophys 2012;522:26-36; PMID:22516657; http://dx.doi.org/ 10.1016/j.abb.2012.04.003 97.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Neurosci 2008; 34:141-8; PMID:18008186; http://dx.doi.org/10.1007/s12031-007-9018-6 98.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Immunol 2002; 169:2274-83; http://dx.doi.org/10.4049/ jimmunol.169.5.2274 99.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Proc Natl Acad Sci U S A 2000;97:12266-71; PMID:11050246; http://dx.doi.org/ 10.1073/pnas.97.22.12266 100.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Mol Pharmacol 2014; 85:472-81; PMID:24319111; http://dx.doi.org/10.1124/ mol.113.089516 101.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Osteoarthritis Cartilage 2013; 21:1807-10; PMID:23954517; http://dx.doi.org/10.1016/j.joca.2013.08.015 102.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods 2004; 34:215-24; PMID:15312674; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Immunol Methods 2004; 290:135-53; PMID:15261577; http://dx.doi.org/10.1016/j.jim.2004.04.014 105.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biotechnol 2008; 135:1-15; PMID:18395925; http://dx.doi.org/10.1016/j.jbiotec.2008.02.012 106.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2009; 385:299-311; PMID:18992254; http://dx.doi.org/ 10.1016/j.jmb.2008.10.051 107.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 2012; 416:94- 107; PMID:22197376; http://dx.doi.org/10.1016/j.jmb.2011.12.021 108.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Protein Eng Des Sel 2014; 27: 351-358; PMID:25225416; http://dx.doi.org/10.1093/ protein/gzu038 110.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Cell Biochem Suppl 2001; Suppl 36:117-28; PMID:11455577; http://dx.doi.org/ 10.1002/jcb.1091 111.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Oncogene 1998; 17:2445-56; PMID:9824155; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Bio- phys Res Commun 1997; 230:242-6;PMID:9016757; http://dx.doi.org/10.1006/bbrc.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biochem 2003; 133:577-81; PMID:12801908; http://dx.doi.org/ 10.1093/jb/mvg074 114.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Oncogene 1999; 18:551-7; PMID:9927212; http://dx.doi.org/10.1038/sj.onc.1202338 115.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Science 1986; 234:364-8; PMID:2876518; http://dx.doi.org/10.1126/ science.2876518 116.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
mAbs 2012; 4:686-93; PMID:22929188; http://dx.doi.org/10.4161/mabs.21696 117.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
PloS One 2011; 6:e29199; PMID:22216210; http://dx.doi.org/10.1371/ journal.pone.0029199 118.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
PloS One2012; 7:e49589; PMID:23166722; http://dx.doi.org/ 10.1371/journal.pone.0049589 119.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Biophys Res Commun 2007; 364:639-44; PMID:17964542; http://dx.doi.org/10.1016/j.bbrc.2007.10.060 120.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nature 1986; 321:522-5; PMID:3713831;http://dx.doi.org/10.1038/321522a0 121.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biol Chem 2009; 284:35029-39; PMID:19783651; http://dx.doi.org/10.1074/jbc.M109.045047 123.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Appl Biochem Biotechnol2009; 157:226-36; PMID:18553063; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Hum Mol Genet 2006; 15:105-11;PMID:16319127; http://dx.doi.org/10.1093/hmg/ ddi432 125.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
mAbs 2015; 7:180-91; PMID:25524068; http://dx.doi.org/10.4161/ 19420862.2015.989023 126.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Biotechnol 2004; 22:1161-5; PMID:15300256; http://dx.doi.org/10.1038/ nbt1000 127.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biol Chem 2008; 283:3639-54; PMID:18045863; http://dx.doi.org/10.1074/jbc.M708536200 128.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
FEBS Lett 1994; 353:143-6; PMID:7926039; http://dx.doi.org/10.1016/0014-5793(94)01027-7 129.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Biol 1999; 285:2005-19; PMID:9925781; http://dx.doi.org/10.1006/ jmbi.1998.2425 130.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Trends Biotechnol 2010; 28:333-9; PMID:20538360; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Mol Ther 2009; 17:2031-40; PMID:19638957; http://dx.doi.org/10.1038/mt.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods Mol Biol 2009; 483:289-312; PMID:19183906; http://dx.doi.org/10.1007/978-1- 59745-407-0_17 134.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Rev Genet 2011; 12:316-28; PMID:21468099; http://dx.doi.org/10.1038/ nrg2971 136.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Curr Gene Ther 2013; 13:211- 27; PMID:23590635; http://dx.doi.org/10.2174/ 1566523211313030006 137.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Theranostics 2014; 4:240-55; PMID:24505233; http://dx.doi.org/ 10.7150/thno.6914 138.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Rev Genet 2007; 8:573-87; PMID:17607305; http://dx.doi.org/10.1038/nrg2141 140.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Breast Cancer Res Treat 1996; 38:11-7; PMID:8825118;http://dx.doi.org/10.1007/BF01803779 142.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
British J Cancer 1993; 68:1140-5; PMID:7903153; http://dx.doi.org/10.1038/bjc.1993.494 143.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Int J Cancer 1995; 60:137-44; PMID:7814146; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cancer Gene Ther 2000; 7:1250-6; PMID:11023197; http://dx.doi.org/10.1038/sj.cgt.7700228 146.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Bioch Biophys Res Commun 1998; 250:699-703; PMID:9784409; http://dx.doi.org/10.1006/bbrc.1998.9391 147.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
JImmunol Methods 2009; 341:30-40; PMID:19038261; http://dx.doi.org/10.1016/j.jim.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Virology 1997; 237:209-16; PMID:9356333; http://dx.doi.org/ 10.1006/viro.1997.8779 152.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Immunol Methods 2005; 300:146-59; PMID:15946674; http://dx.doi.org/10.1016/j.jim.2005.03.007 154.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
2005; 168:863-8; PMID:15767460; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Biophys Res Commun 1994; 204:666-72; PMID:7980527; http://dx.doi.org/10.1006/bbrc.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cell Struct Funct 1996; 21:413-9; PMID:9118249; http://dx.doi.org/10.1247/csf.21.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Neuron 2005; 46:13-21; PMID:15820690; http://dx.doi.org/10.1016/j.neuron.2005.03.009 158.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Curr Opin Chem Biol 2001; 5:409-15; PMID:11470604; http://dx.doi.org/10.1016/S1367- 5931(00)00222-2 161.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Med Chem 2011; 54:3549-63; PMID:21486047; http://dx.doi.org/10.1021/ jm2000882 162.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Int J Mol Sci 2014;15:13768-801; PMID:25110867; http://dx.doi.org/ 10.3390/ijms150813768 163.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cancer Treat Rev 2014; 40:883-91; PMID:24867380; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem J 2000; 351:95- 105; PMID:10998351; http://dx.doi.org/10.1042/0264-6021:3510095 165.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Autoimmunity 2010;43:140-55; PMID:19845477; http://dx.doi.org/ 10.3109/08916930903229239 166.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Rev Immunol 2006; 6:823- 35; PMID:17063184; http://dx.doi.org/10.1038/ nri1957 167.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Proc Natl Acad Sci U S A 2000; 97:12193-7;PMID:11035793; http://dx.doi.org/10.1073/ pnas.210396197 168.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
AmJ Respir Cell Mol Biol 1994; 11:1-6; PMID:8018332; http://dx.doi.org/10.1165/ ajrcmb.11.1.8018332 169.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biotechnol 2011; 152:159- 70; PMID:20883731; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods Mol Biol 2012; 901:11-32; PMID:22723092; http://dx.doi.org/10.1007/ 978-1-61779-931-0_2 171.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nature 2001; 411:494-8; PMID:11373684; http://dx.doi.org/10.1038/35078107 172.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Appl Microbiol Biotechnol 2005; 67:429-35; PMID:15703909; http://dx.doi.org/10.1007/s00253- 004-1882-1 173.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Biotechnol 2010; 28:650-3; PMID:20622827; http://dx.doi.org/10.1038/nbt0710-650 175.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Immunol Rev 2013;253:97-111; PMID:23550641; http://dx.doi.org/ 10.1111/imr.12053 179.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Cell Biol 2003; 5:834-9; PMID:12942087; http://dx.doi.org/10.1038/ncb1038 180.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Trends Genet 2004; 20:521- 4; PMID:15475108; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
"RNA (New York, NY) 2004; 10:12-8; http://dx.doi.org/10.1261/ rna5160904 182.",OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Rev Drug Discov 2010; 9:57-67; PMID:20043028; http://dx.doi.org/ 10.1038/nrd3010 185.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Biotechnol 2005; 23:457-62;PMID:15778705; http://dx.doi.org/10.1038/ nbt1081 186. de Fougerolles AR.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Hum Gene Ther 2008; 19:125-32; PMID:18257677; http://dx.doi.org/10.1089/ hum.2008.928 187.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods 2011; 53:430-6; PMID:21184828; http://dx.doi.org/10.1016/j.ymeth.2010.12.015 188.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Trends Biotechnol 2004; 22:390-4;PMID:15283982; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Clin Sci (Lond) 2006; 110:47-58; PMID:16336204; http://dx.doi.org/10.1042/CS20050162 190.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene 2013; 525:162-9; PMID:23618815;http://dx.doi.org/10.1016/j.gene.2013.03.137 191.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Protein Eng 1999; 12:787-96; PMID:10506289; http://dx.doi.org/10.1093/protein/12.9.787 193.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Hybridoma 1998; 17:33-9; PMID:9523235; http://dx.doi.org/10.1089/ hyb.1998.17.33 194.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Mol Immunol 1995; 32:1345-53; PMID:8643104; http://dx.doi.org/10.1016/0161- 5890(95)00112-3 197.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Mol Med 1998; 76:451-8; PMID:9625302; http://dx.doi.org/10.1007/s001090050237 1034 Volume 7 Issue 6 mAbs,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Cancer Gene Ther 2014; 21:246-55; PMID:24924201; http://dx.doi.org/ 10.1038/cgt.2014.24 206.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Cancer 2015; 6:276-86; PMID:25663946; http://dx.doi.org/10.7150/ jca.10879 207.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene Ther 2003; 10:1018-25; PMID:12776159; http://dx.doi.org/10.1038/sj.gt.3301962 208.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Int J Cancer 2014; 134:2742-7; PMID:24226851; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Annu Rev Microbiol 1997; 51:257-83; PMID:9343351; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Hum Gene Ther 1998; 9:487-96; PMID:9525310; http://dx.doi.org/ 10.1089/hum.1998.9.4-487 212.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Virology 2011; 411:132-41; PMID:21239030; http://dx.doi.org/10.1016/j.virol.2010.12.034214.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Biophys Res Commun 2008; 373:235-40; PMID:18558087; http://dx.doi.org/10.1016/j.bbrc.2008.06.020 215.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Biophys Res Commun 1999; 263:410-8; PMID:10491307; http://dx.doi.org/10.1006/bbrc.1999.1350 216.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Proc Natl Acad Sci U S A 2000; 97:805-10; PMID:10639161; http://dx.doi.org/ 10.1073/pnas.97.2.805 218.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene Ther 2006; 13:1480-92; PMID:16738691; http://dx.doi.org/10.1038/sj.gt.3302801 219.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene Ther 2004; 11:1627-37; PMID:15295615; http://dx.doi.org/10.1038/sj.gt.3302329 220.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene Ther 2001; 8:408- 18; PMID:11313818; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Gene Med2004; 6:616-23; PMID:15170732; http://dx.doi.org/ 10.1002/jgm.548 223.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Methods 2004; 34:240-9; PMID:15312677; http://dx.doi.org/10.1016/j.ymeth.2004.03.017 224.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene Ther 2002; 9:307-19; PMID:11938450; http://dx.doi.org/10.1038/sj.gt.3301656225.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Matrix Biol 1999; 18:239-51; PMID:10429943; http://dx.doi.org/ 10.1016/S0945-053X(99)00022-0 226.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biol Chem 2002; 277:24835-41; PMID:11997396; http://dx.doi.org/10.1074/jbc.M203149200 227.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Int J Cancer 2004; 112:61- 70; PMID:15305376; http://dx.doi.org/10.1002/ ijc.20377 228.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Gene Ther 1998; 5:635- 44; PMID:9797868; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
BMC Biotechnol 2008; 8:5; PMID:18226275; http://dx.doi.org/10.1186/1472-6750-8-5 230.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Virol 2006; 80:8510-20; PMID:16912301; http://dx.doi.org/10.1128/JVI.00420-06 231.,Non-OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biol Chem 2005; 280:685-94; PMID:15513919; http://dx.doi.org/ 10.1074/jbc.M407360200 232.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Biophys Res Commun2005; 338:1791-7; PMID:16288721; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Biochem Biophys Res Commun 2007; 354:864-71; PMID:17266924; http://dx.doi.org/ 10.1016/j.bbrc.2007.01.052 234.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
Nat Commun 2014; 5:3867;PMID:24861166; http://dx.doi.org/10.1038/ ncomms4867 236.,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
J Biol Chem 2000; 275:36073-8; PMID:10969070; http://dx.doi.org/10.1074/jbc.M002765200 www.tandfonline.com 1035 mAbs,OADS,/arxiv_data1/oa_pdf/6b/51/kmab-07-06-1076601.PMC4966517.pdf
"7 © Covagen AB *Correspondence to: Michela Silacci; Email: msilacci@its.jnj.comSubmitted: 07/01/2015; Revised: 08/26/2015; Accepted: 09/04/2015 http://dx.doi.org/10.1080/19420862.2015.1093266 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Arthritis Res Therapy 2014; 16:R56; http://dx.doi.org/10.1186/ ar4491 2.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Arthritis Res Therapy2009; 11 Suppl 1:S1; http://dx.doi.org/10.1186/ar2666 3.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Ann Rheum Dis 2014; 73:492- 509; PMID:24161836; http://dx.doi.org/10.1136/annrheumdis-2013-204573 4.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Curr PharmaceuticalDesign 2011; 17:3141-54; http://dx.doi.org/10.2174/ 138161211798157658 5.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Nat Rev Rheumatol 2010; 6:301-5; PMID:20386564; http://dx.doi.org/10.1038/nrrheum.2010.45 6.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Eur J Immunol 2014; 44:339-47; PMID:24310226; http://dx.doi.org/10.1002/eji.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Arthritis Rheum 2011; 63:2329-39; PMID:21520013; http://dx.doi.org/10.1002/art.30418 8.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Ann Rheum Dis 2012; 71:1741-8; PMID:22550316; http://dx.doi.org/10.1136/ annrheumdis-2011-201024 9.,OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
J Biol Chem 2007; 282:3196-204; PMID:17130124; http://dx.doi.org/ 10.1074/jbc.M609211200 10.,OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Protein Eng Des Sel 2007; 20:57-68; PMID:17242027;http://dx.doi.org/10.1093/protein/gzl055 11.,OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
MAbs 2012; 4:497-508; PMID:22653218; http://dx.doi.org/ 10.4161/mabs.20452 12.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
"Mapping the conformational space accessible to BACE2 using surface mutants and cocrys- tals with Fab fragments, Fynomers and Xaperones.Acta Crystallogr D Biol Crystallogr 2013; 69:1124-37; PMID:23695257; http://dx.doi.org/10.1107/ S0907444913006574 13.",OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Mol Cancer Thera- peutics 2014; 13:2030-9; http://dx.doi.org/10.1158/ 1535-7163.MCT-14-0046-T 14.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Arthritis Rheumatol 2015; 67:51-62; PMID:25303306; http://dx.doi.org/10.1002/art.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Ann Rheum Dis 2007; 66:228- 34; PMID:16935912; http://dx.doi.org/10.1136/ ard.2006.055111 148 Volume 8 Issue 1 mAbs,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Oncology Res Treat-ment 2014; 37:674-7; http://dx.doi.org/10.1159/ 000365597 22.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
Lancet Oncol 2014; 16(1):57-66; PMID:25524800; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
"Viti F, Nilsson F, Demartis S, Huber A, Neri D. Design and use of phage display libraries for the selection of antibodie sa n de n z y m e s .M e t h o d s Enzymol 2000; 326:480-505; PMID:11036659; http://dx.doi.org/10.1016/S0076-6879(00)26071-0 www.tandfonline.com 149 mAbs",OADS,/arxiv_data1/oa_pdf/9f/f8/kmab-08-01-1093266.PMC4966518.pdf
"The pH-dependent bindingantibodies reported so far have been generated through histidine © Chugai Pharmaceutical Co. Ltd. *Correspondence to: Tomoyuki Igawa; Email: igawatmy@chugai-pharm.co.jpSubmitted: 08/20/2015; Revised: 10/09/2015; Accepted: 10/15/2015 http://dx.doi.org/10.1080/19420862.2015.1110660 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Protein Eng Des Sel2010; 23:385-92; http://dx.doi.org/10.1093/protein/ gzq009 3.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
mAbs 2011; 3:422-30;PMID:22048693; http://dx.doi.org/10.4161/mabs.3.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Nat Biotechnol 2010; 28:1203-7; PMID:20953198; http://dx.doi.org/10.1038/ nbt.1691 6.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
"Igawa T, Mimoto F, Hattori K. pH-dependent anti- gen-binding antibodies as a novel therapeutic modality.Biochim Biophys Acta 2014; 1844:1943-50; PMID:25125373; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
mAbs 2013; 5:9; http://dx.doi.org/10.4161/ mabs.26389 9.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
PloS One 2013; 8: e63236; PMID:23667591; http://dx.doi.org/10.1371/ journal.pone.0063236 10.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Curr Biol 1998;8:1335-8; PMID:9843688; http://dx.doi.org/10.1016/ S0960-9822(07)00565-9 11.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Crit Rev Biochem Mol Biol 1996; 31:41-100; PMID:8744955; http://dx.doi.org/10.3109/10409239609110575 12.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
J Biol Chem 2008; 283:25140-9; PMID:18625711; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Mol Divers 1996; 1:87-96; PMID:9237197; http://dx.doi.org/10.1007/BF0172132314.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Biochem J 2007; 405:199-221; PMID:17590154; http://dx.doi.org/10.1042/BJ20070255 17.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Biochem- istry 1998; 37:5450-6; PMID:9548926; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Proteins 2010; 78:950-61; PMID:19899171; http://dx.doi.org/10.1002/prot.22619 19.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
BMC Biotechnol 2008; 8:41; PMID:18423015; http://dx.doi.org/10.1186/1472- 6750-8-41 22.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Acta Crystallogr D Biol Crystallogr 2006; 62:72-82; PMID:16369096; http://dx.doi.org/10.1107/ S090744490503669325.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
J Appl Crystallogr 2007; 40:17; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Acta Crystallogr D Biol Crystallogr 2010; 66:486-501; PMID:20383002; http://dx.doi.org/10.1107/S0907444910007493 27.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Acta Crystallogr D Biol Crystallogr2011; 67:355-67; PMID:21460454; http://dx.doi.org/ 10.1107/S0907444911001314 28.,OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
Blood 2005; 105:562-6; PMID:15374889; http://dx.doi.org/10.1182/blood-2004-04-1482 www.tandfonline.com 73 mAbs,Non-OADS,/arxiv_data1/oa_pdf/8e/21/kmab-08-01-1110660.PMC4966519.pdf
"Partial responses are attributed to several factors:(a) exhaustion of cellular effector mechanisms, 5(b) interaction with the non-signaling Fc gRIIIb,6(c) co-engagement of activating © UMC Utrecht *Correspondence to: Jeanette Leusen; Email: jleusen@umcutrecht.nlSubmitted: 07/10/2015; Revised: 09/22/2015; Accepted: 10/06/2015 http://dx.doi.org/10.1080/19420862.2015.1106658 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Science 1987; 235:177-82; PMID:3798106; http://dx.doi.org/10.1126/science.3798106 2.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Int J Breast Cancer 2011; 2011:352182;PMID:22295219; http://dx.doi.org/10.4061/2011/ 352182 3.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
"J Transl Med 2008; 6:25,5876-6-25; PMID:18485193; http://dx.doi.org/10.1186/1479-5876-6-25 4.",Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Biomed Biotechnol 2011; 2011:379123; PMID:21660134; http://dx.doi.org/10.1155/2011/ 379123 5.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Immunol 2012; 188:3532-41;PMID:22368276; http://dx.doi.org/10.4049/jimmu nol.1103693 6.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
mAbs 2014; 6:409-21; PMID:24492248; http://dx.doi.org/10.4161/mabs.27457 7.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Nat Med 2000; 6:443-6; PMID:10742152; http://dx.doi.org/10.1038/ 74704 8.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Clin Oncol 2007; 25:3712-8; PMID:17704420; http://dx.doi.org/10.1200/JCO.2006.08.80219.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Clin Oncol 2008; 26:1789-96; PMID:18347005; http://dx.doi.org/ 10.1200/JCO.2007.14.8957 10.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Immunol 2005; 174:7792-9; PMID:15944283; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Cancer Res 2011; 71:2411-6; PMID:21427354; http://dx.doi.org/ 10.1158/0008-5472.CAN-10-2583 13.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Biol Chem 2012; 287:25139- 50; PMID:22679018; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
IgA EGFR antibodies mediate tumour killing in vivo.EMBO Mol Med 2013; 5:1213-26; PMID:23918228; http://dx.doi.org/10.1002/emmm.201201929 15.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Haematologica 2012; 97:1686- 94; PMID:22689689; http://dx.doi.org/10.3324/hae matol.2011.061408 17.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Proc Natl Acad Sci U S A 1982; 79:6229-31;PMID:6292896; http://dx.doi.org/10.1073/ pnas.79.20.6229 18.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
mAbs 2016; http://dx.doi.org/10.1080/19420862.2015.1102812 19.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Exp Med 1994; 180:2377-81; PMID:7964511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Int Immunol 2001; 13:993-1002; PMID:11470769; http://dx.doi.org/10.1093/intimm/13.8.993 21.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Blood 2006; 108:3573-9;PMID:16849638; http://dx.doi.org/10.1182/blood- 2006-05-024539 22.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Clin Invest 1999; 104:903-11; PMID:10510331; http://dx.doi.org/ 10.1172/JCI6968 23.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Immunol 2001;166:3266-76; PMID:11207281; http://dx.doi.org/ 10.4049/jimmunol.166.5.3266 24.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Immunol Res 2002; 25:97-113; PMID:11999172; http://dx.doi.org/10.1385/ IR:25:2:097 25.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Mol Biol Cell 2008; 19:5490-505; PMID:18843053; http://dx.doi.org/10.1091/mbc.E07-02-0101 26.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
49:673-80; PMID:5443170; http://dx.doi.org/ 10.1172/JCI106279 27.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Eur J Immunol 1988; 18:313-6; PMID:3350037; http://dx.doi.org/10.1002/ eji.1830180221 28.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Proc Natl Acad Sci U S A 2009; 106:2788- 93; PMID:19188594; http://dx.doi.org/10.1073/ pnas.0810796106 29.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Adv Protein Chem 1985; 37:161-245; PMID:3904348; http://dx.doi.org/ 10.1016/S0065-3233(08)60065-0 30.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Immunology 1996; 89:573-8; PMID:9014824; http://dx.doi.org/10.1046/j.1365-2567.1996.d01-775.x 31.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Eur J Immunol 1996; 26:690-6; PMID:8605939; http://dx.doi.org/ 10.1002/eji.1830260327 32.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Protein Eng Des Sel 2008; 21:515-27; PMID:18499681; http://dx.doi.org/ 10.1093/protein/gzn028 33.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Protein Eng Des Sel 2010; 23:827-34;PMID:20817756; http://dx.doi.org/10.1093/protein/ gzq058 34.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
A novel tri-func- tional antibody fusion protein with improved pharma- cokinetic properties generated by fusing a bispeciﬁc single-chain diabody with an albumin-binding domain from streptococcal protein G. Protein Eng Des Sel 2007; 20:569-76; PMID:17982179; http://dx.doi.org/10.1093/protein/gzm061 35.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Biol Chem 2011; 286:5234-41; PMID:21138843; http://dx.doi.org/10.1074/jbc.M110.164848 36.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Biotechnol J 2014; 9:1215-22; PMID:24678002; http://dx.doi.org/ 10.1002/biot.201400009 37.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Anal Chem 2014; 86:5784-93; PMID:24831253; http://dx.doi.org/10.1021/ac500335t38.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Immunol 2007; 179:2936-43; PMID:17709508; http://dx.doi.org/ 10.4049/jimmunol.179.5.2936 42.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Biochemistry2008; 47:11285-99; PMID:18826328; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Exp Med 2000; 191:2171-82; PMID:10859341; http://dx.doi.org/10.1084/ jem.191.12.2171 45.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Mol Immunol 1994; 31:1415-22; PMID:7823967; http://dx.doi.org/ 10.1016/0161-5890(94)90157-0 47.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Bio- chem J 1994; 299 ( Pt 1):261-75; PMID:8166649; http://dx.doi.org/10.1042/bj2990261 48.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Biol Chem 1998;273:2260-72; PMID:9442070; http://dx.doi.org/ 10.1074/jbc.273.4.2260 4 9 .,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Am Soc Nephrol 2006; 17:3529-39;PMID:17050773; http://dx.doi.org/10.1681/ ASN.2006040388 50.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Glycobiology 2000; 10:477- 86; PMID:10764836; http://dx.doi.org/10.1093/gly cob/10.5.477 51.,Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Mol Biol 2005; 345:1071-81; PMID:15644205; http://dx.doi.org/ 10.1016/j.jmb.2004.11.014 52.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
J Biol Chem 2010; 285:4826-36; PMID:20018855; http://dx.doi.org/10.1074/jbc.M109.081828 53.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
Proc Natl Acad Sci U S A 2008; 105:2337-42; PMID:18272495; http://dx.doi.org/ 10.1073/pnas.0708960105 55.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
An engineered afﬁbody molecule with pH-dependent binding to FcRn medi- ates extended circulatory half-life of a fusion protein.Proc Natl Acad Sci U S A 2014; 111:17110-5; PMID:25406323; http://dx.doi.org/10.1073/ pnas.1417717111 56.,OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
"mAbs 2015; 7:344-51; PMID:25654695; http://dx.doi.org/10.1080/19420862.2015.1008345 59. van Egmond M, van Vuuren AJ, Morton HC, van Spriel AB, Shen L, Hofhuis FM, Saito T, MayadasT N ,V e r b e e kJ S ,v a nd eW i n k e lJ G .H u m a ni m m u - noglobulin A receptor (Fca lphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18).",Non-OADS,/arxiv_data1/oa_pdf/37/fa/kmab-08-01-1106658.PMC4966554.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1337–1348Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1337OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10928 9 Evaluating preferences for profiles of glucagon-like  peptide-1 receptor agonists among injection-naive  type 2 diabetes patients in Japan heather l gelhorn1 elizabeth D Bacci2 Jiat ling Poon1 Kristina s Boye3 Shuichi Suzuki4 steven M Babineaux3 1Outcomes research, evidera,   Bethesda, MD, 2evidera, seattle,   WA, 3global Patient Outcomes and  real World evidence, eli lilly and  company, indianapolis, in, UsA;   4Medicines Development Unit Japan,   eli lilly Japan, Kobe, JapanObjective:  The objective of this study was to use a discrete choice experiment (DCE) to  estimate patients’ preferences for the treatment features, safety, and efficacy of two specific  glucagon-like peptide-1 receptor agonists, dulaglutide and liraglutide, among patients with type  2 diabetes mellitus (T2DM) in Japan.",Non-OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"Japanese guidelines for the management of T2DM recom - mend beginning with lifestyle modifications such as diet and exercise therapy, before  progressing to oral T2DM drugs and/or injectable therapy if target glycemic control correspondence: heather l gelhorn evidera, 7101 Wisconsin Avenue, suite  1400, Bethesda, MD 20814, UsA Tel +1 303 216 2274 Fax +1 303 271 3665 email heather.gelhorn@evidera.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gelhorn et al Running head recto: Japanese patients’ preference for GLP-1 RAs in T2DM DOI: http://dx.doi.org/10.2147/PPA.S109289",Non-OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"Available from: http://www.diabe - tesatlas.or g. Accessed February 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
Available from: http://www.jds.or.jp/modules/en/ index.php?content_id =1.,OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"Available from: http://www.pmda.go.jp/eng - lish/review-services/reviews/approved-information/drugs/0002.htm l.  Accessed January 26, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"Available from: https://www.diabetes.co.jp/usage/trulicity.asp x.  Accessed February 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"Available from: http://www.novonordiskpro.jp/content/dam/nnpro/ japan/ja/ products /victoza/documents/victoza_use_correctly.pd f.  Accessed February 1, 2016.",OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/67/a8/ppa-10-1337.PMC4966566.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/73/dddt-10-2359.PMC4966568.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2359–2367Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2359Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11108 4 Distinct role of the Fas rs1800682 and FasL  rs763110 polymorphisms in determining the risk  of breast cancer among han chinese females Meng Wang1,* Zheng Wang2,* Xi-Jing Wang1 Tian-Bo Jin3 Zhi-Ming Dai4 hua-Feng Kang1 hai-Tao guan1 Xiao-Bin Ma1 Xing-han liu1 Zhi-Jun Dai1 1Department of Oncology, second  affiliated hospital of Xi’an Jiaotong  University, 2Department of Medical  Oncology, Xi’an central hospital,   3national engineering research  center for Miniaturized Detection  systems, school of life sciences,   northwest University, 4Department of  anesthesia, second affiliated hospital  of Xi’an Jiaotong University, Xi’an,   People’s republic of china *These authors contributed equally  to this workBackground:  In recent years, studies have demonstrated that polymorphisms in the promoters  of Fas and FasL  are significantly associated with breast cancer risk.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/dddt-10-2359.PMC4966568.pdf
"In the United  States alone, 246,660 new breast cancer cases are expected in 2016, which account for  29% of all estimated new cancer diagnoses in females.1 Although the morbidity rate  of breast cancer is lower in People’s Republic of China compared with that in devel - oped countries, since the 1990s, the incidence rate has been rising more than twice as  fast as the worldwide average, resulting in its becoming the most common cancer in correspondence: Zhi-Jun Dai Department of Oncology, second  Affiliated Hospital of Xi’an Jiaotong  University, 157 West 5th road, Xi’an  710004, People’s republic of china email dzj0911@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wang et al Running head recto: Fas rs1800682 and FasL  rs763110 polymorphisms and breast cancer DOI: http://dx.doi.org/10.2147/DDDT.S111084",Non-OADS,/arxiv_data1/oa_pdf/f4/73/dddt-10-2359.PMC4966568.pdf
Power and Sample  Size (PS) Calculation software ( http://biostat.mc.vanderbilt.,OADS,/arxiv_data1/oa_pdf/f4/73/dddt-10-2359.PMC4966568.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/dddt-10-2359.PMC4966568.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/dddt-10-2359.PMC4966568.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0a/3e/ccid-9-167.PMC4966572.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0a/3e/ccid-9-167.PMC4966572.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 167–174Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 167 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S111139 Ability of sodium copper chlorophyllin complex  to repair photoaged skin by stimulation of  biomarkers in human extracellular matrix John P McCook1 Thomas J Stephens2 Lily I Jiang2 Robert M Law3 Vincent Gotz4 1Discovery Partners LLC, Frisco,   2Thomas J. Stephens & Associates,   Inc., Richardson, 3ProPath, Dallas,   TX, 4MDRejuvena, Inc., San Diego,   CA, USAPurpose: To examine the effect of sodium copper chlorophyllin complex on the expression of  biomarkers of photoaged dermal extracellular matrix indicative of skin repair.",Non-OADS,/arxiv_data1/oa_pdf/0a/3e/ccid-9-167.PMC4966572.pdf
"2 The normal process of Correspondence: John P McCook Discovery Partners, LLC, 4913 Southern Hills Drive, Frisco, TX 75034, USATel +1 214 448 6513Email johnmccook@att.netJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: McCook et alRunning head recto: Repair of skin photoaging by sodium copper chlorophyllin complexDOI: http://dx.doi.org/10.2147/CCID.S111139",Non-OADS,/arxiv_data1/oa_pdf/0a/3e/ccid-9-167.PMC4966572.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/0a/3e/ccid-9-167.PMC4966572.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 174 McCook et al,Non-OADS,/arxiv_data1/oa_pdf/0a/3e/ccid-9-167.PMC4966572.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/8c/ott-9-4561.PMC4966573.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4561–4568OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4561Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10522 1 clinical observation of gene expression-guided  chemoradiation therapy for nonsurgical esophageal  squamous cell carcinoma patients: a retrospective  analysis of 36 cases Zhe Yang honghai Dai Dongxiao lv a lei Feng Weibin shu Junqing han T umor research and Therapy center,   shandong Provincial hospital affiliated  to shandong University, Jinan,   shandong, People’s republic of chinaObjective:  To make an informed choice of chemotherapy drugs according to the oncogene  mRNA expression and to explore whether it could increase the survival rate of patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/8c/ott-9-4561.PMC4966573.pdf
"The RTOG85-01 study  confirmed that chemoradiation therapy could improve the 5-year survival rate of correspondence: Junqing han Tumor research and Therapy center,  Provincial Hospital Affiliated to Shandong  University, 324 Jingwu Weiqi road,  Jinan, shandong 250021, People’s  republic of china Tel +86 531 6877 6100 Fax +86 531 8706 8707 email hanjq1960@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: Gene expression-guided chemoradiation for nonsurgical ESCC DOI: http://dx.doi.org/10.2147/OTT.S105221",Non-OADS,/arxiv_data1/oa_pdf/3e/8c/ott-9-4561.PMC4966573.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/8c/ott-9-4561.PMC4966573.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/8c/ott-9-4561.PMC4966573.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/9c/ott-9-4617.PMC4966574.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4617–4627OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4617Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10774 5 Efficacy and safety of cord blood-derived  dendritic cells plus cytokine-induced killer cells  combined with chemotherapy in the treatment  of patients with advanced gastric cancer:  a randomized Phase ii study Ying Mu1,* Wei-hua Wang2,* Jia-ping Xie1 Ying-xin Zhang2 Ya-pei Yang2 Chang-hui Zhou2 1Department of gastroenterology,   2Department of Central Laboratory,   liaocheng People’s hospital,   liaocheng clinical school of Taishan  Medical University, liaocheng,   Shandong Province, People’s Republic  of china  *These authors contributed equally  to this workBackground:  Cellular immunotherapy has been widely used in the treatment of solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/5a/9c/ott-9-4617.PMC4966574.pdf
"Many studies have Correspondence: Chang-hui Zhou Department of Central Laboratory,  liaocheng People’s hospital, liaocheng  clinical school of Taishan Medical  University, 67 Dongchang West road,  liaocheng 252000, shandong Province,  People’s Republic of China Tel +86 133 9625 6302 email zhouch2006@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Mu et al Running head recto: Cellular immunotherapy for advanced gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S107745",Non-OADS,/arxiv_data1/oa_pdf/5a/9c/ott-9-4617.PMC4966574.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5a/9c/ott-9-4617.PMC4966574.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/9c/ott-9-4617.PMC4966574.pdf
"2, 379 –388 http://dx.doi.org/10.1080/19420862.2015.1116657",Non-OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
"Alignment of 1HEZ, 1YNT and 1MHH with IGKV12-46 (A) and IGKV10-94 (B) according to http://multalin.toulouse.inra.fr/multalin/ (High consensus color: red; Low consensus color:blue; Neutral color: Black).",Non-OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
"The characteristics of scFv, molec- ular mass and coef ﬁcient of extinction molar, were de ﬁned with http://web.expasy.org/protparam/.",OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Nat Methods 2008; 5:135 –46; PMID:18235434; http://dx.doi.org/10.1038/nmeth.f.202 2.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Protein Expr Purif 2005; 39:199 –208; PMID:15642471; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
"Myhre EB, Erntell M. A non-immune interaction between the light chain of human immunoglobulin and a surface component of a Peptococcus magnus strai n. Mol Immunol 1985; 22:879 –85; PMID:3930951; http://dx.doi.org/10.1016/0161-5890(85)90073-25.",OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
J Biol Chem 2012; 287:14149 –56; PMID:22375011; http://dx.doi.org/10.1074/jbc.M112.348912 7.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Cell Mol Life Sci 2003; 60:617 –28; PMID:12737321; http://dx.doi.org/10.1007/s00018 0300053 8.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
J Immunol Methods 1993; 164:33 –40; PMID:8360508; http://dx.doi.org/10.1016/0022-1759(93)90273-A 12.,Non-OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Structure 2001; 9:679 –87; PMID:11587642; http://dx.doi.org/ 10.1016/S0969-2126(01)00630-X 13.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
J Mol Biol2005; 354:447 –58; PMID:16242717; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Anal Biochem 2009; 388:331 –8; PMID:19268418; http://dx.doi.org/10.1016/j.ab.2009.02.035 16.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Nucleic Acids Res 2009; 37:D1006 –12; PMID:18978023; http://dx.doi.org/10.1093/ nar/gkn838 17.,Non-OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Proteins 1996; 25:130 –3; PMID:8727325; http://dx.doi.org/ 10.1002/(SICI)1097-0134(199605)25:1%3c130::AID-PROT11%3e3.3.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
J Biol Chem 2002; 277:47500 –6; PMID:12221088; http://dx.doi.org/10.1074/jbc.M206105200 19.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
"Beckingham JA, Bottomley SP, Hinton R, Sutton BJ, Gore MG. Inter- actions between a single immunoglobulin-binding domain of proteinL from Peptostreptococcus magnus and a human kappa light chain.Biochem J 1999; 340 (Pt 1):193 –9; PMID:10229674; http://dx.doi.org/ 10.1042/bj3400193 20.",OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Anal Biochem 2011; 417: 274 –82; PMID:21771576; http://dx.doi.org/10.1016/j.ab.2011.06.036 21.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Immunol Today 1997; 18:509; PMID:9386342; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
FEBS Lett 1999; 442:183 – 8; PMID:9928998; http://dx.doi.org/10.1016/S0014-5793(98)01647-0 23.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
Eur J Biochem 2001; 268:694 –702; PMID:11168408; http://dx.doi.org/10.1046/j.1432-1327.2001.01923.x388 Z. LAKHRIF ET AL.,OADS,/arxiv_data1/oa_pdf/23/05/kmab-08-02-1116657.PMC4966575.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/24/f9/ndt-12-1817.PMC4966576.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1817–1825Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1817OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10898 3 long-term administration of escitalopram in  patients with social anxiety disorder in Japan satoshi asakura1 Taiji hayano2 atsushi hagino2 Tsukasa Koyama3 1health care center and Department  of Psychiatry, hokkaido University  graduate school of Medicine, sapporo,   hokkaido, 2clinical Development  Planning and Management, Mochida  Pharmaceutical co., ltd, T okyo,   3clinical research center, Oyachi  hospital, sapporo, hokkaido, JapanPurpose:  To investigate the safety, tolerability, and effectiveness of escitalopram in patients  with social anxiety disorder in Japan.",Non-OADS,/arxiv_data1/oa_pdf/24/f9/ndt-12-1817.PMC4966576.pdf
"The  Diagnostic and Statistical Manual of Mental Disorders-5  emphasized in the “Culture- Related Diagnostic Issues” section on SAD that “The syndrome of taijin kyofusho   (eg, in Japan and Korea) is often characterized by social-evaluative concerns, fulfill - ing the criteria for social anxiety disorder.”1 TK has two subtypes – the “sensitive” correspondence: satoshi asakura health care center and Department of  Psychiatry, hokkaido University graduate  school of Medicine, North 16, West 7,  sapporo, hokkaido 060-0816, Japan Tel +81 11 706 5418 Fax +81 11 706 5081 email asakurap@academic.hokudai.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Asakura et al Running head recto: Long-term study of escitalopram for SAD DOI: http://dx.doi.org/10.2147/NDT.S108983",Non-OADS,/arxiv_data1/oa_pdf/24/f9/ndt-12-1817.PMC4966576.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/24/f9/ndt-12-1817.PMC4966576.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/f9/ndt-12-1817.PMC4966576.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/6c/ott-9-4505.PMC4966577.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4505–4516OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4505Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10003 7 Microrna-490 inhibits tumorigenesis and  progression in breast cancer lin Zhao1 Xin-Yu Zheng1,2 1Department of Breast surgery,   the First hospital of china Medical  University, 2The First laboratory,   cancer institute of china Medical  University, shenyang, People’s  republic of chinaAbstract:  MicroRNAs are consistently reported to regulate gene expression in all cancer cell  types by modulating a wide range of biological processes, including cell proliferation, differen - tiation, and apoptosis, which are associated with tumor development and progression.",Non-OADS,/arxiv_data1/oa_pdf/26/6c/ott-9-4505.PMC4966577.pdf
"Ras homolog gene family member A (RhoA) is a small ( ~22 kDa) G protein/ guanosine triphosphatase that affects tumor invasion and migration in various cancer  cells.5–8 Overexpression of RhoA has been detected in some human tumors in which  RhoA levels correlate with breast cancer stage.9 Studying the regulatory mechanism of  RhoA and developing treatments targeting RhoA may be effective for treating breast  cancer tumorigenesis and progression.correspondence: Xin-Yu Zheng Department of Breast surgery, the First  hospital of china Medical University,  no 155 nanjing north street, heping  District, shenyang, 110001, People’s  republic of china Tel +86 24 8328 3333 Fax +86 24 8328 3333 email zhengxyshy@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhao and Zheng Running head recto: MicroRNA-490 acts as a tumor suppressor in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S100037",Non-OADS,/arxiv_data1/oa_pdf/26/6c/ott-9-4505.PMC4966577.pdf
MiR-490-3p targets RhoA and influences  rhoa downstream factors directly in vitro We searched microRNA.org ( http://www.microrna.or g) and  found that the predicted binding site of miR-490-3p is the RhoA 3′ UTR (Figure 4A).,OADS,/arxiv_data1/oa_pdf/26/6c/ott-9-4505.PMC4966577.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/26/6c/ott-9-4505.PMC4966577.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/6c/ott-9-4505.PMC4966577.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/f7/ijn-11-3357.PMC4966578.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3357–3369International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3357OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10046 9 a novel temperature-responsive micelle for  enhancing combination therapy cheng-liang Peng1,* Yuan-I chen2,3,* hung-Jen liu2 Pei-chi lee2 Tsai-Yueh luo1 Ming-Jium shieh2,3 1Isotope application Division, Institute  of Nuclear energy research, Taoyuan,   2Institute of Biomedical engineering,   college of Medicine and college  of engineering, National Taiwan  University, Taipei, 3Department of  Oncology, National Taiwan University  hospital and college of Medicine,   Taipei, Taiwan *These authors contributed equally  to this workAbstract:  A novel thermosensitive polymer p(N-isopropylacrylamide-co-poly[ethylene glycol]  methyl ether acrylate)-block-poly(epsilon-caprolactone), p(NIPAAM-co-PEGMEA)-b-PCL, was  synthesized and developed as nanomicelles.",Non-OADS,/arxiv_data1/oa_pdf/3d/f7/ijn-11-3357.PMC4966578.pdf
"PTT can induce thermotolerance in cancer cells through the heat-shock response  mediated by several heat-shock proteins (HSPs), including HSP-27, -72, and -90.10 HSPs correspondence: Ming-Jium shieh Institute of Biomedical engineering,  college of Medicine and college of  engineering, National Taiwan University,  No 1, section 1, Jen-ai road, Taipei  100, Taiwan Tel +886 2 2312 3456 ext 81444 Fax +886 2 2394 0049 email soloman@ntu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Peng et al Running head recto: A novel temperature-responsive micelle for enhancing combination therapy DOI: http://dx.doi.org/10.2147/IJN.S100469",Non-OADS,/arxiv_data1/oa_pdf/3d/f7/ijn-11-3357.PMC4966578.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3d/f7/ijn-11-3357.PMC4966578.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/f7/ijn-11-3357.PMC4966578.pdf
"2, 389 –404 http://dx.doi.org/10.1080/19420862.2015.1115166",Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Eur J Cancer 2010; 46:1232 –40; PMID:20307969; http://dx.doi.org/10.1016/j.ejca.2010.02.040 2.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Immunol Rev 2006; 213:213 –27; PMID:16972906; http://dx.doi.org/10.1111/j.1600-065X.2006.00437.x 5.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
"Nat Immunol 2012; 13:991 –9; PMID:22961052; http://dx.doi.org/10.1038/ni.2416 6. van ’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al.",OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Nature 2002; 415:530 –6; PMID:11823860; http://dx.doi.org/10.1038/415530a 7.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Annu Rev Biochem 1998; 67:753 –91; PMID:9759503; http://dx.doi.org/10.1146/annurev.bio chem.67.1.753 8.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Growth Factors 1990; 3:35 –43; PMID:2200452; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
a role formatrix vesicle-associated MMP-13 in activation of transforming growth factor- b. J Biol Chem 2001; 276:11347 –53; PMID:11145962; http://dx.doi.org/10.1074/jbc.M009725200 11.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Mol Cell Biol 1988; 8:4162 –8; PMID:3185545; http://dx.doi.org/10.1128/MCB.8.10.4162 13.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
DNA 1988; 7:1 –8; PMID:3162414; http://dx.doi.org/10.1089/dna.1988.7.1 14.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Proc Natl Acad Sci USA 2008; 105:20251 –6; PMID:19073914; http://dx.doi.org/10.1073/ pnas.0807200106 15.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
FEBS Lett 2012; 586:1885 –96; PMID:22293501; http://dx.doi.org/10.1016/j.febslet.2012.01.040 17.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Mol Cell2008; 29:157 –68; PMID:18243111; http://dx.doi.org/10.1016/j.mol cel.2007.11.039 18.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Nature 1994; 370:341 –7; PMID:8047140; http://dx.doi.org/10.1038/370341a0 20.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Int J Biochem Cell Biol 2012; 44:469 –74; PMID:22226817; http://dx.doi.org/10.1016/ j.biocel.2011.12.013 21.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Cytokine Growth Factor Rev 2009; 20:367 –77; PMID:19926516; http://dx.doi.org/10.1016/j.cytogfr.2009.10.022 22.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Cell Signal 2011; 23:1424 –32; PMID:21515362; http://dx.doi.org/10.1016/j.cellsig.2011.04.004 23.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Cell 1993; 73:1435 –44; PMID:8391934; http://dx.doi.org/10.1016/0092-8674(93)90368-Z 24.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
"EMBO J 2001; 20:480 –90; PMID:11157754; http://dx.doi.org/10.1093/emboj/ 20.3.480 25. del Re E, Babitt JL, Pirani A, Schneyer AL, Lin HY.",OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Biol Chem 2004; 279:22765 –72; PMID:14996829; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Cancer Biotherapy 1994; 9:317 –27; PMID:7719379; http://dx.doi.org/10.1089/cbr.1994.9.317 31.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Cell Physiol 1989; 138:79 –86; PMID:2910889; http://dx.doi.org/10.1002/ jcp.1041380112 34.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Immunol Meth 2013; 391:60 –71; http://dx.doi.org/ 10.1016/j.jim.2013.02.010 35.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Cancer Immunol Immunother 1995; 41:302 –8; PMID:8536276; http://dx.doi.org/10.1007/ BF01517218 37.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Biol Chem 2004; 279:26013 –8; PMID:15044491; http://dx.doi.org/10.1074/jbc.M400655200 39.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Cancer Res 2008; 68:561 –70; PMID:18199553; http://dx.doi.org/10.1158/0008- 5472.CAN-07-2307 40.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Curr Pharm Biotechnol 2011; 12:2176 –89; PMID:21619535; http://dx.doi.org/10.2174/138920111798808392 41.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Trans Med 2012; 10:183; http://dx.doi.org/10.1186/1479-5876-10-183 42.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Protein Sci 1996; 5:1261 –71; PMID:8819159; http://dx.doi.org/10.1002/pro.5560050705 43.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Genes Dev 1994; 8:133 –46; PMID:8299934; http://dx.doi.org/10.1101/gad.8.2.133 44.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Mol Endocrinol 1989; 3:1977 –86; PMID:2628733; http://dx.doi.org/10.1210/mend-3-12-1977 45.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Mol Repro Dev 1992; 32:91 –8; http://dx.doi.org/10.1002/ mrd.1080320203 46.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
190:579 –88; PMID:10727984; http://dx.doi.org/10.1002/(SICI)1096- 9896(200004)190:5%3c579::AID-PATH548%3e3.0.CO;2-I 47.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Investigative ophthalmol Visual Sci 2003; 44:3394 –401; http://dx.doi.org/10.1167/iovs.02-0978 49.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Oph- thalmology 2007; 114:1950; PMID:17908596; http://dx.doi.org/ 10.1016/j.ophtha.2007.07.024 50.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Arthritis Rheumatism 2007; 56:323 – 33; PMID:17195236; http://dx.doi.org/10.1002/art.22289 51.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Kidney Int 2011; 79:1236 –43; PMID:21368745; http://dx.doi.org/10.1038/ki.2011.33 52.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
PloS One 2014; 9:e90353; PMID:24618589;http://dx.doi.org/10.1371/journal.pone.0090353 53.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Oncoimmunology 2013; 2:e26218; PMID:24179709; http://dx.doi.org/10.4161/onci.26218 5 4 .,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
A phase III study of subconjunc tival human anti-transforming growth factor b(2) monoclonal antibody (CAT-152) to preventscarring after ﬁrst-time trabeculectom y. Ophthalmology 2007; 114:1822 –30; PMID:17908591; http://dx.doi.org/10.1016/j.oph tha.2007.03.050 55.,Non-OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Curr Opin Biotechnol 1997; 8:50 –7; PMID:9013659; http://dx.doi.org/10.1016/S0958-1669(97) 80157-7 56.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
Biophysical J 1995; 68:807 –14; http://dx.doi.org/10.1016/S0006- 3495(95)80257-2 57.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Mol Biol 2003; 328:1173 –83; PMID:12729750; http://dx.doi.org/10.1016/S0022-2836 (03)00360-7 60.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Mol Recognition 1999; 12:279 –84; http://dx.doi.org/10.1002/(SICI)1099-1352(199909/10) 12:5%3c279::AID-JMR473%3e3.0.CO;2-3 61.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
J Immunol Meth 2006; 316:18 –26; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/92/kmab-08-02-1115166.PMC4966579.pdf
"2, 318 –330 http://dx.doi.org/10.1080/19420862.2015.1128607",Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
The reference sequence of panitumu- mab was obtained from the IMGT database (http://www.imgt.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
"For mass calcu-lations, Sequence Editor software uses a Periodic table based onthe NIST Atomic Weights and Isotopic Compositions (version2.3.1, http://www.nist.gov/pml/data/comp-version.cfm).",OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Nat Rev Immunol 2010; 10(5):345 –52; PMID:20414207; http://dx.doi.org/10.1038/nri2747 2.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Curr Pharm Biotechnol 2008; 9(6):502 –9; PMID:19075688; http://dx.doi.org/10.2174/138920108786786385 4.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2012; 84(15):6355 – 60; PMID:22881398; http://dx.doi.org/10.1021/ac3013362 5.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Mol Cell Proteomics 2012; 11(12):1758 –67; PMID:22964222; http://dx.doi.org/10.1074/ mcp.M112.019620 6.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Chem 2011; 83(23):8919 –27; PMID:22017162; http://dx.doi.org/ 10.1021/ac201293m 7.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2013; 85(9):4239 –46; PMID:23551206; http://dx.doi.org/10.1021/ac303525n 8.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2014Mar 18; 86(6):3005 –12; PMID:24588056; http://dx.doi.org/10.1021/ ac4036857 9.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
1997; 6(11):2446 –53; PMID:9385647; http://dx.doi.org/10.1002/ pro.5560061118 10.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
2003; 75(21):5817 –24; PMID:14588022; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
2003; 376(7):952 –65; PMID:12830354; http://dx.doi.org/10.1007/s00216-003-2057-0 12.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
2007; 26(5):672 –82; PMID:17492750; http://dx.doi.org/ 10.1002/mas.20142 13.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
2001; 12:1044 –49; http://dx.doi.org/10.1016/S1044-0305(01)00289-6 14.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2011; 83(12):4829 –37; PMID:21526855; http://dx.doi.org/10.1021/ac200493c 16.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
"Anal Chem 2010; 82(8):3283 –92; PMID:20329751; http://dx.doi.org/10.1021/ac1000515 1 8 .A y o u bD ,J a b sW ,R e s e m a n nA ,E v e r sW ,E v a n sC ,M a i nL , Baessmann C, Wagner-Rousset E, Suckau D, Beck A.",OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
"MAbs 2013; 5(5):699 –710; PMID:23924801; http://dx.doi.org/10.4161/ mabs.25423 19. von Pawel-Rammingen U, Johansson BP, Bj €orck L. IdeS, a novel streptococcal cysteine proteinase with unique speci ﬁcity for immuno- globulin G. EMBO J.",Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
2014; 6(4):879 –93; PMID:24927271; http://dx.doi.org/10.4161/mabs.28762 21.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2008; 80(5):1737 –45; PMID:18225864; http://dx.doi.org/ 10.1021/ac7021234 23.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Ann N Y Acad Sci 2009; 1173:664 –9; PMID:19758213; http://dx.doi.org/10.1111/j.1749-6632.2009.04739.x 24.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
MAbs 2009; 1(3):254 –67; PMID:20065649; http://dx.doi.org/ 10.4161/mabs.1.3.8035 25.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
MAbs 2011; 3(2):107 –10; PMID:21285536; http://dx.doi.org/ 10.4161/mabs.3.2.14785 27.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
GeochimCosmochim Acta 1984; 48(12):625 –39; http://dx.doi.org/10.1016/ 0016-7037(84)90091-7 28.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 1993; 65 (4):496 –7; http://dx.doi.org/10.1021/ac00052a030 29.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
J Am Soc Mass Spectrom 1995; 6(4):229 –33; PMID:24214167; http://dx.doi.org/10.1016/1044-0305 (95)00017-8 30.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Rapid Commun Mass Spectrom 2004; 18(18):2093 –2105; PMID:23857929; http://dx.doi.org/10.1002/rcm.1589 32.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2014; 86(5):2451 –7; PMID:24512348; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 1998; 70(20):4410 –6; PMID:9796424; http://dx.doi.org/10.1021/ac980034d 35.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2008; 80(5):1459 –67; PMID:18229893; http://dx.doi.org/10.1021/ac7018409 36.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Proteomics 2014; 14(10):1130 –40; PMID:24644084; http://dx.doi.org/10.1002/ pmic.201300438 37.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Rapid Commun MassSpectrom 2013; 27(16):1837 –46; PMID:23857929; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Chem 2014; 86(19):9945 –53; PMID:25207962; http://dx.doi.org/10.1021/ac502766n 40.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Anal Bioanal Chem 2013; 405(26):8505 –14; PMID:23934349; http://dx.doi.org/10.1007/ s00216-013-7267-5 41.,Non-OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
"Ma M, Chen R, Ge Y, He H, Marshall AG, Li L. Combining bottom- up and top-down mass spectrometric strategies for de novo sequenc- ing of the crustacean hyperglycemic hormone from Cancer borealis.Anal Chem 2009; 81(1):240 –7; PMID:19046072; http://dx.doi.org/ 10.1021/ac801910g 42.",OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
Mol Cell Proteomics 2015; 14(7):2014 –29; PMID:25991688; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
"http://physics.nist.gov/Comp 2003, June 25, 2001, National Institute of Standards and Technology, Gaithersburg, MD, Vols.",OADS,/arxiv_data1/oa_pdf/5f/82/kmab-08-02-1128607.PMC4966597.pdf
"2, 205 –215 http://dx.doi.org/10.1080/19420862.2015.1117719",Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Trends Pharmacol Sci 2009;30:356 –62; PMID:19552968; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
BioDrugs 2010; 24:9 –21; PMID:20055529; http://dx.doi.org/10.2165/11530550-000000000-00000 3.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Pharm Sci 2009; 98:1223 –45; PMID:18661536; http://dx.doi.org/10.1002/jps.21504 4.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs 2011; 3:568 –76; PMID:22123061; http://dx.doi.org/10.4161/mabs.3.6.17922 5.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Pharm Sci 2014; 103:1613 –27; PMID:24740840; http://dx.doi.org/10.1002/jps.23975 6.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Annu Rev Genomics Hum Genet 2012; 13:307 –35;PMID:22970722; http://dx.doi.org/10.1146/annurev-genom-090711- 163739 8.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Semin Immuno- pathol 2012; 34:443 –53; PMID:22437760; http://dx.doi.org/10.1007/ s00281-012-0308-x 12.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs 2012; 4:419 –25; PMID:22699226; http://dx.doi.org/10.4161/mabs.20996 15.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Glycoconj J 2000; 17:465 –83; PMID:11421343; http://dx.doi.org/10.1023/A:1011010206774 16.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Glycobiology 2003; 13:1R –16R; PMID:12634319; http://dx.doi.org/10.1093/glycob/ cwg007 18.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Annu Rev Physiol 2008; 70:431 –57; PMID:17850209; http://dx.doi.org/10.1146/annurev.phys iol.70.113006.100659 19.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Glycobiology 2009; 19:936 –49; PMID:19494347; http://dx.doi.org/10.1093/glycob/cwp079 20.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Nat Rev Genet 2003; 4:794 –805; PMID:14526375; http://dx.doi.org/10.1038/nrg1177 21.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Comp Immunol Microbiol Infect Dis 2009; 32:107 –21; PMID:18243312; http://dx.doi.org/10.1016/j.cimid.2007.11.005 22.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J MassSpectrom 2015; 50:285 –97; PMID:25800010; http://dx.doi.org/ 10.1002/jms.3554 23.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Approval of the ﬁrst biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry.MAbs 2013; 5:621 –3; PMID:23924791; http://dx.doi.org/10.4161/ mabs.25864 24.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Chem 2013; 85:715 –36; PMID:23134362; http://dx.doi.org/ 10.1021/ac3032355 25.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Biotechnol J 2012; 7:1462 –72; PMID:22829536; http://dx.doi.org/ 10.1002/biot.201200078 26.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
TrAC Trends Analyt Chem 2015; 73:1 –9; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Mass Spectrom Rev 2009;28:147 –76; PMID:18720354; http://dx.doi.org/10.1002/mas.20190 28.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs 2010; 2:379 –94; PMID:20458189; http://dx.doi.org/10.4161/ mabs.11986 29.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs 2013; 5:699 –710; PMID:23924801; http://dx.doi.org/10.4161/mabs.25423 30.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
"Xu CF, Zang L, Weiskopf A. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additivefor direct characterization of size variants of monoclonal antibodies.J Chromatogr B Analyt Technol Biomed Life Sci 2014; 960:230 –8; PMID:24835510; http://dx.doi.org/10.1016/j.jchromb.2014.04.023 31.",OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
"Brady LJ, Valliere-Douglass J, Martinez T, Balland A. Molecular mass analysis of antibodies by on-line SEC-MS. J Am Soc Mass Spec- trom 2008; 19:502 –9; PMID:18258452; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
"Harazono A, Hashii N, Kuribayashi R, Nakazawa S, Kawasaki N. Mass spectrometric glycoform pro ﬁling of the innovator and biosi- milar erythropoietin and darbepoetin by LC/ESI-MS. J Pharm Biomed Anal 2013; 83:65 –74; PMID:23708432; http://dx.doi.org/ 10.1016/j.jpba.2013.04.031 34.",OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs 2013; 5:917 –24; PMID:23995615; http://dx.doi.org/10.4161/mabs.26282 36.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Chem Commun (Camb) 2013; 49:538 –48; PMID:23183499; http://dx.doi.org/10.1039/C2CC36755F 37.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Physicochemical characterization of Remsima.MAbs 2014; 6:1163 –77; PMID:25517302; http://dx.doi.org/10.4161/ mabs.32221 38.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs2010; 2:212 –20; PMID:20400859; http://dx.doi.org/10.4161/ mabs.2.3.11780 40.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Methods Mol Biol 2013; 988:93 –113; PMID:23475716; http://dx.doi.org/10.1007/978-1- 62703-327-5_7 41.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Electrophoresis 2014;35:96 –108; PMID:24123141; http://dx.doi.org/10.1002/ elps.20130037242.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Chem 2013; 85:2289 –96; PMID:23323765; http://dx.doi.org/10.1021/ac303158f 43.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Chem 2009; 81:8900 –7; PMID:19817480; http://dx.doi.org/10.1021/ac901506p 44.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Pharm Biomed Anal 2015; 114:53 –61; PMID:26025812; http://dx.doi.org/10.1016/j.jpba.2015.04.037 47.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Biologicals 2013; 41:131 –47; PMID:23146362; http://dx.doi.org/ 10.1016/j.biologicals.2012.10.001 49.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Pharm Biomed Anal 2011; 55:810 –22; PMID:21334842; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Chromatogr A 2011; 1218:8140 –9; PMID:21978954; http://dx.doi.org/10.1016/j.chroma.2011.08.089 51.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Chromatogr A2014; 1371:136 –45; PMID:25456591; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Chem 2014; 86:576 –84; PMID:24308717; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Nat Protoc 2012; 7:1285 – 98; PMID:22678432; http://dx.doi.org/10.1038/ nprot.2012.062 55.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J SepSci 2012; 35:2341 –72; PMID:22997027; http://dx.doi.org/10.1002/ jssc.201200434 56.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Mol Cell Proteomics 2013; 12:893 –901; PMID:23389047; http://dx.doi.org/10.1074/mcp.R112.026567 57.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Bioanal Chem 2012; 403:1291 – 302; PMID:21647803; http://dx.doi.org/10.1007/s00216-011-5109-xMABS 213,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Biochem 2013; 432:82 –9; PMID:23026777; http://dx.doi.org/10.1016/j.ab.2012.09.032 59.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Glycobiology 2012; 22:662 – 75; PMID:22241827; http://dx.doi.org/10.1093/glycob/cws002 60.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs 2015; 7:732 –42; PMID:25996192; http://dx.doi.org/10.1080/19420862.2015.1045173 61.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
AnalChem 2010; 82:6154 –62; PMID:20552988; http://dx.doi.org/ 10.1021/ac100956x 63.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
MAbs 2013; 5:479 –90; PMID:23563524; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Mol Cell Proteomics 2010; 9:719 –27; PMID:20038609; http://dx.doi.org/10.1074/mcp.M900450-MCP200 66.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Proteomics 2015; 127:225 –33; PMID:25907685; http://dx.doi.org/10.1016/j.jprot.2015.04.012 67.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Nat Chem Biol 2010; 6:713 –23; PMID:20852609; http://dx.doi.org/10.1038/ nchembio.437 68.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Chem 2014; 86:5784 –93; PMID:24831253; http://dx.doi.org/10.1021/ ac500335t 69.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Bioanal Chem 2010; 397:3457 –81; PMID:20225063; http://dx.doi.org/10.1007/s00216-010-3532-z 70.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Anal Biochem 2015; 486:38 –40; PMID:26079702; http://dx.doi.org/ 10.1016/j.ab.2015.06.006 71.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Pharm Sci 2014; 103:1967 –78; PMID:24840237; http://dx.doi.org/10.1002/jps.24004 73.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Chromatogr A 2011; 1218:118 –23; PMID:21122866; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Proteomics 2011; 11:631 –43; PMID:21241022; http://dx.doi.org/ 10.1002/pmic.201000517 75.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:1827 –32; PMID:19482525; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Electrophoresis 1996; 17:412 –7; PMID:8900952; http://dx.doi.org/10.1002/elps.1150170221 79.,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
Electrophoresis 2005; 26:2034 –46; PMID:15841499; http://dx.doi.org/10.1002/elps.200410345 81.,OADS,/arxiv_data1/oa_pdf/8c/4c/kmab-08-02-1117719.PMC4966609.pdf
